<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        18-887-17
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ELTROXIN 0.05MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LEVOTHYROXINE SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Tablet Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ASPEN Bad Oldesloe GmbH" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ASPEN Bad Oldesloe GmbH
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ASPEN PHARMA TRADING LIMITED (APTL)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        H03AA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>1. What Eltroxin 50 is and what it is used for</strong><br />Eltroxin 50 contains 50 micrograms of levothyroxine sodium, a synthetic thyroid hormone.</p><p>Eltroxin 50 is used:<br />- for replacement therapy (substitution) for the missing hormone in all forms of hypothyroidism (underactive thyroid).<br />- to prevent the return of new goitres (swelling of the neck due to enlargement of the malfunctioning thyroid gland) after goitre surgery in patients with normal thyroid function.<br />- to treat non-cancerous (benign) goitre in patients with normal thyroid function.<br />- as add-on therapy in the antithyroid treatment (to achieve stable thyroid function) of an overactive thyroid (hyperthyroidism), after normal metabolic status has been reached.<br />- treatment to suppress new tumour growth and as replacement therapy in thyroid cancer, especially after surgical removal of the thyroid gland</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>2. What you need to know before you take Eltroxin 50</strong><br />&nbsp;</p><p><strong>Do not take Eltroxin 50</strong><br />- if you are allergic to the active substance levothyroxine or any of the other ingredients of this medicine (listed in section 6).<br />- if you have any type of untreated hyperthyroidism (overactive thyroid).</p><p>- in certain heart diseases (e.g. recent heart attack, acute inflammation of the heart muscle or inflammation of the heart as a whole) and in patients with untreated poor adrenal cortex function or untreated poor pituitary gland function, unless specifically permitted by your doctor.<br />Eltroxin 50 must not be taken during pregnancy at the same time as medicines for an overactive thyroid (antithyroid agents) (see also under section: &ldquo;Pregnancy and breast-feeding&rdquo;).<br /><strong>Caution is required when using Eltroxin 50 in the following cases:</strong></p><p>- Do not use Eltroxin 50 to treat obesity or for weight reduction. High doses can lead to serious or even life-threatening side effects. Tell your doctor if you are taking any medicines for weight reduction, e.g. orlistat. - Contact your doctor if you have any side effects (see list in section 4).<br />- If you have any heart condition (e.g. coronary heart disease, angina pectoris).<br />- If you have high blood pressure.<br />- If you have problems associated with your pituitary gland.<br />- If you have problems associated with your adrenal cortex.<br />- If you have diabetes<br />- If you have myxoedema (an adult disease caused by reduced thyroid activity, characterised by symptoms including dry skin, swelling of the lip and nose area, and mood changes).<br />- If you have malabsorption syndrome (a disorder where the bowel&rsquo;s ability to absorb certain nutrients is impaired).<br />- If you are pregnant (levothyroxine hormone levels are subject to fluctuations during pregnancy and your doctor may frequently monitor your thyroid function). - If you have any areas in your thyroid gland that produce uncontrolled amounts of thyroid hormone (thyroid autonomy).<br />- If you have gone through the menopause. Due to the risk of osteoporosis, regular monitoring of thyroid function may be necessary.<br />If any of the above points apply to you, you must talk to your doctor or pharmacist before taking Eltroxin 50.</p><p><strong>Elderly people</strong><br />Careful dosing and frequent medical check-ups are necessary in elderly patients.</p><p><br /><strong>Other medicines and Eltroxin 50</strong><br />Tell your doctor or pharmacist if you are taking/using, have recently taken/used or might take/use any other medicines.<br />The following medicines may affect the absorption of Eltroxin 50<br />- cholestyramine or colestipol (medicines used to lower blood lipids)<br />- antacids containing aluminium, magnesium, calcium or iron (medicines to neutralise stomach acid)<br />- polystyrene sulphonate, lanthanum, ion exchange resins, e.g. kayexalate, sevelamer (used to treat kidney failure)<br />- sucralfate (used to treat stomach ulcers)<br />- proton-pump inhibitors, e.g. omeprazole and pantoprazole (used to reduce stomach acid production)<br />- medicines for weight reduction, such as orlistat<br />You should leave as long an interval as possible between taking Eltroxin 50 and any of the above-mentioned medicines, in order to avoid interactions in the stomach or small intestine.<br />The following medicines may affect how Eltroxin 50 works<br />- propylthiouracil (an antithyroid agent)<br />- glucocorticoids (corticosteroids for the treatment of inflammation and allergic reactions)<br />- beta-blockers (medicines for high blood pressure)<br />- medicines containing lithium</p><p>- iodide and contrast media containing iodine<br />- amiodarone (medicine used to treat heart rhythm disorders)<br />- carbamazepine and phenytoin (used to treat epilepsy)<br />- rifampicin (used to treat infections)<br />- barbiturates (certain sleeping pills)<br />- methadone (a narcotic)<br />- tamoxifen and 5-fluorouracil (medicines used to treat tumours)<br />- imatinib and sunitinib (medicines used to treat chronic myeloid leukaemia)<br />- sertraline (an antidepressant)<br />- chloroquine/proguanil (medicines used in malaria and rheumatic disease)<br />- hormonal contraceptives (the &ldquo;Pill&rdquo;) or hormone replacement therapy after the menopause<br />- cholesterol synthesis inhibitors (statins such as simvastatin and lovastatin)<br />- salicylates (medicines for fever and pain)<br />- dicoumarol (a blood-thinner)<br />- furosemide (a diuretic)<br />- clofibrate (medicine used to lower high blood lipid levels)<br />- ritonavir &ndash; used to control HIV and chronic hepatitis C<br />Some medicines can have an effect on thyroid function tests. This should be taken into account when monitoring patients receiving levothyroxine.</p><p><br /><strong>How the following medicines work can be affected by Eltroxin 50</strong><br />- insulin and antidiabetic agents (used to treat diabetes mellitus). Levothyroxine can reduce the blood sugar-lowering effect of antidiabetic agents. In patients with diabetes, blood sugar levels must therefore be regularly monitored, especially at the start of thyroid hormone treatment and the antidiabetic dosage must be adjusted as necessary.<br />- blood thinners (coumarin derivatives, used to prevent blood clots).<br />Levothyroxine may increase the effect of certain blood thinners (coumarin derivatives). During combined treatment with these medicines and levothyroxine, your doctor will monitor your blood clotting levels, especially at the start of treatment and will adjust the blood-thinner dosage as necessary.<br />- cardiac glycosides (used to treat heart failure)<br />- phenytoin (used to treat epilepsy)<br />- medicines that affect the autonomic nervous system (sympathomimetic agents)<br />- tricyclic antidepressants (used to treat depression)</p><p><br /><strong>If you are using the following medicines, please tell your doctor, as these medicines could falsify laboratory tests, which in turn may lead to unreliable test results</strong><br />- androgens and anabolic steroids (for hormone replacement therapy)<br />- anti-inflammatories such as aspirin and phenylbutazone</p><p><br /><strong>Eltroxin 50 with food and drink</strong><br />Soya products and a high-fibre diet may reduce the absorption of levothyroxine from the gut. It may become necessary to adjust the dose of Eltroxin 50, especially at the start and upon completion of a diet containing soya.</p><p><br /><strong>Pregnancy, breast-feeding and fertility</strong><br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.<br /><u><strong>Pregnancy</strong></u><br />Thyroxine has been taken by a large number of pregnant women and women of childbearing age, without any disturbances in the reproductive process having been observed. However, an overactive or underactive thyroid in the mother may negatively affect the course of pregnancy or the well-being of the child.<br />Consistent replacement therapy with thyroid hormones is particularly important during pregnancy and breast-feeding and must therefore be continued. To date, there have been no reports of any risk to unborn infants, despite extensive use during pregnancy.</p><p>During pregnancy, levothyroxine requirements may increase in patients with hypothyroidism (underactive thyroid), due to increased blood levels of oestrogen (female sex hormone). Thyroid function should therefore be monitored both during and after pregnancy and the thyroid hormone dose adjusted as necessary.</p><p><br />However, Eltroxin 50 must not be taken during pregnancy at the same time as medicines for an overactive thyroid (antithyroid agents), as a higher antithyroid dosage would be required. Antithyroid agents can (unlike levothyroxine) get into the child&rsquo;s blood circulation via the placenta and are capable of causing an underactive thyroid in the unborn child. Therefore, treatment of hyperthyroidism (overactive thyroid) during pregnancy should only be performed with low-dose antithyroid medicines.</p><p><br />No thyroid suppression tests should be performed during pregnancy.</p><p>Blood pressure is regularly monitored when treatment with levothyroxine is started in premature babies with a very low birth weight, as a rapid fall in blood pressure (circulatory collapse) can occur.</p><p><strong><u>Breast-feeding</u></strong><br />Eltroxin 50 is excreted in breast milk at low concentrations. If you are breast-feeding, ask your doctor for advice before taking Eltroxin 50.<br />&nbsp;</p><p><u><strong>Driving and using machines</strong></u><br />There is no available information on the ability to drive and use machines during the use of Eltroxin 50. Ask your doctor for advice before taking Eltroxin 50.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>3. How to take Eltroxin 50</strong><br />Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>The following information applies, unless you have been prescribed Eltroxin 50 differently by your doctor. Please always follow the directions for use, as Eltroxin 50 may otherwise not work properly.</p><p>Eltroxin 50 contains 50 micrograms of levothyroxine sodium; for individual treatment, Eltroxin 100 is also available, containing 100 micrograms of levothyroxine sodium per tablet. In children, it may be necessary to switch to products with other dose strengths.</p><p><br />The individual daily dose should be determined by laboratory diagnostic and clinical tests. In elderly patients, in patients with coronary heart disease and in patients with severe or long-term hypothyroidism (underactive thyroid), treatment with thyroid hormones must be started with particular care. This means selecting a lower starting dose, which is then increased slowly and at longer intervals with frequent monitoring of thyroid hormones. Experience has shown that a lower dose is sufficient even in patients with low body weight or with a large nodular goitre.</p><p><br />Unless otherwise prescribed, the following dosage guidelines apply:</p><p>For hypothyroidism (underactive thyroid), adults initially take 1 to 2 Eltroxin 50 tablets every other day or daily (equivalent to 50 - 100 micrograms of levothyroxine sodium) and increase the dose as instructed by their doctor at four- to six-weekly intervals, up to a daily dose of 100 - 200 micrograms of levothyroxine sodium).</p><p><br />To prevent the return of new goitres after goitre surgery and to treat benign goitre, 1 to 4 Eltroxin 50 tablets (equivalent to 50 - 200 micrograms of levothyroxine sodium) are taken daily.</p><p><br />As add-on therapy in antithyroid treatment of an overactive thyroid (hyperthyroidism), 1 to 2 Eltroxin 50 tablets (equivalent to 50 - 100 micrograms of levothyroxine sodium) are taken daily.</p><p><br />In long-term treatment, a switch to a dosage form with a higher active substance level is recommended, if required.</p><p>After thyroid surgery for a malignant thyroid tumour, the daily dose is 3 to 6 Eltroxin 50 tablets (equivalent to 150 - 300 micrograms of levothyroxine sodium).</p><p><br /><strong>Elderly people and patients with heart disease</strong><br />If you are elderly or have cardiovascular disease or suffer from severe or chronic hypothyroidism (underactive thyroid), your doctor may choose a lower starting dose, which will then be increased slowly and at longer intervals with frequent thyroid hormone tests. In patients over 50 years of age, the starting dose will usually not exceed 50 micrograms and the recommended starting dose of Eltroxin 50 in patients with heart disease is 50 micrograms every other day.</p><p><strong>Use in children<br />Children under 12 years:</strong><br />The dose for children depends on age, body weight and the condition to be treated.<br />To ensure that your child receives the correct dose, he/she will be monitored. Give this medicine to your child at least half an hour before the first daily meal.</p><p><br /><strong>Congenital hypothyroidism (underactive thyroid) in infants:</strong><br />For the first 3 months, the starting dose is 10 to 15 micrograms/kg body weight per day. The dose will then be adjusted by your doctor, depending on the response to treatment.</p><p><strong>Acquired hypothyroidism (underactive thyroid) in children:</strong><br />The starting dose is 12.5 to 50 micrograms per day. The dose should be increased gradually, every 2 to 4 weeks, depending on the response to treatment.<br />If necessary, the tablets can be dissolved in 10 to 15 mL water and taken immediately afterwards with a little more liquid (5 to 10 mL).</p><p>When stopping treatment, Eltroxin 50 should be discontinued gradually and under the supervision of your doctor.</p><p><strong>Method of administration</strong><br />The total daily dose is taken whole in the morning with some liquid, on an empty stomach at least half an hour before breakfast.</p><p>To make them easier to swallow, the tablets can be divided into equal doses. Due to a lack of data, it is not recommended to crush Eltroxin 50 tablets.</p><p><strong>Duration of treatment</strong><br />The duration of use depends on your doctor&rsquo;s instructions.<br />- For hypothyroidism (underactive thyroid) and after thyroid surgery for thyroid cancer, treatment is usually life-long.<br />- For treatment of a benign goitre and to prevent new goitre growth, treatment lasts a few months or years and may even be life-long.<br />- As add-on therapy to treat hyperthyroidism (overactive thyroid): depending on the duration of antithyroid medication. If treatment with Eltroxin 50 has not produced the desired response within this time, other treatment options may be considered by your doctor.</p><p><strong>If you take more Eltroxin 50 than you should</strong><br />In the presence of an overdose (intentional or accidental overdose), the typical signs of hyperthyroidism (overactive thyroid) may occur:<br />Palpitations, heart rhythm disorders (irregular heartbeat), angina pectoris (chest pain), muscle weakness and muscle cramps, hot flushes, excessive sweating, mydriasis (dilated pupils), fever, tremor (shaky hands), inner restlessness, excitability, insomnia, weight loss, vomiting, diarrhoea, menstrual disorders, headache, increased brain pressure, as well as agitation (excitation), confusion, irritability, hyperactivity, increased intestinal activity and intestinal spasms. The clinical manifestations may be delayed for up to five days. Thyrotoxic crisis may rarely occur after a chronic overdose, leading to irregular heartbeat, heart failure and coma.</p><p>Please consult your doctor if such symptoms occur.</p><p><strong>If you forget to take Eltroxin 50</strong><br />If you have not taken enough tablets or if you have missed a dose, make up for the missed dose as soon as you remember. However, if it is almost time for your next dose, do not make up for the missed dose; just keep taking your medicine at the specified times. Do not take a double dose at any one time. The treatment specified by the doctor must never be changed or ended without consultation with your doctor.<br /><strong>If you stop taking Eltroxin 50</strong><br />For treatment to be successful, Eltroxin 50 must be taken regularly at the prescribed dosage. If treatment is interrupted or ended too soon, symptoms of illness may therefore return, the nature of which will depend on the underlying disease in each case.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>4. Possible side effects</strong><br />Like all medicines, Eltroxin 50 can cause side effects, although not everybody gets them. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p><p><br />With proper use, no side effects are to be expected during treatment with Eltroxin 50. If the dose strength is not tolerated in individual cases or if an overdose occurs, symptoms like those occurring in hyperthyroidism (overactive thyroid) may occur, particularly if the dose is increased too quickly at the start of treatment.</p><p><br />See also under section 3. &ldquo;If you take more Eltroxin 50 than you should&rdquo;.<br />&nbsp;</p><p><strong>Stop taking Eltroxin 50 and tell your doctor or go immediately to the nearest location where you can get medical attention.</strong></p><p><strong>An allergic reaction: Signs of an allergic reaction may include:</strong> shortness of breath, rash and itching, hot flushes.</p><p>Other serious side effects:<br />- Chest tightness<br />- Heart rhythm disorders (irregular heartbeat)<br />- Palpitations (uncomfortable feeling when the heart beats too fast or too hard)<br />- Heart failure<br />- Heart attack<br />- A harmless increase in brain pressure has been reported, especially in children.<br />- An overdose may lead to premature craniosynostosis (fusion of the skull sutures) in infants and reduced height in children.</p><p>If you notice any of these symptoms, stop taking Eltroxin 50 and go immediately to the nearest location where you can get medical attention:</p><p>Other side effects that may occur:<br />- Faster heartbeat, increased blood pressure<br />- Seizures (spasms, fits)<br />- Reduced bone density (weaker and brittle bones)<br />- Tremor (shaky hands)<br />- Headache<br />- Anxiety, emotional lability, nervousness<br />- Excitability, insomnia (sleeplessness), inner restlessness<br />- Muscle weakness and cramps<br />- Abdominal cramps, nausea, vomiting, diarrhoea<br />- Increased appetite, severe weight loss<br />- Fever (increased body temperature) or heavy sweating<br />- Fatigue (exhaustion, tiredness)<br />- Hair loss<br />- Feeling hot<br />- Menstrual disorders affecting monthly periods, reduced fertility</p><p><strong>What to do in case of side effects</strong><br />After consultation with the treating doctor, the daily dose may be reduced or tablet-taking may be stopped for several days. Once the side effect has worn off, treatment can be restarted with careful dosing.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>5. How to store Eltroxin 50</strong><br />Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is stated on the pack. The expiry date refers to the last day of that month.<br />Store Below 25&deg;C.<br />Keep tablets in the tightly sealed multidose container in order to protect from light and moisture.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>a. What Eltroxin 50 contains</strong><br />- The active substance is:<br />Levothyroxine sodium.</p><p>1 tablet contains 53.2 to 56.8 micrograms of levothyroxine sodium x H2O (equivalent to 50 micrograms of levothyroxine sodium).</p><p>- The other ingredients are:<br />Microcrystalline cellulose, pregelatinised starch (maize starch 1500), magnesium stearate (Ph.Eur.), talc, colloidal anhydrous silica.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                b. What Eltroxin 50 looks like and contents of the pack
Eltroxin 50 are white to almost white, round, biconvex tablets. They bear the impression “GS 11E” on one side of the tablet and “50” on the other side.
Eltroxin 50 is available in packs of 100 tablets [N3] for oral use.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder:</strong><br />Aspen Pharma Trading Limited<br />3016 Lake Drive<br />Citywest Business Campus<br />Dublin 24, Ireland</p><p><strong>Manufacturer:</strong><br />Aspen Bad Oldesloe GmbH<br />Industriestrasse 32-36<br />23843 Bad Oldesloe<br />Germany</p><p><strong>Packaged by:</strong><br />AJA Pharmaceutical Industries Co LTD<br />55414 Hail Industrial City<br />Hail, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in {September/2023}; version number {005}
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><strong>&nbsp;ما هو إلتروكسين 50 وما هي دواعي استخدامه</strong><br />.يحتوي إلتروكسين 50 على 50 ميكروغرام من صوديوم الليفوثيروكسين، وهو هرمون غدة درقية اصطناعي</p><p><br />يُستخدم إلتروكسين 50&nbsp;<br />.(للعلاج البديل (تعويض) للهرمون المفقود في جمع أشكال قصور الدرقية(خمول الغدة الدرقية-<br />للوقاية من معاودة الإصابة بتضخمات جديدة في الغدة الدرقية(تورم العنق بسبب تضخم الغدة الدرقية التي بها الخلل) بعد -<br />.جراحة تضخم الغدة الدرقية لدى المرضى ذوي الوظائف الدرقية الطبيعية<br />.علاج تضخم الغدة الدرقية غير السرطاني (الحميد) في المرضى ذوي الوظائف الدرقية الطبيعية -<br />كعلاج إضافي في العلاج مضاد الدرقية(لتحقيق استقرار الوظائف الدرقية) للغدة الدرقية مفرطة النشاط (فرط الدرقية)، بعد -<br />.الوصول إلى وضع أيضي طبيعي<br />العلاج لكبت نمو أورام جديدة وكعلاج بديل في حالة الإصابة بسرطان الدرقية، خاصة بعد إزالة الغدة الدرقية جراحيا -</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>ما الذي يجب أن تعرفه قبل تناول إلتروكسين 50</strong></p><p><br />لا تتناول إلتروكسين 50</p><p><br />.( إذا كنت مصابا بحساسية للمادة الفعالة الليفوثيروكسين أو لأي من مكونات هذا الدواء الأخرى (المذكورة في القسم 6-<br />.(إذا كنت مصابا بأي نوع من فرط الدرقية غير المعالجة (فرط نشاط الغدة الدرقية-<br />في بعض أمراض القلب ( على سبيل المثال، أزمة قلبية حديثة، التهاب حاد في عضلات القلب أو التهاب القلب ككل )، وفي-<br />المرضى المصابين بضعف وظائف القشرة الكظرية غير المعالج أو ضعف وظائف الغدة النخامية غير المعالج، ما لم يكن<br />.طبيبك سمح بذلك على وجه التحديد<br />يجب عدم تناول إلتروكسين 50 خلال فترة الحمل بالتزامن مع أدوية فرط نشاط الغدة الدرقية (عوامل مضادة للدرقية) (انظر أيضا<br />.(&#39;القسم بعنوان: &quot;الحمل والرضاعة الطبيعية</p><p>:يرجى توخي الحذر عند استخدام إلتروكسين 50 في الحالات التالية<br />لا تستخدم إلتروكسين 50 لعلاج السمنة أو لإنقاص الوزن. فقد تؤدي الجرعات المرتفعة إلى ظهور آثار جانبية خطيرة أو-<br />.حتى مهددة للحياة. اخبر طبيبك إذا كنت تتناول أي أدوية أخرى لخفض الوزن، على سبيل المثال أورليستات<br />.(اتصل بطبيبك إذا ظهرت عليك أي آثار جانبية (انظر القائمة في القسم 4-<br />.(إذا كنت مصابا بأي حالة قلبية (على سبيل المثال، مرض في الشريان التاجي، ذبحة صدرية-<br />. إذا كنت مصابا بارتفاع ضغط الدم-<br />.إذا كنت تعاني من مشكلات متعلقة بالغدة النخامية-<br />.إذا كنت تعاني من مشكلات متعلقة بقشرة الغدة الكظرية-<br />&nbsp;.إذا كنت مصابا بداء السكري-<br />إذا كنت مصابا بالوذمة المخاطية (مرض يصيب البالغين بسبب انخفاض نشاط الغدة الدرقية، ويتسم بأعراض تتضمن جفاف-<br />.(البشرة، وتورم منطقة الشفاه والأنف، وتغيرات في الحالة المزاجية<br />.(إذا كنت مصابا بمتلازمة سوء الامتصاص (اضطراب يتضمن ضعف قدرة الأمعاء على امتصاص بعض العناصر الغذائية-<br /><strong>إذا كنتِ حاملاً(تتعرض مستويات هرمون الليفوثيروكسين إلى التقلب خلال فترة الحمل وربما يتابع طبيبك وظائف الغدة</strong>-<br /><strong>.(الدرقية لديكِ بشكل متكرر<br />.(إذا كان لديك أي أجزاء في الغدة الدرقية تنتج كميات غير منضبطة من هرمون الغدة الدرقية (الاستقلال الدرقي-</strong><br />إذا مررتِ بفترة انقطاع الطمث. نظرا لاحتمال التعرض لهشاشة العظام، قد يكون من الضروري قياس وظائف الغدة الدرقية-<br />.بشكل منتظم</p><p>ذا كان أي من النقاط السابقة ينطبق عليك، تحدث مع طبيبك أو الصيدلي قبل تناول إلتروكسين 50</p><p><br /><strong>الأشخاص المسنون</strong><br />.من الضروري تقديم جرعات دقيقة وإجراء فحوصات طبية متكررة للأشخاص المسنين</p><p><br /><strong>الأدوية الأخرى وإلتروكسين 50</strong><br />.أخبر طبيبك أو الصيدلي إن كنت تتناول أو تستخدم أو تناولت أو استخدمت مؤخرا أو قد تتناول أو تستخدم أي أدوية أخرى</p><p><br />قد تؤثر الأدوية التالية على امتصاص إلتروكسين 50<br />.(كوليستيرامين أو كوليستيبول(أدوية تستخدم في خفض شحوم الدم-<br />.(مضادات الحموضة التي تحتوي على ألمونيوم، أو ماغنسيوم، أو كالسيوم، أو حديد(أدوية تستخدم في تحييد أحماض المعدة-<br />سلفونات البوليستيرين، ولانثانوم، وراتنجات التبادل الأيوني، على سبيل المثال كايكسالات، سيفيلامير (تُستخدم في علاج-<br />.(الفشل الكلوي<br />.(سكرالفات(يستخدم في علاج قرح المعدة-<br />.(مثبطات مضخة البروتون، على سبيل المثال أوميبرازول وبانتوبرازول (تُستخدم للحد من إنتاج أحماض المعدة-<br />أدوية إنقاص الوزن، مثل أورليستات-</p><p><br />يجب عليك ترك أطول مسافة ممكنة بين تناول إلتروكسين 50 وأي من الأدوية السابق -ذكرها، وذلك لتجنب حدوث التفاعلات في<br />:المعدة أو الأمعاء الدقيقة</p><p>قد تؤثر الأدوية التالية على فعالية إلتروكسين 50<br />(بروبيل ثيوراسيل (عامل مضاد للدرقية-<br />(القشرانيات السكرية(الستيرويدات القشرية التي تستخدم في علاج الالتهابات والحساسية-<br />(حاصرات بيتا(أدوية لعلاج ارتفاع ضغط الدم-<br />&nbsp;الأدوية التي تحتوي على الليثيوم-<br />.اليوديد ووسط تبايني يحتوي على اليود -<br />(أميودارون (دواء يُستخدم في علاج اضطرابات نَظْم القلب-<br />(كربامازيبين وفينيتوين (يستخدمان في علاج الصرع-<br />(ريفامبيسين (يستخدم في علاج الالتهابات-<br />(الباربتيورات(أدوية نوم محددة-<br />( ميثادون (مخدر-<br />(تاموكسيفين و 5 فلورويوراسيل (يُستخدمان في علاج الأورام-<br />(إيماتينب وسونيتنب (يُستخدمان لعلاج إبيضاض الدم النقوي المزمن-<br />(سيرترالين (مضاد للاكتئاب-<br />(كلوروكوين/بروغوانيل(يُسخدمان في علاج الملاريا والأمراض الروماتزمية-<br />.موانع الحمل الهرمونية (&quot;الحبة&quot;) أو العلاج بالهرمونات البديلة بعد انقطاع الطمث-<br />(مثبطات تخليق الكوليسترول (مركبات الستاتين مثل سيمفاستاتين ولوفاستاتين-<br />(الساليسيلات (أدوية لعلاج الحمى والألم-</p><p>(ديكومارول )(مرقق للدم-<br />(فوروسيميد (مدر للبول-<br />(كلوفيبرات (دواء يستخدم في خفض مستويات شحوم الدم المرتفعة-<br />ريتونافير - يُستخدم للتحكم في فيروس نقص المناعة البشرية والتهاب الكبد سي المزمن -</p><p><br />قد تؤثر بعض الأدوية على اختبارات وظائف الغدة الدرقية. يجب أخذ هذا في الحسبان عند مراقبة المرضى الذين يتلقون<br />.الليفوثيروكسين</p><p><br />يمكن أن يؤثر إلتروكسين 50 على فعالية الأدوية التالية<br />الأنسولين والعوامل المضادة للسكري (تستخدم في علاج داء السكري). <strong>يمكن أن يؤدي الليفوثيروكسين إلى تقليل تأثير</strong>-<br /><strong>خفض السكر في الدم للعوامل المضادة للسكري. لذلك يجب إخضاع المرضى المصابين بداء السكري إلى المراقبة المنتظمة<br />لفحص مستويات السكر في الدم لديهم، ولا سيما في بداية العلاج بهرمونات الغدة الدرقية، كما يجب تعديل جرعات العوامل<br />.المضادة للسكري إذا لزم الأمر</strong><br />.(مرققات الدم (مشتقات الكومارين، تستخدم في الوقاية من تكون جلطات الدم-<br /><strong>قد يزيد الليفوثيروكسين تأثير بعض مرققات الدم (مشتقات الكومارين). خلال العلاج المشترك بهذه الأدوية<br />والليفوثيروكسين، سيقيس طبيبك مستويات تجلط الدم لديك، خاصة عند بدء العلاج وسيعدل جرعات مرققات الدم حسب<br />.الحاجة</strong><br />(الغليكوزيدات القلبية (تُستخدم في علاج الفشل القلبي-<br />.(فينيتوين (يستخدم لعلاج الصرع-<br />(الأدوية التي تؤثر على الجهاز العصبي التلقائي (العوامل محاكيات الودية-<br />(مضادات الاكتئاب ثلاثية الحلقات (تُستخدم في علاج الاكتئاب-</p><p><br />إذا كنت تستخدم الأدوية التالية، يرجى إخبار طبيبك حيث إن هذه الأدوية قد تؤدي إلى تغيير نتائج اختباراتك المعملية، مما يجعل<br />هذه النتائج لا يعتمد عليها<br />(الستيرويدات الأندروجينية الابتنائية (للعلاج بالهرمونات البديلة-<br />مضادات الالتهابات مثل الأسبرين وفينيل بوتازون-</p><p><br /><strong>إلتروكسين 50 مع الطعام والشراب</strong><br />قد تقلل منتجات الصويا والنظام الغذائي عالي الألياف من امتصاص الليفوثيروكسين في الأمعاء. ربما يصبح من الضروري أن تغير<br />.جرعة إلتروكسين 50 ، وخاصة في بداية وعند الانتهاء من أحد الأنظمة الغذائية التي تحتوي على منتجات الصويا</p><p><strong>الحمل والرضاعة الطبيعية والخصوبة</strong><br />إذا كنتِ حاملا أو ترضعين رضاعة طبيعية، أو تعتقدين أنكِ قد تكونين حاملا أو تخططين للحمل، اطلبي المشورة من طبيبك أو<br />.الصيدلي قبل تناول هذا الدواء</p><p><u>الحمل</u><br />تناول عدد كبير من السيدات الحوامل وسيدات في عمر الإنجاب الثيروكسين، ولم تُلاحظ أي اضطرابات في العملية الإنجابية. إلا أن<br />.فرط النشاط الدرقي أو الخمول الدرقي في الأم قد يؤثر سلبا على مسار الحمل أو على صحة الطفل<br />من الهام المداومة على العلاج بالهرمونات البديلة بهرمونات الغدة الدرقية على الأخص خلال فترة الحمل والرضاعة ولذا يجب<br />.مواصلته. إلى اليوم، لم ترد أي تقارير حول أي مخاطر على الأجنة، رغم الاستخدام المكثف خلال فترة الحمل</p><p><br />خلال فترة الحمل، قد تزداد الجرعات اللازمة من الليفوثيروكسين في المصابات بقصور الدرقية (خمول الغدة الدرقية)، وذلك بسبب<br />ارتفاع مستويات الإستروجين في الدم(هرمون الجنس الأنثوي). لذا يجب مراقبة وظائف الغدة الدرقية خلال فترة الحمل وبعدها<br />.ويجب تعديل جرعة هرمون الغدة الدرقية حسب الحاجة</p><p><br />،(ومع ذلك، يجب عدم تناول إلتروكسين 50 خلال فترة الحمل بالتزامن مع أدوية فرط نشاط الغدة الدرقية(عوامل مضادة للدرقية<br />فسيلزم ذلك زيادة جرعة مضادات الدرقية. قد تصل العوامل المضادة للدرقية (على عكس الليفوثيروكسين) إلى الدورة الدموية للجنين<br />عبر المشيمة، وهي قادرة على التسبب في خمول الغدة الدرقية للجنين. لذا، يجب علاج فرط الدرقية(فرط نشاط الغدة الدرقية) خلال<br />.فترة الحمل بجرعات منخفضة فقط من الأدوية المضادة للدرقية</p><p><br />.يجب الامتناع عن إجراء اختبارات كبت الدرقية خلال فترة الحمل</p><p>تتم مراقبة مستوى ضغط الدم بشكل بانتظام عند بدء العلاج باستخدام ليفوثيروكسين عند الأطفال الخُدج الذين يعانون من انخفاض<br />شديد الوزن عند الولادة ، حيث يمكن أن يحدث إنخفاض سريع في ضغط الدم (انهيار الدورة الدموية) .</p><p><u><strong>الرضاعة الطبيعية</strong></u><br />يُفرَز إلتروكسين 50 في حليب الأم بتركيزات منخفضة. فإذا كنتِ ترضعين رضاعة طبيعية، استشيري طبيبك قبل تناول إلتروكسين<br />.50</p><p><strong>القيادة واستخدام الآلات</strong></p><p>ليس هناك معلومات عن القدرة على القيادة واستخدام الآلات خلال فترة تناول إلتروكسين 50 . فعليك استشارة طبيبك قبل تناول<br />إلتروكسين 50&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>&nbsp;كيفية تناول إلتروكسين 50</strong><br />.تناول هذا الدواء دائما على النحو الذي يصفه طبيبك أو الصيدلي. استشر طبيبك أو الصيدلي إذا لم تكن متأكدا-<br />اتبع التعليمات التالية ما لم يصف لك طبيبك إلتروكسين 50 على نحو مختلف. يرجى اتباع إرشادات الاستخدام دائما ، وإلا ستقل فعالية<br />إلتروكسين 50&nbsp;</p><p><br />يحتوي إلتروكسين 50 على 50 ميكروغرام من صوديوم الليفوثيروكسين، للعلاج الفردي، ويتوفر أيضا إلتروكسين 100 ، الذي<br />يحتوي على 100 ميكروغرام من صوديوم الليفوثيروكسين في القرص الواحد. في حالة الأطفال، قد يكون من الضروري التغيير إلى<br />.منتجات تطرح جرعات بتركيزات أخرى</p><p><br />يجب تحديد الجرعة اليومية الفردية من خلال الاختبارات الإكلينيكية والتشخيصية المختبرية. وفيما يتعلق بالمرضى المسنين، ففي حالة<br />المرضى المصابين بأحد أمراض الشريان التاجي والمرضى المصابين بقصور الدرقية (خمول الغدة الدرقية) الحاد أو طويل المدى،<br />يجب بدء العلاج بهرمونات الغدة الدرقية بحذر شديد. ويعني ذلك انتقاء جرعات أولية منخفضة، تُرفع تدريجيا بفواصل زمنية طويلة<br />مع القياس المتكرر لهرمونات الغدة الدرقية. أثبتت التجربة أن الجرعات المنخفضة كافية حتى في المرضى ذوي الأوزان المنخفضة<br />.أو المصابين بالدراق العقدي الضخم</p><p><br />:ما لم يُوصف خلاف ذلك، تنطبق إرشادات الجرعات التالية<br />بالنسبة للقصور الدرقي (خمول الغدة الدرقية)، يتناول البالغون في البداية قرصا أو اثنين من إلتروكسين 50 يوم بعد يوم أو كل يوم (ما<br />يعادل 50 - 100 ميكروغرام من صوديوم الليفوثيروكسين) ثم تزداد الجرعة حسب إرشادات طبيبهم خلال فترات تتراوح بين أربعة<br />.(إلى ستة أسابيع، (بجرعة يومية تصل إلى 100-200&nbsp;ميكروغرام من صوديوم الليفوثيروكسين</p><p><br />للوقاية من معاودة الإصابة بتضخمات جديدة في الغدة الدرقية بعد جراحة تضخم الغدة الدرقية ولعلاج تضخم الغدة الدرقية الحميد<br />يتناول المريض جرعة يومية تتراوح بين قرص إلى أربعة أقراص من إلتروكسين 50 (ما يعادل 50- 200 ميكروغرام من صوديوم<br />.(الليفوثيروكسين</p><p><br />كعلاج إضافي في المعالجة المضادة للدرقية للمرضى المصابين بفرط نشاط الغدة الدرقية، يتناول المريض قرصا إلى قرصين من<br />.إلتروكسين 50 (ما يعادل 50 - 100 ميكروغرام من صوديوم الليفوثيروكسين) يوميا</p><p><br />.في العلاج طويل الأجل، يُنصح بالتحول إلى جرعة ذات مستوى أعلى من المادة الفعالة إذا لزم الأمر</p><p><br />بعد جراحات الغدة الدرقية التي تُجرى لاستئصال أورام الغدة الدرقية الخبيثة، تتراوح الجرعة اليومية بين 3 أقراص إلى 6 اقراص من<br />.(إلتروكسين 50 (ما يعادل 150 - 300 ميكروغرام من صوديوم الليفوثيروكسين</p><p><br /><strong>المسنون ومرضى القلب</strong><br />إذا كنت شخصا مسنا أو مصابا بمرض قلب وعائي أو تعاني من قصور درقي(خمول الغدة الدرقية) حاد أو مزمن، قد يختار طبيبك<br />جرعة أولية منخفضة، وتُرفع ببطء بفواصل زمنية طويلة مع إجراء اختبارات هرمون الغدة الدرقية بشكل متكرر. في المرضى الذين<br />تزيد أعمارهم عن 50 عاما ، عادة لا تتجاوز الجرعة الابتدائية 50 ميكروغرام و، وينصح مرضى القلب باتباع جرعة ابتدائية من<br />.إلتروكسين 50 تبلغ 50 ميكروغرام يوم بعد يوم</p><p><br /><strong>:الاستخدام في حالات الأطفال<br />:الأطفال أقل من 12 عاماً</strong><br />.تُحسب الجرعة للأطفال بحسب السن، ووزن الجسم، والحالة التي تُعالج<br />لضمان تلقي طفلك للجرعة الصحيحة، سيخضع/تخضع للاختبارات لرصد القياسات. اعط هذا الدواء لطفلك قبل نصف ساعة على<br />.الأقل من وجبته اليومية الأولى</p><p><br /><strong>:قصور الدرقية الخلقي (خمول الغدة الدرقية) عند الرضع</strong><br />للأشهر ال 3 الأولى، تكون الجرعة الأولية 10 إلى 15 ميكروغرام/كغ من وزن الجسم يوميا . سيقوم طبيبك بعد ذلك بتعديل الجرعة<br />.بحسب الاستجابة للعلاج</p><p><br />:قصور الدرقية المكتسب (خمول الغدة الدرقية) عند الأطفال<br />الجرعة الأولية هي 12.5 إلى 50 ميكروغرام يوميا . يجب رفع الجرعة تدريجيا كل فترة من أسبوعين إلى 4 أسابيع، بحسب<br />.الاستجابة للعلاج</p><p>.(عند اللزوم، يمكن إذابة الأقراص في 10 - 15 مل ماء وتؤخذ على الفور بعدها بكمية سائل إضافية صغيرة ( 5 إلى 10 مل</p><p><br />.عند التوقف عن العلاج، يجب الانقطاع عن تناول إلتروكسين 50 بشكل تدريجي وتحت إشراف الطبيب</p><p><br />طريقة الاستخدام<br />.تؤخذ الجرعة اليومية بالكامل في الصباح مع مقدار من أي سائل، على معدة فارغة قبل وجبة الإفطار بنصف ساعة على الأقل</p><p><br />يمكن تقسيم القرص إلى نصفين متساويين لسهولة البلع. نظرا لعدم توافر البيانات، لا يوصى بسحق أقراص إلتروكسين 50</p><p><strong>مدة العلاج</strong><br />.تعتمد فترة الاستخدام على تعليمات طبيبك<br />&nbsp;بالنسبة لمرضى القصور الدرقي (خمول الغدة الدرقية) وبعد جراحات الغدة الدرقية لاستئصال أورام الغدة الدرقية، يكون العلاج-<br />.في العادة مدى الحياة<br />لعلاج تضخم الغدة الدرقية الحميد وللوقاية من نمو تضخمات جديدة في الغدة الدرقية، يستمر العلاج لبضعة أشهر أو سنوات-<br />.وربما يستمر مدى الحياة<br />&nbsp;كعلاج إضافي لعلاج فرط الدرقية (فرط نشاط الغدة الدرقية): بحسب مدة العلاج مضاد الدرقي. إذا لم يؤد العلاج بدواء-<br />.إلتروكسين 50 إلى الاستجابة المرغوبة خلال هذه الفترة، ربما يقرر طبيبك معالجتك باستخدام خيارات علاجية أخرى</p><p><strong>في حالة تناول كمية أكبر من اللازم من إلتروكسين 50</strong><br />:في حال تناول جرعة زائدة (عن عمد أو عن طريق الخطأ)، ربما تظهر أعراض الإصابة بفرط نشاط الغدة الدرقية</p><p><br />خفقان القلب واضطرابات نظم القلب (عدم انتظام ضربات القلب) والذبحة الصدرية(ألم الصدر) وضعف العضلات وتشنجات<br />العضلات والشعور بالحرارة وفرط التعرق وتوسع الحدقة (تضخم حدقتي العينين) والحمى والرعشة (ارتجاف اليدين) والتململ<br />،الداخلي والاستثارية والأرق ونقص الوزن والتقيؤ والإسهال واضطرابات الدورة الشهرية والصداع وزيادة الضغط الدماغي<br />بالإضافة إلى الهياج والارتباك والتهيج وفرط النشاط وزيادة نشاط الأمعاء والتشنجات المعوية. قد يتأخر ظهور الأعراض الإكلينيكية<br />حتى خمسة أيام. في حالات نادرة تحدث نوبة تسمم درقية بعد جرعة مفرطة مزمنة، مما يؤدي إلى عدم انتظام ضربات القلب، وفشل<br />.قلبي، وغيبوبة</p><p>.يُرجى استشارة الطبيب في حالة ظهور هذه الأعراض</p><p><br />إذا نسيت تناول إلتروكسين 50<br />في حالة عدم تناول الجرعة الكافية من الأقراص أو نسيت جرعة، عوّض الجرعة التي نسيتها بمجرد أن تتذكر. إلا أنه إذا أوشك حلول<br />وقت الجرعة التالية، لا تتناول الجرعة الفائتة على الإطلاق، واستمر في تناول الدواء في الأوقات المحددة له. لا تتناول جرعة<br />.مضاعفة مرة واحدة. يُحذر مطلقا تغيير العلاج الذي حدده الطبيب أو إنهاؤه بدون استشارة الطبيب</p><p><br /><strong>في حال الانقطاع عن تناول إلتروكسين 50</strong><br />حتى يتم العلاج بنجاح، يجب تناول إلتروكسين 50 بانتظام حسب الجرعة الموصوفة. في حالة إيقاف العلاج أو إنهائه قبل الوقت<br />.المفترض لذلك، قد تعاود أعراض المرض الظهور، وستكون طبيعة هذه الأعراض بحسب المرض الكامن في كل حالة</p><p><br />.إن كان لديك أي استفسارات أخرى حول استخدام هذا الدواء، فاسأل طبيبك أو الصيدلي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>الآثار الجانبية المحتملة</p><p><br />مثل جميع الأدوية، يمكن إلتروكسين 50 أن يسبب آثارا جانبية، على الرغم من أنه ليس بالضرورة أن يعاني منها الجميع. في حال<br />أصبحت أي من هذه الأعراض الجانبية خطرة، أو إن لاحظت أي أعراض جانبية غير مذكورة في هذه النشرة، يرجى إخبار طبيبك أو<br />.الصيدلي</p><p><br />مع الاستخدام السليم، لا يُتوقع حدوث أي آثار جانبية خلال فترة العلاج بإلتروكسين 50 . في حالة عدم تحمل تركيز الجرعة في<br />الحالات الفردية أو في حالة حدوث جرعة مفرطة، قد تظهر أعراض مماثلة لأعراض فرطة الدرقية، على الأخص إذا تم رفع الجرعة<br />.بشكل أسرع مما يجب في بداية العلاج</p><p><br />انظر أيضا القسم 3 تحت عنوان في حالة تناول كمية أكبر من اللازم من إلتروكسين 50</p><p><br />.توقف عن تناول إلتروكسين <strong>50</strong> وأخبر طبيبك أو توجه على الفور إلى أقرب مكان حيث يمكنك الحصول على الرعاية الطبية</p><p><br />.ردود الفعل التحسسية: علامات ردود الفعل التحسسية قد تتضمن: ضيق التنفس، والطفح الجلدي والحكة، والهبات الساخنة</p><p>:الآثار الجانبية الخطيرة الأخرى<br />ضيق الصدر-<br />(اضطرابات نَظْم القلب (عدم انتظام ضربات القلب-<br />(الخفقان(شعور غير مريح عندما ينبض القلب بسرعة أو قوة كبيرة-<br />فشل القلب-<br />&nbsp;أزمة قلبية-<br />.وردت بلاغات عن ارتفاع غير ضار في الضغط الدماغي، خاصة عند الأطفال-<br />&nbsp;.قد يؤدي تناول جرعة زائدة إلى تعظم الدروز الباكر (التحام ألواح الجمجمة) لدى الرضع ونقص طول الأطفال-</p><p><br />إذا لاحظت ظهور أي من هذه الأعراض، توقف عن تناول إلتروكسين 50 وتوجه على الفور إلى أقرب مكان حيث يمكنك الحصول<br />.على الرعاية الطبية</p><p><br />:آثار جانبية أخرى واردة الحدوث<br />ازدياد سرعة ضربات القلب، وارتفاع ضغط الدم-<br />(نوبات (تشنجات، اختلاج-<br />&nbsp;(انخفاض الكثافة العظمية (ضعف وهشاشة العظام-<br />(رعشة (ارتجاف اليدين-<br />&nbsp;صداع-<br />&nbsp;قلق، وتغيرات عاطفية، وعصبية-<br />استثارية، وأرق ( سهاد ) ، وتململ داخلي-<br />ضعف وتشنجات عضلية-<br />تقلصات في البطن، وغثيان، وقيء، وإسهال-<br />&nbsp;زيادة الشهية، وانخفاض حاد في الوزن-<br />&nbsp;حمى (ارتفاع في درجة حرارة الجسم) أو تعرق شديد-<br />(إجهاد (إرهاق وتعب-<br />تساقط الشعر-<br />&nbsp;الشعور بالسخونة-<br />اضطرابات الدورة الشهرية التي تؤثر على انتظام الدورة الشهرية ونقص الخصوبة-<br /><strong>ما الذي يجب القيام به في حالة ظهور الآثار الجانبية</strong><br />بعد التشاور مع الطبيب المعالج، يمكن خفض الجرعة اليومية أو يمكن إيقاف تناول الأقراص لعدة أيام. بمجرد زوال العرض الجانبي<br />.يمكن إعادة بدء العلاج بجرعات دقيقة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>.يُحفظ هذا الدواء بعيدا عن مرأى ومتناول الأطفال-<br />.لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية الموضح على العبوة. يشير تاريخ انتهاء الصلاحية إلى آخر يوم من ذلك الشهر-</p><p>يُخزن في درجة حرارة أقل من 25 درجة مئوية .<br />.احتفظ بالأقراص في الحاوية متعددة الجرعات محكمة الإغلاق لحمايتها من الضوء والرطوبة-<br />لا تتخلص من أي أدوية في مياه الصرف الصحي أو المخلفات المنزلية، اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد-<br />.بحاجة إليها. ستساعد هذه الإجراءات في الحفاظ على البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>أ. محتويات إلتروكسين 50<br />:المادة الفعالة هي -<br />صوديوم الليفوثيروكسين.<br />يحتوي كل قرص من إلتروكسين 50 على 53.2 إلى 56.8 ميكروغرام من صوديوم الليفوثيروكسين بالإضافة إلى الماء (ما يعادل 50<br />.(ميكروغرام من صوديوم الليفوثيروكسين</p><p>:المكونات الأخرى هي</p><p>السليلوز دقيق التبلور والنشا مسبق التجلتن ( نشا الذرة 1500&nbsp; )وستيارات المغنيسيوم (وفقا لدستور الأدوية الأوروبية) والتلك والسيليكا<br />.الغروية اللامائية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أقراص إلتروكسين 50 بيضاء اللون مائلة إلى الصفرة قليلا ومستديرة ومحدبة قليلا من الجانبين. تحمل نقش &quot; GS 11E &quot; على أحد جانبيها و &quot; 50 &quot; على الجانب الآخر. تتوفر أقراص إلتروكسين 50 في عبوات تحتوي على 100 قرص [N3] للاستخدام عن طريق الفم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>:مالك حق التسويق</strong></p><p>أسبن فارما تريدينغ المحدودة<br />3016 ،ليك درايف<br />مجمع سيتي ويست للأعمال<br />دبلن 24 ، أيرلندا</p><p><strong>:المُصَّنع</strong><br />شركة أسبن باد أولدسلو المحدودة<br />المنطقة الصناعية 32 - 36<br />23843 باد أولدسلو<br />ألمانيا<br /><strong>:معبأة بواسطة</strong><br />شركة اجا للصناعات الدوائية المحدودة<br />55414 مدينة حائل الصناعية<br />حائل ، المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت آخر مراجعة لهذه النشرة في سبتمبر 2023 ، رقم النسخة {005}
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Eltroxin 50 microgram tablets
Eltroxin 100 microgram tablets

Levothyroxine sodium
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 Eltroxin 50 tablet contains 53.2 to 56.8 micrograms levothyroxine sodium x H2O equivalent to 50 micrograms levothyroxine sodium.

1 Eltroxin 100 tablet contains 106.4 to 113.6 micrograms levothyroxine sodium x H2O equivalent to 100 micrograms levothyroxine sodium.

For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablet.

Eltroxin 50
Eltroxin 50 are white to almost white, round, biconvex tablets. They bear the impression “GS 11E” on one side of the tablet and “50” on the other side.

Eltroxin 100
Eltroxin 100 are white to almost white, round, biconvex tablets. They bear the impression “GS 21C” on one side of the tablet and “100” on the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Eltroxin 50 and 100<br />- thyroid hormone replacement in hypothyroidism of any aetiology,<br />- prophylaxis of recurrent goitre following resection of a goitre with euthyroid status,<br />- benign goitre with euthyroid status,<br />- concomitant therapy in antithyroid treatment of hyperthyroidism after euthyroid status has been achieved,<br />- suppression and replacement therapy in thyroid malignancy, especially post thyroidectomy,</p><p>Eltroxin 100<br />- thyroid suppression test.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u><br />For individual treatment, tablets containing 50 and 100 micrograms levothyroxine sodium are available. In children, it may be necessary to switch to preparations with other dosage strengths.</p><p><br />The dosage statements serve as a guideline. If any residual thyroid function remains, a lower replacement dose may be sufficient.</p><p><br />The individual daily dose should be determined by laboratory diagnostic and clinical tests. In elderly patients, in patients with coronary heart disease and in patients with severe or chronic hypothyroidism, treatment with thyroid hormones must be initiated with particular care, i.e. selecting a low initial dose and increasing it slowly and at longer intervals with frequent thyroid hormone monitoring. Experience has shown that a lower dose is sufficient even in patients with low body weight or with a large nodular goitre.</p><p><br />In patients whose medication incorporates levothyroxine and active substances with known interactions, these should be administered at an interval of at least 4 hours (see section 4.5 Interaction).</p><p><br />If the dose strength is not tolerated in individual cases or if overdose occurs, symptoms like those occurring in hyperthyroidism may occur, particularly if the dose is increased too quickly at the start of treatment (see also section 4.8). In this case, the daily dose should be reduced or the patient should stop taking the medicinal product for several days. Once the adverse reaction has resolved, treatment can be resumed with careful dosing. It is useful to record a reference ECG before therapy, as curve changes caused by hypothyroidism may be mistaken for cardiac ischaemia.</p><p><img alt="" width="500" height="383" src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAkACQAAD/4RD6RXhpZgAATU0AKgAAAAgABAE7AAIAAAAQAAAISodpAAQAAAABAAAIWpydAAEAAAAgAAAQ0uocAAcAAAgMAAAAPgAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEFobWFkIEFsWmFocmFuaQAABZADAAIAAAAUAAAQqJAEAAIAAAAUAAAQvJKRAAIAAAADNDIAAJKSAAIAAAADNDIAAOocAAcAAAgMAAAInAAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADIwMjA6MDQ6MDggMTQ6NDA6MTUAMjAyMDowNDowOCAxNDo0MDoxNQAAAEEAaABtAGEAZAAgAEEAbABaAGEAaAByAGEAbgBpAAAA/+ELImh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8APD94cGFja2V0IGJlZ2luPSfvu78nIGlkPSdXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQnPz4NCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPjxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+PHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9InV1aWQ6ZmFmNWJkZDUtYmEzZC0xMWRhLWFkMzEtZDMzZDc1MTgyZjFiIiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iLz48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyI+PHhtcDpDcmVhdGVEYXRlPjIwMjAtMDQtMDhUMTQ6NDA6MTUuNDIxPC94bXA6Q3JlYXRlRGF0ZT48L3JkZjpEZXNjcmlwdGlvbj48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyI+PGRjOmNyZWF0b3I+PHJkZjpTZXEgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj48cmRmOmxpPkFobWFkIEFsWmFocmFuaTwvcmRmOmxpPjwvcmRmOlNlcT4NCgkJCTwvZGM6Y3JlYXRvcj48L3JkZjpEZXNjcmlwdGlvbj48L3JkZjpSREY+PC94OnhtcG1ldGE+DQogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgIDw/eHBhY2tldCBlbmQ9J3cnPz7/2wBDAAcFBQYFBAcGBQYIBwcIChELCgkJChUPEAwRGBUaGRgVGBcbHichGx0lHRcYIi4iJSgpKywrGiAvMy8qMicqKyr/2wBDAQcICAoJChQLCxQqHBgcKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKir/wAARCAIkAswDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3rxPrj+HdD/tCKxk1B/tVtbrbRSKjuZp0iG0thcjzMgEgHGCR1FL/AISjV/8AoRPEH/f/AE//AOSqPHn/ACLtr/2GtK/9OFvU3jjUn0fwNq+ow3c1nLbWzSRzQKjOHH3QA6spycDkHrSbsrjSu7EP/CUav/0IniD/AL/6f/8AJVH/AAlGr/8AQieIP+/+n/8AyVWZpXia70C1XSfEbanrGsR2SXkk4jtkExYHKRqhTaAVblwowDljWnL4308WVjNaWt7ey3tot6trbxr5kcBAPmPuYKoGemcnBCgkVT0/r+uzJTv/AF/XdB/wlGr/APQieIP+/wDp/wD8lUf8JRq//QieIP8Av/p//wAlVzfg7WJ10XQopJtbZdeu5723ujPHOIoAzOkUhnZpAhjC8qvGeqk109h4xttU1CKPT9O1GfT5S6pqyxL9lJUHPzFt2ODh9uw9mNDVtx+gz/hKNX/6ETxB/wB/9P8A/kqj/hKNX/6ETxB/3/0//wCSqr2/xC0+61fTrK207UpItUleOxvRGghuAiFmdcuG2gL1KjdkFcjmsy38e3mrabLJJoes6bBc6mNOs7u2No7g79hchpGBw6vnCsMcjPJos72/rsD03/r+rG3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVUep+PtN0ua6H2W+vLXT5BHqF9bxoYbNjjhyzAsRkEhA23vim6r4+stIuNWhudN1B30uJZ38oQt50RUsXX95wFA537eoAySMoOtib/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KroopBLCkiZ2uoYZGDg06gNzm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqukooA5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KrpKKAOb/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSq6SigDm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqukooA5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KrpKKAOb/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSq6SigDm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqukooA5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KrpKKAOb/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSq6SigDm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqukooA5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KrpKKAOb/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSq6SigDm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqukooA5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KrpKKAOb/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSq6SigDm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqukooA5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KrpKKAON1bx1qmlWUdxJ4F1wB7q3tx5lzYgZlmSIfduGOcuMDGCcAlRlhe/4SjV/wDoRPEH/f8A0/8A+SqPHn/Iu2v/AGGtK/8AThb10lAHN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVXSUUAc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVdJRQBzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lV0lFAHN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVXSUUAc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVdJRQBzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lV0lFAHN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVXSUUAc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVdJRQBxut+OtU0bQNQ1SXwLrgSytZLhjLc2KphFLHcVuGYDjkhWPoD0q9/wAJRq//AEIniD/v/p//AMlUfEf/AJJZ4r/7At5/6IetvUpVg0q6mkuGtUjhdmnTbmIAE7huBGR15BHtSbsrsaV3YxP+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkquNtb3xlp3wnXxneeJ7i7vYrJtQk0+7tLcQSRffCfu40dW2Y53Yz2xxXTzfEbTo9P+1W+n6hfCG0jvL4WkaEWUbpvBkLMoJC87V3NjnbzVNWbT6CWtrdf6/VFv8A4SjV/wDoRPEH/f8A0/8A+SqP+Eo1f/oRPEH/AH/0/wD+SqbP44thrUem6dpWpaozRwTSzWccZjgjmbCO251YjgklQ2ACTii+8d6dZalHapaX13Eb1LCW7t41MUM7EAIcsGY5POxW285xiizvYOlx3/CUav8A9CJ4g/7/AOn/APyVR/wlGr/9CJ4g/wC/+n//ACVXSUUgOb/4SjV/+hE8Qf8Af/T/AP5Ko/4SjV/+hE8Qf9/9P/8AkqukooA5v/hKNX/6ETxB/wB/9P8A/kqj/hKNX/6ETxB/3/0//wCSq6SigDm/+Eo1f/oRPEH/AH/0/wD+SqP+Eo1f/oRPEH/f/T//AJKrpKKAOb/4SjV/+hE8Qf8Af/T/AP5Ko/4SjV/+hE8Qf9/9P/8AkqukooA5v/hKNX/6ETxB/wB/9P8A/kqj/hKNX/6ETxB/3/0//wCSq6SigDm/+Eo1f/oRPEH/AH/0/wD+SqP+Eo1f/oRPEH/f/T//AJKrpKKAOb/4SjV/+hE8Qf8Af/T/AP5Ko/4SjV/+hE8Qf9/9P/8AkqukooA5v/hKNX/6ETxB/wB/9P8A/kqpND8TXOr6/qOl3mhXmkPZWtvcAXksLPIJWmXgRO6gDyepbJyeBgE9BXN2P/JU9d/7Aum/+j76gDpKKKKAOb8ef8i7a/8AYa0r/wBOFvVPx5o/iPX47Cx0WDTH0+O7hubz7XeSRPMI33+UAsTgAlVJYn1GO9XPHn/Iu2v/AGGtK/8AThb10lHVPsHQ43WPCF7ft4mvYDaDUtVtksbWR3YCK2C/MpbadpLNIeAf4fSszUvBHiN4/E8Wk3en2/8AbFlFBBcb3R4NkRTygNp2pkltwJI3N8uea9Foo6WGm07/ANf1ocTd+DtSuLy2S3ltLW0t9DfTYXRmLwSOAGZUwBjCpht2Rg8c0sHhzxHP8OJ/Dd1JpunTLprWEEljJJIrHZsWQ5VSg/2Ru/3u1drRQ9b36/8AB/zYl7rTXT/gf5I4i18M+Ij4j03UrqTTYLfT9KktYLOCSRlgmbaNwYqNwwgGSBgHGO9JY+EdYtbbwpbO9i8WjF5J8yOS0hj2hx8v7w5aQnOzBYdcc9xRTu/6+b/UVrf18jzy38BavJpUvhzULiyXQ5NRkvZ7iGR2ub1HmMvlspUCPkgFgzZA4C54uaj4KvLmy1t4RZNf6zqELXDSu202cbKBFnaTny1PGMbnPPeu3ooTt/Xp/kN6/wBf13EQEIoYgsByQMD8qWiikAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+PP+Rdtf8AsNaV/wCnC3rpK5vx5/yLtr/2GtK/9OFvXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/AOSWeK/+wLef+iHqP4haRrviDwnc6P4eWxzfDyrmS7unh2xEjcF2xvksMrzjGc89Kk+I/wDySzxX/wBgW8/9EPXSEgDJ4ApDTszi73w5r/ifS10bXk07SNG+VJ7bTbl7mS5jXH7ve8cYRTgA4UkjgEZqk/gXWGh1zRIp7KHRdau2nnvFkc3QiYKrQCPbtHyrtD7+B/D3rs9M1NNWja4tE3WROIpyf9dg4LKP7vo3fqOME3qrrf8Arp/kTtp2OH0/w34k/wCEosLu/wD7LtbXTZJ44p7OZ2mubRsiKB0MaqoX5Dnc3Ke5NVvBngHUPDlwkd2LGZbe6lmj1Bp5bieZXZmIEcg2QH5uShbdzwCc13VrcSXCyGa0mtSkjIomKEuAeHG1m4PUZwfUCp6LvcbXQKKKKQBRRRQAUUUUAFFZmi6x/bcFzcwwbLVLh4beUtnz1XgvjHA3BgOuQM96r+E9euPEWkS3l3Yx2Zju5rdViuDMsgjcpvDFF4JU9qANuiiqd7qKWN3ZRTL8t5MYVfP3X2lgMe+0j649aALlFFFABRRRQAUUUUAFc3Y/8lT13/sC6b/6Pvq6Subsf+Sp67/2BdN/9H31AHSUUUUAc348/wCRdtf+w1pX/pwt66SuW+IrTr4SiazjjluBq2mGKOWQojN9vgwGYBioJ6kA49D0qX7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoAPHn/Iu2v/AGGtK/8AThb10led+NLzxi2g2wutC0ONP7W00ho9amclvt0G0YNqOC2ATngEnBxg9B9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQAfEf/klniv/ALAt5/6Ieq3xNe7PgO6tdPleGW+nt7JpU+9Gk0yRuR6fKx5rI8fXnjFvht4lW80LQ4rc6TdCWSLWpndV8lslVNqoYgdASM+o61s3r+M7+zktp/DugbHHUa9NlSDkEf6H1BAP4UaX1GnZnL+LbSytdd1G9hsovsvh3w8YGVIhuuWkOYoCw5Kjyx8v+36Eg5Wl6fbeESsWtut7ceHvCbG8SUbxN5v/ACyIPAjUQEAHglvU16J9u8cf9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0dGv66/5sE7Nf12/wAvxOHhbTNLt/BvhnWLyCy8PyWEkk5/1FvfXQKgQ54BUlpGCZw+B1HW2nhbRL34l6NZaJp0NhZaPp813MqQbJCLh2WOME/Mi8SttGMZxgZrrft3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5Dqm03f1/G/5X/Am2lvT+v67nnmow6KsniLRb+xS8utOVLHw5oDZkZU8pdk6Icnl3OZv4Qv3hg0zVfD8+q+J/+EY1m60XV799Btoh/a8xJsnwyPNDEVImdjk7gUIwMnkCvRvt3jf/AKF7w/8A+D6f/wCQ64q58J/Ee4t9Q01rfwrLpGozSzTR3V5NNcoZCchJTbheM4XdGxAAGeBid9H/AF/w922V5r+uv6Im0/wNow+I1lpWnWdvBZeHtEENy8MCxyXLTsQFZ1APSN2PqXPqc8zrK6Jqfhi8tLqDfetqq6HZW+S39j2yyCIAZz5ZeNWYn7zhgOQOPUYbnxtBbxwp4e0ErGoUFtfnJwBjk/Y+ak+3eN/+he8P/wDg+n/+Q6rm1v8A1vf/ADXzJW2n9aW/yfyPO/GWkR6gvi+awtIlN69poNpGsQUTT4AMrkctsEuBnp5fsMXbICDxbrWk6XeSyardLbaS0/JcCOPzZ7h26AhZgqj1CgcV2/27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0k9LP8Ar+tfv8h6/wBf15L7vM4TxVqOmWMniOz1C0Se18NabGulaOT8r/u932kqeMKQFDH7pQ4+Y1WE2kaTp50fxHi+sPD/AIfhuoNPcbzfzMrNJOU/jClRychSxJ5wa9E+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5DpatNd/8Ag/5/1oPS6f8AXT/L8Tz3S9Ks/CkPw31S3sxLf3EctrczQx5kuWlgeXaWwCw8wZBPAyT6mumvtOnj1rwl4asACLS6fVdQePOyJF34UZ6BpJMKPRT6VPY2/wAQI76S71XTfD+oSLK7WoOryxrbIxOFAFnywB27jyQO2Tm3ZjxjZNK6eHtBeaY7pZn16YvIR0yfsfQdgOBVOV3f5/r+ZNrK3y/4P3HXUVzf27xv/wBC94f/APB9P/8AIdH27xv/ANC94f8A/B9P/wDIdSM6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkrm7H/kqeu/9gXTf/R99R9u8b/9C94f/wDB9P8A/IdUfDkuqzfEnX21yzs7O4/snTgsdndtcIV869wSzRxkHOeMHoOecAA7KiiigDm/Hn/Iu2v/AGGtK/8AThb10lc348/5F21/7DWlf+nC3rpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/Hn/ACLtr/2GtK/9OFvXSVzfjz/kXbX/ALDWlf8Apwt66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I//ACSzxX/2Bbz/ANEPXSVzfxH/AOSWeK/+wLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm7H/kqeu/9gXTf/R99XSVzdj/yVPXf+wLpv/o++oA6SiiigDm/Hn/Iu2v/AGGtK/8AThb1L4r8WJ4TtbW4n0jUNQiuJ0tw1l5PySOwVARJIn3mYDIyB3xUXjz/AJF21/7DWlf+nC3rA+Mup6fZeFtPt73VodNmn1azaN2ljV1VLhC8ih8g7RySQQO/FC+JLu1+Y+j9Gbus+NP7F1fR9On8P6tNNq52QGE25VHClmRiZhgqoJJGR6EmumryDxNc2Gl/EHwMdV8bvqsUtzLIItQks1RY3t5FWQeVEhKsTtBJIOcCnWfhbS9M8V6l8P8A+xbY6Vql3HrMQ+zjy/IX/WRnjHyyogAPRZeOBVJX/r+tld/IT0+5fr+en3nrtFeAR22iroviSwsZA/iq38RzLooaVpbtCHjClCxL7ABhz02j5q0taihutO8SpqrRJ49TUZX0T5sXewFfI8jPzeWQPm2/L97d3pLVJ91f8v8AMHo2uzt+f4aHpPiHxna6JY63JbW0uo3Wi2iXdzbQOikI27HLEAYCMxHXGMAkgVtaXe/2lpFnfeX5f2mBJtm7O3coOM9+teKeJotE0fW/iRPqsOn2mozaDD5EzxIjs7wyq5VsfxNtUnudo64FTaRb+EdU8Z6Joayabc2+teFdl7EJlc3MqmMxluSWcAOQT8wCn0oSvdL+tJP9AdtH/X2f82e30V4zommaXP4cn0vxFaQWieCbW4s3uiPI2u33JUkXaVJjCsSpHMnrVHw/YaZF8NfBerRCOTTLswR+I7kzl42iSKTCzckbRIwDZ6DAPAosns+343t+Qbb+f4Ht9y1wluxs4o5ZuNqSyGNTzzlgrEcexql4i1dtA8N3+rLZyXv2OBpjBE6qzhRk8sQOBk/hxk8V4j4r/szTfDHiObTdQit/DJ1PT30cQ3Rjt2lLL9oEIUhXj2kkqMqCGIGQcbXjK90W/vvGCeKJIJJH0sS+HXlbKyReQSzW56F95O4r823b2qJ3UG1/WiZcEnNJ/wBanqej6ncavpunagtrFFbXlmlw2ZyXjdgpCAbcMME/NkdBxzxp14XoWqaNJ4u0yA6xJYTzeCmgmEkrrLBINn3Yn5VgqFgFA3Bd3I5qh4kvtNs/hv4p0a5GjwvYwwRpqeh3LQwXcpkb906A8TD52ZMtkHJ7VtJLm08//SmjKndxV/L8Un+p9B0V4hey+C5/HHiCzF1pE2mzeGo7uSNrhHiknBciVgThpNhQ7jlsbTmvRfhlqS6t8L/D10LxbxzYRLLKJN5MgUBgx/vAgg981KV03/XVfoO+tv62T/U6qiiipGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc3Y/wDJU9d/7Aum/wDo++rpK5ux/wCSp67/ANgXTf8A0ffUAdJRRRQBzfjz/kXbX/sNaV/6cLeukrm/Hn/Iu2v/AGGtK/8AThb10lABWTp2lXcWoS6hq15Bd3rReRG0FsYY4o9xbAUu5yeMndztHArWooA5jwZ4X1Dwx/a39oarb6j/AGjfSX37mya38t3+8OZHyOBjoRzye3T0UUB1bCobtbl7OVbCaKG5KkRSTRGRFbsSoZSR7Bh9amooAz9I0w6bDO00qz3d1KZrmZY9gd8BeFycABQACTwOp61oUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc348/wCRdtf+w1pX/pwt66Sub8ef8i7a/wDYa0r/ANOFvXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/wCSWeK/+wLef+iHrpK5v4j/APJLPFf/AGBbz/0Q9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc3Y/8lT13/sC6b/6Pvq6Subsf+Sp67/2BdN/9H31AHSUUUUAc348/5F21/wCw1pX/AKcLeukrm/Hn/Iu2v/Ya0r/04W9dDPNHb28k8zBI41Lux6AAZJobtqG4+iuP8B+M7vxPPq1rq9klheWcyyQwjIL2sq7oXIP8RGQfcGs3x148On3GmWnh7UxHcNrNtZ3f+hPIjq8oV41mI8sOBnK5LAdh1p2fMo97fj/WodG+x6FRXMzfEPw1b6deX015cJb2N79humNhcZhm4+VhsyB8w+bG3kc81z1/48v/AA5rPjibV3N7Y6La209nBa2hyvmK5wxGSeQMscAAZwKXS/8AX9ajtrb+ux6PRXO23jfSJLa1aZ7tJprb7Q8Z064BhTn5pAUzGCVbaXxuxxmrfifXV8O6BNfmPzptyQ28OcebNIwSNc9ssw57Cm007Ep3NeiuaXXbPS9TsdK13xJH/a/2eS6mt0RESRACSxGCURcHBLDpyWp2mfEDwxrM9lFpmpi4+3tIlrIsEnlyumdyiQrt3DaTtzkjkZHNHoM6Oiufl8deG4NTawn1NIpFMi+bJE6wlkBLoJivlllAJKhsjB44qGw+I3hTVImlsNYjmjWMyCRYpNrgSeX8pK4Y7+MLknI45GUGx01Fc8njrw9Jpj3y3smxLj7K0JtJhcCbGfL8jZ5m/HO3bnHPSpI/GmhT6Ta6jb3ck8F3KYYVgtZZJWdSQy+UqlwVwdwK/Lg5xQBu0Vhaj4z0LSrWK4vbx1ikTzMpbSyGNM4LuFUmNAQRubAHrVfx1q99p3w51bWPD15BFcW1m11DO8XnKwVd3AyByOh5AznB6Um7K40rtI6WiuStfiHoUWmk6heXAubayjurlfsE+5kIGZEUJ+8UE8smQO+K07Xxdo97HpMlrLdOmsKWsm+wzgSKBnLZT5BjkF8ZHTNU007Ep3VzaormfGniSfw/bWa2rpam5lIl1C5spbi2tI1GS8nllcZ4AyyjnOeDVe88QaqkuiaLp15pl5q2qRyT/b1tn+ypCgBMgiEpLZ3ooHmc5JzxiktdhnXUVieF9ffXNNuWu4lhvLG6ls7qOPJXzIz1XvgghgOvOKyfD/xI0vWbPVru4W5sbewvmtFNxZzRl8EKAMr8zlsjYuWGQCATR1t8/wCvvD/O3z/pHY0VmaJ4i0vxDHO2lXDO1vJ5c8MsLwywt1w8cgV145GQMisrX/EOraT4z8OadBa2baZqs7wTTvIxmVlikkwqABQPkHzEnuMd6dnewdGzqKK4/VfE2sS63q1l4bis2XQ7dJrv7UjMbh3UsIUKsNh2gEud33h8tVovG2oeJblY/Bi2gSHTYdSnkvomfzBKGMcK7WXaxCnLnIHHynPC6X/r+tGHW39dP81/VzuaKxtL8UadqPgy28TSyrZ2EtqLqR52AEK4ydx6ccj8KpW3xE8L3n2b7LqTyi8gNxalLWYi4UdRGdnzuO6Llh6U2rOzBaq501FczH418O6lcaPHaa95UuoTutvbLHtkuCgYPG6Om5ApHP3SCAM84Nifxt4ettYGm3GorHOZDFvaJxD5gGTH523y9+BnZu3e1IDeormLH4keEdSV3sdbgliSOSQzBXEe1GCthyNpILLwDk7gRwRV3TfF+iaqt4ba8aJrFN91FdwSW0kKEZDskqqwUgHDYwcdaANqiuUk+J3g23hkkvtft7DYu8R3ytbSSL2ZEkCtIp7MoIPY1IvxG8LyWpnh1CSdd6oqQWc8kkhKCQFEVCzjYQ2VBAHU8GgDp6K51vH3hcf2YBrELvq0ZksY41Z3nUAklVAJ7EdOvHXim2/xB8M3X2Mw6g5W8n+zxubWZVWbOPKkYpiJ8jAV9pJ7U7O9g8zpKKy7DxJpmp3j21lNLI6uyBzbSLG5X72yQqFfHQlSeeKj17xXo/hryxq9zIjyI0ixwW0s77FxucrGrEKMjLEYGRzSDfY2KK5IfECwl8daf4ftIri4jvbA3iXcVrK8bAsgTDqpXaQWJY/KPlGcnFbmuasujaY9wImuLhjstrZDhp5COEHp0yT0ABJ4FD0V2C1dkaNFc94D8QXXinwLpet38UUNxeRGR44c7FO4jAySe1O8b+KY/Bvg++1qS3luDbp+7jjiZ8ueF3bRwucZJptWdmEfe2N+isC68a6LYWVvcXst1GZ4vOEI0+4aZIx1d4ghdFB/iYAe9bFle22o2MN5YTx3FtOgkimiYMrqeQQR1FIV7k9FFFAzm/Hn/Iu2v/Ya0r/04W9dJXN+PP8AkXbX/sNaV/6cLerniLW9N0W2thqmr/2Wbu5jggdQpeVywxGoKtnPQ8cAk5HUAGxRXMT/ABG8KW9xeQtq6SPYzLBdmCKSVbd2OB5jIpCDIwWJAB4JFRav450XSH164XUpr6bRbRZbvTraLzPJ+8QcquQT3y2AADgckpuyuNJt2OsorlNF8a6VrU2iwtqUlrqV5aG5/s1rdomkXb8zFZE3hQQdrZAb1YVbsPGWi65eSado2oZvWhaWBpbWVY5FB2l42YKsqgkZKMR7iqkmnYlNNXOgoryjQ/GXia6svBFxeahbyLquqXdpfKloFMgTzim05+UARgYwSf73r2Vr8QPD15pWo6jbz3jW2mSiC7J0y5Vo5Mgbdhj3MRkZwDjIziiw+tv66/5HS0U2NxJGrruAYAjcpU/iDyPoadSAKKKKACiiigAooooAKKKKAOb+I/8AySzxX/2Bbz/0Q9dJXN/Ef/klniv/ALAt5/6IetLxDqkmi+H7zUILSe8lgiLR29vC8ryN0A2oCSM9cDgZNJuyuNK7saVFcNH4zurHwXd65c6ppeuv5kdvbw6daSWu24dggik3yyEHcy5yFIGeK1NF1vUl8SzeHvEJtJL1bRb2G4s4mijkQsVZdrOxBU45zyGBwOlVbW39d/yJvpf+ux0tFcs/ji0T4it4Wa3ulaOy+0yXBtJTGCW4+cLtC4DZYkDOADnIq7pnjPQdX1NdPsb1muJIzLCJLeSJbhB1eJnULKvuhI5pLVXQ3o7M3KK5v4ga7qvhnwTqGs6Ja2dzPZRNK6XcjKoQAkkBQSx6fLlc+oo17xDeWtxo2laSsH9qawzeXJcIzxQIib3kZQwLY4AUMMlhyKOgbHSUVwX/AAnl9KsejQw2o8RPqj6WxZWNujJH5pm2htxXy8Hbuzk7d3et/wAMa7capJqen6msQ1HSbkW9w0ClY5corrIqkkqCrDgk4IIyetO39fd/mv6uH9fn/k/6sb1FFFIAooooAKKKKACiiigAooooAKKKKACubsf+Sp67/wBgXTf/AEffV0lc3Y/8lT13/sC6b/6PvqAOkooooA5vx5/yLtr/ANhrSv8A04W9QePIdW1LTING0vTbye21CUR313ayW4a2gyN2FmYBi3TG1hjdweAZ/Hn/ACLtr/2GtK/9OFvXQXFxDa28lxdSpDDEpZ5JGCqoHUknoKPNjXkeb3fh7xH4c+JWm67pS6x4mhmtHs9SaV7GHZHnMZUKItzK2Tgg8E4I6Vm3PhnxdF4TtvDdvoKXUuna5HfxX73kUcNzELgzZPJdX5wfkPcgnpXpuj67Ya/bvcaU80sCNtEr28kaSe6M6gOv+0uR71o003Fry1/G5Ojv/XSx5J4g8KeJ59M8Z6Tp+jC4OtajBfW1013GkWP3IdDk7wwMZP3cEd88F2qeHfE+tXPj6J/D8tr/AG3pMNvaTNdQNE8saMpXIfcAS/ykqOBzt6V6zRS6W8rfhb9Cr63/AK3ueb65oviC5itNS0HTNR0vxAttDAk8V7AYCoydl1GzYZV55QM3zHaa3viBp93e+FoZ7SMzT6de21+0UakmRYpVd1UdSdobA7nFaPijxTY+EtLS/wBTiupIXmSAfZoDIQznA3HoozgZYgZIHU1s0+Z7rvf57kpJaPt+GxwGuNqOofEHwxr+h6Nc6vpNpZ3Je6tbi3Ct5yqFCh5VJ+5zxjkdecc1pOgeKbbQ/BtpP4Wvkk0vXJ7y7P2q1ISJzLgjE3P+uHA/ut7Z9bhVLa4Ntb2JihKmUzIEWMuW5GAd249c4x75qzQnb+vO43rdf1tY4Pwrp2reH9KGian4bbUP7OuJri01COaAxyhnZlIDuHWXDkcqFz/EAc1i6X4Q16f4S2ml3el3FlqNhqjXhtDfLE1wnntJtWaGQ7CVfg5GGX05r1C0u4L+0jurOVZoJBlJF6MPUVNS/wCB+Af1/X3nmL+F7yzjtr7w/wCGdQtZLrUIpdSF5qMd1f7UR0DpJNLIinlRkPu2FsYOKh0vwhqMHhBrHUNG1iO8s9TvLuzudP1KIXCb5GKMrvIA+5XIIkPOOQc16pRTv/X3f5B/X5/5nlA8Ha/NqEF94tstQ1w3+nRWd6ml6q1m0TI0nMirNEkissg3Yzgg4BBrsNZ8MNc/C698MaTFFatJpjWdvG0rMkf7vaqlzliBwMnmr+heJ7HxDdapBYJco+l3RtZ/tEJi+faG4B5IwRzgZ7cc1ZvdYttPv7W2vBJELttkU5X93v7IW7Me2evQc8UPVW7/ANfroCfK+bt+n/DHK6Vouqar4i0TUNV0t9Lh0WxmtCk8sUjXTyKikr5bMBGAhPzEMSR8oqP4e6ReadqWp2N1tax0OZ7HTHByTFIVlIP+6DGn/ADXb3drHe2cttM0qxyqVYwzPE4Hs6EMp9wQabY2NvptottZoUjUk/M5dmJ5LMzEliT1JJJovrf+t/8Ah/vFaysU9W1K/s7iGGz0G61SKZSHlgmhVYjkD5xI6nHPVQx46VyFv4Q1DwxL4f1XTbI6lNpsd1BcWNvKikR3DiTbEZCq4RgoGSvy++BXodFJaDOd8GaHc6Np9/NqIVb3VL+a/njQ5ERcgKmR1IVVBPrmuMg8H+IobefFj81h4pk1mGMXCYvomYkKvPysAx+/t+ZR2O4eq0UbNNdP0tb8kG6afX9bp/mzk/Dmj3jeMNY8UX1lJpp1G3t7ZLKZ42kAi3ku5jZlyd+AAx4HvgV/GVvq9x4t8K3GmaFd39tpt49zczwzQIFVoZI8ASSKxILgnAxjuTxXaUU76ryDv5nC6jpGtaT4i8Q3Oh6Z9vj8QwRgSCZEFrOqGPdJvYEx7dh+QMcg8c1S0zwnqngS5I8P6e+rw3Wk21gxWWOMwzQKyiR97D92Q3O3cwx905r0eil0t/X9ah1v/XT/ACOZ0rQpvC3wzg0W1ifUbizsPJCQlUM0m3nG8hRliepFcVoWi+J7KL4cw3Hhi+T+wYpIr9xc2pCbojECMTZYZ+bjt78V63RT5ndvv/wf8xW0t/Wp4xpWh+K4NR0Tz/CGoRx2fiS71OWQ3VmQIZhIF4E5JYeYCRjscE11nhnS9U0GK50XUfDx1GCLUJ7601BZYTGweVpBkOwdZRuIGFI4HzDPHd0UX0t/XT/Ib1d/66/5nlWl+EdfvfhndaZdadJpmoJrbalHBcTRMJ1+1eeq7o3YDI+XnoR3HNW9d0e41ebXPEus6PNp8LaBJpgsLi4i824LMWOWjZ1UdAvJOWPA7+lVW1DTrPVtPmsdSt47m1mXbJFIMqwpPb+u1vyGnZ3/AK3v+Z4/d6b4kn0rUF1fRdWuNYvtEk0bT1WKzt4mBUt8+LuTL8EljtGFIAycHqbnTtffTfCUUWjTpFbW5hvlilt1urZvLCDEhYhUJB3GNt2MY7iur0nw3p2inNmLqRgCqveXs10yA4yFaV2KjgcDA4rVpuz0/rr/AJsldP67L9EeQ6JoHibSx4Bgm8MXrLoT3IvJFu7ZgokV0UjMuW6hjxnHvxUDaD4rbwnNbf8ACKX/ANobxWNWWH7VaZ8jzxL187GcDGM9T6c17LRRdp3/AK3T/Qb1Vv62a/U4Hw5o2tab4thl0601LS9Fnjkmv7C+u4Z4Ulf5gINrM6kMTuHCegPWp/Guk61qetwpY6fJNYy6dPA9xaTRQzJI2MK8jEOIjjpHzkDPArt6Klq6sNOzuea+FfD2v6Zr3hW8utIaOO18ODTLsNcRZt5VeM5OGO4EKcbc9s4611uu+G59Xvob2113UtMlgheNEtFt2Vt3U4lifB4AyMcVu0VU3z7+f4tv9SYrl28vw/4Y4DwJ4N13SvhvpOlX/iDVdKvbdSZI4Fs5PLyf9WCYXBXvnk5J5xgDW8f6HqGt/DTVNI03deX0tsEj81kRpmBB5OAoJx7DJ7CupoobbdxrRo4b7Frem+MZvESaLcahHqWnQ2j2cNxCJLRo2cgsXdVKkPztJII4DDmtnwL4ek8K+C7HSLh0aWEO8nlnKqzuzlV9QN2B9K6Cii/9f16it/X4BRRRSGc348/5F21/7DWlf+nC3qj8TrDVdT8O2dtomkz6lMupWtw6QyxR7EilWRiTI6jkLgYzz6davePP+Rdtf+w1pX/pwt62NW1W00TSZ9R1BylvAu5yqkk84AAHUkkAD3o2afbX7g8jyrXND8U6lp/xEjt/Cl+H8QeStiHurQbtsSxkt+++XkZ+nvxVu60LxHrOr+Ky3h26sYtX8OR2FvLc3FsQJlWTKsElYgEyAA4xwfbPoei6w+rxzmbStQ0uWCTy2hvo1UngHKsjMjDnqrH0PIxVe68V6faeKk8PyxXhvXs5L1SlsxQxoQCA38Tcj5VyeR6ih7cr7fp/kUm07ro/1X6o4xNO8SnxL4LuT4ZuFi0vTJra5ka5tysTyRooyPMyQChJ2g8EYycgV/DmheJrDxJoWraloN3utNNu7W6iiubZYo3ZkZBDErhFjO0hTw3Tf0zXoPhrxFZ+KtBh1fTFnS2maRUE8ex/kcocr25U9efXFatU27u/n+N/8yIpJWW3+X/DHjWiaF4qtLDwZb3PhO+RtI1i5urs/arQhY5PN2kYm5/1oyP9lvbPT3mi3UHxXWK0VDpWsRJf3y5wUmtiApx/t7os/wDXOu+qjp+jWemTTzWwmaWdsvJcXMk7YyTtDSMSqgk4UYAzwKL63/r+uo3rf+uty9RWNr3iex8PXWlwX0d076pdraQGGEsodum5uij6nJwcA4o17xRY+HrrS7e+junfVLtbSAwwFlDt03N91R35OTg4BxUrX77fMHp91/l/SNmiiigAooooAKKKKACiiigDm/iP/wAks8V/9gW8/wDRD1sapeXVjYmex02fU5VYD7NBJGjsCeSDIyrx1wSKx/iP/wAks8V/9gW8/wDRD1vXl5badYzXl/PHb20CGSWaVgqooGSST0FJjRwer+DL7X7PWtRjtV06+vpLO5trOaVTiS2beplKZUMx+U7Swwq8ntraNpuoaj41m8T6tp8ml7LBbC2tJpI3kGXLyOxjZlwSFAGSeDnHStmy8SaPqPh3+3rS/ifStjyfa2JVNqkhmycccHmmad4n0jVLO4uba6ZI7Vd84uYXt2iXBIZlkVWCkAkNjBA4qr2+X4aW/LQW69f+HOV8R+FdX1TxxqstrEUstW8OnTBerKo+zSb3OSudx4cYwD0OSKLHQdX1W/8ACa6lpL6WPDJLSTvNFIty3kmICLYxbac7iXCngDHp1mjeJNL18yjTJ3dogrMksEkLbWztcK6glTg4YcHHBq695bpfRWTyqLmWNpUi7sqlQx+gLL+dCvHT+ur/AFYP3nf+tkv0RzvxKs9R1P4eavpmjabNqN5fW7W8cUUkabSwPzMZGUYHsSfaquq6bqdxdeGvEtppE5vdLWWOfTXliExilTawU7/L3BlQ8vjGec12dUNW1qy0W3WW+aY7jhY7e3knkf1xHGrMcdyBx3pXsg3ODTwbq1tfw+LFsvN1YaxLqMunJKm7yXg8jygxIQyBQp5YLnIzjmul8I6Nd2l7retanD9mutaulnNqWVmgjSNY0RipKlsKScEjnAJxmrq+LtCfw6muR6gkmnu2xJI0ZmZ87dgQDeXzxsxuzxipE8S6RJoT6x9sVLGPIkeVGRkYHBVkYBg2eNpGc8Yp3t8tPTb/ACQt/wCvX/M1aKoaRrVjrls82nSuwjfy5I5YXhkibAO143AZTgg4IHBBq/SGFFFFABRRRQAUUUUAFFFFABRRRQAVzdj/AMlT13/sC6b/AOj76ukrm7H/AJKnrv8A2BdN/wDR99QB0lFFFAHN+PP+Rdtf+w1pX/pwt6x/ibA2oT+GNLubhrbS73VlW8lCgglUZ4kbcCMNIq9QQTgc9K2PHn/Iu2v/AGGtK/8AThb1u3tjaalZyWmo2sN3bSrtkhnjDo49Cp4Io63A4vw/4h1+0n1zT7qyvvE66bfrbwXdqtrFI6GJXO/c8UZKk7TtA7cdayvExmsfFSSXE2s20XiXTXt4LM6rLH9mvlKlFTy5CiMwPJQ4+Q9QTn0ixsLPTLOO0021gs7aIYjht4xGiD0CjgU6e0trmSGS5t4pnt38yFpEDGNsEblJ6HBIyOxNDs/68rP/AD9QWn9ed/68jx/Tdc1U+AbzUlub9tY8Mae9hdeZeTFGug5V5XUlg5VFDgsrYDj0FWLu58X+GNG1jVY72zOn3NrC9vD/AG1PftCxlVZJxLJCCkex8kAMFK5AxkV6xFZ20HneTbxR/aHMk2xAPMYgAs3qcADJ9Kq6foGj6TDPDpWk2NlFcMWmS2tkjWUnqWCgZP1pt3d/68/xBJL+vu/I8h8W2XiLTfBOtHU7q2l064ksJrK0XV5tQkR/tKbm82WNTsbjA5AIOOK7vwFdxaxLqWqXM99HrHnmG+0ye7lMdgwxhFiZigBAB3gfNkkYBwNc+CfCrad9gbwzo5svN877MbCLy9+Mb9u3G7BxnrVqx8OaJpl+99pujafaXckYie4t7VI5GQAAKWAyQAo49h6UJ2/r0/r+rCZwmv3eqRePvFFnBr1/BCvhoXsCI6AW0gdgSgK45CDlgTycEcYyNNlvH/4Re3u9X1O6TXfCs8t8s19Kd7pHEVdcMNjfMwJXBPfJ5r0q98G+GNRvpr3UPDekXd1OMSzz2MTvIMAYZiuTwB19KLfwb4Ys7q3ubTw5pEE9qu23lisYlaEZJwpC5UZY9PU+tSl7vK/6+L/NfcU3711/Xw/5P7zybwzJfL4Q8E6Bo8jPBqWlNcT+frtzaFpwsW1EmRZGTCksIl2gjJ6Ag6a2XiebxL4T0LxF4qvPMu7K/ivP7Ku9qMYsBHEmxW8wBxk9MrwBzn0yXwxoE2k/2XNoemyafv8AM+yPaRmLdnO7ZjGc85xQ3hjQX1C2v30TTWvLRQlvcm0jMkKjOAjYyoGTgD1rSUk5X/rr+V/wJSaVjz9bF9D8Tav4Rm1jWp21qKCXS5rjV7hpY0B2zBGL5BQgucYyGAPHFUtZ1G7tPE0VzpWsalNHa+IbTTWaW/dIo4yEV4PJLMJz8xJkcA5bgnbXrclnbS3kV3LbQvcwBlimaMF4w2NwVuozgZx1xVG48MaBd3M9xdaHps89wUM0slpGzSlTlSxIycEcZ6VMXZpv+tV+mnz7aA1dNL+tP89Tzy3h1K7vPHsGhzIt23iCH90btrU3CC3iLRLKvzIxUHDDkY7das61q1vq3wT8STRR6haXFis0bQ303nS29zEQVUSBm3YYKQQT+ddtB4Q8NWrXBtvD2lQm6OZzHZRr5vX72F+bqevqaZceF7KaKxsoo4bXSLNxINOtoVjjd1O5M4/hBGdoAyQM8cULZL0/BJfp9/bW7638/wDP/P8ArS2taNI1nC0wxIY1Lj3xzUtFFD1YkrKwUUUUhhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfjz/AJF21/7DWlf+nC3rJ+MVlBefDm5aeSdPKuLdl8m5kiBJmRedjDcMHoc4OCOQDWt48/5F21/7DWlf+nC3rV1bQtI163SDXdLstShjbekd5bpMqtjGQGBwcHrSA4eW1e+8V63oNzquq6dZaRptvNYPHqUyyEt5heZpC26UAgDDll45FZvhfU9R1bxl4Fv9cGNQuPDd282V27iZIcNjtkc/jXos/hjQLq3tLe50PTZobHH2SOS0jZbfHTYCMLj2xSXnhbw/qOofb9Q0LTbq8CeWLmezjeTbgjbuIzjBIx7mqvZ/12a/X8PuGrr+vL/L8TyzwbeTz6F4P0M3FxbaZqV1qf2ma2naFpHSWQpEJFIZc5LfKQTt9M1JNLqljYXup3OrapPp/hbxAsaTG/lX7RZHZ5glKsBL5Zc/M2T+7IJPOfTIvCPhuDSZdLg8P6VHp8z+ZLaJZRiKRuPmKBcE8DkjtV5dL09dL/sxbG2Fh5flfZBCvlbMY27MYxjtjFO+t/63T/4How30/rr/AJ/geV+Hp7i68UXvhm7vdXEOoXcWradIdUuWcWO1sgSb8hdyAFc/8tRT9PuPGGt6udZtLq1tTY6xJb3cc+sT4NusrIITaeT5auV2lX3biSDnBwPVRZWq3KXC20InjjMSSiMblQkEqD1AyBx04FVjoWkHWP7XOl2R1Lbs+2/Z087b6b8bse2aW1v6/rRai1d/673/ABf5HjV9qcGoeHfBvinWNbmW7n8RxfbYp7wrBblWkzH5ROxNnAyAGP8AETmu5+KSrJB4WDO0aHxFa7nVtpUEPznt9a6j/hGtC/tGTUP7F077bI4ke5+yJ5juBgMWxkkAnn3q5eWVrqNnJaahbQ3VtKNskM8YdHHoVPBpdF63/LT8BvVvzTX5/wCZ5Nq2latdReLtP0PWdamh0OWC6sSmqT72k2b5rVpQ+5wQBgMSVL8EV2vg+8tvEdzc+KLC7upbG6jjhtY2upGi2qoLOIy20NuJUkDPye5rXms59K0uCz8LaZpscSsE8lpDbRwp3KqkbAkf3flB9RUuh6TDoWh2mm2+ClvGF3BQu49WbA6ZJJ/Gmuv9eonr/X9f18i/RRRSGFFFFABRRRQBzfxH/wCSWeK/+wLef+iHrpD0Nc38R/8Aklniv/sC3n/oh637q1t760ltb2CO4t5kKSwyoHR1PBBB4IPoaT2A8iCu37Pdm8WDbQ6gkt1g8eQt9mTp2Cgk+wNJ8Tknvdc12XS8PbW+gQf2iyDIZPtQfaSOp8pZTj0b3r1PTNA0fRbSW10bSbHT7eY7pIbS2SJHOMZIUAHjipNO0fTNHszaaRp1pYWxJYw2sCxISep2qAOaq9ndev4WDpb+t7nKlxd/GTT5tNZXt4dCk+1PHyuHlQwgn32yEe2ay9Ys7eP48W16z3PnJoEksaLeyoryCZFVdoYKQc424wTgkE4rvtN0fTNGheHR9OtLCKRzI6WsCxKzHqxCgZPvT5tOsbi+gvZ7O3lu7cMIbh4lMkQPUKxGRnvil2t0v+N/yv8AgHe/W34W/wAjyzTb7VjongzxJa6rfT6trF9FBqNnJcu8MiOG81RCTtjMYUnKhSNpznmvT9RuobGNbgwia5bMUEagb5GPOwH04yewAyeBTbfQtItNUm1O00qygv7gYmu47dFlk/3nAyfxNN1bw9ouvrGuu6PYamsRJjF5apMEJ643A4pt3Wn/AA3l/XcOt/6/r/I4G50RPD2teDklmikT+3Lm41B0PyrdzwyMnHYZbauf9n1rI1JZj4j1LUBgaIvjGxaZiPkJWFEZvcCXywT6qfSvU4PDWhW2jyaTbaLp0OmykmSyjtEWF89coBtOfpVmPTLCHSxpsVjbR2Aj8oWqwqIgn93ZjGPbFCdnftb80/0/qwPVNPrf8b/5/wBXOX0EPL8V/FVxbnNmttZwSMv3TcKJCw+oRkz9RXZVW0/TbHSbJLPSrO3srWPOyC2iWNF+iqABVmgPMKKKKQBRRRQAUUUUAFFFFABRRRQAVzdj/wAlT13/ALAum/8Ao++rpK5ux/5Knrv/AGBdN/8AR99QB0lFFFAHN+PP+Rdtf+w1pX/pwt66Sub8ef8AIu2v/Ya0r/04W9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc348/5F21/wCw1pX/AKcLeukrm/Hn/Iu2v/Ya0r/04W9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzdj/wAlT13/ALAum/8Ao++rpK5ux/5Knrv/AGBdN/8AR99QB0lFFFAHLfEWBLrwlFbymRUm1bTEYxSNG4Bv4AdrqQyn0III6g1L/wAIHpH/AD+eIP8Awo9Q/wDj9Hjz/kXbX/sNaV/6cLeukoA5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH66SigDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKKAOb/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+ukooA5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH66SigDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKKAOb/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+ukooA5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH66SigDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKKAOb/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+ukooA5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH66SigDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKKAOb/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+ukooA5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH66SigDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKKAOb/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+ukooA5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH66SigDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKKAOb/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+ukooA5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH66SigDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKKAOb/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+ukooA5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH66SigDzvxp4K0u20G2eO61wk6tpqESa/fOMNfQKeGmIzgnB6g4IIIBroP+ED0j/n88Qf+FHqH/x+jx5/yLtr/wBhrSv/AE4W9dJQBzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9dJRQBzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9dJRQBzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9dJRQBzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9dJRQBzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9dJRQBzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9dJRQBzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9dJRQBzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9dJRQB534+8FaXa/DbxLcRXWuM8Ok3TqJdfvpEJELEbkaYqw9QQQehFdB/wAIHpH/AD+eIP8Awo9Q/wDj9HxH/wCSWeK/+wLef+iHrpKAOb/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+ukooA5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH66SigDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKKAOb/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+ukooA5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH66SigDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKKAOb/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+ukooA5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH66SigDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKKAOb/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+ukooA5v/hA9I/5/PEH/hR6h/8AH6o+HNJttG+JOv29nJeSI2k6c5N5ezXT5869HDyszAcdAcdTjk12Vc3Y/wDJU9d/7Aum/wDo++oA6SiiigDm/Hn/ACLtr/2GtK/9OFvXSVzfjz/kXbX/ALDWlf8Apwt6x/i48dp4XstQl1K805INTtUmmtr+W1AheZFk3mNlyNueT06jFHVLu0vvA7yivGF8eS+FtT8RXvht77xZ4VsbOGQSG/E6w3LMQyrcSMS642kgFyCRgV27eMNYbUo9Ii8PQrrEyS3EUE+ohYjboygSNIqMVLF8Bdp5B5xzTt/X9ff6aht/X9f8PodhRXn1p8UZdT1DStP0zw7ObvUHuYG+03SRx289vnzI2YBmOCB8wXGGBGTkVieJPEDa/ceFLz7DPbapp/igafdWKXZMYcIzEZ4V14RgxXIHQA5FCV2l3t+drh0b7X/BN2/A9corzu6+JWrW2mz3J8OWpaw1YaZqQOptstixTZKGEJLpiQE8KR6HqKfxSv7vUPDOrwtbCG10y/slhuoL1w0zvJHvR4wqjAWTGCzA5HGRwJXt5/8AA/zQd/6/rY9Qori/EPj6fw9rKQT6MPsH2yCyNzNdeVJM8uAGgjKESqu4bjuBGDwcVXv/AB9rdh4ouPDzeGrd9Rco2mJ/aLhL6IsQ77/IwmwAFgc9cDORlLXYHpud5RXDHxtBY6p4skvPD/2S50O1gkuJ1kRmulYOV+YDIRcEgtyAxO0d+k8P6rPrGmpdzRWQSRVaOWwvftUMgIzlX2qSPwFOwjVorh9U+Ikljbalqtro4u9C0i6a1v7tbrbMhXAd0i2kOqk4OXU8HAPfIu7Ofxf8WL3Tdc0nT77R7fTree3Zr6QSW4Z5cTRgRArKSoBwykADDHOKEr2/rzG9E79P87Hp9Fcj4j8Y3+i+KLDQNL8Oy6lcX9rNNbytdpDGzRLkoScsDyoyRj5h15xjD4x6UNfs7FxYeTc339nsqamj3cM+4rlrcDPl7hjfuz0O3BzSWr0/roD0V2ej0Vx1p411PU5ILnSfDputJu5Zbe3vRdENvTcA8kYQ7ImZCN+5iMjK81RsfiXd3uk+FdQGgxiLxBcyWrIt9l7eRQ5GAYwHB8s8krjI+tAbHf0V5hL8W9Vj8J3XiNfBF0+n2rzwykajCHikjl8vDL6E55Xdgg8EYJ0tZ+JUmhbbbVrDTdN1CVZJoYdR1qOCKWFSoDCTafnbdgJt6qcnGCQDvaK87034qS+ILq0h8PeHpJxeaS2pwzXd4kKHawVkO0OwwSRnHUDjByIrHx1rOv8AjLwn/ZNnbJpOraVJfPHNdskgw0YbIEZBK7uBnDZOSuBVcrvb+uv+TFdWv/XT/NHpNFYfiTxDLos2m2djZLe6hqk7QW0UsxhjBVGdi7hWKgKp6KSTjjvWFZ/Ek6jDDBaaJMmqXF/Np0Nvc3MaxPNErGU+Ym5gi7TyUBORheancb0/r+ux3NFedaj8RYjp0sGr+GTNd2er22n31q0ySRW7yMhimDsAXXJUrhd2RyF61TuviB4h0XWPHF7e6PDf6doIiCQ219tdV8vfuw6AHIbLEHIwAFbrR0v/AF0/zQ99P6/rQ9RorgdS+JcmkQwR6tp+naVe3gaWzTU9YjghlhVUJYybTtbL7dm08qecc10nhDxPaeMfC1prmnqyQ3Ib5GIJRlYqwyODgg8jg07Mm5tUUUUhhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc348/5F21/wCw1pX/AKcLeukrm/Hn/Iu2v/Ya0r/04W9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD1peIY9Vl8P3kfh4wLqUkRWBriQxorHjO4KxBA5HB5xSeiGtWaVFeWXOvf2B4T1O104arp+vLdWljMmpajLfGIzyBFmjaR3BUgsQQBkrgqMYrodHkl0L4hSeG0u7y7sp9LF9Eby4eeSKRZNj/O5Jw25TjOBg4wOKq2v9dr/AJE3sr/1vb8zsqK4G/8AFmrad8U76zu4rRNC07Rft0z/AGpw4Qucvs2YZhswFyMAk7ucVdsfHN02r6Pb6xoosLXXkLadcR3XnEts37JV2Dy2K5IwXHB5pLVXX9atfoN6Oz/rRP8AU7GisnXdLi1K3Jv9Qu7SyijZpBaXT2zZHO8yRsrAAA8ZxzzmuEsL3XLq28JeG9Y1C8RtVe7nnuA7Q3L2sWTEhdcMrkNGWIw3B6Ghag9D1GivJ4/EGo3OuReCWv7oJ/bs1k96szLO1qlsLgJ5g+YN8ypvzuwM5yc11ngy/uP7W8RaDPPNcx6PeJHbzTuzyGKSJZArOxJYqSRkkkjGeeadtL+V/wAv8/zD+vz/AMvyOsooopAFFFFABRRRQAUUUUAFFFFABRRRQAVzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffUAdJRRRQBzfjz/AJF21/7DWlf+nC3pPGvhrUfFGn2lpp2qW2nLb3cV27T2TXBdonV0AxImBleeuR0xS+PP+Rdtf+w1pX/pwt66SjrcDnPGnhq98W+DLjQ4tSgspLpVWe5a0MoIBBO1PMXGSB1Y4Hr1pl/4XvZ9UsNb0/Ura11u1tDZyTyWbSQTRsVZgYvMVh8y5Hz8Z5zXTUUf1+gHj2vWVp4Z+IfgvStO1yztNUmm1C6lmvED+ZNOBy0YdThmyqgMOmATiujuvhxfP/ZclrrsK3Frqx1i7mnsDIbqcjbgBZV2IFOAPmOAvPBz31FNaW/rrcHr/Xrf8zz1vDtpoGn+JoPGGvWFxbeKLh3SAW32dzI0e0xx7pWMjbUXAAzkH1wFl8B6tq3wpsPD02sJa37tDcX13cWhnaSRWEhGA6YO4AZ54GMdx6DRS6fd+GwPV/f+J59qnw21DU7rUbh9etxLfXFrdGRtN3tG8DI2xWMufKJTITqCxO485l134fanrslxeza7aRaul3HNpmoJprb9PjXrGo87nd/EeA2TkEbcd5RTu/6+X+QHF6P4P8QWHiTV9ZvfEVjcS6pDBHIkOktEEMXAI3TPwQWBHuCCMc6HhTwivhm51W6823MupziaSKytfs0CEDGVj3N8x/ibPJ9K6Sii4HF3Pw+eSLVNMttTSHQNYuHuL2ya1LSlnwZBHLvAVWI5BRiMnBHGLdj4W1Sy8fXWv/2tZtZ3FtHafYV09ldI4y5TEvnEbsucnZggYwOtdTRSWmwPW/8AXmczqvhe/wBQ8faN4hi1S3ht9Lili+yNZs7S+bgOfM8wAcKuPlOOc5zwukeGNQ0S9uIbDWEGizXD3Is3tS00Tu5d1WbfjYWJOChIycEcY6WihaaA9TmPDvhW/wDDbPZWeso+iec80NrJaZnh3vvKCXfgpkngpnB+9WHF8ML6Gz0mzh8SmG20XUXvbERWC7gG34RyzENjzCMgLx2zgj0OigDzs/DXVm+G+o+FH8RWeb+7kuHuxpbDaskhkZQnn9dx4OeBxgnmt/UPDWpzahYatpmrwWer29t9lnkks2lt7hCQSDF5gZcMMjD5GSDmulop3/r5W/IP6/U4y68G63N4wOvQ+ILNW/s2SwSKbTGfG9t5csJlzhgMDA+XjOfmqr4d+HF5oMnhuQ69HNJodpLYlksdgnhdlboZG2sCgGeQRngda72ihNrb+t/8394PXf8Arb/JHAfFF7aVtFs73VbfRoPtD3Bv7xJFhjKLhR5sckTRuS/GJFyAw56GHRPCpvtNsZNNvdOSfR7lrjTdUs7SQ29wZUIk3o8rNKDu5cSZY85yDXotFJaIHqcDrHw4vdT02dYdatoNSvdRg1C+u209nSR4dvlokfmjYo2DqzHrzzmjXPhxf6onidLXX4bVPEkUSXKvp5k8tlj8tiv7wcEDgdj3PSu+oo6W/rp/kg63OXvPCuoyvpOoWOrwWutadbm2a4azZ4J4227laHzAQMopGHyCOprorSKaG3Vbmfz5eS8gXaCT6DJwPQZP1PWpqKd2xWSCiiikMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/Hn/Iu2v/Ya0r/04W9dJXN+PP8AkXbX/sNaV/6cLeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/iP/ySzxX/ANgW8/8ARD1sapDqE9iU0e9hsrrcCss9sZ0xnkFA6k5HowrH+I//ACSzxX/2Bbz/ANEPXSUAcxdeCotU0rUYtZvDNf6isXm3kEQi8oxHdH5akttCtlgCWOSck1Y0Tw5cWesXGs61fRahqs8CW3mw25gjjiUlgqoXcgksSTu546Yrfop3DpY5XVvA8er+KrnVJ70i0vtLOmXln5WTJHuLAq+fl+8QeD2wRTdN8GXUV3pLa1qseo2+iA/2ciWnkup2GMNK29g7BSR8qoOScdMdZRSWm39b/wCbB67/ANdP0Rh+I9K1jVfsy6TqdjZwxtumhvLB7hZiPu52zR4APOOc8fSql54Y1XUIbC8utZthren3DzW13FYFYAGXYY2h8wsykHJ/eZzg5GMV09FAHH/8ICqWEMtvqGzW4tQbU/7RaDcr3DKUbdGGH7sodu3cDgD5sjNbHh3QBokd5LPcC71DUJ/tN5ciPyxJJtCjauTtUKoAGT06k81sUU7v+v68kH9f194UUUUgCiiigAooooAKKKKACiiigAooooAK5ux/5Knrv/YF03/0ffV0lc3Y/wDJU9d/7Aum/wDo++oA6SiiigDm/Hn/ACLtr/2GtK/9OFvXSVzfjz/kXbX/ALDWlf8Apwt66SgAooooAKKKitru3vYfOs54riLcyb4nDLuUlWGR3BBB9CKAJaKKKACiiigAoqJbu3a8e0WeI3KIJHhDjeqEkBivUAkEZ9jUtABRRRQAUUVFFd29xNNFBPFLJbsEmRHBaNiAwDAdDgg4PYigCWioUvLaS8ktEuYWuYlDyQhwXRT0JXqAcHn2qagAooooAKKhe8torqK1luIkuJgTFCzgO4HJwOpx7VNQAUUUUAFFRfarf7Z9k8+P7T5fmeTvG/ZnG7b1xnjNI95bR3kdrJcRLcyqWjhZwHcDqQvUgUATUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc348/5F21/7DWlf+nC3rpK5vx5/yLtr/wBhrSv/AE4W9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Ef/klniv8A7At5/wCiHrpK5v4j/wDJLPFf/YFvP/RD10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffUAdJRRRQBzfjz/AJF21/7DWlf+nC3rA+MumWF54X0+5vdIh1KaDVrNYkeKNnZXuEDxqXwBuHBBIB78Vv8Ajz/kXbX/ALDWlf8Apwt6l8V+E08WW9rBNq+oafFbTpcBbLyfnkRgyFvMjf7rLnAwD3zQviT7NfmPo/RnA6VLZ6D8W7RbbQpfBdjNps+bCRYkj1KVdrZRIGeIMigknIYg4xirmnfErxDqc1rPp+ivdWeoWkk8PmaXeWqWTCPegluHQpIrdNyAYOMbgc11Nv4EtT4gttZ1vVdS128s0dLQ35hCQbxhiqRRopJHGSCaLTwPFYabPp1jrmrQWDIyW9qHhK2YII/dkxliACcBywHYcCh35bdbf5/5r7g0uc/4f8eeItRfwrJe2+llPEmmzTxQwrIhhmRA43SEnKMD0C5X1apNP8e6xqHgnQ7821jbajrGpSWBkKu9valXkAYjcrN/qwAMrksOnSrdr8Lrey/sL7L4l1yP+wIHgsf+PU7VcbTuzB8x24HPoO+ScfW/BUGgeFdN8P8A2nX9Q0b7dJPcTpaQ3skQYMdjQiEiRC7luY32nnjAIqTjd22v+v8AkSr213/4H+Yg+I/ilryztU0rRmRteOiTXYupf3jgEl1i2YUYHTzGweD611ngzX7/AFn+2bTVxbNeaTqL2by2sbRxygIrqwVmYqcOARuPIrA07wKdVj07/ida1baXpNxHd6bG1ja2j+YFIO6IW64QA4AKqcls5+UjpvDfhOLw1fatdRapf3zarc/ap1u/KwsmAuV2RrjgKMHP3R75FpdP+vh/+2+8Hrt/W/8AwPuOY13x/rWm3OsXVna6e9npOowacbG4LpPcNL5eJRIuQq5kGF8tiQp57U/UfHGv/wBneINX0q3037H4bmaK7tJRI8lyUjV5fLlBUJjcQMo27H8Oay5dGF3401HUp01+z137S5sgmjW9xGEUbU23b27hFYDO3zUxuIwDyetn8C2t410017d20WpANqlhasgt7x9oVi25C65AAOxlyOualfCvT8dP+D9/kU7c1n/S/q1jFm8aa1qVz4ms7FbOxS00SHUbC4KtM5EiufnXKgEbOgzjrk9KyNA8S+M7XTfBuiWn9i3L6vozXEV5cJMpRo4lYK6Bjn7y5YNzknauOezTwJZr4k1PV31LUHGpWYsZrM+SIFhAIVVxGGGNzYO7vzniqun/AA3tdN1TQr2HXdYkOh25trWGV4GQxkBSG/dZ5VVHBH3c9SSaVr+tv/bv80Trb+vL/gmM/wAR9Zk1dF0/Spr22h1D7Bc29vpF47Ha+ySZbkL5QVWz8pBOB94Hiuk8bazq/h+0sNR02SyWxW8ih1AXFs8jLFI6pvQrIoXbnnIPBz2wZ4PCMFnrNze2Gpaha295KZrnTonj+zyyHq/KF1J6naygnqOTnT1nSbXXtDvNKvwxtryFoZdpwwDDGQex9Km9ku/9af13HpzPt/X4/wCRw1l401++1nX9EiutK+32d9bw2En2CTZJC7EOzKZssVKSKdpAzGfXAx/Fvi7xLe+D/FcKvYadPper29huhjeYSwyGLuWXBPmc8dMgf3q7y18D6Paa1pWqxCc3el2bWcLvJu8xTj5nJGWYfNzn+NvWs2T4Y2Fxa69Bd6xq1wmuXCXU+9oQYpUKlXj2xDGNijDbh8vIPOWrdf61X5pP7w/r8/1/I5S6k1fw94/8Y6hpX9ki/t/D9reXUrWjrHcSIZifkV8gsFxuLsRgfer0G68Uw2fw/fxTLCzRJp4vTCvU5Tdt/XFZN18Nobu+1e6k8R62JNXslsbjDW5xEM8LmEkH5n5yfvH0GN2z8N2dv4Rj8OXby6jYpa/ZGN3tLSR424baqjpxkAdPXml9lr+uv/ADTmT+/wC5f8E871T4leKrDSdZuIdOR1s7D7dBeXOhXtrACGAa3YSlSzYOQ6kA4Pyir3jHxb4ks7rxBp1jc2EEcXht9VtphauZYmB2spPmYPQkHAxkcHHPUDwRbTeHrvRdU1XU9UsrmBrZVu5I90MbDGFZEUkjAwz7m9+tUm+Gel3N1JdanqWrahcS6Y2lyST3QXfC27OVjVVJ+brjqAcZ5okk1Zef5O36Di7NN+X5r9L/AHnIxWepJ4w+Hk6Saa+rTaNdIb37IyKEEUZQMu8s+3d03qCSxG3OK0rHx54kubTw1qlwdJh0y91B9N1Mi2kLRTLI8YZGMoAV2QKMglSw+9W8nw8hi1PR76PxDrIm0e2a2tsm3YFWUKxYGE8kKvTA+UYHJzl3vg600jwLeeC7S41jUpdTaWW2mmg3CCVn3lzNFGqJtc7xuIPXHYVbkm7rv+rf5ERXupP7/l/nYbf+L/F1tq+kwWsWizWms6pPZ200kcqPEiK5VmUMQ+dhO4FcjHAzkPk8XeKprPWpbCLSDN4bVUv4WjlYXkoiWWRYn3Dy1AbALK+T1Arcv/A9tfT+H5E1O/tF0Bg9tFb+VsdgmzL742JypI4I6k9cGn6h4Js76/vLiK+vrGPUhjUba1dFjvPl2/PuQsp28ZRlJHU1HSy/rt+pSd3d/wBb3/Q5xfijLHeahdXdjCmj2/h6LW7fy3LTyK/8LZwqnIIwM9jntVWGHVG+NXhq+1tNM+0XWkXZD2UDIyrmIiN2ZiZNu44b5Qdx+Ud+km+HWmXHiC61K4vL2SC608aZJppEQtvswBwgAjDjBJOd2cn04pLD4d2VnrGl6lPrOs30+kxyQ2YuLpQEjbb8jbFUuBtH3iSe+cDFJxun6/8At3+a/rdO9ren/tv6p/1sni/xbN4c1jT4Jbm00zT50dpNQvraSSHeCAsRdWVYic53OSOMAE1iabqfiRPiJ4vmN5Y30Njptq8NmsRiDkpI6qsrSbVG7OWIOQR93Fdnrvh/+3baW3k1O+tIZ4vJmjtzHtkTnIIdGxkHBIwcYwRWRN8NtEmbUVWW9ittS0+PT57WObEZjjRkQjjduCsR1x0OM81K2f8AX9f16utL+Wn5r/g/1txWtePfEN74S8X20F/pv2iw0iO+hv7K0kVCsgcMi7pCGI28SqxXn7vGK6DStd8UweIJPD13eaPMRoA1C2uItOlj2Pu2BXUztuHHYr+FaUnw20+5W/Goarql7/aOmLpl0ZpIh5kalirfLGMMNx6YHqCasyeBbV7yyuxq2qR3NrZtZSSpKga6hYglX+TjkZBTYR2py8v60dv0Fva/9fDf8mcvY/EvUp9F8PXupzabo6app4uGu7q1la2knJIEIkDgQ/wnLls5wBmvT1OVBODkdulcfD8NdPtvCieG7XVtXi0ryRBLA1wkvnR/NlSZEYqDuwdm04AxjFddDClvbxwwrtjjUIi+gAwBTlbW3cWun9f1/XyfRRRUjCiiigAooooAKKKKACiiigAooooAKKKKAOb8ef8AIu2v/Ya0r/04W9dJXN+PP+Rdtf8AsNaV/wCnC3rpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/8AJLPFf/YFvP8A0Q9aXiHT7zVfD95YabfLYXNxEY0uWiMgjzwTtDKc4z3GOtZvxH/5JZ4r/wCwLef+iHrY1Swl1GxNvBqN3psm4MtxabPMXBzj51ZSD0IINJ6oadnc8s1C4Tw54X1fQtP0LT/D+pi6sbW5uNHiEaT29xKIxMGADBseYMEkqe54NdPo1rbeHPijLoOiW6WumXGji7e1hULHFKsuzeFHQsGOT3K561uN4S0+40e90/UXuL86goF1czuBLKQAFOVChcYyAoAB5A5qTRfDcOj3U95LeXepX9wixyXt6UMhjXO1PkVVAG4ngck5Oau+uv8Aw+lvwepLWll/Wt/y0ON1fXtV0j4sapc3WoW50fS/DxvmtvsrF9m9twVvMwGJjB3FSMcY71oWfi3XrXV/Dg1yGwksfEi7YBaRuklnL5RlCuzMRICoI3AJgjpzW5feDtN1HxI+s3L3BkmsTYXFuHHk3EW4sA4xngk9CAc85qPSvBlppl3aTS399qCaepXT4bxo2WzBXb8hVAzHb8uXLHHfk5UdEk/61f8Amv63ctW2v60X63LPiLSNF1GzebxJbRXtlBGSbe4QSRE8fNsIOW4wO4zx1rgbTSryE+DPCWviWaxvHvbq5tblvMBjTLQ20hOdwUSDIOQdncV32u+H5dbltXi1vUdM+zMXC2awMrt2LCWJ8kdsYxVa48IJd2FvHeazqc9/a3BubfU2aETwuVK/KBGI8bSRt2YOeQTzSQM89huJLnxNF4KlBbQV8Rz25iPKPAtoJxbn/YDt93ptXb04rsvAz/ZNc8U6HbLs07S76NbONQAsKyQI5jUDooYkgds46VfbwPpp0aKyjmuop4bo3qagrqbgXJzmbJUqWOSCCu3BxjHFaOiaHbaFaSRW7yzyzyma5uZyDJcSEAF2IAGcADAAAAAAAqk9Plb1emv4P+rif9fe/wDNf0kaVFFFSMKKKKACiiigAooooAKKKKACiiigArm7H/kqeu/9gXTf/R99XSVzdj/yVPXf+wLpv/o++oA6SiiigDm/Hn/Iu2v/AGGtK/8AThb10lc348/5F21/7DWlf+nC3rpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/Hn/ACLtr/2GtK/9OFvXSVzfjz/kXbX/ALDWlf8Apwt66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I//ACSzxX/2Bbz/ANEPXSVzfxH/AOSWeK/+wLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm7H/kqeu/9gXTf/R99XSVzdj/yVPXf+wLpv/o++oA6SiiigDI8T6G/iLQ/7PivpNPf7VbXC3MUau6GGdJRtDZXJ8vAJBAzkg9DS/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFrpKKAOb/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFrpKKAOb/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFrpKKAOb/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFrpKKAOb/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFrpKKAOb/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFrpKKAOb/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFrpKKAOb/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDjdW8C6pqtlHbyeOtcIS6t7geZbWJGYpklH3bdTnKDBzgHBIYZU3v8AhF9X/wCh78Qf9+NP/wDkWukooA5v/hF9X/6HvxB/340//wCRaP8AhF9X/wCh78Qf9+NP/wDkWukooA5v/hF9X/6HvxB/340//wCRaP8AhF9X/wCh78Qf9+NP/wDkWukooA5v/hF9X/6HvxB/340//wCRaP8AhF9X/wCh78Qf9+NP/wDkWukooA5v/hF9X/6HvxB/340//wCRaP8AhF9X/wCh78Qf9+NP/wDkWukooA5v/hF9X/6HvxB/340//wCRaP8AhF9X/wCh78Qf9+NP/wDkWukooA5v/hF9X/6HvxB/340//wCRaP8AhF9X/wCh78Qf9+NP/wDkWukooA5v/hF9X/6HvxB/340//wCRaP8AhF9X/wCh78Qf9+NP/wDkWukooA5v/hF9X/6HvxB/340//wCRaP8AhF9X/wCh78Qf9+NP/wDkWukooA43W/AuqazoGoaXL461wpe2sluwltrFkw6lTuC26sRzyAyn0I61e/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFrpKKAOb/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFrpKKAOb/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFrpKKAOb/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDm/+EX1f/oe/EH/AH40/wD+Rak0Pwzc6Rr+o6pea7eau97a29uDeRQq8YiaZuDEiKQfO6FcjB5OQB0FFABRRRQBR1jWLLQdMe/1N5Et0eOP91C8zszuqIqogLMSzKAAD1rJ/wCE80j/AJ8/EH/hOah/8Yo8ef8AIu2v/Ya0r/04W9dJQBzf/CeaR/z5+IP/AAnNQ/8AjFH/AAnmkf8APn4g/wDCc1D/AOMV0lFAHN/8J5pH/Pn4g/8ACc1D/wCMUf8ACeaR/wA+fiD/AMJzUP8A4xXSUUAc3/wnmkf8+fiD/wAJzUP/AIxR/wAJ5pH/AD5+IP8AwnNQ/wDjFdJRQBzf/CeaR/z5+IP/AAnNQ/8AjFH/AAnmkf8APn4g/wDCc1D/AOMV0lFAHN/8J5pH/Pn4g/8ACc1D/wCMUf8ACeaR/wA+fiD/AMJzUP8A4xXSUUAc3/wnmkf8+fiD/wAJzUP/AIxR/wAJ5pH/AD5+IP8AwnNQ/wDjFdJRQBzf/CeaR/z5+IP/AAnNQ/8AjFH/AAnmkf8APn4g/wDCc1D/AOMV0lFAHN/8J5pH/Pn4g/8ACc1D/wCMUf8ACeaR/wA+fiD/AMJzUP8A4xXSUUAc3/wnmkf8+fiD/wAJzUP/AIxR/wAJ5pH/AD5+IP8AwnNQ/wDjFdJRQBzf/CeaR/z5+IP/AAnNQ/8AjFH/AAnmkf8APn4g/wDCc1D/AOMV0lFAHN/8J5pH/Pn4g/8ACc1D/wCMUf8ACeaR/wA+fiD/AMJzUP8A4xXSUUAc3/wnmkf8+fiD/wAJzUP/AIxR/wAJ5pH/AD5+IP8AwnNQ/wDjFdJRQBzf/CeaR/z5+IP/AAnNQ/8AjFH/AAnmkf8APn4g/wDCc1D/AOMV0lFAHN/8J5pH/Pn4g/8ACc1D/wCMUf8ACeaR/wA+fiD/AMJzUP8A4xXSUUAc3/wnmkf8+fiD/wAJzUP/AIxR/wAJ5pH/AD5+IP8AwnNQ/wDjFdJRQBzf/CeaR/z5+IP/AAnNQ/8AjFH/AAnmkf8APn4g/wDCc1D/AOMV0lFAHN/8J5pH/Pn4g/8ACc1D/wCMUf8ACeaR/wA+fiD/AMJzUP8A4xXSUUAc3/wnmkf8+fiD/wAJzUP/AIxR/wAJ5pH/AD5+IP8AwnNQ/wDjFdJRQBzf/CeaR/z5+IP/AAnNQ/8AjFH/AAnmkf8APn4g/wDCc1D/AOMV0lFAHN/8J5pH/Pn4g/8ACc1D/wCMUf8ACeaR/wA+fiD/AMJzUP8A4xXSUUAc3/wnmkf8+fiD/wAJzUP/AIxR/wAJ5pH/AD5+IP8AwnNQ/wDjFdJRQBzf/CeaR/z5+IP/AAnNQ/8AjFH/AAnmkf8APn4g/wDCc1D/AOMV0lFAHLN8RdBW6jtWi1wXEiNIkR8PX+9lUqGYDyckAuoJ7bh6ipf+E80j/nz8Qf8AhOah/wDGKL7/AJKnoX/YF1L/ANH2NdJQBzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFdJRQBzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFdJRQBzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFdJRQBzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFdJRQBzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFdJRQBzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFdJRQBzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFdJRQBzf/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFdJRQBy0vxF0GCSGOeLXI3uHMcKv4evwZG2ltqgw8narHA7KT2qX/AITzSP8Anz8Qf+E5qH/xijxR/wAjF4M/7DUn/pvvK6SgDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKu6N4n03Xrq5tbD7YlxapHJNFeWE9q6q5cIwEqKSCY3GRn7prXrm7H/kqeu/9gXTf/R99QB0lFFFAHN+PP8AkXbX/sNaV/6cLeukrm/Hn/Iu2v8A2GtK/wDThb10TuscbPIyoijLMxwAKAHUVmad4l0LWCw0jWtPvyr+Wfst0kuGxnb8pPOATj2rToAKKKKACiiigAoqK6uUtLWS4lWVkjUswiiaRyPZVBZj7AE08SoZBHvXft3bM849cUAOooooAKKbHIk0SyQuskbjKspyGHqDWbfeJtG028sLS91GCO41GYwWkW7c0zg4IAGeh4J6DvR5AalFFFABRRRQAUUU2WRYYXlcMVRSxCIWYgegGST7DmgB1FNikE0KSIGCuoYB0KkA+oPIPseadQAUUUUAFFQPewIsbAtKskvlAwxtIA2SDnaDtAIIJOAO5qlrPiXRvD1qLjWdRgtYzMsA3tkmRhlUCjJLEc4x05oA1KKKKACiiop7hLfy/MWQ+ZII18uJnwT67Qdo9zgD1oAlorO1rxBpXh23hn1q+itI55lgiL5zJI3RVA5J+lX5JEhiaSZ1jjQZZ2OAo9SaAHUUUUAFFFNjkSaJZIXWSNxlWU5DD1BoAdRRRQAUUU1JEk3eW6ttba205wfQ+9ADqKKyNc8VaP4bCnWLpodymQiOCSUogwC7BFJVBkZdsKM8mgDXopsciyxrJGwZHAZWHcHvTqACiiigDm77/kqehf8AYF1L/wBH2NdJXN33/JU9C/7Aupf+j7GukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/FH/IxeDP+w1J/wCm+8rpK5vxR/yMXgz/ALDUn/pvvK2NT1fTdEszd6zqFrp9sGCma7mWJMnoNzEDNAFyis6bxFotvoyavPrFhFpsmCl690ghbPAw5O05+tX45EljWSJ1dHAKspyCPUGgB1FNSRJN3lurbW2ttOcH0PvTqACioJr60t7iC3uLqGKa4YrDG8gVpSASQoPJOATx6GorvWNM0+7trW/1G0tbi6JW3hmnVHmI6hVJy34UAXKKp6hrGmaR5H9q6jaWP2iQRQ/aZ1j81z0VdxGT7CrlABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN2P8AyVPXf+wLpv8A6Pvq6Subsf8Akqeu/wDYF03/ANH31AHSUUUUAc348/5F21/7DWlf+nC3rB+KEnm6t4O029bbo9/rAS+BOElwhaON+xVnA4PXFb3jz/kXbX/sNaV/6cLetnVNKsNa0+Sx1a0hvLWTG6KZAykg5B+oPIPajqmHRr1Ker6bpebPUbu3jE2lsZbVwAGU7GXav1BIwK4S18T+JRofhXxQNS+0w+ILmGCfS3t4/Kt1mB2tGygSZTgnczA8/d7d3pPhfS9FZWs1upGQYja8vp7oxDGMIZXbZx/dxUNt4M0KzvTdW1pIj5Zo0+1SmKBmBDNFGW2RMQTygU8n1o6/18/v79A6f18vuPP9J8WeKRpuhapqWtLdG48SS6TcW0dpHFFJF5kiBuhcMCgIw3Tg5PNdD4Y1DxJ4it7LxLBq0a2UtzOlzpLwJsjhR3RdjBd/mgqM5bacn5RxV5Phd4UjtLa1S1vxDa3ZvYU/te7+ScnJk/1vXOT9ST3OdSz8I6LYapNf2VrJBLPIZZIkuZRA0hOTIYd3l78jO7bnPen0/rsv1uJ7/wBd3+jX3HCw+LfET+F9D8Zx6iZbfU7+O2l0dreMRJFLN5alGC+Z5i8E5Yg88DtTTxV4uj8Ozatc67G81p4n/sowx2MawyxGdYfmBy+RncMOPQ5r0SDwdodtqRvoLSRJPMaVY/tMvkpI2cyJDu8tHOT8yqDyeeTWZ/wq3wp/Z72P2W/+zyXYvXT+17vmcHPmZ83O7POfUA9RRFpPX+tV+if3jlqtP60f+a+45PxD4p8UaNpnjmCz1oSzaE9tLb3V1aRtJslQFkwgVeCeCVPvmrE8uoWXxS8V6gniCSBLPQbe4jjvPL+yoT52A+I9wRSN3ykMSTkkYFdLqHwu8K6pcX819bahK2olTeD+17tVn2/dDKJQCB2GMDtV6fwL4dupGku9Pa5eSyFjI09xLIZYRnAfcx3kZPzNluTzzSW3n/wLD/r8U/8AM4L/AIS3xTa2HiyOLVZ5ZNP0WHU7S41PT40bcRIXCogQ7D5eF3jcD1BHWW61rxDu+wXWvXEg1PwpLqXmRQQxm2mQJkx4QnDb+QxYg9CO3Xy/DbwxPDPHLaXjC5tFs52/tO53TQqSQjt5mWHJHJzg46cU+H4e+HIdQtr1ba7ee1tDZRGbUbmRRARgxlWkKsD7g9AewolZprv/AJS/zX3AnZp/19n/ACf3lXwFaXC/CPR4m1S7eWbS4mS4ZYg8OYhgLhAuF7bgT6k15zpEN8/w5+G0suq3FxPda9HIJLlEbysrNkLtVSe5yxY5PUjivZ9H0TT9B0mLTdKgMNpEoVEaRpCABgDcxJOAAOTwABWJ/wAK18LCGxhjsbiKPT5zcWqRahcRiKQnOQFkHTJwOgBIGATVyknUcvNP7nciKtDl62a+9WOSHjTX7X7VoXnXup3o8QSaZFeQR2qXJiFv5wID7Id46ZIxgZwTwWHW/iFFfeH9O1S5/sr7dq01kXntreS5ng8lpElby3aNGG0ggDBIB6fKezj+HfhmOHUIxZXDjUZxc3Bkv7h2Mw6SKzOSjj+8pB4HoKln8C6Dc3GnXFxFeyTabJ5ttK2pXO5Xxjcx8zLnHGWzxx04qVbS/lf7lf8AX7yn1t5/r/XyOK1zxJ4l0XUFVPEDag1hfWFncJbWMYgYSlFkacsuVkJbIWJ/lBXIwabc+I/FkejeNNVbXoxJ4a1BxBbx2UaQ3ESxRuY33bn53EAqwOeeRgDttQ8A+HNTury4vLGRpL2SOacR3c0avJGQUk2q4AcbR8wAOBjOK5jwr4LN34k8R3nijQL23iuNUF3aCe+VoZ0CIq74o5WV2BTcPMU4yCDnOHFrr2/WP/B0G7b/ANdf+ALda3ruj+KNTttQ1q8kg1TS/tOiwtDApgn3BWiBEXzMC8e3dngnIOM10Pim41jQPhjqN1Z6msuq6fYNN9subdW8xkXcxKLtUE4IGBgZ6HpTtT0k+IvE+mSXukyQwaJdG6iup2jInfyyq+WFYsAC2TuC8qMA1sa1o1l4h0e40vVUkks7ldk0cc7xF17jchDYPcZ5HB4qJawsv67f15BFpTTev9a/l+JwK6z4n1HxVY6auvC0tbrw1/aG6CyjMqzAoN259ynknjaBgkYzgjp/Bmv3Wt/DXS9c1B4UuriwWaZ2+WPdt5Y+gyM+1RQ/Dbw3BdJcRRais0dobJH/ALYu8rARjYP3vA/kQD1FaukeGtK0Lw8uh6bbMmmqjRrBLM8wCt1XLsTjnpnFVJpxaX9av9GvuJimrX/rRfqn9557oXibxRPq72b6w10LvQJNQiubmwRYEnV1GYFAjkaLDceZyflIY803QPEniS9j8GNqGuSyf8JLpM7zrFbwx+RIkauskfyE7uSCGyp6gDpXYxfDnw1AsYhtbuMxWz2iOupXIdYXIJjDeZnbwMDPGOMUlp8N/DNjPpU1ta3ito6lLENqdyywKeqhTIQQRwQQeMDoAKHZq39fa/zX3Bre/wDXT/J/ecB4Q1TX9I8C+AJYdckuINY1IQXcdzBG77X3thHAGBlCTuDMS33hjFZur2t6vgvx7LNrF3dkeJoYUS5WNlBEtvh/lRWzjC43AYAwAea9Pb4aeFTb2MC2NzFFp85uLVIdRuYxFITnI2yDpk4HRQSBgE0/Uvhx4X1b7Z9tsJiL24FzcCK+niEkoxhsI4A+6p46lVJ5ANNP3r/1vF/o/vG+iX9fF/mvuOfuLnxXd6t4u8PaX4inW+sra3vdOumtYCUaQSZhI2YKZQYJG4Z+8aytY8WeIL34fyeIvDXiCa2bTNEFxdJc2cMomuDkFWwq7XXY2cYXJX5SOD3I8N6b4d1K88Q6VpmpX+qXEaQypHqDyPMgIAG2eYR/LyckgjnHU5q2PgLSp/C+o6Xq1jsg1e8lvLy3t53iDF2ztLRsCeAoIzgnPap6f1/Wz+9D6r+v61X3MyxfeIj4i0rw7P4hlD6razag17BZwrJAiLEPJQMrIcs7HLKTjj3rKg8Y+KVudItbm9tz5Pid9FvJVtQGvYwpdZAc4Q4GGAHXoVxiu/u/Cuk3um2llcRXBSyAFtMl5Mk8XGOJlcScjg/Nz3zVW98BeHdQh0+K4tJ1TTZjPaiC+nh2Sk5Mh2ONz5J+Zsnk88mquua/T/g/5aee5Fny262/R/rqed+LdS1PxN4Kn1t9TeGzj8QQ2i6YsUewJFerGGZiu/zCV3feC4ONveur+Mi3P/CuLhrS/uLNhdWysYNvzq0yKVO5Tx82ePTnIyDqah8OfCuqT3cl/pXmreSrNcQfaJRDLIpBDtEG2FuBltuSODkE1r6poWma1okmkalaLLYSKqmFWKYCkFdpUgrggEEEYxS+yl53/L/Ir7V/66/5nDxXniseP9W0dvE26y0qxtL1CdPiMkyln3o5GASwQjcoXBIwBg5reGfE/jPVLjS9alsrpdE1C0ea6e+eyS2tcx7o2hMchlK54YOCec/L0rtdN8HaLpOvT6zYw3CX1xEIZXe9nkVkHQbGcrxyRx3Pqcln4N0PT5Lg2to6x3G4vbtcytACwIYrCWKITk5KqM5NLp/Xn/wPSwdf6/r/ADPObfxF4jvPtthda7eSxXnhubUFu0tYoVSZGAP2YlA5iIbgyKSRghqk8MXXiK0X4f6Jb+IZBp+q6K80pe0iaaMpEhAV9u3A3jGVJ4+Ytnju7LwB4b0+WCS2spd0Fs9pGZLyaTEL43RkM5yvAwDkDtioIPht4YtrvT7m2tLyKbTYjFaMmp3I8pCMEACTByABzngKOgGKuv6/7e/zX3C1/r5f5P7zj9N8WeJP7L8Paldaw1wZfEL6NcwG2iVLiMSSJ5jYXcJPkB+Uqv8As1PpfiXxxrt/ZalpNldjTri7lguBcrZ/ZIYQzosibZfPLqQuVbg/MAF4rpV+F/hVNPgsltb8W9vdm9iQavd/JOTkyA+bnOcn6knqTnSTwbokV9c3UEFxC90WaVIb2dIy7dXEauED553gBs85zU/1+C/W43vp/Wr/AEt9x5/oHirxRPp3hHUNS1v7QdX1W5065gjtIo49oM211+UsGUxjvgjqCeTu/B+C7XwxfzXmq3l+ZNVvEAuRH8pW4cFgVRSS3U5JHoAOK0oPhj4WtYdPhgtb5Y9NuGurRP7VuiIpW6sAZfr1/vN/eOdvSPD+maEbo6Ta/Z/tUzTygSMwLsSWIBJCgkk4GBkk45qrrX+u3/BE7v8Ar1/zRwGqeK/EEvhzxH4q03Ujbx6BfzwJpbW8ZiuY4SA3mMVMgZvmIKsoHHB73bazvLn44G6/ti/ijbQ4pza7INgUzEeVzHu25Gc53Z/ixxXU3Hg/RLrVW1Ca0czSOskqLcSLDM4xhpIQwjdhgYLKTwPQUDwhpA8VHxGEvP7UKeWZf7QuNhT+55e/Zt77duM84zzUx0cb9P8AK356jlqml1/zT/DY26KKKACiiigDm77/AJKnoX/YF1L/ANH2NdJXN33/ACVPQv8AsC6l/wCj7GukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/FH/IxeDP+w1J/6b7ypfEnh+81W5stQ0vVnsb3TvMa3jkhSW3d2XbmRSN3TIyrKQCfWovFH/IxeDP+w1J/6b7yr+p+G9O1e9iur4XRkjTZtivZokdc52uiOFcezA0hnF6Vq0/iXx/4WvNVthAj6Hc3EcG7cguPNjR2XPXCk4P91/etb4ZtLJ4VvoQ7Lbw6rfQWbKc7YVnYLtz2HIHbAFb+qeGtK1i1t7e8tmVbX/UNbTPbvCMYwjxsrKCOCAcEcGrtnZ22nWUVpYwpBbwqFjjQYCiqurW9fxd/+AL/AIH4K3/BPIfCmq6to3hK3RNYvLm41rxPPpyz3UcT/Zh58u6QYQZZgn8W5QSMADiu28L6nq8PjLW/DWrXranHYwwXVvfSxokpWXeNjiNVQkFDggDg9O9aSeCvD0djeWaacogvZzcSp5r8SFt25DuzGd3zDZjBORzV7SdEsdEhkj0+OQGVt0ss87zyyHGAWkkZmbA4GScDihPTX+tED1en9at/lp+JynjOxtB8RPA1+LWH7YdQmhNx5Y8wx/ZZjs3dduecdM1k3SQ3TfFCbWgN8MQiRnPKW62odNp6gby7cd8967XWfCOka9qllqGppdtc2DbrZob+eERtz8wWN1XOCQSRkg46cU7UvCei6vqK31/ZmScKEfbNIizKDlVlRWCygEnAcMBk4pPWNvX8epSdpJ+n4XOH8KmbVvEWqN4qQPMvhqwXZNzhJEkMxA7ZcYP+6PSuo+GdxdXfww8PT6gzPO9jGSzklmGPlJJ7lcGtLWPC2ka7PFNqVs7yRrs3RTyQl0zkxvsYb0J6o2VPpWrHGkUaxxKqIgCqqjAAHQAVble77/8AB/zM0rJL+tkv0HUUUVBQUUUUAFFFFABRRRQAUUUUAFFFFABXN2P/ACVPXf8AsC6b/wCj76ukrm7H/kqeu/8AYF03/wBH31AHSUUUUAc348/5F21/7DWlf+nC3rK+It/e6XqnhGezvr2KKbWo7e4tbbGLhWRjhgBuPKjuByc+2r48/wCRdtf+w1pX/pwt6reNtC1rW9Q8Oy6NFYNFpmpLfTm7uXiZgqsoVQsb5zvJySOg9cg+0vVfmH2Zej/Iq3HxQsrayS4fQdZONR/sy4jC24a0nJUKJCZdu1t64ZSRzyRVrWviHYaBqclpqGl6qVW5gtFuYbdZYpJZcbVBViVI3DO4L7ZyM5Ft4O1A6P43g8U/YLe01q4e8iltLp5Gg/dqoLbo0wV8tWBBPP0ycfxHb6nbfCnw9PqjRNrN5rWn3NwzgqplaZMA98ABV+gqo2bin/d/G35a/gD0v8/w1/yO1h8eaezX8F3Z31lf2MkUb2E8aGaQynERTYzKwY5AO7jBzjBqhc/FTRbGzlkv7HVbe5t76OwuLI2oklgkkxs3FGZNpDAghiD0GTxWdq/w71DxNJf6rriaWupTta+RZEG5tQkDMwSRmRS4fe2TsGOMA45j1fwHqc/hiG00Dw94X0W5a/trq4gs5miiIhkDj51twXLYxyo288mkrde6/T/g/wBbj8v6/rQnbx1qur+NIvD9voOs6VBPp1xI88q26TRMsgjEoVnPyjkjhidynaRUHw68dSSeEfDVprFvql3falbTNFfShCtzKhZmjyzht20ZBICkDg1uax4f1t/HFv4i0kafJt0mWxkguZnTDM6uCGVGyDtIzjjrg9K5vRfAvizTbPwPazRaKy+HJ5HuHS/lJlV1ZPkHkdQHJwSORjPOaI2tZ7/8GX6WB7t/1sv1Ojs/iLb33huXV4NA1n91fmwayKQG48wNtb5BKRgHtnPGQCOai0/4paNqFhJfrYavBYxmSP7TPZFFMqSiLysZ3byzDCkDPPcECK10GeD4ranc2Ukb2Bgjv3tmyAt6ytEG3cgAxjngnOD9aWmfD/WJfh/caJrMljbXo1ZtTtpLSd5o932jz1V9yIcZ+U47c+1Ctu/66P8AVoHvZf11/wAk/mbZ8f6cseqQapp+qabeafbfaprKWEPO8B48yPyWcMM8HDZXvimDxbYvoGm2+jwatcz6hpq3UEVuUkuYICoAldpX25G4dSxYg4Dc1UvvC+varPqes3lvpkOrzaS+l2trHeSNAqu2Wd5TEGz0wAnGMZ5yKeheD/FGgS6NfW39kyXUGkx6Tf2z3UvllIiSk0b+XndycoVA5xu4yVa8Wv6+1/wPvY9ndf1t/wAH7kVfh74whuPDvg201yfVrvVdT+0yQ3LGQIxUy581shW+UcIc4+UgDAI6qLxzaS6NPq/9mamNNiiknjulgWVZ0TGWVUZmGc8Bgp4JwAK5DQvAPi/Rn8HxyyaJdw6DNcSSus00LMswZSqjYwYruJySueBgfeNx/AmuQXmp3OjW2laat7p8sE1nb30wt7yeQDMzR+XiIr8xBUMWzgkU5u6bXn/wP6/pEYpNJ+Rs2nxHsr59PS20bV2k1SxN7p6mGNTcqACyjMmFYbh9/apzwTW54c8QWnifQ4dU09ZY4pGdDHMoV43RirKwBIyGUjgkccE1xOleEfFllqXg2ee20Yx+HtNks5tmoSkyllVAy5g6YjU8/wB4jtk7/wAO9B1fw34ZfTtdSyEwu550azuHlUrLI0mDuRCCCxHQ5xnviqko3dv61/yJV7K+/wDwP8zq6KKKgYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN33/JU9C/7Aupf+j7Gukrm77/kqehf9gXUv/R9jXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfij/AJGLwZ/2GpP/AE33ldJXN+KP+Ri8Gf8AYak/9N95XSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN2P8AyVPXf+wLpv8A6Pvq6Subsf8Akqeu/wDYF03/ANH31AHSUUUUAc348/5F21/7DWlf+nC3rpK5vx5/yLtr/wBhrSv/AE4W9dJQBUvtK0/U2gbUrC1vDbSebAbiFZPKf+8uRwfcVFq2gaNr8cceu6TY6mkRLRreWyTBCe4DA4rQooARVVECooVVGAAMACloooAKCAykMMg8EHvRRQBV07StP0ezFppFjbWFsCWENrCsSAnqdqgCrVFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN33/JU9C/7Aupf+j7Gukrm77/kqehf9gXUv/R9jXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfij/kYvBn/Yak/9N95XSVzfij/kYvBn/Yak/wDTfeV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzdj/wAlT13/ALAum/8Ao++rpK5ux/5Knrv/AGBdN/8AR99QB0lFFFAHLfEVp18JRNZxxy3A1bTDFHLIURm+3wYDMAxUE9SAceh6VL9u8b/9C94f/wDB9P8A/IdHjz/kXbX/ALDWlf8Apwt66SgDm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DrpKKAOb+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOukooA5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q66SigDm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DrpKKAOb+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOukooA5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q66SigDm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DrpKKAOb+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOukooA5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q66SigDm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DrpKKAOb+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOukooA5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q66SigDm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DrpKKAOb+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOukooA5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q66SigDm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DrpKKAOb+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOukooA5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q66SigDm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DrpKKAOb+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOukooA5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q66SigDm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DrpKKAPO7y88Y/8ACydGZtC0MXA0m/CRjWpijL51nuJb7LkEELgYOcnkYAPQfbvG/wD0L3h//wAH0/8A8h0X3/JU9C/7Aupf+j7GukoA5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOukooA5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOukooA5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOukooA5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOukooA5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOukooA5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOukooA5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOukooA5v7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOukooA878R3njE694TM+haGjrq0hhVNamYO32G64Ym1G0bdxyAeQBjnI6D7d43/wChe8P/APg+n/8AkOjxR/yMXgz/ALDUn/pvvK6SgDm/t3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOukooA5v7d43/6F7w//AOD6f/5Do+3eN/8AoXvD/wD4Pp//AJDrpKKAOb+3eN/+he8P/wDg+n/+Q6Pt3jf/AKF7w/8A+D6f/wCQ66SigDm/t3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOukooA5v7d43/6F7w//AOD6f/5Do+3eN/8AoXvD/wD4Pp//AJDrpKKAOb+3eN/+he8P/wDg+n/+Q6Pt3jf/AKF7w/8A+D6f/wCQ66SigDm/t3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOukooA5v7d43/6F7w//AOD6f/5Do+3eN/8AoXvD/wD4Pp//AJDrpKKAOb+3eN/+he8P/wDg+n/+Q6Pt3jf/AKF7w/8A+D6f/wCQ66SigDm/t3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOukooA5v7d43/6F7w//AOD6f/5Dqj4cl1Wb4k6+2uWdnZ3H9k6cFjs7trhCvnXuCWaOMg5zxg9BzzgdlXN2P/JU9d/7Aum/+j76gDpKKKKAOb8ef8i7a/8AYa0r/wBOFvXSVzfjz/kXbX/sNaV/6cLepvFfipPCdpa3M2lX+oR3NwlsPsXk/JI7BUB8yRPvMwGRnHfFHkBvUVg6H4utNa1a70mWzvNM1WzRZZbG+RA/lsSFdWRmRlJGMqxweDit6gAoqjqusWejW8Mt/JsE9xFbRDu8kjhVAH1P5A0usatZ6Fo91qepSiK1tYzJI3sOw9SegHrQHkXaK5608VG68e3fhptNlh+z2KXq3TyKVmVm2jaoyRyCOcHjpjmuho6XDrb+u4UUUUAFFRRtcG4mEsUawjHlOshZn453LtAXB6YJz7Vi2Xihrvx3qPhp9OlgNlaRXS3LyKRMrsR8qjJABUjnB46YwSbuwdLm/RRVLVtXs9EsfteoSiOMyJEvqzuwVVHuSRQBdooooAKKKKACikY4UkAsQOg71heD/E58WaNNfNYSae0N5NatBLIrsrRuVOSvHUdiR7mjcPM3qKKKACiqWl6vZ6zbyz6dKJYop5IC46Fkba2PYEEfhV2gAorl/E/jm10DR9dvLS0k1SbQ4kkuoIZETbuBOCzHjAGTwTgjAPSujtpvtFpDNt2+YivtznGRmjzAlooooAKKiuWuEhzZxRSyblG2WUxrtyNxyFbkDJAxyeMjqMzxZr7eF/Cmoa2tjLfixhMzQROqEqOpyxxgDnueOATxSbsrjSbdkbFFQWNz9t0+3utmzz4lk25ztyAcZ/Gp6ppp2ZKaaugoorAHic/8LBHhdtOlTOntfLeNIu1wHVNoUZPVuScdOM9aS1dv67j6XN+iorZrh4c3kUUUu5htilMi7cnaclV5IwSMcHjJ6mWgAooooAKKKKACiiigAooooAKKKKAObvv+Sp6F/wBgXUv/AEfY10lc3ff8lT0L/sC6l/6Psa6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8Uf8jF4M/7DUn/AKb7yukrm/FH/IxeDP8AsNSf+m+8q14m8U2PhSzt7nUobySO4nS3U21u0gVnYKCzdEGSOWI9s0AbVFZmt62miw2+LO5v7m6l8qC0tdnmStgscb2VQAASSWHSq174nTTtNs573TL6O9vpPKt9LBia4kfBO0bZDH91SxJfAHUigDcorP0XWrbXbA3NoJIzHK0M0MoAkhkU4ZGAJGQfQkHggkHNO07WLPVLi+ispPMNhcfZpyOgk2KxAPsGGffNAF6iisHXPFkXh+UNeaXqL2KuqTX8UaGGAsQBuBYORkj5lVgO5GDR1sBvUVg614ttdHvxZJZXuo3Kw/aZ47JEY28OceY+5l4yDgDLHBwpwaZe+NNPgNmunW91rEl5bfbEj09UYrb8fvSWZRt5GBncewODR0v/AF/Wj+59g/r+vw+9HQ0VW03UbXVtMttQ0+ZZrW5jWWKRejKRkGrNNpp2YbhRRRSAKKKKACiiigAooooAKKKKACubsf8Akqeu/wDYF03/ANH31dJXN2P/ACVPXf8AsC6b/wCj76gDpKKKKAOb8ef8i7a/9hrSv/Thb1gfGfVLWw8JWEc2qWen3MurWbQPdMMDZOjM+0spZVHJ5HHcVv8Ajz/kXbX/ALDWlf8Apwt66SjZp9mn9wdGeVeJvDGrW+n3/iptW/tbUL5bS2lk063MEcWniZXk8tQ7scqWJbcTjpVePTtKutZ1tPA+pWth4YvNHEc8+nANaR3jS7UKhDt3bchwpHGM9jXrtFHl6/iv6frqH/A/D+remh4Jq39k6l4dtYdQ0PQBa6V4hsIZb7TEV7CaIth9oIwn910yQCQCTXffFyxs7v4M6sq2cUkMNskkCGDiIKVwQpHy4XPpgV3tFO+lvO/4L/IFpJP+t2eG6nL4IufHOsWjy6QNMt/CapHbb0SFGErsMJwMjKsDjjcCOuadp0lhpmh+C/iRb2kGoXMunppupTRIJJHkeMIjEgE7xIojJ64cg9K9wrJv9JutS1KL7VdwHS4njmFqtsRI0qHcC0hcgrkA7QgOQOe1CfT+t3f707B/X4JL8Vc8rk8J+FbP4peHvDF39lAm0S5W7sUuTGkkxaMgiIMArH52G0Anbn+EYhv7eKfR9SSVo4viLFqrtp/z/wCmCP7RiLZ/EYPL6/wY3Z5zXuFFNPby/wA7/wDAD+vwseFXGrRw6l8Q7fRNQe5KanYvdpbXTTTLbfILopyWAGXBC/d5AxjFQX1zptt4n8R/8K3WIW1xodm6Ppds8kCoLh/OK+XgZ2bvlDKScgfNmvfKKlaJL+trfd/wQ/r8b/eeIfYTp/hrVdU8Ma/YanpV1NaG8s/Dli0EMESyjz2AEshDtGTuAwcDPWpvGWieCG8EPfeG/sN5pT6tYTyRwbJbO1AmVZCgA2x5XO8Z+o559poqk7W9V+FtPTQVjxnV7fQ5pfFFt4gS3trsIv8AwiybfLlSIQLs+xjghvMByE5zgHjFY7voz654rg8Y6haT6gnhe0a6jur3eqXaq+/apbCsG2EBQMFgRgtz79RUvVNf1ta/r37lJ6r+uqf6adjwvRJvDOq+IvBVvdXGnXL694dlj1NWmV2vJMRBRJzl2DLIFzyCpA6V0HgLRbX7db+F73TICfBdxKY5WtwAxkObeRTjBYxlixHO4AnmvT7lZ3tZVs5I4rgoRHJLGZEVuxKhlJHtkfUVT0jTJLBZ5rydLm+u3ElxNHEY0ZgoUBVLMVUAcAsep55q3K7b9fzbX3XZHL7tv62t+JyHjy4sY/GGgw+LhD/wi0sM4mN2B9mN1lPKEuflxt37d3G73Arzzw6+kWF34d1OVFtbTT/FOpQSXtzE0axxSLLsHmuACpOB1xnAPNfQdFTF2/rzv/wPQp6q39bNf8E+frGSGCxvbO2W103w8nie9N02oaXI9isbJiIOm6NTHuDDrtUhcjpXqvw90hNM8ImyGrwa3ZvNI9vNBBsgET8iOMF3zGMkD5iMcdq6yiktFbyS+5IHq7+bf3tv9TwjQrSy03waYrGxt7W2j8Uypr/kQeWUtFnl2LKVA+QApkHgIem013HgG2tYfFmvv4VeE+E5I7drRbRgbUXHz+b5O35QMbM7eN2e+a7+imnZf12S/QHq/wCu7f629DwPxbFoGjyfFlriCwsr+e2jFs7RKkjLJAM7WxnDOD9W9TWnaWPhDxB8Qbjw3FLptzZ6x4Zha4jimWQzTq2VkzkkyBCG3fexg5r2moL5LuSykXTZ4Le6I/dy3EJlRT7oGUn/AL6FLpZ+n4Nfrcb1/rzT/Sx41a2umah4Fvj4jtILCXwdp02l/aR/o2y56bo3XaV3KsRG04PnEc80ml6fo1r4P8D6jtgbQL6KP/hILhpi8EhS1ZEE+SV2h/lOeMqoPQV6/pOmjTLaRWk86eeVp55tu3e7HnjsAMADJwAOT1q9Vcz187frf72/yJ0/P7tEvuseA6+2n6VoV5NFqMdt4eXxNYyaGBdlITHmMz+WMhWiB3EDlRgkYxmr3ju40i9g8eR+KDC+qLaM+gGbktbfZwc2575ffv284+9xXuFFLpb+tkv0/FlJ2d/63b/U8/8AF97ZSfAO+ubi4ls4jo+Y3kd7VxIE+Qc7WBLADafvZxgg1x2my+DX8YeGbdrrSpLS+8MSHUEkuUZLlkEezzsnDlQJcbs4Cn049xoobvJvv/k1+v4EpWio9v8Agf5HzTaato+v/D+0sJbm1vb6z0K78g3s3mpE6yPtEEY5M6qFOQwKIVOCDXbaX4j0O8+I2ii71u0YSeDysz/bQrZLI5ywYENtDN1zgE+9ewUUdb+v4qS/9u/Abt/X/bv+X4nz/pWs6MPhX4Xku7y11LTLfWbpL2wnu4gt0C0zKrvM4QkBlkAkYbuDycUxhosNl4SnvfEMMn2vxMxS3TX2nit7X5ysRCymMbMxqdvAyBk559o13RdR1C+sb/R9VjsbmzDhUubX7RA+/AJZAyNuAGAQwxuPXNXNM06WzM095Olze3O0zyxxeWh2jACrkkDr1Zjz16U7683mn+X+QS2svP8AG/8AmeJ2ur+G1/tfRElsZdKj8V7ILX7QiWMUbQA4mABHlFw+FwAzgDI5qpb3mjx6H4QstR1aCKS18W3Fu1ut48CJAJJOPKL8IP3YAbO0EDPPP0NRSTtbyt+Fv8vxCWqfnf8AG/8An+B4HZappUd1qWnW9xav4Ss/FTjULa2KtBDavb/LvVeBD5+c/wAOQc8ZrovEHhLw1aeF7XxN4Whh1NNAvxqVuRtmjEGQ0sMJAxsCksoGQrDjFetVl61pt9qsQtIL6G2sZkeO7Q27PLIpGMRuHAQ9eSrde1F2krbq34Jb/cPRt321/G/+ZR8G2Vn/AGfca5bWkUE2uTG9kdYtjOh/1W7jOdm3Oe5PrXRU2ONYo1jjUKiAKqjoAO1OodumxKvbXcKKKKQwooooA5u+/wCSp6F/2BdS/wDR9jXSVzd9/wAlT0L/ALAupf8Ao+xrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5vxR/yMXgz/sNSf+m+8rI+MOp2GneBANQvbe1Mt/aeWJpQm/bcRs2M9cKCT6AE1r+KP+Ri8Gf9hqT/ANN95XSUdUxo5PxPdeBtSjsE8S3mllriMyadPJOqSMGx81vIDu3HK42HJ4rmR9v0mfwVrvim6kFpYm8t7i6uhtMSSA+RLMTjadiBWJx8z816lRRtsLfc47wBDJNP4k1cZ+xatqrT2ZI4kiWKOPzB7MUJB7jB7153FZWmm/8ACVx6VYQ20q+Ko/7SNrBslTTiYmYEqMiM5Jx0I3n1r3WimnZp9kl91v8ALX1DdWfe/wCf+eh574It7CLx3q0vg17Y+FJLKEqtiym1F3vcN5W35QdoXdt4zjPNM+JF2mox/ZPD3iqJNf050mi0KNoZvtUgZSoliKmTHTnIC8N2BHotFF9V5B38zzu51G38LfETXr/xBMlvFq2m2osmfgTSR+YGgT+8+WBCjk7uBWD4LiPw9v7GXxhMtkl14etreJ5yAFmjeRmgz0L4kXCjk4OM4r2Kii+n9ef+YeX9dP8AI5f4badeaX8PdMt9SjeG4ZXmaF/vRCSRnCH3AYD8K6iiihu7uJBRRRSGFFFFABRRRQAUUUUAFFFFABXN2P8AyVPXf+wLpv8A6Pvq6Subsf8Akqeu/wDYF03/ANH31AHSUUUUAc348/5F21/7DWlf+nC3rpK5vx5/yLtr/wBhrSv/AE4W9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc3ff8AJU9C/wCwLqX/AKPsa6Subvv+Sp6F/wBgXUv/AEfY10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc34o/5GLwZ/2GpP8A033ldJXN+KP+Ri8Gf9hqT/033ldJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc3Y/8lT13/sC6b/6Pvq6Subsf+Sp67/2BdN/9H31AHSUUUUAYni7S77V/D4t9KW3a7ivbO7jS5laON/JuY5ipZVYrkRkZ2nk1W+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q66SigDiZ7bxvN4qsdZ/sTw+v2SyubTyf7bn+fzngfdu+ycY8jGMc7u2OdL7d43/AOhe8P8A/g+n/wDkOukooA5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOukooA5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOukooA5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOukooA5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOukooA5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOukooA5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOukooA5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOukooA5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOukooA4nVLbxvqWo6Ndf2J4fi/su9a72/wBtznzc280O3P2Tj/Xbs8/dx3yNL7d43/6F7w//AOD6f/5DrpKKAOb+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5DrpKKAOb+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5DrpKKAOb+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5DrpKKAOb+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5DrpKKAOb+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5DrpKKAOb+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5DrpKKAOb+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5DrpKKAOb+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5DrpKKAOb+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5DrpKKAOb+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5DrpKKAOb+3eN/+he8P/8Ag+n/APkOjQdP1z/hKtU1nXrXT7T7VZWtpFDZXj3P+qe4cszNFHjPngAAHoa6SigAooooAjnuYLWMSXU0cKM6RhpHCgs7BVXJ7lmAA7kgd6krlviLbQXnhKK1vIY57ebVtMjlilQMkim/gBVgeCCDgg1L/wAK48Ef9Cb4f/8ABXB/8TQB0lFcTD4W+HFx4iudEg8J+H5L21gSedF0uAiJXJCgnbwTgnHp9RVXxF4W8IaLcaRFa+APDV4dRv0tGV7OGNkBBJdR5TbsBWJGV4HWje3mHfy/4c9Aorz/AMT+FvCOg2+nyWfw/wDDd893fw2hjezhiZRI2Ny/um3FepHHAJzxV6fwb4Ds472bUfA+h2draAE3M2m22yUYySoUFuDxhgCT0Bo6X/r+tQ62Oyork/8AhAPBn25YB4C0UxNEX+0/2ZbeWDnGzGN+7v8Adxx1zxVj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6SivK/7J8NnRRfL8NPCryHWP7NESxR4dfN8oyK32fkhs/KQBhT83r2H/CuPBH/Qm+H/APwVwf8AxNHS/wDXf9Q2dv67HSUVxOveFPh74d0eXUL3wboTKhVEij0qAvNIxCoijbyzEgD60aL4E8OXlvM2tfDjw5psyS7Y0jtbedZEwCGyI1weSCCOCDgkYJNwO2orm/8AhXHgj/oTfD//AIK4P/iayPFHhnwF4V8OXetXXgHSby3tF3yx2mlWpcL3YB9oOPTOfQGgNzu6K850/QvCV9fQWtx8JbbTTcxs8M17pth5ZIGdpMTuyk57r61J4f8ADvgjVdH0+51PwP4ZsLrUJJEgt4rKGYOFLfMreUpIKruyVHUU7Cuj0Kiub/4Vx4I/6E3w/wD+CuD/AOJo/wCFceCP+hN8P/8Agrg/+JpDOkormj8OfBAB/wCKM8Pn2/suD/4mobPwB4MubOOabwFotnI4y0E+mWxdPYlAy/kTQB1dFc3/AMK48Ef9Cb4f/wDBXB/8TWN/wjngP/hM/wDhHG+H+lic2hu1uv7LtDCUDBccfODk45UA4ODxR1sHS53tFeaz2fw1h1Z7RfAuly20V2ljPqEekW32eG4cgLGScMTllGVUgE4JFF9Z/Dax1SW0/wCEE0u4gtZ47a8vodItjBaSyEBEcnDEksudqttyN2KFrt/X9XX3ruB6VRXN/wDCuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNAHSUVzf8AwrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATQB0lFc3/AMK48Ef9Cb4f/wDBXB/8TR/wrjwR/wBCb4f/APBXB/8AE0AdJRXN/wDCuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNAHSUVzf8AwrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATQB0lFc3/AMK48Ef9Cb4f/wDBXB/8TR/wrjwR/wBCb4f/APBXB/8AE0AdJRXN/wDCuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNAHSUVzf8AwrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATQB0lFc3/AMK48Ef9Cb4f/wDBXB/8TR/wrjwR/wBCb4f/APBXB/8AE0AdJRXN/wDCuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNAHQNcwLdR2rTRi4kRpEiLjeyqVDMB1IBdQT23D1FSV53eeAfB6/EnRrVfCehi3k0m/keIabDsZlmswrEbcEgOwB7bj6mug/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDoJbmCCSGOeaON7hzHCruAZG2ltqg9TtVjgdlJ7VJXnfiPwD4Pg17wnHB4T0ONLjVpI5lTTYQJF+w3TbWAXkblU4PdQe1dB/wrjwR/wBCb4f/APBXB/8AE0AdJRXN/wDCuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNAHSUVzf8AwrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATQB0lFc3/AMK48Ef9Cb4f/wDBXB/8TR/wrjwR/wBCb4f/APBXB/8AE0AdJRXN/wDCuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNAHSUVzf8AwrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATQB0lFc3/AMK48Ef9Cb4f/wDBXB/8TR/wrjwR/wBCb4f/APBXB/8AE0AdJRXN/wDCuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNAHSUVzf8AwrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATQB0lFc3/AMK48Ef9Cb4f/wDBXB/8TR/wrjwR/wBCb4f/APBXB/8AE0AdJRXN/wDCuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNAHSUVzf8AwrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATQB0FtcwXlrFdWc0c9vMgkilicMkikZDKRwQQcgipK5v4cf8AJLPCn/YFs/8A0QldJQBzfjz/AJF21/7DWlf+nC3qXWvFOn2OpwaDb6lZLr18MW1rLKNyjB/eFc5IABOON2MD1FX4itOvhKJrOOOW4GraYYo5ZCiM32+DAZgGKgnqQDj0PSpft3jf/oXvD/8A4Pp//kOgDzLRvEX9i3/xDu7LWdL1fWNPsoI45LSMoHKhy8pQyOTteX5iDjIxx0p91Np2m+KX1Hw7B/aVzonh6fU/tpO9tUuHGxJSRy4UB8N0AfC4FelfbvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHTu/w/Rr9bhpf+vL/K3zOE0e20a6+Ifhz7M4vnttOm1O71hmDHUJSAgOc/Mq+Y5H8K52rjkVWtLHQNW8DeH7STT7E2mt66dQliS2Xy0QbpgiqBhjsEcZC9csPUV6J9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdO/X+t7/5fcLW1v62t+r+84G8ntNMs/Ft/4bitdJEmpWulzXNjEI/sdrGyxySsVGFI3ScnkKFPQCotRsNOlXX5vCGn2p0W50tNNSUx7oNTvppAEkyQRLtyMyc5LHk449D+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5Dqemv9aW/zfk2Prp/Wt/8l6HB6q48J3+s3GmzRjUdJ0SC1luhH0aaQZkbriOJVUqDwAWx3NMhn8O6P44vNU0lPMj8P+HpLuS7bLG/llP+tLn752xEb887sA4rv/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5Dp3b38/xv/mJJL8Pwt/kc7pwtxe+DdAl/fCG1lv5cgfvpAPL3Fc8qTLI+fYeoqDwdpdv/a2ueHLOzW3stJ8Qm7QJHsSFTHHIiJjgZZjwOAu4dxW7qk3xFutPeLS9M8PWFyWUrcHWJZdoDAkbTaAHIBHtnNOsf+EzsLcxxeH9BZ3YvLK2vTbpHPVm/wBD6/oMADgU+bVy/rdNfdawW0Sf9aNfjco+O9H0/wAS+MPCekX2m2l8EnmvpvtECybYY0wV5B4aR48jvj2rj4lh8S6fB5QW78bTasGc9ZdEhSflf+mK+UmMceYW/izXWaJp3xAsb6XUdZ0/w9qmpPELcXA1aaFUiDEhQgtDyScse5A4AAFbn27xv/0L3h//AMH0/wD8h0lpb7/x/wCArjlr/X9dWc14H8LaZrF5rviC4tYvs17rbXFnBEnlKpgbYJSFxuYujNk56+5yvxY8QaPt0nwtf69baVJqV7E9zI9xEjQW8eZC58zKgFkCjcCCTjBrpPt3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5Dpdl2t+H/DB1b73/AB/yuctF4r02x8I+Jf7K8Sr4hu48u2pCSNo1eXEUKM8YWPcMDhQMAZOM8xSab4ZHi6KbU9MtJrfw54fTyftNsrNzltxBBxtWIYJ6GQgcmuu+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5Doe2n9aNfqHr/AFqn+h55B4ebwz8INL1PAstQllVpLqD92mlwXUwMxVV+VQiMRuxxjPAHF60sPCk/iK/e1s7I+FbiwWzbKhk1i8LeYGTP+vdVX74ySSeTg47X7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOm7Nv+ulv8/nqJXt/W97/wBeRwBOlr8Jb6PVre1uNfjX+xbmfUI45XiYzCKMO5GAo+SQL7Bupybur2OmQapqurLa2y6RoHh5LeUeRte5JXzFhfIB2BVQlT134PGQey+3eN/+he8P/wDg+n/+Q6Pt3jf/AKF7w/8A+D6f/wCQ6Hrv/Wlv1f3lKy/rzX+SLPhW1i0bwPpVtJOpjs7KNHmb5VwqjLc9F4+mK5rwbrFl4n8SeLtf0e+tr4xtHp9r5Eqv+7iQsG4PAaR5MHuFBGRW59u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHRJuTbfUUdEked+H4Trnhfwh4Y0tvNuLa6TVNfdR/x7yoxlaOQ9pGmI+U84BOMUmjwtrXhPRPCVk3manPqn9o+ISo5tNs5mcSf3XZgqqDyRyBgV6L9u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdPm1v53+f8AlotPIXT+vP8AHV6nSUVzf27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh1IzpKK5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOgDpKK5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOgDpKK5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOgDpKK5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOgDpKK5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOgDpKK5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOgDpKK5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOgDpKK5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOgDpKK5v7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOgAvv+Sp6F/2BdS/9H2NdJXnd5eeMf8AhZOjM2haGLgaTfhIxrUxRl86z3Et9lyCCFwMHOTyMAHoPt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AOkorm/t3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoA6Siub+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgDpKK5v7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6ADxR/yMXgz/sNSf8ApvvK6SvO/Ed54xOveEzPoWho66tIYVTWpmDt9huuGJtRtG3ccgHkAY5yOg+3eN/+he8P/wDg+n/+Q6AOkorm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6AOkorm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6AOkorm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6AOkorm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6AOkorm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6AOkorm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6AOkorm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6AOkorm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6AOkorm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6AOkorm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6AOkorm/t3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6AD4cf8ks8Kf9gWz/8ARCV0lc38OP8AklnhT/sC2f8A6ISukoA5vx5/yLtr/wBhrSv/AE4W9dJXN+PP+Rdtf+w1pX/pwt66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5u+/5KnoX/YF1L/0fY10lc3ff8lT0L/sC6l/6Psa6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8Uf8jF4M/wCw1J/6b7yukrm/FH/IxeDP+w1J/wCm+8rpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4cf8AJLPCn/YFs/8A0QldJXN/Dj/klnhT/sC2f/ohK6SgDm/Hn/Iu2v8A2GtK/wDThb1d1q/1q1uLaDQdIt79pVd5ZLu8a2jiC7cDcschLHdwMdjzVLx5/wAi7a/9hrSv/Thb1u310ljYTXMyTOkSFmWCF5XP0RAWY+wBpS0Vxrc4Cw+IHijVPB6+ILbwtp0drNBPJG39rSSGNow3+sX7OMA7CAQTyQOM10Hh3xrpmp+GLS+1LVdNt7z+zob2+hFyq/ZldAxZgWyi89W/OuV8GyzW3wDuLS50zVYby3tbmF7WTTZ1mLuzlQqFNz53ryoIHOTwcZ/haN4fEHw/h/sXU4I7fw/LZ3rPpM8ccUjCPCOxQAZaNzzx3/iGbS1kvT8pP9ES9k/X81/wT0lfFvhxrG3vV1/SzaXUvkQTi9j8uWT+4rZwzew5qaLxFos6zNBrFhItvGJZil0hEaEkBmweBkHk+hrz3RtK+x3+r+FtW01rnQtB828tk+zmdZorhT5cQjAJbZmddoHTZisrw94cuIvhT4Rmg0KeGfS76KXVLV9PaO5kiR3YgIyhnwzK4AznBxk8UtPy/H/Ib0/H8P8AM9U/t7Tb7w/Pqek61prWyo22/wDNWW3jYd2KsAQD1G4fUVX8SeJLfQNBe5a+01bySJjaR3l0IEuZAudqnknPoATXmvi/RW1XRfHmr2ejX0tnq9jBFZ2baZN5012gced5BTep5Qb2UH5c9MGtGRrhNU1abUdD1O8tdZ0KG3sHXT5XMZVHDwSIVzESzA5cKD68VM78rtv/AMD+v60Grcy/rt/XyO78Ja3LrvgjSNbvxFDLe2UdzMEyEQsgY4yTgc9zTl8XeG2toblfEGlGCeQRRSi9j2yOSQFU7sEnaeBzwfSue8MabJP8D7HSNe03ULRv7JW0uLUKPP4TYSoBPJ6gHn1A6Vy+r2/iTUvCWtWc1rc6tDp11Yy2t8dLe1urpIpw0iGIgFygXIZVAbccCtZqPtGltf8AC5EbuCfU9PHiPRDLeRjWdPMlgQLtPtSZtyegkGfl6HrjpRD4i0S4gu57fWNPlismKXUiXSMsDDqHIPyn64rxb4i276i/jLVrnw9enT7iy017S7u7QRjzI5sEBXw6sRLj7oP3gccZu/ErTotc0vxNrkOkz2+n2ugG2Zr2yMBmnWQMhVHAb92AcPjHz/KTzUL+v6/D7i9L29P0/wA/wPX7bXtIvWuhZ6rY3Bszi5EVyjeQf9vB+X8aiHibQWsp7xdb042tsFaecXceyIMNylmzgZBBGeoNeb69ZQ69cXOpQaDfHT7Tw9NYzxy6XJm6mYoYo0iKbpAhUncAVGeD1wyHQ7i38E+CNQsbPU9NFjCiakbDTV+2xssJjDGGWJi+1iw+6Th8r60W0fy/N/5X+ZK6f10T/X8D06XxDosFna3c2r2EdteMFtpnuUCTk9AjZwxPtTn17SI7yG0k1WxW5nQSQwtcoHkQkAMq5yQSQMj1rzQ+Gl8O6RDqHhq+8Qx3kTXM9vLd6QblZxOyM8T28cSNGGcAj5UK4JPHFTyDXbHUbG/07TrmK/1BrRdS0OTTjLZ5VI9zx3CjbFsU8bmwTGQFJ5ppXf8AX9f1t1D+v6/r5nokGoQmS/aXUrKWG2kAYRkKbYbQSsh3EZ79F4I47llv4k0O80p9TtNZ0+fT48h7uK6Rolx1y4OB+deTR6TdzzeKYtJ0W+gtB4ntdSa3bTZIFu7ZPL8zy9yqrncjNgctjPORmL4gaMddtfFGtWGh6hPa6hYW1tb27aTN5092kjEy+SU3rtT5d7KOuAfVLVJ+n5J/8D1RXW39b2/LX0PZbLVtO1KW4i07ULW7ktX8udIJlcxN/dYA/KfY0261rS7K+isr3UrO3u5lLRQSzqkkgHUhSckfSuJ8PS7/AIwahNbabqNtYzaJawxyy6bPBCXRnYruZAAQrrx9R1BFL4th1PT/ABM+peG1vLi7umgt7jTJ9Naa1vFU53CYD9yVDH5mbbkfdJotqvMm+j/rsztDrelDWBpJ1OzGpFN4sjcJ5xX+9szux74qKLWLOMXUl3q+ntDHciBSjhPJYhcROS5y5Jz/AA8MBjueK8L6fDE8uj+KNDvptUttZm1G3u/ssjRS7pWaOUTgbAQjBSrMDhcYIxXDX2n20mg6xaR+FNUI/wCEvivrSIeHrjC2++Le6jysAFUfIHJ6Y5GSKu0v63X+b+71G9E2un/B/wAl9563rnxB8N6J4cuNYfV7G4ghl+z/ALm5Rg02ceXkE4Pr6DJPStWz1a01C9Q2Gq2F1byWwmSKFg7sCeJAwbBTHH3evftXkXiO2vtSuPHyado2rNHPcabcW4/s2dFnELIJTHlBuI29BkkDjNbF0sMvxP8AEV0ukarZ2194b8mW8j02WMPKC7H97tClxGVwS3YLnIwJvZX9f/Sb/noO19PT81+jPR7HXdJ1NbhtN1Syu1tWKXBt7hJBCw6hsH5T7Gof+Ep8Pi1mujrum/Z7dVeaX7ZHsjVvuljnAB7E9a8f0+x07WWsLnxZokbjTdEexs7VtAvJftbYVlcedbqA4CHCIXPLEMRWpounf2b8NfBDxeGZ4r6CSGO7uG0uYz2TIjje0KhXf5mYAkFRvLYIq3Hf5fm1+n42JT0v/Wy/r5Hqaa3pUllb3ianZtbXRAt5xcIUmJ6bWzhvwqunirw9LHbSR69pjpdymG2ZbyMiaQHBRDn5mz2HNeOR6W1vpvhmHUPD+q3Nzp/iy5uJZH0WWRktzJI28lI9oVi0Z+Xg44Hy8Ta5FPNoHxDS10LWGmvtZt5bQJo1xumVfKyy/u+RmOQ5/H+IZSs/6/w/5/gN6Oy/r4v8l957nRUVrOtzaRTxrIqyIHAljaNgCM8qwBU+xAIqWlsJaoKKKKBhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzd9/wAlT0L/ALAupf8Ao+xrpK5u+/5KnoX/AGBdS/8AR9jXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfij/kYvBn/Yak/wDTfeVc1vU9Ys9y6Ho8WoPHH5kn2i7NspHPyowR9z8dDgdMkVT8Uf8AIxeDP+w1J/6b7ym+LNdSz2aW0GqhbtD511ZaZc3Iij6EAxRsA56DPTk+gKd+g15lSHx8NV0/RG8O6abrUNatmu4bW8m+zrFEuN7SOFfGCwAwpyT6ZNSf8J5FdaZpzaVZG41TUriW1isZpfKEcsW7zRI4VtqrtPIU54wDmslli0rxLonibT9J1JdFi0ubTDbxWEpmtwJEaNvICmQKdhH3cj5SQKzNO8O6l4futF8TXtndSBdR1G4vLS3jaaS3iuiSp8tAWYrtQEKCfmPpVu35/novuJ6f121f3noHh7Xl12zuC8H2a7s7h7W7ty+7ypVxkBsDcpBDA4GQRwOlZ1x4xggn1a6lltbbRtGJiury4lC+ZPgHy0JIAxuUEknLHaBxUfgfTbmCTXdXvIZLY61qTXUUEqlXSIRpGm5TypITdg8jODzWNoch0jwd4tsLuG4ku7fUb0tFbW7zSSCdi8TBEBZgRIOQOMHPQ1E7qLa3tf56f5lxSb+dvlr/AJFvwr45Op6IPEWta14ci0OeFGDxXGxrOZgCYJXZyrEAjn5Dn+GusfWtLjs4LuTUrNLa4x5MzTqElzz8rZwfwrzTQhd2lr4H1i803Uzp+laQ9jd2502cz29yUiUP5OzewwrLuVSOfQk1jXfhn7DcaDNPoN5LFJ4sk1G3ij0yWZrKzYHIbah8sM+19hx15GVONZJc/Ktr/rb8tfQzT9zmf9aX/PT1Z7TDewXenLe6dIl7DJH5kL28isswxkbWztOfXOKyfCHiV/FWjzXsunSabJDdzWr28siuytGxU5K8dR2JHua14obbTrIRWsCQW8KnbFBFgKOuFVR+gFefeDIr/VfCPiDT7H7bot5Pqt1NHNqOlTxgxSzFgQr+WWyuR8rArnnBxWfV27fqi/sr1/R/8A6HRPGtvr3jPV9CtLSQR6bDFILxm+Wcuzqdgx90FCN2eTn0ydfWdYtNG09p7u8srV3+SD7bciCOSQ/dXcfU+gJ9jXEeFtD8Rab8WdUlvpLI6eNKtYRJa6VJbxSBWl2pGTMwUrnJ+9kEcL1N7W/tGnfE6HUtQ0y71DS7jSzZwSWtq1x9mmMhLhlUEqHXaN2MfLgkUS2SXn+v5iW7fa36f8OWPC3j6zvvAWma/wCKr7TNIe+Z1AkuBFGWDsoVS55OF/8ArCt8+I9EGsR6SdZ08alKoaOz+1J5zgjOQmdxGBnp0rxrw/p2rQ+FNH0u58M6ppk66VfWq3ZsTM/7x9wiCgskQYYO6Vf4cAc870tveaJ4A8GeKrLTbk6nolpDaXVo8JimkhkRY3jKtg5D7WGf7vvVOzu/P87/AOS+/wC9baev4W/r5fd6GPFnh1o45F1/SykkzQIwvI8PIv3kBzyw7jqKtahq+m6TYfbtV1C1srTIH2i5nWOPnp8zEDmuD8R6Re6LZWV5o096ms2lk0TLHpbXltftI250kVRlcuM7sqBuySRxWx4407Udc+D+qWUVhs1G40w4s4iG2ybQTGvryMCp6X/r+vy/NrWSXf8Ar+v6tv8A/CQaN9tubP8Atew+02kYluIPtKb4UOCGdc5Ucjk8ciq8/i/w7b2t9cPrensmnxCa62XKMYUIypYA5Ge3r2rynxmlxrd9ql2nhXWbuyuvCZs4mfS3JFz5jMgMTDfkMBzt4OG4HzVaSCeXW9Jt9P0bVIYz4PnsGJ0qeGNZiEKxszIFU/K/XHJ9SMp3s++v4c3+S+8cbNr5f+2/5v7j0PRPF1h4l0vR9R0rVNPVL8bjbNIskjt5ZYxKQww6nluG4BGB1EfgbxHf+JdLv59Vtra2uLTUp7Ix2zs6fum253MATznnA+lcBYKYNR+GE83h/Vo7nTrQ295P/ZE5aFTb+WFdghKjzM8HGPvdCCeq+FTy/wBna8s9jf2bSa3dXMYvbKW3LxyOWRh5ijOR6cjvitZJKTttr+a/Qi75U3vdfk/+AVPEvxXtLfR/ET+FJ9Mv9Q0N1WWGe56j5Q7qi8sFZgvUDORkYruLLWdN1D7QLPUbS4e0O25WGdXMDYzh8H5T7GvJPFlpqEOifEjTzouq3Euq30Ulp9msJZlmUxRDgopB5Rs+mOcZGXeILTUNX8TeIIvD2m6rBHcaJYrG/wDZskCzGKYu8StLHs3+W20BuMnaehFQvhX9dLlvf+u6R63pmsaZrVu0+j6jaahCrFGktZ1lUMOoJUkZ9quVxPgfSLZNXv8AXYLzxBc3F9DHFcHWLJLTBTO0CMQxZIDEbsEYwMmu2oasSjm/hx/ySzwp/wBgWz/9EJXSVzfw4/5JZ4U/7Atn/wCiErpKQzm/Hn/Iu2v/AGGtK/8AThb10lc348/5F21/7DWlf+nC3rpKACmTI0sDokrwsykCRACyH1GQRke4Ip9FAFDStKXS4pM3M95cTsHnurjb5krBQoJCKqjgDhVA9uTV+iigAooooAKKKKAMPxd4Xh8Y+H30e8v7yyt5XVpGszGHcKchcujYGQDwAeOuMik8ReFo/E3hGXw/f6nfRwzxrFPcQ+UJplHXOYyoz32qPbFbtFHSw763ILG2azsILZ7iW6aFAhmmC75MDGTtAXP0AFT0UUPUS00CiiigAooooAKKKKACiiigAqpqumW+s6Tc6dfBzb3UZik8uQo2D6MOQat0UAY2meHnsZI3vta1LVzCcwfbjEPKOMZHlxpuOCeW3Hk81s0UUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN33/ACVPQv8AsC6l/wCj7Gukrm77/kqehf8AYF1L/wBH2NdJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+KP+Ri8Gf9hqT/ANN95XSVzfij/kYvBn/Yak/9N95Wb411zU9D1aG4mn1Cx0FbZjJfWFrHcLDLkjM6srOIwMEFAOQckCjrYZ21RR3CS3E0KrIHhxuLRMqnIyNrEYb3wTjvXDQ6n4i8UatrR8O6zDY/2NeRW8NtJCjw3amOORnlO0uAQ5C7CuMZO6sjWvFfiqy0v4jNBqlqs+gmN7J/sQKxxmLzCu0ty3ONxJHGdvajb8/y/wAxLV2R6ozBFLOQqgZJJwAKoyQ2B1i1u/JZruSNkjuIo3KlMZwzL8uO43Hr05ryfx1q+vxaV4k0q4124kjl8LjU1eKGKIxOGKPGpC52MPUlhzhq6i21DW9I8Z+EdFbV2vdOvtOuHlE9vGJneNVIJdAq4+cAAKv3eSc07df663/IV/6+5/qd/RXkmmeMPE2p6xp1pp2u2j6re3dxDqWlz2SzppCR79rbY2jkAO1RudyG3ZX0p+j694sn8FXmu6j4qtY3jvLiwCNpwCErdCNXQKGcybQwVPmBLLnOCSJXH1t/X9aHrFFeO3Pi/wAW2ui6mkGqOsun+IrSwWbUbGIzyQTeVwwjKoD+86hQccYB5F3W9d8S6d/wnEEPiKYnw9ax6hayG0g3PvjZvJf5MFMoegDYP3uOS2l/62T/AFGtXb+t7HqcsiwwvK4YqiliEQsxA9AMkn2HNEUgmhSRAwV1DAOhUgH1B5B9jzXM+KdX1O2+F9/rWlTw2t/Dpxu0eSHzFBCbyNuR15APbrg9KwtY8S6zp9npGpX9zqFpo8mlpLcahYWkU6xzsvLToVLCMAggoBznJAotq0+n/B/yEtUn3/4H+Z6LWbeaN9v1KK4ub66a1i2sLDEYhMituWQnZvJBA437eBxWD8SNb1TRvh7cav4cvoIZ4zERLJB5odHdV+UZAB+YHJyOOnORg+I/FuveDNZv7R7uTWo57CO6tjJDCj2sjXCQ7fl2KU/eAjec/KcseoS3t1/4Fw3X9d7Hp1UdW1qx0S2SfUZWQSNsjSOJ5ZJWwTtREBZjgE4APAJ7V5Zr3iH4i6HoOp3Baeyt4prX7LdavBZyXD+ZKI5I9tvJsABZSGIzjI681peJND1keNPByXfizUJJJL+62SQ21snlDyJGGAYmydvyZPBHOAeaaVw2ueiaXqlnrOmQahpk4ntbhd0cgBGR06HBBz2PNW68rvfFviJvCeo+M7HUGWLTtSktho7QRmKaGOfyjltvmCQ9QQ2Og2miLVfG18/jCaHxNa2/9g3brDEdKVo5I/s6ybSN4YEFhht3UHIIOAm0k35X/L/MEne3nb5nqlFeW6Rrfia8vfB9vc+IZceI9Gee4ZLSEGCREjbfFlTgnec7ty8cAdKp6d458S6tpekaXD9vuL+4F8ZrvTY7QTsLe4ESnbcMsQznLYB9gOoqUWnb1/C/+Qk7q/T/ADPWri4htLaW4upUhhhQvJI5wqKBkknsAKzNK8V6Jra2raXqEc63kbS2zbWUTKrFWKkgbsEdu2D0INcbouueLdd1K18P61MfD+p22mm8vGgSGV5m81kQDO9AuF3MBk/MACMVhaUZLX9mey1GNgL3TSbu3kXgiVLlun+9yuO4YjvSt/Xza/Qb3t/Xc9mopFO5ASMEjOKWkG5zfw4/5JZ4U/7Atn/6ISukrm/hx/ySzwp/2BbP/wBEJXSUAc348/5F21/7DWlf+nC3rpK5vx5/yLtr/wBhrSv/AE4W9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc3ff8AJU9C/wCwLqX/AKPsa6Subvv+Sp6F/wBgXUv/AEfY10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc34o/5GLwZ/2GpP8A033lXtX8MaVrpb+04ZpA6qkiR3UsSyqu7CuqMA6/M2VYEHPINUfFH/IxeDP+w1J/6b7yukoAxJvCGiT6uNT+yPDdFBHI1vcSQrMgGAsiIwWQAcAODgVn3Hw08MXR1Xz7W9YawQb9f7Uugs+OgIEmAAOMDAxx04rq6KAOWf4b+GJbuS5uLO6uJZLL7A/2jUbmUPb4x5ZVpCCO/TOeevNSSeBNDW+sNRt7a4+3aXEY7J21G4CpnqGAfDbuNxYEt3ziulood3/X9dwPNvDvha/jt7a2l0vXtJvIWUz3J8QSPZt82ZPKiWc8EZADRpjPYiukt/h94btvDs+hx2c50+ef7S0cl9PIwl3bt6uzlkbcN2VI55610tFMDk7v4Y+Fb4zfabO8PnzR3EoTVLpBJKgAWRtsgyw2j5uuRnrzT5/hx4aupNUe4t76RtXjEV8Tqt1+/QdFP7zgDpxjgkdCQepopAY9z4W0q88Knw5cx3L6YYhC0RvZg7J/dMm/eR2wW5HHTiqz+BtBk02LT5ILtrWKJIfKOoXBEkaltqP8/wC8X5mG1sjBxjAFdDRTuwWmxxnxS0nUNX+HN3o+g6TJqE9y0SLBFJFGEVXViSXZRjC44yckcY5GnpvhLRU025EulSZ1OEJeR387XMhTH+qZ2d/lXJAVW2jnFdBRS7+YdvI5i6+Hfhy90YaVeQX09mJFkCyardMwK8qN5k3bQeQudoIBxkVZ1LwZo2r6jYX1+t89zpwAtXTU7mPy+CM4WQAsQSCxySOCSK3qKLgYj+D9Dk1ZtRa0fzmkEzxi4kEDyA5EjQhvLLggHcVzwOeKrxeAtAhh1eKOG9Ca026//wCJlckzH1z5mV44+XGQAOnFdHRR0sF9bnL23w58N2dxps9vBfJJpcLQWR/tW6PkxnqoBkxjtz2AHQDCW/w38MWumpY29pdRxRXDXMTjUrnzYpG+8yS+ZvTd3CsAcnOc11NFO7Aw73wboeoS2ctzaSefZbhDPFcyxSgNyys6sGcMeSGJB75rPTwFptrZ2mi6VZ22n6BDMt1NbQgl7mVWDKGJ/hyqkkklsAcDr1lFLYAooooA5v4cf8ks8Kf9gWz/APRCV0lc38OP+SWeFP8AsC2f/ohK6SgDm/Hn/Iu2v/Ya0r/04W9dJWbr+ix+INIawluri0/fQzpPbbPMjeKVJUI3qy/eReCCMVm/8Ivq/wD0PfiD/vxp/wD8i0AdJRXN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItAHSUVzf8Awi+r/wDQ9+IP+/Gn/wDyLR/wi+r/APQ9+IP+/Gn/APyLQB0lFc3/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i0AdJRXN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItAHSUVzf8Awi+r/wDQ9+IP+/Gn/wDyLR/wi+r/APQ9+IP+/Gn/APyLQB0lFc3/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i0AdJRXN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItAHSUVzf8Awi+r/wDQ9+IP+/Gn/wDyLR/wi+r/APQ9+IP+/Gn/APyLQB0lFc3/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i0AdJRXN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItAHSUVzf8Awi+r/wDQ9+IP+/Gn/wDyLR/wi+r/APQ9+IP+/Gn/APyLQB0lFc3/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i0AdJRXN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItAHSUVzf8Awi+r/wDQ9+IP+/Gn/wDyLR/wi+r/APQ9+IP+/Gn/APyLQB0lFc3/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i0AdJRXN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItAHSUVzf8Awi+r/wDQ9+IP+/Gn/wDyLR/wi+r/APQ9+IP+/Gn/APyLQB0lFc3/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i0AdJRXN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItAHSUVzf8Awi+r/wDQ9+IP+/Gn/wDyLR/wi+r/APQ9+IP+/Gn/APyLQB0lFc3/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i0AdJRXN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItABff8lT0L/sC6l/6Psa6SuSk8D3suqwak/jbxAbu3hkgik8qw+VJGRnGPs2DkxJyRkbeOpzZ/4RfV/wDoe/EH/fjT/wD5FoA6Siub/wCEX1f/AKHvxB/340//AORaP+EX1f8A6HvxB/340/8A+RaAOkorm/8AhF9X/wCh78Qf9+NP/wDkWj/hF9X/AOh78Qf9+NP/APkWgDpKK5v/AIRfV/8Aoe/EH/fjT/8A5Fo/4RfV/wDoe/EH/fjT/wD5FoA6Siub/wCEX1f/AKHvxB/340//AORaP+EX1f8A6HvxB/340/8A+RaAOkorm/8AhF9X/wCh78Qf9+NP/wDkWj/hF9X/AOh78Qf9+NP/APkWgDpKK5v/AIRfV/8Aoe/EH/fjT/8A5Fo/4RfV/wDoe/EH/fjT/wD5FoA6Siub/wCEX1f/AKHvxB/340//AORaP+EX1f8A6HvxB/340/8A+RaAOkorm/8AhF9X/wCh78Qf9+NP/wDkWj/hF9X/AOh78Qf9+NP/APkWgA8Uf8jF4M/7DUn/AKb7yukrkrrwPe3tzZT3PjbxA8tjMZ7dvKsBscxvGTxbc/JI4wcjnPUCrP8Awi+r/wDQ9+IP+/Gn/wDyLQB0lFc3/wAIvq//AEPfiD/vxp//AMi0f8Ivq/8A0PfiD/vxp/8A8i0AdJRXN/8ACL6v/wBD34g/78af/wDItH/CL6v/AND34g/78af/APItAHSUVzf/AAi+r/8AQ9+IP+/Gn/8AyLR/wi+r/wDQ9+IP+/Gn/wDyLQB0lFc3/wAIvq//AEPfiD/vxp//AMi0f8Ivq/8A0PfiD/vxp/8A8i0AdJRXN/8ACL6v/wBD34g/78af/wDItH/CL6v/AND34g/78af/APItAHSUVzf/AAi+r/8AQ9+IP+/Gn/8AyLR/wi+r/wDQ9+IP+/Gn/wDyLQB0lFc3/wAIvq//AEPfiD/vxp//AMi0f8Ivq/8A0PfiD/vxp/8A8i0AdJRXN/8ACL6v/wBD34g/78af/wDItH/CL6v/AND34g/78af/APItAHSUVzf/AAi+r/8AQ9+IP+/Gn/8AyLR/wi+r/wDQ9+IP+/Gn/wDyLQB0lFc3/wAIvq//AEPfiD/vxp//AMi0f8Ivq/8A0PfiD/vxp/8A8i0AdJRXN/8ACL6v/wBD34g/78af/wDItH/CL6v/AND34g/78af/APItAB8OP+SWeFP+wLZ/+iErpKo6JpUGg6Bp+kWbSPb6fax2sTSkF2VFCgsQAM4HOAKvUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/2Q==" /></p><p>Elderly and patients with cardiac disorders</p><p>In patients over 50 years of age, it is not advisable to exceed doses above 50 micrograms per day. In patients with coronary heart disease, daily doses of 25 micrograms or 50 micrograms every other day are more suitable. In this disease, the daily dose should be increased by 25 micrograms or 50 micrograms every other day every 4 weeks.</p><p><br />Children</p><p>For congenital hypothyroidism and juvenile myxoedema, the highest possible dose not to cause any toxic effects should be given. The dosage is based on clinical reactions, growth assessment and appropriate thyroid function tests - clinically normal pulse rate and absence of diarrhoea or constipation are among the most useful indicators. During the first year of life in a child with neonatal hypothyroidism, the level of thyrotropin may remain elevated due to the resetting of the hypothalamic-pituitary axis. In infants with congenital hypothyroidism, the appropriate starting dose is 50 micrograms levothyroxine sodium every other day, with an increase every 2 to 4 weeks of 50 micrograms every other day until an optimal response is achieved. The same dosing regimen is used in the treatment of juvenile myxoedema, although the initial dose in children over one year old is 2.5 to 5 micrograms/kg/day. To determine the actual prescribed dose, the equivalent of the calculated daily dose must be rounded to the nearest 25 micrograms.</p><p><br />In infants with congenital hypothyroidism, the appropriate starting dose is 25 micrograms levothyroxine daily, or 50 micrograms levothyroxine every other day, with an increase of 25 micrograms daily, or 50 micrograms every other day every 2 to 4 weeks, until an optimal response is achieved. The same dosing regimen is used in the treatment of juvenile myxoedema, although the initial dose in children over one year old is 2.5 to 5 micrograms/kg/day. To determine the actual prescribed dose, the equivalent of the calculated daily dose must be rounded to the nearest 25 micrograms.</p><p><br /><u>Method of administration</u></p><p>The total daily dose is taken whole in the morning with some liquid in the fasting state at least half an hour before breakfast.</p><p>Due to a lack of data, it is not recommended to crush Eltroxin 50/Eltroxin 100 tablets.</p><p>If the patient has forgotten to take a dose, he/she should make up for the missed dose as soon as he/she remembers. However, should the next dose be imminent, the patient should skip the missed dose and only take the subsequent dose. No double dose should be taken at any one time.</p><p><u>Duration of use</u></p><p>Duration of use: in hypothyroidism and post thyroidectomy due to thyroid malignancy - usually life-long; for euthyroid goitre and prophylaxis against goitre recurrence - a few months or years to life-long; in concomitant therapy for the treatment of hyperthyroidism - depending on the duration of antithyroid medication. For the treatment of euthyroid goitre, a treatment period of six months up to two years is necessary. If treatment with Eltroxin has not produced the desired response within this time, other treatment options should be considered.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1
- untreated hyperthyroidism of any aetiology
- untreated adrenal insufficiency
- untreated pituitary insufficiency
- acute myocardial infarction
- acute myocarditis
- acute pancarditis
- during pregnancy, concomitant intake of levothyroxine and an antithyroid agent is contraindicated.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Laboratory monitoring</u><br />Levothyroxine has a narrow therapeutic index. The appropriate levothyroxine dosage is based on clinical assessment and laboratory investigation of thyroid function tests. In the initial phase of uptitration, careful dose escalation and monitoring is necessary to avoid the sequelae of under- and overdosing. The symptoms of an overdose with levothyroxine are essentially those of endogenous thyrotoxicosis.</p><p><br /><u>Levothyroxine should not be used for treatment of obesity or weight loss.</u></p><p><br />In patients with euthyroid status, doses within the daily hormone requirement range show no weight-reducing effect. Higher doses can lead to serious or even life-threatening manifestations of toxicity, especially when administered in combination with sympathomimetic amines, e.g. those used on the basis of their anorectic effect.</p><p><br />Medicinal products for weight reduction: orlistat may reduce the uptake of levothyroxine and thus cause hypothyroidism. To avoid this, orlistat and levothyroxine should be administered at an interval of at least 4 hours. Regular monitoring of thyroid function is required.</p><p><br /><u>Special patient populations</u></p><p>Prior to initiation of thyroid hormone therapy, the following diseases should be excluded or treated:<br />- Coronary heart disease<br />- Angina pectoris<br />- Hypertension<br />- Pituitary and/or adrenocortical insufficiency<br />- Thyroid autonomy.</p><p>In coronary heart disease, heart failure or tachyarrhythmias and diabetes mellitus or insipidus, even milder forms of pharmacologically induced hyperthyroidism must be avoided at all costs. In such cases, more frequent monitoring of thyroid hormone parameters must be performed (see 4.2). Special care during use is necessary in elderly patients, in patients with symptoms of myocardial insufficiency and with ECG changes suggestive of cardiac ischaemia, as well as in patients with diabetes mellitus or diabetes insipidus.</p><p><br />In secondary hypothyroidism, it must be established whether adrenocortical insufficiency is present at the same time. If so, this must firstly be replaced with hydrocortisone.</p><p><br />Treatment with levothyroxine may lead to intolerance, including dizziness, asthenia, malaise, weight loss, hypotension and acute adrenocortical insufficiency in patients with pituitary insufficiency or adrenal insufficiency due to other causes. It is therefore advisable to administer corticosteroid therapy first, before levothyroxine is given.</p><p><br />Patients with myxoedema have increased sensitivity to thyroid hormones; in these patients, a low initial dose with slow dose escalation should be selected.</p><p><br />Patients with malabsorption syndromes have reduced thyroxine absorption. It is recommended to treat malabsorption to ensure effective thyroxine treatment at the regular levothyroxine dose.</p><p>During pregnancy, a reduction in thyroxine serum levels may occur with a concomitant increase in TSH serum levels to values outside the normal range. In patients taking levothyroxine, TSH measurements should be performed on a quarterly basis. Elevated serum TSH levels should be corrected by increasing the levothyroxine dose. As postpartum serum TSH levels are comparable to pre-conception levels, the levothyroxine dose may again be reduced to the pre-pregnancy dose.</p><p>Haemodynamic parameters must be monitored when initiating levothyroxine treatment in preterm infants with a very low birth weight , as circulatory collapse due to immature adrenal function may occur.<br />In the levothyroxine treatment of postmenopausal women with hypothyroidism at increased risk of osteoporosis, thyroid function should be monitored more frequently to avoid supraphysiological blood levels of levothyroxine. In order to minimise the risk of osteoporosis, the levothyroxine dose should be titrated to the lowest possible value.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Interactions that reduce levothyroxine absorption</u></p><p><br />Cholestyramine and colestipol inhibit the absorption of levothyroxine.<br />Levothyroxine absorption may be reduced by concomitant intake of antacids containing aluminium, magnesium, calcium and iron, polystyrene sulphonate ion exchange resins (kayexalate, sevelamer), sucralfate, lanthanum and proton-pump inhibitors. Hence, the longest possible interval should elapse between taking levothyroxine and any of the above medicinal products, in order to prevent interactions in the stomach and small intestine (see section 4.2).</p><p><br />Soya products and a high-fibre diet may reduce the intestinal absorption of Eltroxin. An adjustment in the dose of Eltroxin may become necessary, especially at the start and upon completion of a diet containing soya.</p><p><br />Medicinal products for weight reduction: orlistat may reduce the absorption of levothyroxine and thus cause hypothyroidism. To avoid this, orlistat and levothyroxine should be administered at an interval of at least 4 hours. Regular monitoring of thyroid function is required.</p><p><br /><u>Interactions that affect levothyroxine</u></p><p>Anticonvulsants, such as carbamazepine and phenytoin, increase the metabolism of thyroid hormones and may displace them from their plasma protein binding sites. Initiation or discontinuation of anticonvulsant therapy may alter levothyroxine requirements.</p><p><br />Rapid intravenous administration of phenytoin may lead to increased plasma levels of free levothyroxine and liothyronine and, in isolated cases, may promote the development of cardiac arrhythmias.</p><p><br />Medicinal products with enzyme-inducing properties such as rifampicin increase the metabolism and excretion of thyroxine, which increases levothyroxine requirements.</p><p><br />Barbiturates and other medicinal products with liver enzyme-inducing properties may increase the hepatic clearance of levothyroxine.</p><p><br />Propylthiouracil, glucocorticoids, beta-blockers, lithium, iodide and iodine-containing contrast media inhibit the conversion of T4 to T3.</p><p><br />Amiodarone can have numerous effects on thyroid function. These include increased levothyroxine requirements in patients with hypothyroidism. Due to its high iodine content, amiodarone may cause both hyperthyroidism and hypothyroidism. Particular caution is advised in cases of nodular goitre with possibly undetected autonomy.</p><p><br />Treatment with tyrosine kinase inhibitors (e.g. imatinib and sunitinib) has been associated with increased levothyroxine requirements in patients with hypothyroidism.</p><p>Salicylates, dicoumarol, high doses of furosemide (250 mg), clofibrate and other substances may displace levothyroxine from its plasma protein binding sites, thereby leading to an increase in the plasma level of free thyroxine.</p><p><br />Sertraline and chloroquine/proguanil reduce the efficacy of levothyroxine and increase the serum TSH level.</p><p><br />Co-administration of oral contraceptives, as well as other medications such as oestrogens, tamoxifen, methadone and 5-fluorouracil, may increase the serum concentration of thyroxine-binding globulin and thereby increase levothyroxine requirements.</p><p><br />There have been reports that some HMG-CoA reductase inhibitors (statins) such as simvastatin and lovastatin may increase thyroid hormone requirements in patients receiving levothyroxine treatment. It is not known whether this is the case with all statins. Thus, during concomitant use of statins, close monitoring of thyroid function and appropriate adjustment of the levothyroxine dose may be required.</p><p><br />Post-marketing cases have been reported that indicate a potential interaction between medicines containing ritonavir and levothyroxine. In patients treated with levothyroxine, the thyroid stimulating hormone (TSH) should be monitored at least in the first month after the start and/or end of ritonavir treatment.</p><p><br />A large number of medicinal substances can affect thyroid function tests. This should be taken into account when monitoring a patient on levothyroxine treatment.</p><p><br /><u>Interactions affecting other medicinal products</u></p><p>Levothyroxine may reduce the hypoglycaemic effect of antidiabetic agents. Therefore, blood sugar levels must be checked regularly in patients with diabetes and the dosage of the antidiabetic agent must be adjusted as necessary.</p><p><br />Levothyroxine may potentiate the effect of anticoagulants by plasma protein binding displacement. Thus, during concomitant treatment, regular monitoring of blood coagulation is required and, if necessary, the anticoagulant dosage must be reduced if excessive hypoprothrombinaemia and bleeding are to be avoided.</p><p><br />Phenytoin levels may be increased by levothyroxine.</p><p><br />If co-administered with cardiac glycosides, it may be necessary to adjust the dosage of these cardiac glycosides.</p><p><br />The effects of co-administered sympathomimetic agents may be potentiated.</p><p><br />Levothyroxine increases the sensitivity of catecholamine receptors and accelerates their response to tricyclic antidepressants.</p><p><br /><u>Interactions in association with laboratory tests</u></p><p>Some medicinal products, e.g. androgens and anabolic steroids, can lower the serum concentration of levothyroxine-binding globulin and therefore reduce levothyroxine requirements.</p><p><br />Falsely low plasma levels have been observed with concomitant use of anti-inflammatory agents such as phenylbutazone or acetylsalicylic acid and levothyroxine therapy. The use of acetylsalicylic acid together with levothyroxine initially leads to a transient increase in free T4 serum levels. With continued treatment, free T4 and TSH levels return to normal and patients subsequently achieve clinical euthyroid status.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Levothyroxine has been taken by a large number of pregnant women and women of childbearing potential, without any disturbances in the reproductive process having been observed. However, hyper- or hypothyroidism in the mother may negatively affect the course of pregnancy or the well-being of the child.<br />Replacement treatment with thyroid hormones should be administered consistently, especially during pregnancy. To date, there have been no reports of any risk to the foetus, despite extensive use during pregnancy.</p><p><br />During pregnancy, levothyroxine requirements in patients with hypothyroidism may increase due to oestrogen. Thyroid function should therefore be monitored both during and after pregnancy and the replacement dose adjusted as necessary.</p><p><br />During pregnancy, levothyroxine is contraindicated for use as concomitant therapy in the treatment of hyperthyroidism with antithyroid agents, as a higher antithyroid dosage would be required. Since antithyroid agents, unlike levothyroxine, can cross the placental barrier at effective doses, this may induce hypothyroidism in the foetus. For this reason, in the presence of hyperthyroidism, antithyroid agents should always be administered as low-dose monotherapy during pregnancy.</p><p><br />During pregnancy, suppression tests should be avoided.</p><p><br /><u>Breast-feeding</u></p><p>Levothyroxine is excreted in human milk at low concentrations; this might be enough to interfere with neonatal hypothyroidism screening. The amount of thyroid hormone secreted into breast milk during lactation, even with high-dose levothyroxine therapy, is not sufficient for the development of hyperthyroidism or suppression of TSH secretion in the infant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>With proper use and monitoring of clinical findings and laboratory diagnostic values, adverse reactions are not to be expected during treatment with Eltroxin. Classification of adverse reactions by frequency is not possible on the basis of the data available.</p><p><br />If the dose strength is not tolerated in individual cases or if overdose occurs, symptoms like those occurring in hyperthyroidism may occur, particularly if the dose is increased too quickly at the start of treatment. In this case, the daily dose should be reduced or the medication should be discontinued for several days. Once the adverse reaction has resolved, treatment can be resumed with careful dosing (see section 4.2).</p><p><img alt="" width="500" height="160" src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAkACQAAD/4RD6RXhpZgAATU0AKgAAAAgABAE7AAIAAAAQAAAISodpAAQAAAABAAAIWpydAAEAAAAgAAAQ0uocAAcAAAgMAAAAPgAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEFobWFkIEFsWmFocmFuaQAABZADAAIAAAAUAAAQqJAEAAIAAAAUAAAQvJKRAAIAAAADOTgAAJKSAAIAAAADOTgAAOocAAcAAAgMAAAInAAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADIwMjA6MDQ6MDggMTQ6MTg6MTcAMjAyMDowNDowOCAxNDoxODoxNwAAAEEAaABtAGEAZAAgAEEAbABaAGEAaAByAGEAbgBpAAAA/+ELImh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8APD94cGFja2V0IGJlZ2luPSfvu78nIGlkPSdXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQnPz4NCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPjxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+PHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9InV1aWQ6ZmFmNWJkZDUtYmEzZC0xMWRhLWFkMzEtZDMzZDc1MTgyZjFiIiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iLz48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyI+PHhtcDpDcmVhdGVEYXRlPjIwMjAtMDQtMDhUMTQ6MTg6MTcuOTg0PC94bXA6Q3JlYXRlRGF0ZT48L3JkZjpEZXNjcmlwdGlvbj48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyI+PGRjOmNyZWF0b3I+PHJkZjpTZXEgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj48cmRmOmxpPkFobWFkIEFsWmFocmFuaTwvcmRmOmxpPjwvcmRmOlNlcT4NCgkJCTwvZGM6Y3JlYXRvcj48L3JkZjpEZXNjcmlwdGlvbj48L3JkZjpSREY+PC94OnhtcG1ldGE+DQogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgIDw/eHBhY2tldCBlbmQ9J3cnPz7/2wBDAAcFBQYFBAcGBQYIBwcIChELCgkJChUPEAwRGBUaGRgVGBcbHichGx0lHRcYIi4iJSgpKywrGiAvMy8qMicqKyr/2wBDAQcICAoJChQLCxQqHBgcKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKir/wAARCADjAsQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3bVPF2laRqp025GoTXawpO0dlpdzdbEdmVSxijYLkxvgE5+U1W/4TzSP+fPxB/wCE5qH/AMYrA1zxTD4Y+Jl8HSOS51HT9MtLVZpvJiMhlvyN8mDtHynnBPTANdKviiLT4Z28WC10IW4j3zz3qfZ3Z92Akjbc/dx8yqfajpcCH/hPNI/58/EH/hOah/8AGKP+E80j/nz8Qf8AhOah/wDGK0ovEehzyRxw6zp8jyW32tFS6Ql4P+eoGeU/2ulY+r/ErwnpPhyTWv7e0+7tFlECNa3SSB5TjCZUkZ5BPoOTxQBN/wAJ5pH/AD5+IP8AwnNQ/wDjFH/CeaR/z5+IP/Cc1D/4xWk3iTQ0t7Od9Z09Yr8gWkhukC3BPQRnPz/hmo7nxX4dsri6t7zXtLt5rNQ1zHLeRq0AOMFwTlQcjr6igCj/AMJ5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/Cc1D/4xWrBruk3Opf2fbapZTXvlCb7NHcI0nlno+0HO3kc9Km1DUrHSbRrrVb23srdeGmuZVjQfixAoDcxP+E80j/nz8Qf+E5qH/wAYo/4TzSP+fPxB/wCE5qH/AMYrSuvEeiWVhb317rGn29pdMFguJbpEjmJ5AVicMTjtRP4j0O1s7i7utZ0+G2tZfJnmkukVIZOPkZicK3I4PPIoDczf+E80j/nz8Qf+E5qH/wAYo/4TzSP+fPxB/wCE5qH/AMYq7b+LvDd3ps+o2viDSprG3OJrqO9jaKI9cM4OB+NOl8UaBBptvqM+uabFY3ThILp7uMRSsegVicMeDwKAKH/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wnNQ/+MVsafq+m6t539l6ha3v2eQxTfZp1k8tx1VtpOD7Gm6lrmk6N5P8AbGqWVh577IftVwkXmN6LuIyfYUAZP/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxVfTPGz33xI1nwrPp8cCabaR3aXq3O8So+Oq7Rtxz3Nbuna9o+sef/AGRqtjf/AGdts32W5SXyj6NtJwfrR0uHWxlf8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFXYPFnh26s7u7ttf0ua2sv+PqaO8jZIP99gcL0PXFXtO1Ow1exS90m9t761kzsntpVkRsHBwykg8jFAGJ/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMV0lFAHN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFdJRQBzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxXSUUAc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMV0lFAHN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFdJRQBzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxXSUUAc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMV0lFAHN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFdJRQBzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxXSUUAc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMV0lFAHN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFdJRQBzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxXSUUActbfEXQby1iurOLXJ7eZBJFLF4ev2SRSMhlIhwQQcgipf+E80j/nz8Qf+E5qH/xiucsvGNp4E+APhvXL6B7iOLSbBBFGcFt0SAnoegyfwrv0vrV9OW/E8YtGiEwmZgF2EZ3ZPQY5o6XDyMP/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrK0/wCJ9hdeNNR0idtNi0u009dQj1mPUlkhkjZ9nzfKFXnP8RFdLbeJ9Avfsf2PXNNuPtzOtp5V3G32gr94Jg/MR3xnFHQV1/X3mf8A8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFaaeIdFkjvZI9XsGSwz9sZblCLbAyfMOfkwPXFNh8TaFcxLJb61p0sbQNcq8d2jAxKcNICD90Hgt0BoGZ3/AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFaVt4k0O90mXVbPWdPuNOhz5t5FdI0KY65cHAxnuauWd7a6hZx3dhcw3VtKu6OaCQOjj1DDgigDB/4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYrQg8T6BdNttdc02ZvtH2XEd3Gx87/nnwfv8AH3etWLfWNMu9RuLC01G0nvbXHn20U6tJDnpuUHK/jQBj/wDCeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wnNQ/+MVqWmv6PqGoz2Fhq1jc3lv8A662huUeSL/eUHI/GmN4m0Jb25szrWn/arRDJcW/2pPMhUDJZlzlR7mgDO/4TzSP+fPxB/wCE5qH/AMYo/wCE80j/AJ8/EH/hOah/8YrJX4saDfeHo9T0K9028eS9FqtvPqcNs2DIV3fOeu0FwuMsOldZPrmk2upRafdapZQ3s3+qtpLhFkk78KTk9D09KdmBk/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MVdu/Fvhuwubm3vvEGl209oAbiKa9jRoQcY3gnK5yMZ9RU2o+ItE0hbdtW1iwsRc8QG5ukj83/d3EbuvakBmf8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MV0lFAHCar8aPAug3S2uuaneabcOgkWK80i8hdlJIDANEDjIIz7GivBP2q/+Sp6b/2BYv8A0fPRQB7Z4o0yx1v4g6vpet6DJrOl3Gj6f9pES5a3xLfESDBDZzx8mW54HWqng3wU82l+I/D802qXXg28gSLT4tYidJoGO4OqLIocIvybdwHI49Td8QX1hY/FLUTqPjb/AIRUPo1hsPnWkf2j99eZ/wCPiN87f9nH3uc8Y2f+EXvNZ0+GaD4ieIZrWXZNFNaNYqJACGUh0thlTxxnBHByDRbR+f8AX/DDu9DH8KaBf6p8LJtL8axSzziGTSi1u+ZZIY3MYcE9CcZ69ACa5jxHpfijUPhtqFnNb3WsCx1e1ktrv+zngurqCNlLF4SAzMuMbgPmAyBXo0HhHU7eBIYfHPiBUQYUeRp5/wDbWpP+EX1f/oe/EH/fjT//AJFptty5vT8HcnlVuX1/FWOA8WeHb/V/inPNqba9b+H9a0ZbFJ9MtFmMbbstHIGikMQbOdwC84yRjilrunXMPxE8UMujaxdQnwh/Z8F0dNll86fH3Q6ptZiCMkcZz6V6Z/wi+r/9D34g/wC/Gn//ACLR/wAIvq//AEPfiD/vxp//AMi1Nvd5fX8b/wCbGvi5vT8Lf5I8j8H6Lcab4p+F5tfD2qWUdnp1ympudKnjWOaRdv7xigGSynk9sHoRXovxA0y+k8T+ENcggnubHSL6SS8it4mldVeIqsgRQWbB7KCea1/+EX1f/oe/EH/fjT//AJFo/wCEX1f/AKHvxB/340//AORa0lK7T7O/43JUbX81b8LHkGuaNrjfCPxDAdH1WU6j4re5sbKKwlaVIPODFtgXcinaxBIHUetdd8VLnSPDo8MeJJGSyFrqH2jy5rWVYZmMO0ecY42dGAACkoxzxjGSOx/4RfV/+h78Qf8AfjT/AP5FqrP4Gvrm/tb2bxx4iM9pv8lgliAu4YbIFtg8DuDiou7JLy/BJfoVvJyfW/4tv9TzfQZbGXwPoTeFi3icv4la4mu7OKcLpDSMzMwi+VyArEDeNp3ZIxxWLd6DrcfwV1fSJtB1d7yTxU0y240+WRni8wMXARSCuAeR8vYdRXsNv4HurC4vLuHxvr8ct24luJGjsDuKqFB5tuAABwMCrS+GdVdAyePNfZWGQRDp5BH/AIC007O68v8A23/5ETV1r5/r/wDJHKeALe7i+Mnju6k07ULaxvhaNazT2UsMUvlx7W2llAJBP49uKm1WxurT40TXut6PPqmgatpC2EbxWjXSQOH3MkiBTtVs/eI29M103/CL6v8A9D34g/78af8A/ItH/CL6v/0PfiD/AL8af/8AItF9Y+Wn4WH38/8Agf5HnOpW11H8S/HE48K6lf2U/h6O3gtxaSxxXTKozCsqjb0OPlPYgZNM8H6NqcnxAvLjXNH1NLG/8Jw27k2siLuGN0IZuQwGQA7bjjJJ616PJ4b1SGJpJfHuvIiAszNDp4CgdSf9FrL0pTrmnW1/o/xE8RXtpdTPDFPBZWbIWUsCSRZ/KuVI3HCnjB5GVFaW/rXm/wAwa6/1pb/5EwLDw3f3Oj6p4e1K41WfS7BrY6bqwsDDewvEWYKQVHnLHtUh1Uht2Bk12vgOXV5vCyN4gjQXXnSBZltTbNcpu+WVoW5jZhyVPfsKP+EX1f8A6HvxB/340/8A+RaP+EX1f/oe/EH/AH40/wD+Rad31/rz/r53FZdP6/r/AIax0lFc3/wi+r/9D34g/wC/Gn//ACLWbZQHUdav9JsfiTrk99pwQ3cKQWB8nfnaCfsuM8HjOR360hnbUVzf/CL6v/0PfiD/AL8af/8AItH/AAi+r/8AQ9+IP+/Gn/8AyLQB0lFc3/wi+r/9D34g/wC/Gn//ACLR/wAIvq//AEPfiD/vxp//AMi0AdJRXN/8Ivq//Q9+IP8Avxp//wAi0f8ACL6v/wBD34g/78af/wDItAHSUVzf/CL6v/0PfiD/AL8af/8AItH/AAi+r/8AQ9+IP+/Gn/8AyLQB0lFcJ4s0zXtB8F63q9n441x7jT9Pnuollt7AozJGzAMBbA4yOcEVNpVuuuxSyaJ8UtR1KOE4kezbTJgh9CVtjigDtaK4nSYoteaZdD+Kmoak0GPNFm+mTGPOcbttscZwevpV+Tw3qcMTSTePtejjQZZ2h08BR6k/ZaAOnorjdYsJvD+lTalrXxH1uysoADJNLFp4VcnA/wCXXqScYqza6BqN7Zw3Vt4+8QPDPGskbfZ7AblIyDg2uehoA6miub/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWgDpKK5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRaAOkorm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFoA6Siub/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWgDgfDsF741+GWmaRZyGws4PDkFpcf2loVzItwHgTc0Lh41bGAARuJ6jjGee06LxPrHwIuPCU2jawdQ0e4jCifT5rddQs45gcIXUZO3jYfmIHSup+HU9lqPg3w7p9j8UblL7+yrfOmW02mu8GIVJQIYGfC9PmJIxya6HShb67PJDofxXvtSliG6SOzk0uZkGcZIW2OOaFpt5fg7/wBfMJa/130MjStMudS+Neoax/YF4mhahoMdoZ7iAQgvuyVaN8P0+Xlc8enNHgrw1r9h4I13w7Mklu+mSXllotxKTl43G6OQE9huCgj0IrrP+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFoaTi49LNfjf8AV/eC0d/NP7lb/I8/+Hfh+XT/AAql9qw8SrqulaRNp82nXFgqwqOuI9kIM+SuVIZzz71b8AeE7e/+AthpGu6TqFneLBJbS5tmhu4S0u7K7wDjIRvQ7R1xiu1/4RfV/wDoe/EH/fjT/wD5Fo/4RfV/+h78Qf8AfjT/AP5FpuTd/P8A4P8AmxJWafb/AIH+R5n4k0zxlqvgi1dlvb1dL8QQ3LXNvp/2e8vrVFH7027r80it2KfNsBC4r0zwRo1vo+j3BtLvVbtL66e8Z9UiWKTe+C2IxGmwZycFRyTR/wAIvq//AEPfiD/vxp//AMi0f8Ivq/8A0PfiD/vxp/8A8i0X0/ry/wAkN62/rv8A5s5L4eaa8/ibx297pF3bG51f7TZy31hJGrgLhZELqAcMM5HPQ+lY3wv8J31ja23/AAkZ8Rf2zoT3imze3RLScTFiWWbygZQ/yn/WMQ3YCvRv+EX1f/oe/EH/AH40/wD+RarpomoPHK58eeIokhcxu01pYxjI7jdaDI56jIPY0loreVvu0uNvr53/ADPMPCml643jbwRft4e1HSbWKyv7cwNbSmPTyS3lxsz5b0O5jg5+XA4HVfC3Tbiy8KroniLQbhPEGlS3S/bZrM7JPNZmMsc5G0hsgEKc+orp00DU3u5bdfHPiUPEqsxazsghDZxhzabWPByASRxnGRUj+GdWRGY+OvEJCjJxb2BP5C15pyd4tP8ArVv9RLe/n+ljxy40jWLb9nrw9ocugaw2pWOsI01vHp0sjKFnd2b5VOV2kfMODngnmtjxZomrw2nxDt49K1C8uPEUlrcaXJb2ckgIARcMwU+WyHnDbTjkdDj0aHQtRmgglHj3xFGLgAxrNa2MbnIzjY1oGBwCSCMjBzU//CL6v/0PfiD/AL8af/8AItNu8m31/wCB/kJWumun/B/zPKfFelanJ418YyPpGqXbTeERYQ3MWmzSLNcYGVRghBJyOhx19DjTTSNVt/AvhjV9Kh1S28QWejw2L2NzpsksN4O9vMhG6P5lP7w7QMgk4Neh/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItJOy/rz/8AkmFrf15JfodFEXMKGRQrlRuUHIB7inVzf/CL6v8A9D34g/78af8A/ItH/CL6v/0PfiD/AL8af/8AItIZ0lFcnNomoQQyynx54ikELBXWC0sZWUnHG1bQnPIPToc9Ksf8Ivq//Q9+IP8Avxp//wAi0AdJRXN/8Ivq/wD0PfiD/vxp/wD8i0f8Ivq//Q9+IP8Avxp//wAi0AdJRXNN4Z1VFLP4819VUZJMOngAf+AtV9P0e91SyS70/wCIGvz28mdkq29htcZxkE2vI9COD2oA62iub/4RfV/+h78Qf9+NP/8AkWj/AIRfV/8Aoe/EH/fjT/8A5FoA6Siub/4RfV/+h78Qf9+NP/8AkWsxIDJ4kfQI/iTrb6rHB9oe1WCwLJHkDc3+i4H3hgHk0eQHb0Vzf/CL6v8A9D34g/78af8A/ItZt1btY65ZaPdfEnW49RvwxtrbyLAvIFBJOBa8AAHk8dqAO2orm/8AhF9X/wCh78Qf9+NP/wDkWj/hF9X/AOh78Qf9+NP/APkWgDpKK5N9E1BfI2+PPEconfy0aG0sZFzgn5itoQo4PJwM4GckVY/4RfV/+h78Qf8AfjT/AP5FoA6Siub/AOEX1f8A6HvxB/340/8A+RaP+EX1f/oe/EH/AH40/wD+RaAOkorm/wDhF9X/AOh78Qf9+NP/APkWj/hF9X/6HvxB/wB+NP8A/kWgDpKK5ObRNQghaQ+PPEcirII2EFpYysGJAwQloT3GT2HJwOasf8Ivq/8A0PfiD/vxp/8A8i0AdJRXN/8ACL6v/wBD34g/78af/wDItH/CL6v/AND34g/78af/APItAHSUVyOn6TeapbGew+IWvTRhyjYt7AFWBwVYG1yCPQ81a/4RfV/+h78Qf9+NP/8AkWgDpKK5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRaAPm39qv/kqem/8AYFi/9Hz0VR/aVsLnTviTp8V5q15qrtpMbCa8SFXUedMNo8qNFxxnkZ5PPTBQB7P8TFV/EmoK6hgf+EeBBGf+YhdVqazq/iZ/F/i3T7bXVs7XTdIivrMQWUZZHPmcMX3bgfL54HB42kZNvVvCWj+LfiXq1vr0VxPDBpOmyJHFezQLuE96QxEbruIIBBOcdsVqn4ceG2uLy4ePUnmvrYWtzI+sXjNLEOikmXp1/M+pyteVpef4pL9B6XTfl+d/yOXtvFHiSW80N49WQ/294fmv/KmtEMVrMiRspQLtcj5zkM59sdKg0PxF4nvoPAst3r7k+JrOQXKpZwgQusXmCSP5eG4IO7cvfaOldXJ8MfC8i2SmDUV+wW5tbUprF4hiiPVARKDg8D6ADoAA+2+G3hmzbSmtra+T+x8iwH9q3REAPUAGTGCDjBzxx04rRuN3/XV/5r7iEnb+uy/yOR0XxX4iudV8MxXOrySRza3qGl3Y+zwgXKQrKUdsJ8r/ACD7u0H0qtB4p8XJLaWq6+sqt4ul0eSW4sYzK8IXK8oFUEbT/Dk5HIxg9xB8NvDFtZfZYbS7EYu/tysdSuTIk5zmRXMm5SdxzgjOec1Gfhd4P+1R3MOktbTR3RvA9rdzQkzEk722ONxGTjOcAkDAJqU1dN/1qn/mvmVLVO3n/wC3W/NfccoPGniC1N1oQmvNTvB4gk0yK8gjtVuTELfzgQH2Q7x0yRjAzgng9n4HufEk+k3Mfi60lguYbl0t3naDzZ4OCjyLCzIrckEDA4zgZpsfw78Mxw6hGLK4cajOLm4Ml/cOxmHSRWZyUcf3lIPA9BW7p+nW+l2ot7QSlRyXmmeaRzjGWdyWY4AGST0oTVvkvyQPV6f1ucLFq+szeIrvRNY1jU9D1G8nmGnH7FA9rLGoYp5MhQ5fbtZlkJPytgAVF4X1jxDrWmaZZPrNwda0+S6GrBoYAs0kTbVjYCMbVYspUrg7c8k811snhvS7K8/teCwuby8tVdreH7U7hWbJPlpI4jR2yRu+Xg4JxVbQvD0Ivdb1a800WVxrrJ58DMpkEaxhAHKEjd977pI5HNLpby/Hp/wQe9/P/h/+Aef6/r+pXvwx8T2OpatrNhrtrpT3FxZ3VrDEw9TFIibXiP3cglgDywNaN9rHiqOf/hHfDkmr313p+lwXS3USWGZpJC+1ZhKYx5Y2Afu1Df7Wevbt4M0KRL9bize5GoQm3uDc3MsxMR/5ZqXYlF77VwM89abL4J0KT7Efs1xFJYp5cE8F7PFLtzkq0iuGcE8kMSD3p6f18w1/r5f5M49Na8Y6j4pu9MvNUTR9vh2LUPItbaKR7e4LFWXe29XAZD2xg4HI3U7w34r1281LwPc3uoedD4l0+WW5tPIRY4XSNXDRkDfk5IOWI9AK6mfwD4en1a41NoLxLu4tvskjw6lcxjycY2BVkCqO/AHJJ681Ha/Dnw1ZS6RJbW14jaKCtgP7TuSIATyADJgg9MHIxgdBimmuv9fF/mvuE12/rRfqn95Hrep39543s/DGnag+lh7CS+luoo0eR9rqiookVlxySxwTjGMZzXB+CNW1rSdJ8HWsF9CLXUNe1G2vYxbjdKRJO4IYn5RlegGffsfU9Z8M6Tr09rPqVu7XFmxaCeGeSCWPPUB42VsHuucHuKyIvhh4Rt5LSS00t7VrO4a6h+zXk8IEzdXIRxubHGWzxx04pRdt/wCtf8tBy1TS/rS356mBdeNNS8O32rN4lm1CC6iF1cWVm9rGbS8ijR2RYZVXdv2hWYO27KnAAok1nxTp83hqUa0t6PEsLI0c9nGUspvIMqvGECsyDaQVdmJ4+YV2SeE9GXU479raSWeIOIhNcSSRxbs7isbMUUncQSADg4ziobXwRoNksq2ttcRh4mhQfbpz9nRuCsOX/cj/AK57eg9BS6f15/noPr/Xl+Xbr1OF0XxV4o/4V9o2v6hrUU9xr0tvZIhs0SO0d5mUygjk/JgbTxkD1NUrnVNT8H+OPFsou59YvHg0m2hmljhSU+bLImSB5cZYbjj7o6Z7mvR7bwP4etfCZ8MpYF9I7W09xJLs5yNrOxZcHkYIweRioYvh54ViluZW0lLie7txbTz3cslxLJGOil5GLdhznPA9BVXV3/Wnb/g+fkT0/rvv/wAD/M4XVdf+Imj6ZMZ3msYBqdlDa3WqwWklzPHNIEkRlt3Ma7SfvbeQccHmtnWdU8QeFtQj/wCEh1vUf7HWE7dWtdOhaNZGd+LlQpZVVTHhk2qcEsecV0F38PfD19pcOn3kV/PBDKsqb9Vui4ZTlMyeZuIU8gE4B5GKvan4V0jWD/xMoJplIUSR/a5VSYLnAkQMFkHJ4YEHvQmvx/Cy/wCCBrqwZQynIIyCO9LQAAAAMAdAKKkYUUUUAFFFFAHN/Ef/AJJZ4r/7At5/6IeuT1bRdR0/xRrXjPwrG0up2d6I72xU8ajaiCElMf315ZD65Heus+I//JLPFf8A2Bbz/wBEPV7SPDWnaHd3dzp/2zzb198/2i/nnDN0yFkdgDgAZAHAA6AULR3/AK6D6WPP9M8ZrqNtbv4ZuTDF4l8QPCt4IgXgQW4diFYEb8pt+YEA5yDiszxtqevt4c8UaBfaxcyHSbzTzFqEUcUclxFPIoMcoCbcrz90Ln5cjGQfUJPCWhyadcWP9npHb3Fybt1idoysx6yKykFGzzlSDnnvTJPBuhTaDc6NPZNNZ3TB5/NuJHllYYw7SlvMLDauG3ZGBzxTVtPl+Fv8mTb9fxb/AMyl46he3+E3iCGa5lunTSLhWnmCh5D5TckIqrn6AD2ribLxJrF58P8AVdZ0HXpNOk0DS1jGk3FrFIA8cO7zJAVDjePuYfbgBjnla9M1Lw9pureH5dEvopW0+ZPLkijuJIy69wXVgxz355yc5zWHcfCzwncjE1pfHNoLJyur3amSAZxG5Evzr8x4bPHFS7+95/8AB/zLTXu36f8AA/yOdHjHXNBvY5tTv21WG48LSau0BgjjEc0QTITaAdrb+QxbBHBA4qc6n4mtrrwx5mvzXEXiiIxSBbaFTYSmAyiSH5DlRtIKyb+3NdPa+AfD9nqtnqMNvdtdWVsbSBpdRuJFWEjBQq0hVh7EHoD2FWtK8JaNot0LjTraRHVSkSyXMsqQKeqxI7FYh04QAcD0q203/Xd/o19xmk0l/XRfqm/O+p5tb+NNcsF8Nz6prt5IttfyWHiFWgt1jU+Y0aSMRGCgLlMYI+X3yTqJqPir/hKvDWmnxLJ9i1y1u7l2ayh8+EKAyBW2heA69UPIOd2cDs7nwb4fu4NXhudMikj1p1fUAS379lUKCeeMBR0x69SaS/8AB+janrlpq91FdC9s4mht5Ib+eIRIwwQFRwvPc4ycD0FLpr/Wn+exT30/rX/Ip/DrWr7XvBcF3qsonu457i2km2BfN8qZ4wxAAAJCgkAYzXUVk+HfDOl+FNOaw0OGaG2aVpSkt1LP8zcsQZGYjJ5IHck9Sa1qHZvQAooopAeLfDibWoNTtToOnafelvCOi+b9svnttv7uTGNsMm7v1xjA60+wXxQ2h+P73Rbv+ydatdbe4eGy8u5SYLbxFow0sXORnB2g5x1HXpfhd4O0ey8I+HNft1vRqN1otoJpG1G4ZXHkjC+WXKYG44GMLnjFbVl4a07wc11eeH9K1O9uL+UG5jGpPMXY8GRhcTbcgAAkfNjA5p3t91vxT+7QfX5r8rHIeKfFWuN4XvvFHhLxEVsLe2tEjintIpUkeUqWcHarBgskfcrncNvpY8R+Lde8Gazf2j3cmtRz2Ed1bGSGFHtZGuEh2/LsUp+8BG85+U5Y9Q7xN4LvLP4Ly+GPD2jfbbq6lV5Le2ljREZpvNf5pGX5Ryo79OOuOs03wloqabciXSpM6nCEvI7+drmQpj/VM7O/yrkgKrbRzinpd9v+B/n1F0V/6szz7XvEPxF0PQdTuC09lbxTWv2W61eCzkuH8yURyR7beTYACykMRnGR15rofEF94i8MSWsup6pqd1pC+dLc6jp+nwu8J3ZRZY9rExqpPzRru4BJAya2br4d+HL3RhpV5BfT2YkWQLJqt0zAryo3mTdtB5C52ggHGRWjqPhnTNVgEV8ly6eWsTbL2aMyIM/K5VwXHJyGznPOan+vwD1OAvvFvi7V77UG8F215frpc8MUXk/YltbwGOORjKZZBKuQ52lAAOPvcgV9a8U+LLWHx3djW0iXw5JBNawQWcYV1aMSGOQtvJBDYJUg5GQQOK9Cl8HaHJqUd8tm8E6RLCRbXEkKSRqMKsiIwWQAcAMCBWfdfDXwxejVRc2t666w4e+X+1LoCcjpkCTAAHGBgYAHQYp3XT+tgXmZlz4j1Kx8ZeVrl3faZYXcsEWmyJaxy2Uu4KSkj7S6SltyjLKuCMZNcnrWqa9rnw5mbUtbmjurXxZHYGWyhjiWSNbpEHysG4H3gCTz1yOK9MHgrQ99szwXMotWV40mvp5E3qAFdlZyGcbRhmBIIyDmq1v8OvDNtpF3pkdncNaXlwLqZJdQuJCZg24SBmkLK24A5UgkjmmrJp/1un+jFrb+uzX6pmFbXHiq/wBe8YeHovETrPp9ravp12lnCHRnVz84KlWJKgE4A/uharWuu67rPg+21PSvEFxBd2GjyTX6T2kEiPcjK7XUKpBDJLwjKOFyD37HSvBui6Lrl1q+mwXEd7doEndr2eRXUfdGxnKjHbA4BIGMmlHg7Qk03VLCGyMFvq8zz3y288kTTO2Nx3KwYZxyAQOvqaiV3F23t+O3639UilbmTe36af5fizzwyav4h8SfDi4k8RahZzaho01xM1qkGPN8qMlwrxMuTvIOQcDpjnOnoupeIZnu/DOo+I7xtct9ZCG7Ftbgmz2eYrBfK24ZAVJwSHzzjiuqg8DeH7W30qKKxlZdGDCx33crtErDBTczksuMDaxK8DjgVHpOk/bPFs/im90h9Nu3slso47ho2m2B2ZixjZlwTtxhieDn0rRtcza21/O6/wAvQiz5bddP8v8Ag+pQ8f6prumah4Zi0TUYbOHUdUSyuQ1qJHZWVmyrE4GNh/hPUc8YPPahrnjo3mo6VoH9oapqGhiGLz4obGKC9kZA5M4kkDqCGwPKAxgnJ6Dvdc8K6T4jubGfVoriSTT5fOtjFeTQiOT+9iN1BPbJzwSO5ovvCukajrCarcQTJeqgjaW3upYfNQHIWQIwEijJ4cEcn1qFovn/AJf8HTzLdr/L9X+ljhPEni3X7LWDcWWpN5dvqFjbS2NtbxyQRLMUDieVlz5mX+URPwNpIwc1r6XfeJfE93d6lpWsR2cVlrEli+myQoY2gjfY7M20v5pGWXBC/dBB5NbF98P/AA1qNxdzXVg+68kjlmEV3NGrSRkFHCq4AcbV+YAHAxnFWl8IaLHrUuqRW0sVzMQZxHdSrFOwGA0kQbY7Y/iZSeBzTVv6+X+T+8T20/rf/gfceVWeo+IvD/gXxHrGn+IbiaaPxM9u4vLeKXKfaFiJUhVwxDDk7lAXAUV1Wp65r+py+LbjR9WOmf8ACNPsgt/s8bx3TCFZWMpZS207to2Fcdcmt2/+HHhfUra7t7rT5vJvbr7ZPHFezxK8uc7sI4xyA2BxuAOMjNW7vwXoV9cLNdW0zv5axSYvJgLhFGAJgHxNx/z03UvspeX6L/J6eY9OZvpd/m3+u5w6eJ/FGua1dRxasNJtZPDEOrwRQWaNLBK+flLSbgwypz8o4OOCM08eNNZbSdE13Wbi90zR73SYJnvbG0jngjuHB3m4BUuqDKlSu0ddx6V2F34E0C+1e71OeG8F3eW32WZ4tSuYwYf7gVZAqj2AHJJ7mo4fh74bg0qDTEtLn7DAqots2oXDI6LnajgyYdBk/K2R2xwKpNdv6u/0a+4nX+vRfqn95W+JNww8KW1tHJth1HUbSznYd4ZZlVx/wJSV/GsT4j+ItY0T+0P7B1Rrf+zNL+2JZ2VqkrFgzczmRSqRYXACsrnDYziu61vRbXXtFn0y73LFKBtePAaJlIKuvoVYAj3FY83gjTtaR5/FFpHc389qbK6ktZ5oo7mLnG5AwHckZyVJOD3qenzv+H+f5lLz/rXX8DnNQ1rxPd+MNU02DXVsLSPw8mpQfZrKMyRyFiMFpN4YZQ9hw2BgjdWRrPjvxDP4Mt9Z0/VDb3Ufh6LVHs7G2SUmQgljOZFKpEQOArK5w2M4ruz8OvDjXk10YdQ8+e0FlI41a6y0AGAn+t4H07knqTUMfww8JRWf2RNNm8j7GbFkN/cEPBzhGy/zAbjtznb/AA4p6W/r+9/mvuEt9f6+H/J/eZH9o+JtY8cano8WvjTbZNHt762a1s4y8buzAhjJvDDKHPA4OBgjJ57SNU1XxX4s0XVPth0q+ufCU0kk1vEjkMJ1G5A4ZcEjPIPB/GtpfBb3nxRumvtD1JNCXSoLGC8XUtocxs7FW2TeayEMBhgQSORjBrp5vAPh6bVP7QFtdQ3AtPsSm21C4hVIMY8tURwqjvwBzz15o815/lJfqgXZ+X/trf5M47SfFWuvH4J8SatrcqaNrFsIb62WCERpcmMlH3bC4VirDG4YYrzjipZhfnxX8PrjVb6e7mubq9nUzxxo0SNbsUjwiqOFwCSM5zWzqHgywPh2HwRp2h3H9ibo5DcXFyJYYlWUMUG+Qy7sDgbdoz17Vu6p4R0fWdZsNV1CG4e7045tWjvZolj9fkRwpyODkHI4ORxTbV7ru/u/4f8AAVtLPscNpPi/XV8W6d9o1KTU7DUIL6R1jtkS2BhwUFu+1ZGGOCzblJ5U1f0ebxT4g8K2niFfEXl2eqabJPcW0cMQNmzJmPyG2Ekg8N5hbPUY6V0Nj4A8N6ZdWdxY2MsUli8j2v8ApkxEO8YZVUvgIf7mNvtVjTfB+iaTNK+n2jwpKzMbf7TK0CFs5KQliiE5OSqjOT61DV4tf11/z/AraV/P+v68zznwhqeu6R4Z+GkcesyXNnrDBLqK4t4y+Ps7OFVwBhQU7gsc8t2rp/Ct94k8Sx2HiODV4ksprqeO50qSFPLjhV3RdrBd/mgqM7m2nJ+UVor8N/C8a6YsVlcxLpUnmWSx6jcKIW6ZAEnPHyjOcL8o44q/aeEdFsNVm1CytZIJZ5DLJElzKIGkJyX8nd5e/Izu25z3rRyTk36kWdrf11MTxzqWvWfiTwtZaLqkVjbapeva3H+irJJ/qncMGY4GNvTb1xzjIPO3fiDx3LeahaaBFfand6FPFau8cdjFbXreXG8jTCSQSITuOPLwBx97kDv9X8LaVrup6fqGpR3D3OmyebatFeTRCNvXajgE4yOQeCR0Jou/Cmj3utf2rNbyreFAkjw3MsSzKOgkRGCyAejg1MdN/wCv610/yKf9f19xxF34q12LxlYtBqjXFlPrg06W2gtkNrFGUJwZWUOZgw52MyDoRmtLQb7xL4q/4nVhrKWtumpz2k2mPChRYI5GjLBtpfzvlDDJ2842962X+H/huS6e4NjKsjXgvwEvJkVJxz5iqHAQnPO0Dd3zVuHwlottrE2p29rJDcXD+ZMkdzKsMr8fO0Iby2fgfMVzwOaUbW1/rb/gg99P63/zX3Hlei6j4h0H4fDUrLxBcTtN4pa1nW8gikJja9MbbWCrhmzkk7hxhQtdDq3iXxBdab4u1vStUNivhm5lihsTbxtFdCKJHbzSyl/myQCjLjjrXR3fw38LXtpJbTWE6wSXf21o4b+4iHnbt24bHGPmJbA4DHOM81duvBuh3l8bu4tJGkYKJVF1KsdxtAAMsYbbKQAOXDHin0/rsv8AJ/ePrf8Ard/5rXyPPdQ8WeK5Y/GV3HrC2UekaXbalZ28VlHlS8byGOQvuLD5cEjB7jbznduvFGpWniK2m1q4vtM0m8S2FnPBaxzWjs+3ckzbTIjlsqDlVww6mtm8+HPhq/uNVmura9d9YQJfY1S6VZlB4UqJAAB0AAAwSOhIqwvgfQVS2Q29zJFaujpFLfTyRsyBQpdGcrIQEXBYHGARzTTV/wCvmTr/AF8v+D95QjdrP4xyW9vxDqOjfaLhB08yKUIr49SrkZ7hR6V19Y2k6JJb6veazqbxyajdosP7rOyCFCSsak8nliSeMk9AABWzU/ZS/rd/8MP7Tf8AWyQUUUUAfJP7Vf8AyVPTf+wLF/6Pnoo/ar/5Knpv/YFi/wDR89FAH0lY/wDJU9d/7Aum/wDo++rpK5ux/wCSp67/ANgXTf8A0ffV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/AOwLef8Aoh66Sub+I/8AySzxX/2Bbz/0Q9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBwXw+8VaTD8OfDloZbh5bbRrNZTFZzSIG+zodgdUKl8fwAluRxzW3a+PfDt5Ho8lteyvHrbtHYSfY5gsrLnKlimEPynhsE4OK4HwBoes2+i+D7/AMOwahYRXVhaPqYkuopLG4iECruEZYukpAUjYoH94mn6d4V8VWuk+E9Lj0NR/wAI/rMk00897GqTQnzQHTbubpIOCAc8YxyCOtr+X/BCWl7f1vY72Txjo02qHR7TUlTUJS8MDvbSNC0yg5QSYCO64yUD7uD0rB+Hvj2PVdB0u38Q6iJdavp7mJWW1aOORo5XGwMBsDBFB2lt2OeetO8K6dq3h/Shomp+G21D+zria4tNQjmgMcoZ2ZSA7h1lw5HKhc/xAHNcxpGg+KrTRfBtpN4Wvkl0vW57y7P2q1ISJzLgjE3P+uHA/ut7ZqNr/d/XkEtn8/1/4B6lrOvadoFvFNqczp50nlQxwwvNJK+CdqRoCzHAJ4BwATVOLxroM9nYXVreSXMeo7jbC3tpZXYKcMWRVLIFJwxYAKeDiqfjK01a5utFbS7FrqCK6Y3T27QrcQqUKho2lICjJwxU7tpOK43T/CGsWXgu0tzpGsWus6dLefZLvTtRg8xRJOWXcZJNsiMCpbfk/L0zip6DPTLvXNN0/QzrN9eRW2nLEJWuJTtUKcYJz65HHvWJH8S/Ck9uJrfUpLgMEKRwWU8kkgdN4KIqFnG0EkqCBg5xg1Y1CLWn+G81veWw1HW5NOMMsVmyIskzJtYqXKqBkk8kcflXL22keI4vDfguzOiTxixtTbagsM1utzbsIwgKyFiBGSCWMbb8beOopvRyS6Wt+P8AkvvEtk/X9Drx4x0N7TTrm3vHuotSXfa/ZbeSZnUYyxVFJVRkAswABIBIrlk8fjTPHeuR65qatocOm2t9aLBYuWiSQuGZtoZyBtBLEBQCMgdTl2HhLWLX4f6NbPpGr2mu6VDNFb3OnX8AkQtJ0O+TZJGwwxDZPy9M1HNpHjKS88TTah4enu7rUfDkGnie2ntljnuVVw5UNKCq5lyMgcKeOgI7K7Xn+o0r2T8vzR6rJfWsWnNfy3EaWixec07NhQmM7s+mOa57/hZHhNdPvb241YWsFgqPObu3lgZVf7jBXUMwbHBUEHtmo7ez1n/hUcdhHpkS6wmlC3FlfmOSNpVj24faWVlJHrjB571wOreFvFU1j4kFv4e1S6k1rQILGMz3tqWSZTIGDDzQiLhgcRjb7ZJFOSSk0v63JhrFN7/8N/n+B6jp3i3RNVu7m2sr3dLbQrcSeZE8QMTZxIrOAHTg/MpI461zMHjiTVfippOmaRf+ZpF1YXEzxPYPEzuhXbIsjgb0IbgoNvB5PbF1jwz4i8R69exjRbvTba98LHSxdzz25WOcnfhlSVm287SQDz7c1p2ll4p1Dx14X1W68Nrp8GnWNxaXpmvYiAX8vDRhCxZfkOAQp6528ZElzL5/+3L/AC+8V3b7v/bX+rXyOs1PxhoWkasul3t+P7ReEzrZwxPNMyDuI0BY9D25xxVCX4l+EIYrN21uEm+jeW3iSN2ldUDFv3YUsCNjDBAORjrxWN4tu7my+L3haez06bUZF06/zb27xq7DMPTzGVfzYf0rJsfCviDTvFPhy7fRJZY11W+1K9eC4hMdp9pDKqDc4ZiuQWKgjrjPSlFXt53/ADa/r/glPS/9dL/8D5+R1sfxN8KS6Fe6yl/cGxsHRLmQ6dcgxFlDKShj3bSCDuxjBHNF38TvBtjeXFtda/bRyWsiR3BwxWBmztDsBtX7pHJGDgHkjPK+J/CviO4j8e6bpmkG6TxEsUtrdm5jSNSIkjZGBO8MNuR8pB9RWj4btPEVn4u8Tapqfhm5hW7sLZIPJureRZpIUYMikuDyW+UsFGBzt6UtLXXb+v1HYt33xH0vSrPw41rNf6zBrU7JFexWEku5FDMTiKMZPy4AC5xzggE1pL8RfDTaWNR+2XK2v23+z2d9PuFMc+QNjqY8pyQMsAMnGa4vQ/DHiW08I+A459CljvPD9+7Xds9zDko0cih1ZXKlcyDPO7g8HjKat4U8UHRvEOj6foona78QR6rb3Ul5GkUkZljkK9S4YFCDlcY5BJ4qrLms9r/qv0b+4l3smv63/Wx6PD4k0u41R9PhmledJTCWFtJ5RkAJKCXbsLAKcgNkY5rVrgbXRdds/HFvd6NaX2m2l1cSTatFLeRTWUoO4bo1J8xZSQrcKq8nOTXb2VxLdWwlns57JyzDyZ2QsADgH5GYYPUc5wecHil0Q3uT0UUUgCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA+Sf2q/8Akqem/wDYFi/9Hz0UftV/8lT03/sCxf8Ao+eigD27xBfWFj8UtROo+Nv+EVD6NYbD51pH9o/fXmf+PiN87f8AZx97nPGLulPaa7ctb6H8WrzUp0Te0VnLpczKucZIW2Jxkjn3rm/iiZRr2ptbxpJMF8PGNJHKKzfb7rALAEge+D9DXW6jqHiSHSdWu9Rs9H0m/t7Njps8U5vN7bWeRfmWJukanAGO+TjAV0ouT6X/ACT/AFHa8lFdf8y9/wAIvq//AEPfiD/vxp//AMi1m3EBtNftNEuPiTra6neI0kFr5FgXdVBJbAteBweTjpiubtfHGvaNb6HqOq37apFqHhifU57byI4wssUcbgoVXPzbyCCSO4x0onfUo/HXgTVtV1ZtS+02d7cmJYURImNurFYtoB2+m4sfftVSXK9el/1/yJTurrrt+H+Z23/CL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItcjbeKvEcWh+FfFb6g15ba9cww3GkmCMRwLMDtMTKu/cuBnczA88DtqeF7vxV4l0rTPElprlultqMcrT6fPbK0dqCGEfllQHZlYKGDPg/NjbwKGmr36afMZq3Ph/VLS3aaXxz4kZFxkRWdjI3Jxwq2hJ/AVL/wi+r/APQ9+IP+/Gn/APyLXnQ8S+Ol+GcPiw+JrdmN19mmtTpiYI+2GIMjZ+U7TjkMOB3yTqeIvEXiq11Dx75GupBFoFjDe2UcNlH3SRyjl924HaASMHpjbzk/r8v8wSbdv67HY/8ACL6v/wBD34g/78af/wDItH/CL6v/AND34g/78af/APItcprfinxbql/d2nhKzvjc2VlbXEa2oszFJLKpbbN57q/l8AfuwD157V0vijxJf6J4IttQ8iO31C6ktrYhyHS3kmdULHBwwUsT1wcdaLPbzsJNPUpQwm51u90e2+JGuTahYxrLc28dvYM0St0zi06n06+1Xrfw9ql1bRTx+OvEipKgdRLaWMbAEZ5VrQFT7EAiuPeLWdG+IHix4daa7voPDUE0F5eW0ZIxJMcMkYRT0OOB1Gc45sy+K9cg8PeHtY1W71C20q40eKe61Gws4plS4ZMlp0KlhGMhgYwOc5IFCV1/Xn/kN6O39bL/ADOs/wCEX1f/AKHvxB/340//AORaP+EX1f8A6HvxB/340/8A+Ra5TUfFGu3+j+K9f0bV/ssXhyeRILP7PG8V4scSSMZCVL/NuO0oy4GOtN0/xH4ov/EevTT6ukFhpNraailjFYLl45I5HaFmYls4AG4Y5AIA5BWyu+1/kw32/robd7AdO1qw0m8+JOuRahqJYWtt5FgXl2qWY4FrwAAeTgdq0v8AhF9X/wCh78Qf9+NP/wDkWuFkn1S/8Q/DfXdS1Y3i6jPLc/ZVhRY7ctaOwWMhQxABIO8sSeeOlWNG8S+O9fOn6tplrdQ6dqKSec96lm1raqVPlvGElEzEMFDK/Xn7vSnJcu/zDfVbHZf8Ivq//Q9+IP8Avxp//wAi0f8ACL6v/wBD34g/78af/wDItcZomreONS+HOm+JP7Uub975U+022n2UCzQIHfdJDv8AlZsbBtYHgEjniu+8K6vb63oEd5aX8t8hkkQyTweTIhDkFHTA2sv3TwOmaLb+QFT/AIRfV/8Aoe/EH/fjT/8A5Fo/4RfV/wDoe/EH/fjT/wD5FrpKKQHN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItdJRQBzf8Awi+r/wDQ9+IP+/Gn/wDyLR/wi+r/APQ9+IP+/Gn/APyLXSUUAc3/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i10lFAHN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItdJRQB534+8OapB8NvEssvjTXLlI9JumaGWGxCSAQsSrbbYNg9Dgg+hFX9Kt112KWTRPilqOpRwnEj2baZMEPoStscVo/Ef/klniv/ALAt5/6IeuT1bRdR0/xRrXjPwrG0up2d6I72xU8ajaiCElMf315ZD65HehWvr/Ww7dja0mKLXmmXQ/ipqGpNBjzRZvpkxjznG7bbHGcHr6Vfk8N6nDE0k3j7Xo40GWdodPAUepP2WuQ0zxmuo21u/hm5MMXiXxA8K3giBeBBbh2IVgRvym35gQDnIOKzPG2p6+3hzxRoF9rFzIdJvNPMWoRRxRyXEU8igxygJtyvP3QuflyMZBdtvl+Nv8yb3v8AP82v0O31iwm8P6VNqWtfEfW7KygAMk0sWnhVycD/AJdepJxirNroGo3tnDdW3j7xA8M8ayRt9nsBuUjIODa56Gjx1C9v8JvEEM1zLdOmkXCtPMFDyHym5IRVXP0AHtXE2XiTWLz4f6rrOg69Jp0mgaWsY0m4tYpAHjh3eZICocbx9zD7cAMc8rU3S5vL/glcrfLbrdfl/md3/wAIvq//AEPfiD/vxp//AMi0f8Ivq/8A0PfiD/vxp/8A8i1yQ8Y65oN7HNqd+2qw3HhaTV2gMEcYjmiCZCbQDtbfyGLYI4IHFTnU/E1tdeGPM1+a4i8URGKQLbQqbCUwGUSQ/IcqNpBWTf25q3Fr+vNr80yU00n/AFsn+p03/CL6v/0PfiD/AL8af/8AItH/AAi+r/8AQ9+IP+/Gn/8AyLXA2/jTXLBfDc+qa7eSLbX8lh4hVoLdY1PmNGkjERgoC5TGCPl98k6iaj4q/wCEq8NaafEsn2LXLW7uXZrKHz4QoDIFbaF4Dr1Q8g53ZwFbqv66/kPZ2Oq/4RfV/wDoe/EH/fjT/wD5Fo/4RfV/+h78Qf8AfjT/AP5FqP4da1fa94Lgu9VlE93HPcW0k2wL5vlTPGGIAABIUEgDGa6ihqzA5v8A4RfV/wDoe/EH/fjT/wD5Fo/4RfV/+h78Qf8AfjT/AP5FrpKKQHkvw6nstR8G+HdPsfijcpff2Vb50y2m013gxCpKBDAz4Xp8xJGOTXQ6ULfXZ5IdD+K99qUsQ3SR2cmlzMgzjJC2xxzXH/DibWoNTtToOnafelvCOi+b9svnttv7uTGNsMm7v1xjA60+wXxQ2h+P73Rbv+ydatdbe4eGy8u5SYLbxFow0sXORnB2g5x1HV6de1/xS/Udney7r8rnoX/CL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/Itcb4p8Va43he+8UeEvERWwt7a0SOKe0ilSR5SpZwdqsGCyR9yudw2+ljxH4t17wZrN/aPdya1HPYR3VsZIYUe1ka4SHb8uxSn7wEbzn5Tlj1BZ3t1/piWqujqv+EX1f/oe/EH/AH40/wD+Rajm8P6jbgGf4ga5EDnBeLThnAJPW19AT9BXDa94h+Iuh6DqdwWnsreKa1+y3WrwWclw/mSiOSPbbybAAWUhiM4yOvNaWqaZrUPxX8I2974qv5xIt9MPLggjUKuwhCuwg/KxUt1wONpySrX/AK8rgbWiWsniTTBqOh/EfXL2zZ2jWaO3sNrFSVOCbXkZHUcGtH/hF9X/AOh78Qf9+NP/APkWvO/DOo6toujaVc2mpulre+LLywms1gjKskk83zbiC28MMgggY4IPWtzT9R8RLc6t4Vv/ABNePraanCLS8+zWwb7G67wwURbD8qSqSQfmXjGQKaV9v62/z+4Ho2v6td/5HUf8Ivq//Q9+IP8Avxp//wAi0h8MauAT/wAJ34g/78af/wDItcOvinxbp2g+LNcv9bhvB4fvp7VLRNPVI5x5cewkgll2s277xyMj0xs32p+JtC8SwaSutf2imq6Zc3MU93aRk2c0QU8CMJujO/ADcg/xGk9Ffyv+F/yHbW3nb8bGzDoeozWC3n/CeeI4oWTzCZ7SxiZVxn5le0BX6ECqGlKdc062v9H+IniK9tLqZ4Yp4LKzZCylgSSLP5VypG44U8YPIzm+HPFGt+KLXwvprao9hdX+hjVLu9hhjMkjblUIispQDLEt8ucYxjOaw/BGra1pOk+DrWC+hFrqGvajbXsf2cbpSJJ3BDE/KMr0Az79jfLZtP8ArW35k3XLf+trnon/AAi+r/8AQ9+IP+/Gn/8AyLR/wi+r/wDQ9+IP+/Gn/wDyLXO2niPWk1DUNN1a/vNN1p0uZLOC8sI3s5UTOxoXTBbAwxV33deAKzdD8ReJ76DwLLd6+5PiazkFyqWcIELrF5gkj+XhuCDu3L32jpUJN7f1e/8AkN6f12/4c27v4WfbvE1p4gufG3iltSs0KQSrNaoqKeo8tYAhB4zkc4Gc4FbP/CL6v/0PfiD/AL8af/8AItQ/DzWL/WfDlw2rXH2q4tNRurPzyio0qxSsiswUBd2AM4AHtXVU9lb+tQ6v+tjm/wDhF9X/AOh78Qf9+NP/APkWj/hF9X/6HvxB/wB+NP8A/kWukopAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLXSUUAfHf7Sthc6d8SdPivNWvNVdtJjYTXiQq6jzphtHlRouOM8jPJ56YKvftV/wDJU9N/7AsX/o+eigD2fxXZeHb/AOJt/D4otdZuo10nTpYU0yK+cB1uLwhn+yjgg4Kl++dvepGh8EyLMLiz8aXHnQtAxuLXXJSEYjcFLAlc4AJXBI46Eiq/jfXvEPhvxxq2peGbe0vHTS9NE9nPC7PMnnXxPlsrrtYKrdQ2SR079Pr/AI2S0+Hi+ItBSO9mvLcSafE5+WVmUsM8g4ABZsc4U0m1yt/1/TKV+ZIwLW28B2d5p9zDpPioyabAba1Eum6zIscR6ptZCpUjjBB4AHQDCWdp8PbG7sriHw7r7Pp7s9mJ9D1WZbUtgny1eMqg4GAoAHbFbui+M1g8EaTq/iu5hN3qFqt35WnWMzbUKhjiNTI5C7hl+nc4om+Immjxfo2jWa3F1Fqlq10l5BayyxFMqFw6qRj5sluijGSMirakpW6/rv8A5kKzjfoZ9leeDdP1IXtppHiNZFcvHG2iao0MLEEFo4jEUjJyclVB5PrTLW48GWVxdS2Wl+J7YXRZpIodI1ZIgzfedIxHsRz13KA2ec5rVufHGmapY6ha+G9URdTjs5bi2kns5THIqcF4ywVZVB4JRiBkVB4F8c2etaBoNvql8x1q902O5fzbZ4lnOwFyjbQjYJ5Ck49BUpXX9db/AOTG9P6/ruYhsfADeGF8PHSPFf8AZSz/AGgW/wDZ2s/fznO7Zuxu+bbnG7nGeaSXT/AM/wDaPn6Z4wkOqRLDel7PWz56L0Vvl6Dp9CR0JrsrHxpoOp6pHp1lf5uJ1ZrcvBIkdyAOTFIyhJQO+wnFcx4b8as+lyR+LvEEdtfv4gm061a3gVPtHlyBRGqEOcHuckgN94dQ1du3f/gIHor/ANdX+grTeC2aycaZ4qjlsYlgimi0vV0kManIR3VA0i+zlhWnqHiXwxquky6XqGka3cWMqeW8D+GtQ2lew/1HGO2OlbUnirR4tQntJLl1e2O2aU28nkxtjO0y7dgYDkjdkDrWfa/EfwperaPaasssV67x28ywSeXK6EhkD7dpbg4XOSOQCKW6DY5j7D8Pt0ztofiaSee1+ySXMmlau85hyTsEpTeBzg4PI4PHFSqngZNJh0xdL8VfYoY1hEJ0zWCrxqWIjf5PnQb2G1srjjGABXcaLr+neIbWW40qZ5FhlaGVJYXhkikHVWRwGU8g4IHBBqlJ418Pxa6ukSX5W7abyATBJ5Xm7d3l+bt8vfjnZu3e1PW/9f11/ENv6/rsc7dXXgu8vjdzaN4iDsFEsceh6pHDPtAC+ZEsQSTAAA3qcYFPsdQ8I6br1/rNrpvigX2oqFunk0fVpEkA6Dy2jKDHQYAwCQMA1r2fxF8KahLAlhq6XK3F0bOOaGGR4vO/uGQLsUntkjd2zWJ8Q/Hh0i1jt/D2pLHfR6hbQXGbF5YyryKrRiXHlpJht2CS2B07gV20l1/UH1/rb/hinBZfDy3uLWVPDmvP9jnNxaxS6FqkkVs57xxtEVQZ5woAzg4q1HN4Lgmu3t9M8UwC8LtLHDpWrxxhm+86RrGFjc5J3KA2STmuw1/xJo/hfT1vvEGoQ2Fs0gjV5jjcx6ADqTwenpWbcfEHw3aafqV7cXs8cOluq3mbGfdFu+623ZuKHqHAKn1pb6f1/WwGFYXPg3TNBg0aw03xTBY2zM0CrpWr74iylTtk8vevDHgHjPFaOleJfDWiaetlpmm+IIYFYtg+HtRdmYnLMzNCWZiTksSST1NWNc+IWiaIuqRyG7mvNNsft0lvHZTEvF2ZW27WGTgkEgc5xg4p2vxV8LrptpJqupfY72WyF5LavazLIiADc2wruC8kgkcgEjIGad27/wBd/wDJh2X9dP8AM0f+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GKx9U+Jmi6f4R1LxBo+oza9Al4tshggMscUrBAEBjQZQbgckkktgHOANzTPFWi6pq18lprLtJZ20cl1ZzReULQHcQzhkDIxHVWPAA+UdSv6/UP6/Qj/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GKdB4+8MztcA6mLf7PAbljdwyW6tCOsqGRVEif7S5HI55p+keOPD2u3lrbaVfmeS8tzc2x8iREmjGNxV2UKxGRlQcjPIFOzAi/4TzSP+fPxB/4Tmof/ABij/hPNI/58/EH/AITmof8AxiukopAc3/wnmkf8+fiD/wAJzUP/AIxR/wAJ5pH/AD5+IP8AwnNQ/wDjFdJRQBzf/CeaR/z5+IP/AAnNQ/8AjFH/AAnmkf8APn4g/wDCc1D/AOMV0lFAHnfj7xppd18NvEtvFa64rzaTdIpl0C+jQEwsBudoQqj1JIA6k1a0jV/C+h3d3c6faeLPNvH3z/aNL1ecM3TIWSNgDgAZAHAA6AVrfEf/AJJZ4r/7At5/6IesLTPHGr6d42n8P+MRZfZ5pxbadqlpA8MUs/lq5hdGkfaxDjb82GwR1prV2W4dCSS/8GSadcWP9h67Hb3Fybt1i8PalGVmPWRWWEFGzzlSDnnvTJLrwXNoNzo0+j+IprO6YPP5uh6o8srDGHaUxeYWG1cNuyMDnitLSPEWoWUWrT+L9R09obW9+x24sbCWN5G2g4C+ZIzsdwAVRng9c8Ra98TNH03wfda3pxnvTBOtq0K2koeGZiAFljKh4+oOGAJ4A5IpdNPL9LfoHX7/APg/qR6lrfhbVvD8uiX2neJG0+ZPLkij0TVIy69wXWIMc9+ecnOc1hXGkfDy5GJtI8XHNoLJytlramSAZxG5C/OvzHhs8cV1/jDWL63+HGqa14fn+yXMFk91C13ZvkBV3YMb7WUkDHzdCeQelVoviBoumaTZ/wDCRX729wNOhu7md7SQQqHXq0gTy1JOQFzkngDpR3v/AFv/AMENrW/rb/NGLar4Is9Vs9Rh0vxW11ZWxtIGl03WJFWEjBQqyFWHsQegPYVa0q/8H6LdC407SvEiOilIlk0TVZUgU9ViR4isQ6cIAOB6V0el+MdC1m8a20++3yC2W7G+GSNXhbpIjMoV17EqTg8HFV4fH3hy4mkihvJndYGuEUWU+biIdXh+T98B/wBM91N3W/8AX9aiVraf12MK5uvBF3Bq8NzoGtyR606vqAPh3Uv37KoUE/ueMBR0x69SaL+78H6nrlpq91p3ioXtnE0NvJDpWrxCJGGCAqRhee5xk4HoK3bPx94ev5dIS1ubpv7aUtYM2n3CrMBkn5igC8KThiOOehBqIfEfwsb1LI6jIt7J5nl2jWcwnk8vIbbGU3MMqwBAOSCBnFJ9n/Vhmb4d1bwp4V05rDQ9O8TQ2zStKUl0XVZ/mbliDJExGTyQO5J6k1rf8J5pH/Pn4g/8JzUP/jFbGkavY67pUGpaVOLi0uFzHJtK55wQQQCCCCCCAQRVym731A5v/hPNI/58/EH/AITmof8Axij/AITzSP8Anz8Qf+E5qH/xiukopAePfDeTwnpHhvQtXSy8UnVZNItYriZLHVp4pMRDgAKY2QEtt2jaM5Wtay1fwv4Oa6vPD/h7xne3F/KDcxjTdTmLseDIwuBtyAACR82MDmsj4deLdY0/TdNsdc1PRbXw/pXhrT72SZrORJdksRVULmYqCNgy235s4CjNeiaV428P61cxQadqHmPNafbImeCSNJYeMurMoVsZGQCSuecUdP6/rowe7v8A1/V0eWeJri0s/gvL4Y8PeGvEF7dXUqvJb22gXiIjNN5r/NJGvyjlR36cdcdbpt/4OTTbkS+HvEmdThCXkd/oWpXMhTH+qZ2jf5VyQFVto5xW4fiT4RSG5ln1mO3it4hO0lzFJCskZbaJIy6gSKSQNybhkj1qWHx/4bubKS6tb+SeNGVAsNpM8khZA42RhCzjac5UEYz6Gn0YdUctdW/gW90YaVeab4unsxIsgWSw1pmBXlRvK7toPIXO0EA4yK0dR1Twjqs1hNf6X4klm08MttL/AGJqiugZdrAsIgWyAM7ickA9ea27jx14dt9KtdR/tBp7e8Vmg+y28s8jhPvny41L4X+LI+XvipH8ZaEsNrKl41xHdW/2qN7a3kmAhxnzGKKdi8HlsAkY60agcQmlfD6Ozt7ZNJ8XiG1uzewp9i1v5JycmT7vXOT9ST3ObNj4l0nUvGQ8S33h3xJp89vZNYwi48PXjSsC+5mPlxsu35V285+ZsgV1+peMND0i+jtNQvTFI7KpcQyNHEW+6JJApSMtkYDkZ7VznxQ8c/8ACO+E9WGiaktvrFrCJA/2J7hIicYVmA2RswPy7zz6GhXuv68vyHa+n9b3/MZpVz4M0aDUobLSfErxao5e8jutG1W5WZiMMSJY2GSODjrgZ6CkguPBttbXMEWm+KsXMRgd30vV3kSM9USQoWjXj7qECu1n1K207RTqOp3CQW8UQkllfgKMdaxD8SPCaWMl1c6utokdwts8d5BJbyrKwyqmORQ+SORx05pNdP67Ep3V/n+pzkVv4Ch07TrKHRvE8cWmE/YnXStXEsAPVVl2b9h/u7tvtUMWmfDq3ktHtPD/AIjtWs7hrqH7No+rwgSt1chIxubHGWzxx04rqp/iN4UtLa7mv9XSyWzkWKdLyGSB1ZgSuEdQzBgDggEHBxmrlr4w0K7kv40vvKfT0ElytzDJAUQ5w4DqNyHBwwyD2NPW9w02OXlm8GTSO8umeKWZoGgUnStX/cowwwj/AHf7skcEpgnuaqW1l4Cs20prbSvFqf2PkWA+wa0RAD1ABXGCDjBzxx04ra174m6PpnhLVtXsRc3U2nKA9q1nNHIjt9wujKGVD/eIAI6Grf8Awm+iPfPs1K7a6t9Oe8m0pLN/NEeV+dozH5itzgKSMhicHqFtr/W1x7/16IxdGn8HaAu3SbHxdAv2lrplOnay4eVs7mYMh3ZySQcgnkjIzW//AMJ5pH/Pn4g/8JzUP/jFVNC+Iul6n4NsdevVurb7Wm4W62E7SNwCdiBC0igEZdQV966bTtRs9W06C/024jubW4QPFLGcqw9abTWjFpuYn/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxWlqXiDTtJuoba8kl8+ZS6xw20kxCjq7bFO1R/ebAycZqrqXjLQtIkjTUL0xeYqsXEEjpErfdMjqpWIHsXK5pbjK//AAnmkf8APn4g/wDCc1D/AOMUf8J5pH/Pn4g/8JzUP/jFSReOdBnk1dIp7stoo3Xy/wBn3AMQ68fJ8+QMjbnI56c0XHjjw/aPbLdXksP2gJhpLSZViL42CVimIS2RgSbSaNwI/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABiltPiD4WvtVbTrLWIZ7lZ2t2EasyLIqFypcDaPlBPJ7EdQataV4s0XWtQksdOu2e5jj80RyQSReZHnHmIXUCRM/wAS5HvRuGxU/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GKluvG2iWepajYTyXgudNgFzcomnXD7YycBgVjIcdfu56N/dOJLXxfot4ti9vcTGK/tGvYJmtJljMIGS7OVCp1HDEHketHn/X9aMP6/r70Vv+E80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGKZN4/8ADBsdQkl1n7AtnEHmkuIHgZEY7VkQSoN6k9GAZSfWrN34v0TSLOxa+1CWT7TAJo3W2kkdo8DMrrGnyLyMsQqjPagP6/r7yH/hPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABisG78epH8QtMFprdrfeHLzS7mdV0+H7SzyxOgOGj3M5wx+VQMYOc9tC4+JOlf294dsNPW5vINcjeeO5gsppE8sDjBVeu4jOfujO7HFOz08/wDg/wCTC/8AX9epe/4TzSP+fPxB/wCE5qH/AMYo/wCE80j/AJ8/EH/hOah/8Yqt491jVdFTQZdJuooI7nWLa0uleAO0kcjgEKScL35wevGOtaGp+NdA0e+a11G/MToypNIIJHigZsbRLKqlIycjG8jOaS1V/O35f5g9Pz/r7iD/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8Yq+niXS5NVk06OaV543EbsttIYg5GQnm7dm7HO3dkZGRS6b4k0zV7gw6fNLIfmKu1tIiSBSAxR2UK4yw5UkUbgZ//CeaR/z5+IP/AAnNQ/8AjFH/AAnmkf8APn4g/wDCc1D/AOMV0lFAHN/8J5pH/Pn4g/8ACc1D/wCMUf8ACeaR/wA+fiD/AMJzUP8A4xXSUUAc3/wnmkf8+fiD/wAJzUP/AIxR/wAJ5pH/AD5+IP8AwnNQ/wDjFdJRQBzf/CeaR/z5+IP/AAnNQ/8AjFH/AAnmkf8APn4g/wDCc1D/AOMV0lFAHN/8J5pH/Pn4g/8ACc1D/wCMUf8ACeaR/wA+fiD/AMJzUP8A4xXSUUAc3/wnmkf8+fiD/wAJzUP/AIxR/wAJ5pH/AD5+IP8AwnNQ/wDjFdJRQBzf/CeaR/z5+IP/AAnNQ/8AjFH/AAnmkf8APn4g/wDCc1D/AOMV0lFAHx3+0rq9trPxJ0+4s47yNF0mNCLyymtXz50x4SVVYjnqBjqM8Gir37Vf/JU9N/7AsX/o+eigD3DXpdRT4rXB0zRLvVhHY6ZLN9nlgTy0WW+HPmyJkndwBnoc44zTh8Daxodr4gigt5NT0+JJ00DT4XjV4vtK5kyXdVAViQOchS2M5ArrrH/kqeu/9gXTf/R99U2keLbXXY9VOl2V9K+l3hs5YpIhE7uApJUOy8YYcnGccZ4yuW6a73/Rf16jvZp9rfqzg7XwprI03w1dajoWryfYdIGmXen2Ori1nRl2/vFaOdUdDg8M4PQ4zxWrD4RvdC8T+G5/Duiqmm2Om3dmYGu932YyOjrvLsWYfKc7d3Jx05r0Wircm3f1/G/+bJSSX9dLf5I8k0bwr4mfWNIudR0ie3ZdJvLC6P2iAQW8jlCnlRRthYvlIGBvxjcOM1YsPBuu6poHhnQ9Rsn0geHbdo5L0zRyfaH+ztCDEEYnb8+4lwp4Axzkep1jReJ7GXxlN4ZWO6F9DaC7Z2hKxFCwUbWP3jk9sgYIJzxSvdcvf/gv9WO7Xvf1rZf5HH6f4Z1i7s/CGlahpUlkPC0scsl550TR3XlwtGBEFYt8xIJ3qmB61z66J4tGjC3/AOEP1DzP+Et/tnH2uz/1Hm78f6/72OMdM969pop8z5ubrv8AO6f6IVly8vT/AIDX6s8/vdI1yy8YJqnhqx1O2We4M2pQG7he0uowuOI2fckzALgqFXP3mrm9M0LxXbeGvCNlN4Uv0m0vXpL66xdWhCxFpCCD53J/ejj/AGW9s+yUUk7W8rfgN638/wBbr9TjPAtjqtjrviuTVNIuLCG/1Q3drLLLC4lQxonRHYg5QnkDgjvkDndR0DxPca/DePoc8gsvES3qLaXFvFBLb4Yb1TepaTBBYyc5+7kdPVaKXVPtb8Lf5A9U13v+N/8AM8YbQfFZ8LS2o8JX/wBok8WDVxGbq04g88S9fOxuwMY9fbmrOpeGPFieEb/w1aaF9sc60uo21+15EkUsbXQmKvk71cZIPykYHBPAPr1FOL5Ukun6W/yQPW9+t/xv/mzi/ibp+r6z4DNhpOkyX97NcW7tFBNEojCSrIx3SMgI+UgY5JI4AzjnNe8NeIfEWq+OVTQ7i0h1nRoLaznuJ4NrSx7ztISRiMlwAcY4OccZ9XopLQadv687nlOr+HPFXiHV9Qu00NLGC98LSaXtur2PzEmJYgYTcpGcc7sYOeuRV3SdN8Qjxx4VvLzw5dW9rp+iyWVxObm3YRyN5eMgSbj/AKsg4B6jrzj0mimnZ3X9b/8AyTJaurf10/8AkUeQz+GfE2o+EfGNmfD9xa3N9raalZxzXNufPjDxEqCshCtiI/ewORz1xd1Lw34g8R+JvFqTaRcaXa61ocdhBevPC6LIvmE5CyF8HzAPu9j7E+o0UulvK34WKvrfzv8Ajc84vtI1vWbvSdQn8PXNpLoFpcRrF9ot2a8kkiEYWIiTATq2XKHgcemZ4d0LxLZXHw5juvDV5EmhWc1vfym5tisbPGIwQBKSw+XPA6Ed8getUVXNrf8Arr/mTZWsFFFFSMKKKKACiiigDm/iP/ySzxX/ANgW8/8ARD1mx6I/iq38R6V4k0C+sLO+uhNBPLNAScRxqroY5GKuGTcMgdvcVpfEf/klniv/ALAt5/6IeukoA8tsPB3iqy03TrrU5Bquo6Rrkl6yxuiHUIfJMSsMkKr4OcMQMg8jOab4g8Ga1rOk+KdUttNaC+1iaxkh02SaPzNtu6k7mDFA7YbjcRwvPp6pRTu/68rf5Csv69W/1Oa8aQalqnw41e0sdMluNQvbGSCO0jljBDOpUZZmVeM5PPY4z38+tdH8Z6X4J1vw4PDF/qMOqaaRBcNc2gmgneMxtFKTN8yLgFWGSFIXHHHs1FTbddylJrl8v+B/keTXHhrxFrGrabA+i3unW58LTaRNevPbsLeaQJg7VlLEDZjIB6j3I2LHQdW1W+8JrqekvpY8MktJO80Ui3LeSYgItjFtpzuJcKeAMenoNFXzP+vVv9WRypJL5fgl+iPJb3wL4misbr+zI083QNTN54dRpwFnV38yRWGflADPGM9s+1bF7o+sWPjnwlPZ6LdX1lpNhcRXN1DLAoaSRVHCvIrE5Qk8Y+YdecehUVOyt/W1inq7/wBb3OO+F+nappPg9rPXNMm025W+uZRHLLFJuWSVpFIMbsOj4Occg9sGuxoopt3AKKKKQHhXg+18S/2CLy28Ialc2mpeELDT7aaO6sxudIW+chpwQh8wEZG71UVoSeEvEuqW3hnTZtBvLGO28N3OlXV09xbFYJZI0QHCylmUGPPAPDDvkD0H4cf8ks8Kf9gWz/8ARCV0lHS39df82O7vdf1t/kjznUrTXtT+G99p03g6RdaTSn06ORbi2IkLpszE5kyI8gMQ+w4A4JGKbqnhrVbrS/Cd8dL1F20u0a2u9LtNT+yXA3Ii7lkjlVSQY/ulwCG65GK9Iopt3bff/g/5sS0SS6X/ABt/keaTeE77TzpVpoGg3FrpTpdG4Ed6jXkMkuD888jlgjHcX8pi2QuMgHObbeFfEdp4I0RdP0rVNN8Tadp0dnHc2t9b+XuBb5Z0ZyrxAgHgM3znABzXrtFF/wCvv/zA8uvPAk93r+rxeINH1DWbPWZEnMlnrMttbROIkUpLCJkyu5MhlVzg4I4FQa/4X8TDQfGnh6w0b+0I9dla5s75bmJEQsqKY5A7BgV2cEBgRjkV6xRRd9PT8v8AJB/w5zPiO21u6+HkkFlp9rNqzQxhrRmSVMgrvCmRQrMBnaWAGQM8V5r4o0nV9K0bxJeXmm3iRahqWkz273l3HK7sssasjFWO1gR2G0djXuFZPiLwxpXiuwSy1yKaa3jlWUJFdSwfOvKkmNlJweRnoQD1FF/e5vNfmmFly2PMfiRp2pXeh+JfE99pr6ar2NpYwWs00bSSbboOXfy2ZQMsAOScZzjpWr4k8Ja540vb7UvsEmjvFp6WtrDNdqsl0yzpMcvCx2IfLChgdw3E4GK7jXfC2leJdEXSNaiuLiyUqTGt5NGX29NzIwZvXknkA9RWnbQJa2sVvEZCkSBFMkjSMQBjlmJLH3JJNJafLb+vvC7vf+tLW/I8v1TwPLqXgjxC2leHdRsdZ1GzSBl1XVzdyzFGDKodppFC/ewSV5PIFaM1hr978S4dQfw9cwWLaFLYNctcwFY5HYOMgSbsYGDhT8x4yPmr0Oih6/j+Ka/UFp/Xo/0PIbDwZrttoXhOXUNH1CVtH099OubDTtX+yztnZ+9SRJUVhmP7rOMgg9Riu48Pw2fha307w/ZaPdWNtP5rw5uBOsbElyjs0jOWPJJwVB43dM9NTPJi8/zvLTzduzzNo3beuM+lU5NvX+v6YrWVjjvHWiX1/LHe6FbapHq9tCUtL7TruKPaWPKypKwV48hSchjzwM1hXngi+u9evz4l0m/1y11mGDz207WJLWCKRYljdJIfOQNGSu4MAx5II4GfUaKlaFXOG1LwvqcfjKzm0mCP+ytRs0s9Y/fY8tYTujIB5bcC8Z74YE9Ky9T8CG78Ua3Hq+jalrGm6zOs6SW2syW8EREaLsmhEyAgFAQyq55xjgV6bRTu9/63uL0POdF8N6xdx+PrK90640hNcmb7HcySxOCpt1iziORmBBXODjgjvkCz4L8Li01C1v8AUvD+pWWqWVubY3V7rUl7GynG4QhpnwpKg/MqEccV3tFCdvuS+5WDdW+f3nHeLfD2p33ibStQ0ZRsmil07U280IUtnw28erKVwAP7/wBaxNI8AaxH4J8ReHLuaOFGgl07SJg2cWxLMhbByP8AWbCOuIwa9MopdLf1/W/3sd9b/wBf1t9yPKLvwhczeFdYntfCWrrr8+lTaapvNc+1+Z5gAxGZbhlEefmJbY2BwpJxUV5a+IVv9KGj6Ndw6jHoK2WoxqlrcNGhbAUhrmNVOVZlYOwIJyvFeuVjaj4T0jVNUXUp4riG9CBGuLO9mtXkUHIVzE67wMnAbI5ND13/AK3/AM2Lpbt/wP8AJHB6RYahZ+JvDlzpHhzV59L0XRbjTXeee1EolBQBCDMMnMRBI+XJGDjJFfwh4Y8UaafBM97oUsT6St9bXcb3UJMYmIZJMq5BXjBxlge2Oa9Zt7aG0t0gto1iiQYVFGAKkquZ3v8A1rf/ADYraWX9dDi/iTZatf2miJouj3Gptbatb3kwhlhj2RxNuP8ArHXJPYD05xWTf+GdbSw8XaHFpkl7F4mnlmhv/OiEdr5kSoVlUsH+UrxsVs8dK9KoqVomu9/xt/kir6p9v+D/AJs86tvDGsaN4l09/DkWoWsJlVdTaW6ieyuokXZv8ssXSVgqkbFA/vE1P4a0fW9D8Rt/Z9lqNpoAtXeXTru7hnQTnDKtqdxZQPmBDlV6YHeu+op3ZNktCK1me4tYpZbeS1d0DNBKVLxk/wAJKkrkexI96loopDCiiigAooooAKKKKACiiigAooooAKKKKAPkn9qv/kqem/8AYFi/9Hz0UftV/wDJU9N/7AsX/o+eigD2LxTqMkXxrg0iS7lsbDVrGxhuriGUxOdrX7JEJAQULMOoIPGARmuYlvW0fQPHMejeIbqG6svE8BYx3QaZ4n8mPDsctt5YbsgkpyTzXprabY6t8RvEFnqtlb31rJo2m74LmJZEbE96RlWBBrWuPCHhu7svsd14e0qa18wSeRJZRsm8DaG2lcZxxn0pxdnf+t0/0/EHqrf11/zOU1S/vNE8cNeawb250q8vbe1tLqx1Ftlo52AQy22Qp3P/ABgM2HwcCsF9S1m48GxeK7fU9Qj8Qf20bRrH7SxhKG6MXkG3zsyE53bd3Gc4r0+Pw7okV5BdxaPp6XNsu2CZbVA8QwBhWxlRgAcdhTv7B0c6s2qnSrH+0WTY159mTziv90vjOPbNC0S/rt+fX/h7j1v/AF3/AK+X3eSWt9rOm+B/EXiF/Eer3d1p2rXVgkk86tHHAZkjMrRhQhZFBYHAA57cU7Wb2Pwn8QtWn0PUpb28PhF5rJLu8a5d5BKzZUsWZhgbtoyAAcACvV9N8OaJo1vNb6Po+n2ENx/ro7W1SJZOMfMFAB49aNO8O6Jo/wDyCNH0+w+XZ/otqkXy5Jx8oHGSTj3pdvJfpb89R7383f8A8mT/AEseSa5H4u0/wfrms2/iBbLTptHe6h+ya5LfzPOpB8xGlhXy0YHBVCAONu2uj1XTdX0i3sNQtb3VdctEja8vbE6u0FwDsjxJGQV3Iu1iYmYLlz7CuxPg3wwbS4tT4c0k291IJZ4fsMWyVwchmG3DHPc1NP4a0K6sIbG50XTprS3UJDbyWiNHGoIICqRgAEDp6U79v6/r9Ogl0v8A1t/Xz6j9AvrfU/DenX1jLNNbXFrHJFJcf6x1Kggt/tY6+9aFIqhVCqAABgADpS0SabuhLRBRRRSGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/AOSWeK/+wLef+iHrpK5v4j/8ks8V/wDYFvP/AEQ9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfw4/wCSWeFP+wLZ/wDohK6Sub+HH/JLPCn/AGBbP/0QldJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAfJP7Vf/JU9N/7AsX/o+eij9qv/AJKnpv8A2BYv/R89FAHsPjSfQLP4kXtz4l8IjxJG2m6ZbQ/6LbTGCSW5u1UfvnXG5toyPTnHFaWh6N8Pda1a70mXwDpemarZosstjfaRbB/LYkK6sm5GUkYyrHB4OK5v4s6na2Hia+jm1Sz0+5lj0FoHumGBsvrpmfaWXcqjk8jjuK29Y8Etd22pa9rXiazmv9Sgt7aG5WzKWSwLIJBG0fmMWRzwxL4IPYU1td97fgrfiwfb+t9fwOo/4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJrzy406y8T+AZNdtPDmljUPDOoC5tW08Ca1vFiCFxAxXmNkG3AGAy+ozVnVRp8tnpviqeyjj0PX9UE+sSGDAe0ELLAZ+M+XkIzbuBu54zTt/Xra336/cLpf1/Df8AT7za13QPBWieI9B0s/DzRJ01i4eAXQ0+2VIWVGfBG3cSQp7Y9+x2rn4deEEhzZ+CPDUsm5Rtl0+GNduRuORG3IGSBjk8ZHUcJrqeENN1bwRp+matbSaXPrktxHE12phWN4HG2IggeVuYKAMrltvtXOT634dj8C3UFtq9nDbad40QWUUN6EjSA3CNwobDR7d5GQVABI6URV2l/W6X6g3bX+vtP9D2T/hXHgj/AKE3w/8A+CuD/wCJqjp3hD4d6pcX0Vl4S8PyGwuPs05GlwYEmxWIB29gwz75rz3xLfaTN4zfVLaa2ivLPxHZLLc3Mu+6WFtikRkY8q2YHuWDEt0zWL4jtfDOl+HvGiyfZdL1EeJoxEYX+zOYWaE7SVI3JtaRgpyOGYDjIUVfX+vs/wDyQ3pov63/AMj2WT4deDxcRCLwR4baE58120+EMnHG1fLIbJ65Ix71L/wrjwR/0Jvh/wD8FcH/AMTXC6pF4f8ADvxa8L2/h68t7aW8sr6VLf7aWjaSQAxsEZioLsz4IA3c9cVe+G9t4dvF0nUDcmHxfbwNHrECvtuJpWGH+0p94gMMqWwBxg4IFCV1/Xn/AJa+qE9DqpPh14JSJmXwVoMjKpIRdLgyx9BlcfnXO+E9A8I+LPD9tqsHw68O2YkupoJ4J7SAvEsbumQVjIZsqPlyByfmOOZ/Gdxpq+PtJt/GQhHhyWylEX2wD7M15vXaHz8u7ZnZnvnHNec+GtS0exXwHHLevaS2/iG/j8u6lkiDRMZirbXID8sg34PJ25zkUQ1+f+dv68hy0T8v8r/15nsf/CuPBH/Qm+H/APwVwf8AxNH/AArjwR/0Jvh//wAFcH/xNcBbT3WlarqmneH49K1nU7y0vLu01Kyyl5DIVJjW7Q5znIVXJHQAKOtV4INAkk8P3Ph+7htpltJE8UyQ3JhkWH7OdxumBDLIJMYZiHBzg9anpf8Arr/kPrb+un530PR/+FceCP8AoTfD/wD4K4P/AImuf0TQPBOseJ9e0d/h5olo2jvEnmSafbN54kUsGAVTgYA6nPPIFcP4dg0u2+EXhrXIiZre4uYrfxDdxTvI32ZZJGKy4J+UOy7s/wAJIPFJJPZ2us+L4fBxih0mS702WSa3s5JrRbUIPMI8sqpT5lyqsMqW7ZqrWbXy/LX7n+ZPT8fz09f+Aes/8K48Ef8AQm+H/wDwVwf/ABNH/CuPBH/Qm+H/APwVwf8AxNeReINP0bSPBfnjxZpt1p15rtlNaR6UWsrO3/eKJljAmcEbQWYZwhycCuj17T9I8H+Io7vSLfSNStpGjhTSJnYXkTO+9ms2JOc79xRQBx94AYp2/O34J/rYL/5/id1/wrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATXSUVIzm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mukooA5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJrpKKAOb/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDia6SigDm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mukooA878feAfB9n8NvEt1Z+E9DguIdJupIpYtNhV42ELEMpC5BBGQRVfQbT4ca34iv9Al8AaZper2Kh3s77S7TdIpAO5GjLqwG5c4PGRmuo+I//JLPFf8A2Bbz/wBEPXKT2OleObzXH8M63ZDxDpOpi5sLq3nWRoW8iJSGCnJjYqyMOnB7ihb69v8AIfQ0PD/hvwVr8t8jfDOw0w2U3kOb3TLIh3xkhfLZ+gI5OBzxnnF3WPB/w80LSptQ1Hwl4fjgixk/2XBliTgKPl5JJAH1ri4tS1HUtDtrzxHp507T5PEcg8QW0pzHFGsG35z0MRkCkk8EEZ4rL8T6TYSeDfFsmlw21z4TjvrCfTdiLJbwtvT7Q0PUCPB5K/L98etO23y/G3+ZPV/P82v0O/8AFPhXwV4a8L3+sp8P9EvxZQmZoItOtkYqOScsAMAZPrxwCeKu6X4F8EalpFnff8IT4fj+0wJNs/syA7dyg4zs561F47n0rTvgzrhtWtbLT/7KlitwoEUY3IVRVHA5JAAHXIxXlEmueF7rwVrf/CT3GmQeJU0RTpl9DdKnnW4jIiWGRSG3bgyumck5HKnAm9ubyt+pSV+Tzv8Ap/mz2b/hXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImvLrPUbGy8RafB4KvLE6rqHg2XCw3Cs9zdKEMO45yzgB8Z5wD2FaOl6XoWrap4Xj8OR2txcSwND4ogXDNJEYDuF2p5L+ZgDf8ANnOOM1bjr/Xdr9PxIUrpP+tk/wBdO9j0D/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJryY2S+Hrayu7fR4S/w+1JobqRLUeZNbSOdu045xFL5h/2uepNad5pXhjSPiN4PsNTNjaG6sLyfUbGS4CQs7qDl4shDkmQcj5guOdowul1/Wl196Kejt/W9mejf8K48Ef9Cb4f/wDBXB/8TR/wrjwR/wBCb4f/APBXB/8AE1i/BjUbW/8AhzElldxXMVpeXVugikDCKMTP5a8dBsK49iK76hqzA5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/ia6SikB5BpumfD3wx8F/DviHxJ4U0icPplkZZBpcMssrvEhZjkZY9WJJ6Amu5j+HngWWJZI/B/h5kcBlYaXByD/AMBrzjwhqLeMvD+g6XoUWjaxb6N4et7a7trrUzAVnlt1VztWGQnamUycAF2HJBxg3/i/Sbr4Jt4d1rX7RNb0LUIbIpBqZUzxpOqh1IZfMXyicnGAQSQCOBa/h917f5P5g9P6+Z7P/wAK48Ef9Cb4f/8ABXB/8TTJfhz4MELmDwX4deQKdivpsKqT2BIQ4Hvg/SvMNUu/h6fE3jXRNWu9KGk3VpaTRW8U8QL3bCRWkjycebymW98scZqmbrQtL8HeNtJ8U3WnWvjS3sNs91bXKwm5RYx5AjZNp4wgaPqT1BBFJ6Rb8rlJXkl5/wBf13PW4vhz4LMKGbwX4dSQqN6ppsLAHuAdgyPfA+lVP+EP+Hh17+x18JeH2vRbm5aMaXB8ibgoJ+XjJJx9DXCatNb61FoEOo6zodroFzoUSWd3qlqbm3NyMh9jiaNUlA24JyeGxjBqxo/hbRV+KNvYeJre01qabw1FGt3eWKh7yRZGR5MHJ3bNoJyTgjJq3G0reb/C/wDkZp+5fyT+9r/P8D0H/hXHgj/oTfD/AP4K4P8A4mj/AIVx4I/6E3w//wCCuD/4muK8H6Hp9vqg8G32mW/2fwney6hFLJAu1kfJt3yRjcA7gnOcw5Neo2l/aajYJe6dcw3drIu6Oa3kEiOPVWHBpOyVyutjD/4Vx4I/6E3w/wD+CuD/AOJriLqLwfbWt/q6fDLQJ/D9i9xFNeR21uJlkhJU/uWjA2ll2ghyc9VA5rE8NXuhnxvoOoJJZW9tfpqMN+bmQNcSnAbZdvhVLAZxGQdo7kVmMPAP/CkPFUkC+HftI1C6WJkWDfnz5PIC9/ubtmP4c44oS6v+tbD8vP8ARnqGi+BvD959oGtfDbw3pxjYeS8NtBcJMpGcg+WrAjoQV+hNav8AwrjwR/0Jvh//AMFcH/xNeceIbHSdQ1eHTodT8OaP4budNj/saeexEtuJi8nmNbuk0aRzAlSDyx7dDmxBYaVd63faN8RtUZr77NaLompXA+zSuojXdJbbs7ZTICWC5blQcjFO39f118iVsdja+D/h5e6re6fbeEvD8k9iI/tAGlwYQuCQv3euBn8RWcNA8E/8LBHhdvh5oiZ09r5bxtPttrgOqbQoUnq3JOOnGetQeCdP0ez+LnjMpY20N+8ltJA/2cLL5TQKXbOMgM4OfVhzzVbxPr+mWXxjmjlvczxeFrlTBayr9oLb1cKg/vlQWA9BnpU7NX7N/wDkrf5lJXvby/NG54j8IeCtA8N3+rJ4A0S++xwtMYItNtlZgoyeWAHAyfw4BPFS6N4J8EavoFjqQ8EeH4jeW0c4i/s2Ftm5Q2M7OcZ64rzfQhZPca3a6CbHZqnhBnht9PcyfaJgXUlm4E03OGYKDng1YtotBez0O60WeG38nRZYfEtzbTmHYqwAKk8ikFZRJjAJDAA9qHopN/1bmv8AkLdpf19lr82dVqeheENH1jw7pt98ONAMuszNA80FnbtFbusZfGSgZshTg7QPXHStG/8ACPgPRrGS71nwb4at4/tCww+Xp8LmTewVOsa4Yk9OceprgdM8RaMvhb4RfaNYslKTfvS1yoKEW0iNk54wzBfqQKzc6Bqnwt1NRLaanbWHjBXMk0ouTFbm6Qb2dix2mPI3E8rnkir5bT5fP9Uv1Jv7ql/W0n+h7H/wrjwR/wBCb4f/APBXB/8AE0f8K48Ef9Cb4f8A/BXB/wDE1w2reH9I8LeLM+H9FtIbDxjYf2aqwWaqkU/UHbt4Vo2ZiOAfLHevTNK/sjT1XQdJltIm0+FB9ihdd0KEfKSg5AOOpHNT0v8A1/X+ZXX+v67r5GZ/wrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATXnnilvC8/wAVvFEGtXtpLGPDQaS3vLzdGk25jxGzbVYKI2wAMZDdTk4ttcf8JVo+hxa94g0e1sbrQbWOyvdUtTcL9rG9ZTFIJoxHcKdvXLccdDlR1jf+vtf5fiN2Ts/62/z/AAPXf+FceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8Aia858PeH/Dut/FDVdF8QXsfiCaLSLB5Uup2zLMhfe3lFzt42Ep0AfBHzHOl4X8O6bb6td+B5NGtWh0TUn1aFpLYFWjkBaAgkfeDMy564ix3p2/r5k6/16f0jtP8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JrzSxt4bvS9Da3MS/EOPU0/tJQw+1+UZj5wlH3jD5ZON3yY27e1Zdx/Y2m+E00w28X9oaP4081bS3tjJNaQm63gqiKWVTGOMDBHAz0pxV2l52/FK/pr+A3or/wBbP/L8T1//AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/ia4SK50vSfFl3aXkml6jb6k11czanbzNbX9gm2TJuSCG8tQWRXJXHygDvXMeE9T0ax0/wCGl3p+oWS6xdNdW9xK1yrSyBkk2xuSc48zZhTwGIxyalar+vP/ACA9i/4Vx4I/6E3w/wD+CuD/AOJo/wCFceCP+hN8P/8Agrg/+JrzfwXp32q9stVufE+n2mr21rLHrVnZ6c8d87GM7jcsZ2LbGG5XKAcYXggU6wt4H0zU/Cxn0KIwQws2t6fGWt7hvNBMV5Fnh3x84LncpYnHSnazt/X9f0g8z0b/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iay/AHiTTZdEKTQ6VpO6+NpbmyuQbS+cIuGticbl2jG1RwVbrjNS/E66sLfw9ZR6uoNpcahDE/nTCK26k/6QxUjyjjBGPmOBkZzQ1Zr5fiC1/H8C/8A8K48Ef8AQm+H/wDwVwf/ABNQ3Pw68IJDmz8EeGpZNyjbLp8Ma7cjcciNuQMkDHJ4yOo8vgvrDT/A7W17cWcun2PiuaO40zekEE0BDFYcSsEROQyq7BTtA7ioNRm0a08ApqT65bxxSeJrZ7K0i1zzorO3EyHySqStENqFmKrlQMdcA0RV2vl+Nv8AP8Aen4/hf/L8T0+18H/Dy91W90+28JeH5J7ER/aANLgwhcEhfu9cDP4ijWPB/wAPNC0qbUNR8JeH44IsZP8AZcGWJOAo+XkkkAfWuBvx4e0nXviPdS2SJNL9leKWyVYpfIljTe4lCnZEWyXfBHDHk1i6ta6Q3hfxrZRRaTJZ297pt7b29lEPs8MTGPfJGpyNpG7c4AB5pLW3y/QD2H/hXXg/7Zt/4Qjw39m8vPmf2fDv356bfLxjHfd+Hepf+FceCP8AoTfD/wD4K4P/AImvP2vbC0+JviCy8E3Vst6/hYCwsop8Ks4LFVjjJwnyhG2qAMYbHOaht4tBabw/deHruG2nS0kXxTLDcmGRYfs53G6YEMsgkxhmIcHOD1o+zf8Ard/5B1t/Wyf66Ho3/CuPBH/Qm+H/APwVwf8AxNH/AArjwR/0Jvh//wAFcH/xNeQ+DNU0Cwg+F93BqNkmpXMtzb3kzXKtM6MkmI3YnOPM2YU9GIxya96sNQstUs0u9Mu4Ly2kzsmt5RIjYODhgSDzVONhXMP/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/ia6SipGc3/wrjwR/wBCb4f/APBXB/8AE0f8K48Ef9Cb4f8A/BXB/wDE10lFAHN/8K48Ef8AQm+H/wDwVwf/ABNH/CuPBH/Qm+H/APwVwf8AxNdJRQB8d/tK6LpWg/EnT7XQ9Ms9Nt30mORorO3WFGYzTAsQoAzgAZ9hRV79qv8A5Knpv/YFi/8AR89FAH0lY/8AJU9d/wCwLpv/AKPvq6Subsf+Sp67/wBgXTf/AEffV0lAGdrFlf6hAtvY38VnBIGS5LW5kkZSMfu23gIw9SrfSrtvbxWlrFb26COKFAiIo4VQMAflUlFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Ef/klniv/ALAt5/6Ieukrm/iP/wAks8V/9gW8/wDRD10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHK/DW7t5Phv4ZtY54muIdDsXkhVwXRWhXaSOoBwceuDXVV4n4X8f+IdJ+Ft4INO0xz4d8Oabc2weaT94j2+SXIHXCj5RgZ/i7jq5fGviGx1TUbG5sbS+nXRE1W0isopNwO4q0bZYmTBwQVCk9MZo/r8L/kD0/r0X6o9BorgIviC0miWL2OpaXq15qGoRadDJBBJAsMrAs/mwszOhUAnYWBPTIzWbr3xE8TeHIdYsLix0u91PS5LR/tC+ZBBNBcSGNWEeXYOGGCNxGOc/wANOzvb+un+aDp/X9dD1GmTCVoHFu6JKVOxnQsqt2JAIyPbI+tefan4u8U2OoeJ7BTo5m0bT01OKU20pV42DnyivmD5sxn58gcj5KhHjvxNqWqXFrplrpNnGPD8WsQS3HmzsS/8DKCmOQw4PHB5+7Uu1v68/wDJ/cPr/Xl/mvvOx021XT7yUalqVvPrGoLvYxoIdyxgL+7jZmIVd2eS2C555xWjY2UWn2vkwlmBZnZ3OWdmJLMfckn29OK4nR/H2p6trvh+EafapY6xoTamuJWMokXy8pzhVX5+uTn2xy3wh431fV/Fsekat/Zsq3GmtfA2MbgWzrIEaEylmSYjdyyY5HTkVo4u9uuv4X/yf9NE3XLf+tbf5noFRW13b3sPnWc8VxFuZN8Thl3KSrDI7ggg+hFLOZVt5DbKjzBCY1kYqpbHAJAJAz3wa800/wCIniXUNO8JzJYaVG+uX9zZ3DGSQiExmXbtXHzcR5JJGTxgZyIWug3ornp9FeYL8Q/Em3T7cWWlTXD+IpdDup8yRplclXSP5iMqDkFzg8c5yLA+IuoWenX9tqUUMuqW2tnSI5rOxnkjc+WJRJ5CF5DhM5UHkjqByBaq6/rb/NBs7P8Arf8AyZ6PRXlY+Ivi3dptudEt42utZGmG8vbS5s1mVk3rLHBINwGAwILcEDGc5HUeKdd8QeGPhneay9vptzq9jamadA8iW5Kj5ivBY+ykj0z3o6X/AK7/AKgtXb+t7fodZRXneo+NPEOmSWun3iWaX2oRPd28tnpl3frFCoj+V4ovmLF3I3ZC4APU7agT4kaqbbSZdYtYfC4u7dy8mr2U4iecOyCLeSnkg4VgXBJDYAzTs/6/ryFfS56TJIkMbSSuqIoyzMcAD1JpsFxDdW8dxaypNDKoeOSNgyupGQQRwQfWvLL/APtXU/FXxBs9Vu7G80u30iHFo9mTw0crrglyMhskkqc8Y24puneNb3SfB/h3SNFhZryLw/a3jsdKur5XBTaseIB8hJVvnY4Hoey6N+n43/yH6f1t/mehnSbq51xLzUruCa3tXMllbxWxQxsV2lnYu284LAYC43Hg1dFjH/aRvnZ3l8vykDEYjUkEgAepAJznoK4WD4hX8uqabBqkcHhv7daQyRQavaSgzzPndEJcqqMpGNhBZsg4FXbPxhfXXi6+0aSfTrS7imkW20y8hlhluI1UkSpMSVkDHaSFQ7RnOTT1X4/huLdX/rudtRXmWhfELxBeWvhnUNVt9MjtdZ1C4sJYLZZC8bJ5u1w5bBH7rBG3nOcj7oXSfiTrOranYTWOjXN7pmoiTakekXcTWoCko7XDjypFbAHygYLDlutJ6DPTKK8803x/f3vhXUNQglsr/UbOJXn02CymiuLNmYAiSFmLuFXJyNu/bwBmum8Ja4uv6S13Hqmn6mgfZ51jE0QBCjcrxszMjBs/KTkDGadmK5u0UUUhhRRRQAUUUUAVr2xjv1jSdn8tJFkMakAOVOVz3wCAcDGcc5HFWaKKAMXxBo1/qc1jdaTqiWF1YyM6Ce2+0Qybl2nem5TkAnBDDGT1qzpemzWskt3qFzHdX9wiJLLFD5UeFzgKhZiBlmPLMeeuMY0aKACiiigAooooADyOuPeq1jYx2ELJGzu0jmSSSQ5Z2PUnt+XA6CrNFABRRRQAUUUUAFFFFAHyT+1X/wAlT03/ALAsX/o+eij9qv8A5Knpv/YFi/8AR89FAH0Bc+I9D8P/ABT1f+3tZ0/TPP0XT/K+23SQ+Ztnvc7dxGcZGceorS/4WP4I/wChy8P/APg0g/8Aiq5nxT4n1Hwl4/1fUbHRRq9v/ZWmJcRR3BSdQbi8AMabGEhxuJBZegxnPHQXnjC5nstDv/CtnYatYavIsaTy37QbCQWBwInzwrZ5BBGMdcC1/IHp+ZN/wsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVWsdb0oav/ZTanZjUtnmfY/tC+dt/vbM7se+KpXfjbwrYEC+8TaPbFiQPOv4kyQSCOW7EEfUGgCt/wsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVWomv6PJex2cerWL3MsH2mOBblC7w/wDPQLnJT/a6VXXxd4bfT7i/TxDpTWdq4jnuRexmOJicBWbdhTkjg0AU/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqtVNe0iTUGsI9VsXvEh+0NbrcoZFi4+crnO3kc9OafpusaZrMHnaRqNpfxf89LWdZV6kdVJ7g/kaAMf/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrVm13SLbUf7PuNUsor0IJPs0lwiybScBtpOcZ4zVWLxl4Ym0ubUofEekyWMDiOW6S+iMUbHorPuwCc9CaNwKn/Cx/BH/Q5eH/APwaQf8AxVH/AAsfwR/0OXh//wAGkH/xVXpfFWgQreNJren/AOgqWugLpCYQBk7gDkcc81R0fx94c1fwnD4i/tewtrCQhXlmu0VYWPRHJICtgj5TzzQAf8LH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFVr3Gt6VaRpJdanZwJJGZUaS4VQyAZLAk8gDnNRQ+I9EuLi0t7fWdPlmvY/NtY0ukZp0/vIAcsPcZoAzf+Fj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8Aiq3b2+tNNs5LvUbqG0tohukmnkCIg9Sx4Fcf4Z8bXGvQa3JdXmj2KWOrLZ2twkhmhmjKxsPmLLuZg5AIwASOGxy1q7L+tUv1A0/+Fj+CP+hy8P8A/g0g/wDiqP8AhY/gj/ocvD//AINIP/iq15Na0qLVBpsup2aX5UOLVrhRKVJwDsznBPGcdaamvaRJrDaTHqtk+pIu5rJbhDMo9Smd2PwpAZX/AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FVqw67pFxeG0g1SyluQGYwpcIXAXG47Qc8ZGfTIrndK8cf2x8SLjQ7CbTLvSo9O+1R3dnc+c7OJAhViPlXB3ccnpyOlC1aQPRN/1vYu/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVaMHiTQ7q3up7bWtPmhs2K3Mkd0jLAR1DkHCn60j+J9AjRXk1zTVVp/sys13GAZcZ8vr97n7vWgDP/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8Aiq6KORJolkidXjdQyupyGB6EHuKdQBzf/Cx/BH/Q5eH/APwaQf8AxVH/AAsfwR/0OXh//wAGkH/xVdJRQBzf/Cx/BH/Q5eH/APwaQf8AxVH/AAsfwR/0OXh//wAGkH/xVdJRQB534+8feD7z4beJbWz8WaHPcTaTdRxRRalCzyMYWAVQGySScACug/4WP4I/6HLw/wD+DSD/AOKo+I//ACSzxX/2Bbz/ANEPWfonj+W58ZXXhjxFpcWlagn/AB6SRXTTwXhCK7qjtGh3KHUlcdDkZxQtXYOlzQ/4WP4I/wChy8P/APg0g/8AiqP+Fj+CP+hy8P8A/g0g/wDiqNF8S3txFq0/iWz07R7bTZzC06akZVJChmZi8UYVcMOcnv0xya5498PaJ4UPiB9Us7ixZhHBLDcqyTOTgKrAkfU9gCe1H9ffsH9fcH/Cx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVP8T+IpdO8A3/iHw79i1H7PaNdQl5z5MqKNxIZAc8A4xweOR1p9h4u0iS0sY9S1bTrbUriyS7e0a5RHClNxYITu29efbrR38v+D/kHbz/4H+ZD/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVa1lrelaldTW2nanZ3dxAqvLFBcI7xqwypYA5AI6Z61Avinw+7XoTXdNY2C7rwC8jP2YesnPyD64oAof8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FVdg8W+HLqe0htfEGlzS3wLWscd7GzXABIJQA/NypHGeh9KVfFfh14GnTXtMaJC4aQXkZVSnL5Of4e/p3oAo/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FVvWl3bX9nFd2NxFc20yh45oXDo6noQw4IqagDm/8AhY/gj/ocvD//AINIP/iqP+Fj+CP+hy8P/wDg0g/+KrpKKAPBPC+neBbvwFAmp/E5bObWNEs7XUbT+0rBPLWOFQIwGjLKVyy8nPJzzzXUw3HgWHxFHrR+KsL3UdkliAdWsVUxKQ38KA5LDJ57kdOKl+FHifV7zStG8PTaPZRW9h4fsLg3a6gzs6SQ4j/d+SAD+7ORuwM8Fq6Dwv4wv9ZvNdj1rTLHSoNFuTayzpqLTBnCq5PzRIAu1hyT1zx3pq/4X+W36g/P+uv6HPNN8NJlu5Lzx5plzf3VxHcnUX1a1WaKSMYjZNm1BtBI+7yCd27NVtVT4d6zpNzaX3xMtGuLyWKS6v11WxE84iO6ND8mxVU8gKq89c5OfRF8S6E+jHV01rT20wdb0XSGEc4+/nb196lOt6UNH/tY6nZjTdnmfbftCeTt/vb87ce+aW39f12A83uT4Cu7/V7yf4qwNLq9ithc/wDEz08DylzjaPL4PzPz/tn0GK9laeAbGaSWP4tK8j6YNLDPqmnfJbrnaBiIcjJ5OTzzmuq8K+PE1W18QXuu3WlWVjpeom2iuorrMLReWjq5kbAJO/qAB256npW13SV0cau2qWQ00rvF6bhPJK+u/O3HvmhrTXt+a/4LD+vut/kvuPMLCy+HVjNprf8AC0YbiLTbB9Ohhl1awCm3cAMjFUDdAvIIPyjnrm5ptz4A0W5s721+JVtPcafYSWEG/VrI5hO0hcbQMqVXB46fNmuh1jxs1j4m8NRWcumTaFq4naTUPtG7AjiZ8qR8m3gfNuPfjvXQP4h0aPRV1eTV7BNMYAretcoISCcZ3529fem293/W/wDm/vYWV7f1/Wi+5HNad4+8Mf2AlvqXj7RDemNla5XU7XzFyTtY4+QuBjOF25B4xxXK2Fh8PdOj0iOH4ro0ej3cl5ao+q6eQJH3bsnyskHe/f8AiOO2PXILiG6t0ntZY5oZFDJJGwZWB7gjgisPxL420Twpe6Za6zf21rLqM3lRieZYwqgElyT0UYA+pAo15vMN4+R55Fpvw+iuo5/+FthzHqZ1YI2qadtNyQQX/wBVnBBIxnHtVyKL4cImqed8SbWeXUL5dQE76vZrJa3CjAkiKKuDgAYO4EDBHJz6RHr2kTXv2OHVbKS6yw8hbhC+VALfLnPAZSfQEetRweJdCubG4vLbWtOmtbVilxPHdoyQsOoZgcKfrSWm39bf5L7kG7v/AF1/zf3s4LUrvwNqz6VJe/FWB59MuhdJKNUsAZZFBClx5e3ABYYUKPmJOTgjV8UeJvAXivw3d6LdePtJtLe8Ty5ntdVtQ5Q9Vy+4AH6Z9CK6WbxV4et4bmafXtMiitJBHcO95GqwueiuSflJ9DU2o6/o+kW8M+rarY2MM5CxSXNykayE8gKWIB/CjdBs7nE3ur+AbyHTGX4jafbajpkflQanBqtmJypADKwIMbBtoyNmMgEAUatrHgTWdNlsLr4lWS2txGIrqNdXtCLhctuDbgdu7dglNpwBjGK7e913SNO2/wBoapZWm5PMXz7hEymQN3J6ZI59xV8EEZHINPcFpseY3k/w5uLzU7i1+Idhp7alZx2c622sWu0IilVIDhudrFecjnOMgGorST4f6fa6Wun/ABOtba70y2+yR3serWXmywA5WKQFCjAdjt3D1yTn0Y61pY1Q6YdSsxfqoY2nnr5oB6HZnOD9KbBrmk3N/c2NtqllNd2gzcW8dwjSQj/bUHK/jRd7/wBf1qw8v6/rRHEatq3w/wBatvsl78RNPaxZ1ea0/te1KTbcEAk5cDIydrLk5+lJfar4C1HUra8uviTYv9jkkmtIjq1mVt5W3DzFJG4lQ5AViVwB8pxXWSeKtF0rTLW413xHo8K3BYRXLXCQRTYPOzc5zjgHBPNLZeMvDGpSmPTvEekXcgjaYrBfROQi/ebAb7o7noKQHnVpY/Dyzs9HtY/ipE0Oj3r3tsrarp5zIxOdx8vkfM/H+2fQY2NN1TwDpAmgsfiRZR6e5ZotPGsWvlWzNzmM43gAkkKWKjsOBXZL4q8PNYRXy69phtJg5iuBeR+W4UEths4OApzjpg+lStr+jpfW1k+rWK3d2u+2gNygkmXGcoucsPcU9dg8/wCv61OKi1fwCmrz6pL8RrCa/ljSFLhtWtFaGJXD+Wu0AEEjncGJGRnFLpWt+BNIeaa2+JGntdXd2t1e3Mmp2W+7IXaEYBQqrgAfIqnjr1z28WtaVcalLp0Gp2ct7CQstslwpkjJGQCoORwCeewq7RsBzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVXSUUgOb/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8Aiq6SigDm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqukooA5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKrpKKAOb/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8Aiq6SigDm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqukooA5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKrpKKAOb/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8Aiq6SigDm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqukooA5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKrpKKAOb/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8Aiq6SigD47/aV1vSte+JOn3Wh6nZ6lbppMcbS2dwsyKwmmJUlSRnBBx7iir37Vf8AyVPTf+wLF/6PnooA9t8SalHp/wAULnzLXULjNnpMh+xafPc7VS4vdxbykbb179ecZwabP4T1Tw/4+0yXw9EZfDWoah9ru7UKR9gn8t8yIOyPnkdm57109j/yVPXf+wLpv/o++rpKFpr5/wCX+QPX7rfn/meQWfhV7rUpLLxRc+JGuLPWJdShhgsI2tJlMrMrCcW5JBRtrIZNx5ABGKs+AvB2mav8NNW0m70OTTZLi5vokNzprW0kcUspZCm9AcbRGeOBtA6jA9Woo6W/r+tB31v53/P/ADPLLnTvE3ir4YX0t5p8ttrJiis2tZVCGZIZAZtue0uHxngjb61D4n0S58YXmr6j4d068ton8N3OnypdWclq1zM2DEgSRVLbcN82MfNgE849Zooev4/irf15hH3dv6s0/wBDx+4t5tf8Q6VJN4e146XJ4Yn067lFmYZInYpldsm1sjYQMA5JBGRk113gafWmvtUtdVEl5Z23lx2uqXGntZTXGN25HRgN23jDgBTuOB1rsqKpyv8Aj+Lb/Um2lv62S/Q871OLUtL8ced4fjvLtNS1CJr/AE6705mgwoRTcR3IG2MqoU4YncV4ANMt9KuNO+JF14dhtf8AiS6nKuuBgPkjdCBJHj/alEL9O716PWdpujiwuJbme+utQupVCGe68sMEBJCARqqgAse2T3JxSi7W/rtb7mkxvW/9f1pdHC6VbatYa6+k6ZHeX2jTQXMxTUNNaGTTnkywVJ8BZAzEjaNzDqWxWBpenaxb+HPBU13H4g0y003TJLC8FlpyzTxTHyxuMMkMjFPlZdyrn0+Uk17VRSWi/rz/AMw6/wBeX+R45aeHdP8ADXjzwWlppWs3drp9reK1/caXJK8YkOYgzxxALgl8LgFAeQM1m2Kz23hPQlXQtajkt/F8l7JGui3IdLfzZGDkCPONjr/LsQPdaKd9U+3+dweqa7/5Nfqcb45S7h1fw1qq2NzqGmafevJeQWsLSyLujZY5RGvzPtY9ACRnOOK821WwnFtrb/8ACJ6tiXxbbalYyrpTyHywYjI6qoLpwjkkqM7scnIHvdFEXyu/9bp/oD1Vv66/5nnGpJqdh4xFx4ajvblNVvonvdPvdMcwgBUU3CT4AiKqFO1iclcAA1i22hX1z4R0Lw1Ppt5Hr+l6ql3c3rWcghCiYvLKs+3Y+9CRtBLHdggc49hooTtby/Tb+v8AgWHrf+v6/rzPEdI8Mvc/DPxRBovhyW1vP7Ynmt7efTXtHmtWlVjHH5irw8S7cD2BxVzWLXUvEfizU7nwzoOqWaah4VexjurizNoIpt7EI3mYbOBtGAeoPTmvYqKXby/ysO+/m7/jc8L8SeGLXU/Bms6kbfxTquqNpJ09LK/0ZVEbggxhUit03lWziRdyqM8jIrq9Z0yKz0zS9a8NRX2k6nDZHZ5OiSTpcbljUxTwhA4J2IM/KVC8nAxXpNFNv+vv/wAyVpb+u3+RQ0J7qTw/p76jZR2F21tGZrSMgrA+0ZQY4wDxV+iihu7uCVlYKKKKQwooooA5v4j/APJLPFf/AGBbz/0Q9YEmk2XjmPxBYSQ6lp9zHqC3dhfTadNbtDIsUarLG0iKGwyMCAeR7EGt/wCI/wDySzxX/wBgW8/9EPXSUf1+T/QDyO007xUdN07UfEmnu02n+InutSt7SJpPPjWHYs0aAEuN219oyfQZGKg8RaBf3uieMtW0jTb0Wep3dhcW9l9ldJpDE6GaUQkBwSB0Khjs6dK9jop3f5fp/khW/r5t/qct49me6+F+ueRZ3kst1p8sUNvFbPJMzOpVRsUFupHbjvjBrzLzrz/hX2vaB4g8Patqd1e6UGsLxdDuZN52ERwOvlnynjdeOgPDcE5Pu1FTbddy1Jpxfb/gf5HjBtb+61jSrPQtO1KwkfwfPp6zvpc8EUNwwQorsUAXBVjz0PuRnY03S31bUvBa2Wk3mnTeH4mi1FrmzeBVjMBQwq5AWUF8H5Cy/LnPTPp9FW5X/rzb/wDbmZqNkl/WyX6I8ZudE8S6bp6nTtNupf8AhC9TaTTolj51C3kbJRD1IWFynHGR7VpX2lw6d8TfBtzcaNdTzWdhc/br6DS5ZlWRwCuZFQjO7zSBnjd23c+qUUru39drFPVv+utzh/hH58fgX7PdWd7ZSRX11iG8tJLdgjTO6YV1HG1h047dQRXcUUUN3AKKKKQHhvw30+01zUNPa+tvEdvA3hjS7eC5thf2UMjxxOZB5sexWA3LgkkHPyk5pbHTb6XS/EtrpNn4ihiHiKHUUNxZzmee1VYwWRrpGEjhlJ2tknb06V6b8OP+SWeFP+wLZ/8AohK6SmnZ6f1qn+gPW/8AXSx5G+kJpzQatpsGv6qdR1eK5ub3UtNcPZyLE6eatpFFExOMLkqV+YNziqmi2OqaTpmi3F5pOqXNnpXiG/lvbc2LeaRI0nlTrEqjzACwP7sEDOQOK9nqK4u7ezRHu54oFd1jVpXChnY4VRnqSSAB3NCdtv62/wAgeq1/rf8AzPGbWLULTV9TlTwpqUVnceKBfQXz2EjiBGgC+asCEOx3Aj5l2rvyckECXQdP1TSbHRbu70nVLi00nX9QkvIDZN5u2RpPKuFiVR5gG7P7sH7xwOK9mooTskl5fhZfoD97f+t/8zyzU7bTbfxp4MbR9A1SPTor26vZmGlXDJG00Zw7DYTGTIejbSOuAMGuf0i01YW1neiDxFpmn2msak0gtdIJuI1nk3QyrDNC5ZNu4HYpZd/bmvcZZY4IXlndY441LO7nCqBySSegoiljnhSWF1kjkUMjochgeQQe4oQf1+f+Zyvg+30zwppNlolvLqjpdyyy2z6hbMpbcS5BKxqkfJJCEKcA4HHFfx7b3R13whfW9lc3cNlqrPcfZoTIyK0EiAkDtuYDPQZ5IFddJaQS3UVxKm+WHPlkk4QkYJA6ZwSM9cEjvU1F9UxW0a/rU8Y0jwz9v8J+O7bRtAm0+8m1KabTxPpjWrNE6IuIjIgA3BXXA9eeDzS8W+G7XUPB+uapDb+KdZ1O8tIrMW9/ooUo6OGTbHHbpkqC48wZUDI3cgV7pRS2t5JfgrFdb+bf43PJriWJ/H2r3cGiaotnJ4WS2if+xLkAyAu3lj9312so2/h1BAreCIrnSYNNvfEWkapLZT+HbXTEhOlzySQTRlhLG8ewsobK/MRtOOvSvYqKfRr+vtf/ACTF/X3W/wDkUeJeF/CI0zxn4Wstb0Gacx6Nd291NJpzywp5kgaGF5tpQ7Y9y8tgdO4z7DYalaXz3ENp5qtaSeVIksDxFT2IDgZU9mGVPYmp1u7drx7RZ4jcogkeEON6oSQGK9QCQRn2NRrFZ6bHcXBKQq7GWaWR+p9SxPQAAegAxQ5XWvn+d/1C2v8AXb/hjgb231fT/GTL4d+13EGp3rSXdne6a3lWxC7DcRXIAVfuqdjFiewFYfhzwvEbPTm8TnxLc3+hWksNxYz6ZGbVleMrIFdLcG4RuoUO7EkZGc1699qgNqLoTx/ZynmCbeNhXGd2emMd6W3uIbu2juLWaOeCVQ8csbBldSMggjggjvStaPL/AF2C+t0eM6Pqmp6R8I/DejWej61Y6lMj2dxeDRLl302LdmRgqxlskbQuBgnB/hNa9vDZ6Z4o8JX+iaLrCaNY293p5LaZOJQ7+Wyu6MocKxDZdgBnJJxzXqdFVfW/9f1q/vFbS39f1seC+HtGkTXvB66z4R1GGa31LUTcTTaW0qiGZpDFukQMAu6ToxGDk4xhju3XhA3Ouaro+rzeILW3n1FLywi0uxhNq6xqhi/feQxhK7NuGdRgccGvXaKSdmn/AF3/AEHL3r/13/zPO9Ii1LSPG8Flpcd5eaPcXFxdXMN/prIdOZt5LxXGArhnJGz5mw+cgcV3tleRahZx3MCzJHICQJ4Hhcc45RwGH4ip6KXSwdbhRRUUF1b3XmfZp45vKkMcnluG2OOqnHQj0oAlooooAKKhjvbWa7mtYrmF7iAK0sKyAvGGztLDqM4OM9cGpqACiioZ7y2tpIUubiKF532RLI4UyN6KD1PsKAJqKKKACiiigAooooAKKKKACiiigAoqGe8traSFLm4ihed9kSyOFMjeig9T7CpqACiiigD5J/ar/wCSp6b/ANgWL/0fPRR+1X/yVPTf+wLF/wCj56KAPpKx/wCSp67/ANgXTf8A0ffV0lc3Y/8AJU9d/wCwLpv/AKPvq6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/8ks8V/wDYFvP/AEQ9dJXN/Ef/AJJZ4r/7At5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooA+evBWg6ILqASeAIvEIl8K6TO6wW1oTHI0cm5z5zp8zYGSuSdvPaui8I+NJ9G8D2Onx3M02pT6ld25ils7m+k0xULP5UkcY8yQoCq9QOc7sDnS+HngSX/hENE1u18Wa5aXV/odjHKsS2ZRY0hBRFD27EBd7c5yc8k10Vv8NNGs9NSCxuL+3vVvGvv7USZTdG4YbXkLMpU7hwVK7fanfT+u/wDX9XB6v+u3+Zg23xA8VXH/AAjsMmiW9lLqWpTafPJfQzwE7EZ1ljhdQwRlXOGOR93/AGg5fiFr8enWpltNNlmTxL/Yd7MokjUjzAokjjyxyVPQvwf71dHqHgdNSvtHvLnX9W+0aTObiN1+z/vpCuws4MWPukjC7RySBnmsg/Ca2MDRf8JTr+G1T+1ic2mftOQd3+o6ZGdvT2pq3Mr/ANar9Lie2n9aS/W33EGu+P8AWtNudYurO1097PSdRg042NwXSe4aXy8SiRchVzIML5bEhTz2qpqXxB8WWUHi24lsdGt18MvC0kSvLcG4jZA7KH/d7WwRhtpAPGD1qCTRRdeM9Q1K4XX7TXhcP9i26Lb3EexRtTbdvbuEVgM7fNTG4jAPJ3bj4Xw6jZ67HqHiHV93iHyzqCw/ZwuVULtTMOQuAF5ycDrnJpR2T/rp/wAH77FO3Nb+v6/4c3vFut3mieB9R1rSreCe4tLVrlYrmQohCjcclQTnGcDue461zX/CYeJ7zxFaaVYwaTbpdaB/aiXMwllIkygIMYK4XLEY3E9DnjB6jVvDa6x4Pm8PXOp3qRT2/wBmmu4/KE0iYw2coUBYZBwo68YrFt/hultqMN8nijXDPBpp0yNmFr8sJ9vI+8CAc+o7jIpPd/10f62Etlf5/ev0ucx/wlHiXxJrfgK+0q4sbVdT065vGs54HaMypGoILhwcHeQDg7eSQ3Sr+keNfGGo+C/+Ehnt9Bt4ZHaABpXUW7LcmMyMWZQ6BBnaCrEjA+9gbFn8MbCw0/RLa01nV45NEjmhs7oSQ+aI5Bgof3e0gYBBxnjknmn2vw2sbTwjB4fTV9VeK2vBe210zQ+dDIH38YjCkbiThlPX6Yp2vptf9f8AIWtvP/gf5mNpfxE1W/gXThHZNq0+tS6VBdfZpYoCEh84zGFm3j5eNu7k4wwBzVnVvFPjTRRolteaZpH2jUNXOnPcea4R0ILJKkYyVBCtlWfIIxznI0W+G2mOt2W1HU/Pnv11KO5EqCS2uAgTfGdmOQOVYMpyRjHFT6r4HGsNpL3niHWDLpd0LtJFNvmWUDaGceVtGASMKFHzEkZ5paafK/4X/X7/ALh9bedvxt+n3ffzniLxz4o8Nbf7QGiGW1FqLi3hSWVrsyuEdkw+YEXPBkVgx4zxTdY+IHiew/4TCdLTSYrfwxLC2w+bK1zEyhyM5QI20jnDAHIwetdBrPw60/WrrVpZNT1O2TVvKa5ht5IwnmRbdkg3ISCAoGM7T/dzzVO7+FltfW+vw3XiTXHXxAU+3H/RQSFG0BcQcDaAPw9eaSff+tv+CVpcmj8X6w/inxHpo0+zePTdMhvrJVnKtOX38SM2FTlMdwOufTk9W8UXPifwf410bWxpmoxWuhC+huLS2dIyXSQgDezh9rICJFOCegBFdWfhlZz3WpzajrusX39qaeunXUczQKrRKCFI2RKQw3Mcg9znIwKLr4Z215HfCbxDrRk1DTk026l3W+6SJSxH/LHAOGYZAHB9eaJJOLS7f5/8AcJcsk33X6f8EnurWC8+DbQXcEc8TaICY5UDKSIcjg+hANc34O13X7bTfCugo2mqmpeHBPZSNBI5gkiSMfvPnG9SHB42EYxk9a7c+GgfBf8Awjn9q3/lfZvsv2z915+zGP8Annszt4zt6e/NY9l8P7XRb3RtTGu61OPD9k9rbwskDh4iBkMqQhmOFUfLz8oxyTm205yfR/5S/wA0ZRi1CK6r/wC1/wAmZem+L/FmqeGbT7N/Yv8AwkKXlzDqFrLbypDGsGdwBEhZcny8Od3EgO2k0bx5r8+meFNb1WDTv7N8QOtu8FtHIJbaRlZkbeWIZTtwRtBGc5NaOm6Za2+q+JfF0VpfxxahAgjha1l8x9sfzusG3eGbCKRt3HywcdKyvhZ4UD+DPDt1rT6v5+mRYi03UYfJS0m2lWZVMau3DHBYsBk7cVP/AAP1v/XQp26ef/A+78Rmn/EnXtWvbKXSNHe8stRWTylfS7yBbXCkxvJdMhjdGIAOxeM8bqxdV8VeN9e+G2la8LjR9NtNSurRPKht5ZZMtdbCCS4GwjaSByfmGRnNeh2XgqPTIbi103WtVtrGTeYLNGhMdozc5j3RlsAkkKxZR/dxgVWg+HOnQ+A7fwodR1GW0tJUmt7h2i86JkcSJgiMKcMO6n3zQrXV+6+6+o31t5/8Awta+Iut2F/eW+mafJqkukzR291BbaJeSm8YojOY5U3Rw4D8K5cnHJHBMV58Q/E1raeI7+Wz0qG20DVIbZ4AJZJJ4X8vOGyoVwJAc4IzxjjcevHg2CHWJNQsNU1KyNyqi9hhkQpeEKFDPuQsGwANyFScDngVjXnwqs76y1q0m8Ra2IdaukuroKbYfMmAAp8ngfKn/fA55ORPv/Tuv+CD/r0LFv4wuZPHVzod1dWNg6yhLWyu7eRJbuPaGMkcxbY/XG1VJXHJrL074h6ve6dDbz2lhb6xea7caRCELyQReUGLSN91nwEPHy5yOldLP4Pivbqxl1HV9SvEsZhcRQzGLaZhnbISsYbIzwoIX/ZrOsPhnYWOnz251fVbiV79tShu5TAJbW5bO6SMrEBzuOVYMvbGKSt1/rVf8H/gdB+X9aP9bf8AB64Ws/EXxJoen65bS6fpl1qui3VrHJNukignhuDhHVPmYMDwVLY4zk9K6jw9r+p3XjHXNA1gWjvp8cFxDNaxNGDHKG+RgzNllKH5hgHPQdKr6p8OLLV9FuLC61fVBLeXEVxeXyGDz7lo8bA2YigUFVOFVRx7nN7SvCCaX4svvEB1jUru5v4I4JorjyfL2pnYQEjUgjLd/wCI57Yat1/rRfqD8v61/wAjg9Qvb7wt40+I2r+HYNOi+x2VnezpNCxE5CSMwwhXDMM/OSeexrW8U/EHV9GmFzaJpq2aJaSC1lV5Z7lZmCswKN+5C54LqQx6YrU1L4a22p3XiCabxBrKDxBCsF3HGbbasa5AVMwkjCllySTgnnOCI5vhZp89ne20mt6z5d9FAtwBJCN7whRHL/quGARRgfKcfdzzQtlfyCWrdv62/wCCSv4vuk8fTaHd3Njpq+ZGlnb3lvIHvlIVneKbcEJGWXywpOVBJwcVS+JFqH8S+B7m3itxfLrXlxTyx7iimCUkZGDjIBwCM4FdBqHhCDVrq1fUtT1C5t7a5S6Fo7R+W0qYKMSE3jBXOFYDJOQRxVnxB4ctfEUNqLia4triynFza3NswEkEgUruAYFTwxGGBHPShaJeT/y/4P8AWiN7+a/zOMn+I2qaZPd6JqkMD6zDqK2aXNlYTzxMjQGZZfs6FpDhQQUDdedwHRIviTq/9k28N9pdxZancX01rHO+i3jpJHGm/wA9bUDzipyBtJGDn5uOejl8A6ZLp5ja5vRfm6F4dVEii688LsEmdu0fL8u3btxxtxU994Qh1CytlutU1E39pL50GqK0a3CPt2kgBPLwV4K7Np9M0dNf62/4Pb/I9P63/wCB/W/I2Hj/AMWX2oeH7CTRbXT31K5urWWa9guIixiRmWVIXCsEYbThmz1Xj71dZ4I8QXniLw7Lc6hHAt7a3lxZymAFY5GikZNygklQcA4JOPeobvwMt7rOkapP4h1c3WlFnjYfZ8Suy7WZwYcZK8YXaB1AB5q34U8KReE9OurO21O/vlubmS6Z7zyiyySHc5GxFHJJOCD+XFGlv6/ruL+vz/4Bx1l8Q/Eq6FqeuatY6XHZ6ffzac9ta+fLK8wkSOMqQuWXczZGzJGMDPFV7z4l+KtPs7xv7GjuUgubVI7+606706KRZpPLKiOZSxdWK5+bBBz2xXV6Z8PdOsfD2qaNd31/qdrqlw9zMbtow6SudzMhjRNp3YYehAxiud+JGi3Vl8P1shd6/r9zJfWoR1tvPmjjSZHY4giAGFUncwyTgZJwKFa6v5fpf+uw3qnbz/4H4FrVfH+reGNW1DStagsry62W0mny20bwo4nm8kJIGZyCrckg8jsKq+JPHvijwmutWN5a6VqF/Z6WdVtbmNZLeF4lba6tGWc7gSCMNhs9VrpI/A2lX1ndy6pPfapcagkW+7vdqTIsbb4goVEEZVjkfKDnrk1DqPw6tdX0m/tNT1vVbm41C3FpPfsYBP5AJPlLiIIoJJyQu4+vApdNf67fd17jur36af8AB+/Wxzmq3vjaXxp4PS71HR7W3vbuaWKGC0lkG0WxbEhMi7iNzgYwPut/s1Pa/EzU7vWLOe30q4uNHuLmSCVY9Hu1a2jUsBObkjynU7RlQBjd944NdXeeDra+/sN7jUL83OisTDco6I8uUKMHwgHKn+EKR2Io07wfbaXdzfY9Rv106WRpTpZaM26uzbiV+TeATk7d+3k8U3voSr217f5nAalf6h4j1r4eeJLyDTktL7VA9kkcLfabeN4JCFaUsQ24AEgKoBAHzda6b4p3Or2+maGui38Nn9o1q0hl823Mu4GQEdHX5cgZHccZFSR/C3So/wCzoRqms/YdLu/tdhZC6CR2zYYbVZVEhT5jwWOOgwMg7/iPw5a+JrCC2u57i3NvdRXcM1uyh0kjbcp+YEH6EGndXVtr3+Wg9bv0t89f8zk9R8ba+mn+INV0qPTZrPw1M0N3BLFIJLwxxq8pjYPiLG4gAq+cdRXeWF4moadbXkIYR3ESyqG6gMARn865658BafcTXYS+v7ez1A51CxikQxXp2hSXLIXBIUAlGXPfNdOiLHGqRqFRQAqgYAHpS6fd/wAH73sHXT+u33dT5K/ar/5Knpv/AGBYv/R89FH7Vf8AyVPTf+wLF/6PnopAfSVj/wAlT13/ALAum/8Ao++rpK5ux/5Knrv/AGBdN/8AR99XSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Ef/klniv/ALAt5/6Ieukrm/iP/wAks8V/9gW8/wDRD10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHnvgvxroGj/AA58LWuo35idNIsUmkEEjxQM0CbRLKqlIycjG8jOa6bU/GegaPfrZ6jf+VKSgdhDI8cJc4TzJFUpHuPTeRntXl3gnwzrafB+XQodNe+h8TabBNDqAmjWO1ElnEmJVZg/yleNitkY6V1mh+HdS8M6nq2mT6Kdd0rVJIpo7nzItsbLCkZWZJGBxmMEFA/XpxTjZ7/13Xy79Qlpt/XZ/Pt0OlufGegWmtJpdxf7Llplgz5MhiWVhlY2lC7FcjGELBjkcc1V/wCFh+Ghpv283lwtsL7+z3drC4Hl3GQNjgplOSBlgBk4zWZ4f0nVNGvdS0jUdAGpWVxqkmo2uoebEYk3v5gEiu28OjdCqMOAciud1fwp4nOj+IdH03RRcG68Qx6rb3Ul3HHFJGZY5CvUuGBQg5XGOQSeKI6tX/rVf5v7gl1t3/R6/l953Nl4+8MalrH9l6fq0Vzdi4a1Kwo7KJVUsULgbQcA9+xHUGuhd1jRndgqqMlicAD1rhvBltrWnav4wv8AVPD11bfbr0Xdsgnt3M4EKJtUiTg5Q437RgjJHIG/fR/8Jd4Hu4bR5LM6nZSRIz43RF1K5O0kHBPUEg9ietKWkbrey/IcbOVntcZa+N/D15JdJHqAjNrAbmQzwyQgwjrKhdQHT/aXI96juPH3huysUu9R1E2ETuiIL22lt3ZnLBQEkUMc7W7dBnpXLaL4Miks2k1fwnqJ1CGxeykN9rsl1FOjgBlh3TPtVsA/MqEccemF4psPEGleCdUivPt76VHqWnDTINVuIpbkEXKbgZELZjPy7d5Ldc1Vle3p+dvyJ1tf+tv8z0u38Z6DcJfMt60TWDKtxHPbyQyKWOEwjqGYMeFIBDds0QeNNAuNJuNSS+KwW03kTJLBJHNHKcYjMTKJN5yMLtycjAOa4nxF4Q1zxVrVx4h/s2fTnhS1jh09r4RT3KxSs75lhciMnd8hDZyOcZqSfwVcRW1trfh7QLy11GDU4b+4stU1Q3E955aPGQZGlkUHa/y/PjgZxUrbX+ttfz9BvfT+tNvv67HTS+OvDd1bWbR6+bN7m/W0jjMJSZ5gwzC0UiFlzkA5UEA5yOtXH8aaAmvrozXzC8eb7Ov+jyeUZcbvK83b5e/HOzdu9q5fxjZ6vqmnaTNpHg66SYazb6hdwrNaJLiIjcXPm7WYgADDNwOSOKz77QPE934gt7uXRJ9tn4jW9Vba4t44Ht8Mu8IGBeTBBYyc5+7kcU1rZPv/API/5v7hPa67f5/5L7yLV/GPiqy0nxZNHqdr5uk69b2kTCyGPIkEXygFjhh5v3juzjoM8d9D4w0a416/0aKW6N/p0XnXMRsZwETsQxTa2ecbSc4OM4Nea63oXiu80/xhbW3hK/dtW1q2vLVvtVoAY4/K3E5myD+6OB/tD3x03jXTNQm1zQtV0mI29zqStpF9FI6h1glUuWyuQWjKsRgkctz3pLVL5ffyr9dxu138/uu/02OqPiXSW8LHX5L02mltD5v2q4iaHap4DbZFBHtkc8dc1mRePfDNtHY2j6417d3Fgt5EiwNJcTw7QfM8uNM5IOdoUHrgccaPiWCf/hDtRtdLsZLuZ7R4ILaFkQsWXaAC7KoAz3PQfhXn+gab4msNa8J3N14S1FY9H8Py2Fxi5tDmYiPAX9/yD5R54+8ucc4NLu39aS/VL7w1sr/1t/wfuPTtM1Oz1nS7fUtMnW4tLmMSRSqCAynvg8j6GsYeMdJ1O4n0vRtURNSaGRrZ5rWQxSFeCyMdqzBT1CMcdyKzvhxo2p2Hwxt9G1uxl0y8jWaJkeSOThmYhgY2YYw3rnINQeFLPV9H8K2Okap4Wae80O1MEF5HNbslwAhUGEs4ZWYAAhwg5PzY6k18Vv63/LQI9Bvw++IVrrPhfRF13UQ2sX1tJMzfZ2jikKM28K4Xy8qByudwHJHeodZ8YSyaLoWqeEtfS+sL3X4rOeZ7dWMkbzbWRGAUADBXdtYkd881gaJofirTNJ+H0E3hW/L6DNM18EurT5Q0boNv775vvg/QHvxUcOh+K4/B+nWR8I35ubfxOdUkQXdpxB9oaXr52N2Gxj1B7YJvTnT81+a/QW0bLs/yf6nS/Ezx3/YPh+8TQNTWHVLaaJZD9iedE3so8svjy0kIYMAxJx/Cc5rdh+IPhafVn0yHWYZruOf7NKsasyxy7WO1nA2rwjdSORjrXEa54Y8VN4W8TeG7PRPt39o6l9vtL83USRlXmSQpIC28MuCOFIIA57Vo6T4f1/U73x5HqulTaMNfhRLe5+0RSoCLfyjjY+772SMquR1weKzXw/j+Wn5lWXN5bf8AB/r0Olb4ieFY4rqW41dLWO0iE0j3UUkIaMnaHQuo8xSSAGTIJIq3pHi/RNdv/sel3jTT/Z1ukDQSIskTdHRmUBxzglScHg4NeeXHgy8l8I6gU8JasfEC6VNp0b3Oum6R/MXafJ824IVMgMdwQgDgE8Vp6VYeIIPG/h7UJ/DN9Ha2Ph97GdzcWpKzEowGBNkj92Rnplh2yRaSvZ/1o/8AJfeTrb+vL/N/celUVFazPcWsUstvJau6BmglKl4yf4SVJXI9iR71LUjCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD5J/ar/5Knpv/YFi/wDR89FH7Vf/ACVPTf8AsCxf+j56KAOk+PvxB8T+BPinD/wimp/YPtui2/2j/R4pd+ye42/fVsY3t0x1rzf/AIaD+J3/AEM3/khbf/G6KKAD/hoP4nf9DN/5IW3/AMbo/wCGg/id/wBDN/5IW3/xuiigA/4aD+J3/Qzf+SFt/wDG6P8AhoP4nf8AQzf+SFt/8boooAP+Gg/id/0M3/khbf8Axuj/AIaD+J3/AEM3/khbf/G6KKAD/hoP4nf9DN/5IW3/AMbo/wCGg/id/wBDN/5IW3/xuiigA/4aD+J3/Qzf+SFt/wDG6P8AhoP4nf8AQzf+SFt/8boooAP+Gg/id/0M3/khbf8Axuj/AIaD+J3/AEM3/khbf/G6KKAD/hoP4nf9DN/5IW3/AMbo/wCGg/id/wBDN/5IW3/xuiigA/4aD+J3/Qzf+SFt/wDG6P8AhoP4nf8AQzf+SFt/8boooAP+Gg/id/0M3/khbf8Axuj/AIaD+J3/AEM3/khbf/G6KKAD/hoP4nf9DN/5IW3/AMbo/wCGg/id/wBDN/5IW3/xuiigA/4aD+J3/Qzf+SFt/wDG6P8AhoP4nf8AQzf+SFt/8boooAP+Gg/id/0M3/khbf8Axuj/AIaD+J3/AEM3/khbf/G6KKAD/hoP4nf9DN/5IW3/AMbo/wCGg/id/wBDN/5IW3/xuiigCrqXxy+Iur6Vd6bqHiHzrS8heCeP7FbrvR1KsMiMEZBPIOatf8NB/E7/AKGb/wAkLb/43RRQAf8ADQfxO/6Gb/yQtv8A43R/w0H8Tv8AoZv/ACQtv/jdFFAB/wANB/E7/oZv/JC2/wDjdH/DQfxO/wChm/8AJC2/+N0UUAH/AA0H8Tv+hm/8kLb/AON0f8NB/E7/AKGb/wAkLb/43RRQAf8ADQfxO/6Gb/yQtv8A43R/w0H8Tv8AoZv/ACQtv/jdFFAB/wANB/E7/oZv/JC2/wDjdH/DQfxO/wChm/8AJC2/+N0UUAH/AA0H8Tv+hm/8kLb/AON0f8NB/E7/AKGb/wAkLb/43RRQBV0345fEXSNKtNN0/wAQ+TaWcKQQR/YrdtiIoVRkxknAA5JzVr/hoP4nf9DN/wCSFt/8boooAP8AhoP4nf8AQzf+SFt/8bo/4aD+J3/Qzf8Akhbf/G6KKAGSfH74lzRNHN4jWSNxhkbTrUhh6EeXTl/aB+JqqFXxKAAMADT7bj/yHRRQAv8Aw0H8Tv8AoZv/ACQtv/jdZHiL4ueOvFdgllrniGaa3jlWUJFFHB868qSY1UnB5GehAPUUUUAakXx/+JsMKRp4nYqihQXsrdjgepMeSfc80/8A4aD+J3/Qzf8Akhbf/G6KKAD/AIaD+J3/AEM3/khbf/G6P+Gg/id/0M3/AJIW3/xuiigA/wCGg/id/wBDN/5IW3/xuqEfxq+IUeryal/wks8ly+MebDFIkfGPkjZSsZI6lQM980UUAX/+Gg/id/0M3/khbf8Axuj/AIaD+J3/AEM3/khbf/G6KKAD/hoP4nf9DN/5IW3/AMbo/wCGg/id/wBDN/5IW3/xuiigA/4aD+J3/Qzf+SFt/wDG6P8AhoP4nf8AQzf+SFt/8boooAP+Gg/id/0M3/khbf8Axuj/AIaD+J3/AEM3/khbf/G6KKAD/hoP4nf9DN/5IW3/AMbo/wCGg/id/wBDN/5IW3/xuiigA/4aD+J3/Qzf+SFt/wDG6P8AhoP4nf8AQzf+SFt/8boooAP+Gg/id/0M3/khbf8Axuj/AIaD+J3/AEM3/khbf/G6KKAD/hoP4nf9DN/5IW3/AMbo/wCGg/id/wBDN/5IW3/xuiigA/4aD+J3/Qzf+SFt/wDG6P8AhoP4nf8AQzf+SFt/8boooAP+Gg/id/0M3/khbf8Axuj/AIaD+J3/AEM3/khbf/G6KKAD/hoP4nf9DN/5IW3/AMbo/wCGg/id/wBDN/5IW3/xuiigA/4aD+J3/Qzf+SFt/wDG6P8AhoP4nf8AQzf+SFt/8boooAP+Gg/id/0M3/khbf8Axuj/AIaD+J3/AEM3/khbf/G6KKAD/hoP4nf9DN/5IW3/AMbo/wCGg/id/wBDN/5IW3/xuiigA/4aD+J3/Qzf+SFt/wDG6P8AhoP4nf8AQzf+SFt/8boooAP+Gg/id/0M3/khbf8Axuj/AIaD+J3/AEM3/khbf/G6KKAOR8V+Mdd8b6rHqXie++3XcUIgSTyUjwgZmAwigdWbnGeaKKKAP//Z" /></p><p><img alt="" width="500" height="292" src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAkACQAAD/4RD6RXhpZgAATU0AKgAAAAgABAE7AAIAAAAQAAAISodpAAQAAAABAAAIWpydAAEAAAAgAAAQ0uocAAcAAAgMAAAAPgAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEFobWFkIEFsWmFocmFuaQAABZADAAIAAAAUAAAQqJAEAAIAAAAUAAAQvJKRAAIAAAADMDMAAJKSAAIAAAADMDMAAOocAAcAAAgMAAAInAAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADIwMjA6MDQ6MDggMTQ6MTg6NTkAMjAyMDowNDowOCAxNDoxODo1OQAAAEEAaABtAGEAZAAgAEEAbABaAGEAaAByAGEAbgBpAAAA/+ELImh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8APD94cGFja2V0IGJlZ2luPSfvu78nIGlkPSdXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQnPz4NCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPjxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+PHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9InV1aWQ6ZmFmNWJkZDUtYmEzZC0xMWRhLWFkMzEtZDMzZDc1MTgyZjFiIiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iLz48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyI+PHhtcDpDcmVhdGVEYXRlPjIwMjAtMDQtMDhUMTQ6MTg6NTkuMDI1PC94bXA6Q3JlYXRlRGF0ZT48L3JkZjpEZXNjcmlwdGlvbj48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyI+PGRjOmNyZWF0b3I+PHJkZjpTZXEgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj48cmRmOmxpPkFobWFkIEFsWmFocmFuaTwvcmRmOmxpPjwvcmRmOlNlcT4NCgkJCTwvZGM6Y3JlYXRvcj48L3JkZjpEZXNjcmlwdGlvbj48L3JkZjpSREY+PC94OnhtcG1ldGE+DQogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgIDw/eHBhY2tldCBlbmQ9J3cnPz7/2wBDAAcFBQYFBAcGBQYIBwcIChELCgkJChUPEAwRGBUaGRgVGBcbHichGx0lHRcYIi4iJSgpKywrGiAvMy8qMicqKyr/2wBDAQcICAoJChQLCxQqHBgcKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKir/wAARCAGmAtMDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3rxZqs+g+C9b1ezSN7jT9PnuollBKMyRswDAEHGRzgiqX27xv/wBC94f/APB9P/8AIdHxH/5JZ4r/AOwLef8Aoh688ufF8uieKdRsPHlxrWg39xdSR6XrAmc6bJCW/dJsBMatjgkqWHJ3DihaysD0Vz0P7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOsyXx5qFv48v/DVzo1rCYtPe+sLl79sXqjjAAiO3B68kjqA1LJ471CPxbZ+HG0ixi1GS2iuJ4rjUzGSHJDCD91iYoASclO34C1tbr/wf8mD03/rb/NGl9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHXLaX8Q9Vh1/xxdeIba1i0Xw6wQmC4dpFCoWG1DGAxbPJ3LjgYPWmR/Gi3ufDutX1lY2N5d6XYJqJtrbVBKjwMTlWkWM7JVA5TBAJHzHOaV1a/lcOtvOx1n27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdcz/wtbUW1iy0yHwo0tzqOkJqtrtv12KhGWExKfIB6qHzkcDPHV+CPFcPjXwXp/iG3t2tUvIyxhdtxjYMVYZ4zyDzgVTTV/L/AIP+TFdaef8Aw/6kX27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh1haf8VoLxdOv5dNEGi6pqbaXaXf2ndKZgzKC8W0BUJQgEOT0yBVrSfHeqav4k1/Rrbw7G02iX0FvK63/AMrxScmQZjHKrzs74Iz0yJN/16f5ob03/rf/ACZp/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHXLR/Fu7vL7SW0/w/bvper6rJplrdz6i0chdCQWaIQtgHa2PmPbO2rt18UHsfFmn6Vf6FLbW2oag2nQyTTFLjeOknklMGJuzhzn0pLW1uv/A/zQP3b36f8H/Jm59u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdcfqvxludHPiaS58NxtbeG7+C1uZE1DJkSU4Dopi+8MglSQOvzV6HrWuWeg+G7zW78sLS0t2uJNoyxUDOAPU0bR5un/AAL/AJMOvL/XYzPt3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ647x54j8Q3vwh17UZdNn0LZYxXlhfWGqEs25gQpKhGRgOo5XnhjV7VviLeeFfC9ncyaPLfR2+kw3lzeXNw0KSggBkjfYwkl/i2sVyDnPWja9+n/B/yEne1uv/AAP8zo/t3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ6y9S+Ixi1HRbHS7C3ln1iyF7bjUL37IJAcfu0Oxw0mDnadv1qzZeN59R8e3nh20sLULYSBLgz33l3O0oGEqQeXh48kLu3g5zx6uzvb1/DcLq1/wCtS39u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIddJRSGc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHXSUUAc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHXSUUAc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHXSUUAc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHXSUUAc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHXSUUAc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHXSUUAc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHXSUUAc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHXSUUAc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHXSUUAc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHXSUUAc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHXSUUAcTP4i8bxeKrHSv+Ef8P8A+lWVzc4/tmc58p4F+/8AZeP9d02nPXK7cNpfbvG//QveH/8AwfT/APyHSagwX4o6GzEADRdSJJ7fvrGuW0HxZq1r8bNQ0LX5ibHW7KO+0ZSSFjCDDRjP8RALED0oWrsD0Vzqvt3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6474jeMbrUPD/jLTtAhuIh4ftd1xqUGoPbSRTlN6rGEHzgD72WUdsNV/SfHWpWGoeDdD1DTY5YNb01JI9Vmvm3PKsIZlZfLPzHry/PJ68ULX8Pxv/kJuzt6/hb/ADOi+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOuf1v4rJ4dews9YtNOtNTu7aS8MU2q+XAkCnAxK8YLSN/Cm0c5yR1qcfE1rrxF4b0/StIW6tvEenSXtpctdFGQou4o6bDgcgbtx78cDJvt/W/+TG9N/6/q6Nn7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOs238eX9x4vg8Ovo9pa36wQTXcFzqeyVQ4+YwgRlZgnIJ3L06Vnx/GXRZfGB0dPs3kjUv7K3teKLkz/3hb4z5W75d+7r2xzTSbdl/XQNk2+n/DnRfbvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHUXjzxjN4K0yxvo9NXUIrm+itJF+0GNo/MOAwGxt3Pbj61m+JfiSfCs1pZaxY2Vlf6hcyx2f2zU1htmhjUMZZJih2ZzjbtJ3cdOaW/wDXp/mH9fn/AJGv9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHWM/xOF34X03WdB0h7yG/glmMtxMYbeDyuGR5lR8MSCF4wxHUUlr8UodW0bwzNommedqXiRZGtLO5uPJVBGCZC8gVsAYwMKckjpzh2ev9f1sBtfbvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh1zOueNPFUHjTwZpEGi2tlJqwnmubW5vuQY0OULojjHIYEA5IAO3mqNj8SRozeNb3UrO9klsNYhsktm1Hz42dwEURZjXykPBI+bkk0W/r5pfmxN2/ryb/JHafbvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh1h6t8TZ9G0zxKLvR4Tq3h6CO6ms0viYpoX6Mkvl5zgHIKDnjOOaNI+KLX2uvpl9ob28raEmtwCC489pIyOYyNq4cHgYJB9ulLpf8Arq/0Y+tv66f5o3Pt3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ6b4I8WTeMNJOp/ZrGO0kCtBJZ35uc5zuRwY0KOvGV569a6am007MSdzm/t3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOukopDOb+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrpKKAOb+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrpKKAOb+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrpKKAOb+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrpKKAOb+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrpKKAOb+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrpKKAOb+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrpKKAOb+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrpKKAOb+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrpKKAOb+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrpKKAOb+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrpKKAOb+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrpKKAOb+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5DrpKKAOJ8R+IvG+ieFdV1X/AIR/w+v2Gymuc/2zPJjYhb7n2Vd3TpuXPTI6121c38R/+SWeK/8AsC3n/oh66SgAooooA5v4j/8AJLPFf/YFvP8A0Q9U9V8EXusaHJoN7ri3GjXO4XKXFkHuNpbIWOUMFQDoCUZgO+eaufEf/klniv8A7At5/wCiHrnJdK8ASapcWOjfDnT9aezk8q7ksdKtBHbvwdrNIUDMAeVTcR3FHUDR1HS9B8T+NdIW1mZr/wALXBM6JuUxo0XyoxPVSSh4yDtI7GtDxV4PHitrWO7uIBbwXMdwN9oGmiKEEeVIGHlsSOSQ3BxgdapaN4Q+H+uaebyz8F6KkYlkhKz6NFG4ZHKtlSmRyDV//hXHgj/oTfD/AP4K4P8A4mnrp9/zD/hjLb4Z201z4tS61B5NP8UANPbiIB4X2bcrJnkdCBt4I6npRceBtZvPhldeELvxHBL5tqLKK8/s4grDgD5l835n2jG4FR32mqfjHQPBPhLSIb//AIV5ol8kl3DbME0+2QReY4QOxK5xkgYAJ59MkbSfDrwgbuVZPBHhpbcKpjkXT4S7NzuBXywABxg7jnJ4GOZteNum33f8OGzv8/v/AOGMGD4Y6xb67p+qJ4lszJY6GdGVDpTYZccSH9/1zg49AR3yOi+HvhGTwN4Js/D0t+moC0L7J1tzDuVmLYK7m5yTzn8Kd/wrjwR/0Jvh/wD8FcH/AMTR/wAK48Ef9Cb4f/8ABXB/8TVXbv5/5t/m2Ky08v8AK35I59PhPHE+mWcWqqNE0zWDq8FkbT955hLNsMm/GwM2R8mcDGT1rX8L+DLzw94u8Sa3c6tDeJrsyTG3SzMRgKDao3eY275eDwMnnjpWT400DwT4P8My6wPh5omoLFIiNHHp9sm0MwUMSV6ZI6AnnpWzH8O/CDXUgk8EeGltwqmORbCEuzc7gV8sAAcYOTnJ4GORXtp/W3+SHLV6/wBb/wCbPKtEm1ey8apfW8fhDUW/tB5BpizXMepQCWTa0gtdxjhcBgSwUZXktzmuxPwguDqVtfSeJnmmttfbWVeaz3M4IA8pjvycAABhgAfw9MdV/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNEXZK3T/gP80Evevfr/wf8zjdb+DN9rVv4sgbxLbwx+JbyG5kxpjEwCI5VR++5zhcn2PHPHoGqeH4Nd8Iz6DrDedFdWv2ed4l2Z+XBZRk455AyfxrJv8AwD4Ls9OuLmLwLod08MbOsEemW4aQgZ2gsAAT7kCs/wAKeF/A3inwnp2uJ4F0C2W+hEwhOnQMUB7Z2DNK14uPTT8rfkg2al6/8ES9+Hur6h8L7jwbeeJo5VeBbWK8OnfMsKkYDr5vzPhcbgVH+yaoar8I7vWY5EvfEzESaCNH2rZfLGQQTKgMh27toDLyT/eHGOo/4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoet79f8AJr9WC0tbp/wH+iKGqeAZNW8EWfhq81C1mt4LaK3kklsNx+QYMkXz5jk6YbLAY6Grd/4MXUvEekandXMLDSZTLA32XFznBATzg3+rweVKkk9x0qT/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iabk27/ADEkkuXpsdJRXN/8K48Ef9Cb4f8A/BXB/wDE0f8ACuPBH/Qm+H//AAVwf/E0hnSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E15/4j0/wR4P8AGur3GoeALO90qHStPdzZ6Zaulqzz3SFzGxUkthQSiscIM9BQG57JRXnOqaT4BsdN03UNO+Hema3aakyLBNp2nWRXL42Z8xk4OeozjHOK6EfDnwQVBPgzQASOh0uDj/x2nZiujpaK4218H/Dy91W90+28JeH5J7ER/aANLgwhcEhfu9cDP4isy10HwVceP73ww/w70SA2tkl4t09hbFZlZtvyqFJAyCPmweOmOaXWw+l/67HotFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAGV4x07UtV8eaLaaRf29hJJpGoiWS5tDcK8fnWW5NodMZ6Zz0z3ORneIfg/a3mqaLqXhGTR/C17pcvnGey0Zd0zYwQdsiDYeflIJ9+uZrzwD4PX4k6Nar4T0MW8mk38jxDTYdjMs1mFYjbgkB2APbcfU0/SNH+Get+I9X0Sx8IaGbvSGQT7tJgCtuB5Q7eQCCp9CCKFvp6g9tdhb/wCGEt7J4jVNb+z2/ia3RNSijtMnzVXaZIiXOwMOqkN7EVf1L4dW2peG/DulS6jcFtBuYJobtlXzHEYwUO3aBuXK5/nV3/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJp3t+H4bfcKy/P8dyvrvgqW/8AGWl+KNF1NNN1Kxha1cS23nxXEDclCoZSCDyCG/A0zVPBd9qPxF0LxQNZiRNIgkh+ytZbjN5gw53iQbeMY+U4x3zU3/CuvB/2zb/whHhv7N5efM/s+Hfvz02+XjGO+78O9S/8K48Ef9Cb4f8A/BXB/wDE0lpa3QHrdMb4k8H/APCS6hYS3dzAIbK7jukzaAzxlCpAjlDDYCQd2Q2QSOOtV/Dngifwt4g1a40rVlGk6rdNey2MlrueOZsbiku7AU4+6UPsRVr/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaFpt/W3+SG9f6/ruQfEHwdd+NdIsrG01WLTPst7FeF5LQz7zGcquN64GetHirwVJ4g1bRNasNSXTtZ0WRmguGt/OidXGHR49ykgj0YEetT/wDCuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNC029Q3/Ip+IvA914i1zSNQn1x4l0+KdJLcW4McrSoU3qC3ysoJwTu/nnDsvhDJpugeGILHXxHq/hmSQ2moGzykkchJeOSLzOQQcZDA1tf8If8PDr39jr4S8Ptei3Ny0Y0uD5E3BQT8vGSTj6Gr3/CuPBH/Qm+H/8AwVwf/E007ar+tX/wQer1K+s+C5tX8U+HfEH9reTe6KZgR9mDJMkq7WAG4bSOxJbHcGsFPhE1wvihNW1tLhNevY79PIsvKa0mjbKEEyNuAwMjAzz610Nz8OvB6W7Gz8EeG5ZuNqS6fDGp55ywjYjj2NS/8K48Ef8AQm+H/wDwVwf/ABNL+vxv+YPXf+v6uc7qXwuvdXtvFMl9r1udR8RWsFo9xHp5WO3jjGCFjMpJJyTktxx1xzJo3w01DSvGVnr7eIYJGtdEXRxFHpxQlVGRJuMrAHcM4wRjj3re/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mmm1t/W6/Vhv/AF6f5IXw/wCEk0XxFq+stLbm41PYrpa23kJtTdhmG5t0h3cvxnA4FdHXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TSDrc6SivNrPQvCN/wCLNe0C3+HGgR3GlW8M0UlxZ26pcmTfj7sbFFynUgnr8vr0i/DnwSUG/wAGeHg2OQNMhIB+uygNnY6Wiub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iajn+HngqK3kkj8EaDM6KWWNNMtwzkDoMqBk+5Ao2A6iivPvBvh3wR4t8L2+sf8IBoNj50kqfZ30+3dk2SMnJCYz8uePzPWt3/hXHgj/oTfD/8A4K4P/iabVnYDpKK8t8RwfD3RNIvb6x8AaJqgsNQjsLkRafbIsTvs5JK5IBkUHAJyenBNdd/wrjwR/wBCb4f/APBXB/8AE0ulw62Okorm/wDhXHgj/oTfD/8A4K4P/iahf4deEBdxqngjw0bcqxkkOnwh1bjaAvl4IPOTuGMDg54AOqorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK4Dxf4a8E+E/Cd/rn/CvtEv1sojK8MWnWyEqOpyy9AOe59Aa1rb4feCLi0hm/wCEL8Pr5iK+3+zIDjIz/coA6miuVf4d+EBdRqngjw0bYqxkkawhDq3G0BfLwQecncMYHBzxX0jwf8PNc0/7bpvhHw/Lb+bJErjS4MMUcoxHy8jKnBoA7KiuNvfCHw70/UNPsrnwl4fFxqErRW8Y0uDLFUZyfu9AFPPuPWrEHw68IM8wufBHhqNVfEJj0+Fy6YHLAxjac5GBngA55wADqqK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgA+I//ACSzxX/2Bbz/ANEPXSV534+8A+D7P4beJbqz8J6HBcQ6TdSRSxabCrxsIWIZSFyCCMgivRKACiiigDm/iP8A8ks8V/8AYFvP/RD1yfw+1rTvBVnqHh3xfewaRqQ1S5mSS+cQrfJJJuWSN2ID8MAQCSCMGus+I/8AySzxX/2Bbz/0Q9dJQtGD1Vv6/rU8w8e3GjapqWkWV5ZxBLyG7eEaom20kfCgN5WMyzE8oMqcbjnpXG+F/wDhHfFHiHwRYavqUeoSXPhmWG7tpNRZiZAY9qlN/wAr4DnjB+XP8II+gaKcXy/15Nfr+AO7/rzT/Q+fvEc+kP4d1F9dRT4vtNfi3oyM90LUXa+WIwAWMPl7cBcqW/2jVzVte0CDxT4+j+3yTpOunF4VvirL85EgctuMcSlgJAF+UMRgE17rRQnpZ/1t/kHW/wDW9zwizuVsNK8SWVg9v/ZVv4htJby20lGWKOxeONnKICSIycliuAw3HGDivUvBlj4bs7W8k8G3UM2m3U3nLHZyK9rC2MFYtvyqMrkqD1OeM10tFF9Lf1sl+guv9ef+Z4F42n0u58PeLU8Qqp8WQaopto5FJn+yefGIvJHUxFcZ28Fs55rUgu9G1jxh49sLHX47R723sGRriR5CrZbcjRsQwTc6q6fKF3kHbXtNFJaK39dP8im9b/1vc8Xi1SO90ayjk07TLXw7a60IdXudKk3adcwC3IV14AEQbYrryoK4JPNYnimPSLKx1B7LUo7bwu+uaa2lCG9MVuWLKbnytrBWjAweMqpDEYIJr6Doqk9b+n4W/wAhPa39df8AM8l1Ow8NaT4xm0nXoLeDQm04S6HHOxaA3LySNMYycjzeU2gcgfd71yGismp+E/DFjrV/pul6O2iLDbTa7psjw/ag7byhMsQWQLsKtznnaeDX0TRS6Wf9b/5jv/X3f5fmeJ+H9E0S6+LH9i61rB1y5t9BtmZp7l1Z7iOXIcRlyUbakbYHY5P3jnc8BT2+neMf7HhXS9WaS2kuf7X0/K3ChihAvE5+dhtwxOTtPyjmvUKKE+/n+N/6+RNt/l+CS/r1CiiikMKKKKACiiigAooooAKKKKACiiigArzPxdrOlaP481A6xqNpZLLbaJt+0zLGHC3t0WxuPOByfQV6ZXN2P/JU9d/7Aum/+j76jqmBxV5pF94P8SaVp+jRfavCer6rBcQeW2Rps28MVH/TJ+SMdG47isnUYY7rSdTE7RxfEZNWdrDDAXgj+0futn8Rg8vrj5Mbs969vopxdv69P8hPV3/rr/mebeC9P0my+L/jX/QbSHUWlt5InW3VZPLaFS7AgZCs4OT0LD1rlviHr1pa/FbVI3ls7uxj0OGPWLTzk85rcSu8iop4LBSrFeuwnGCQa9yopdV5f5WKvo13/wA0/wBDwSWb4eXnjTW47C90iXRP+EXDxW4u1NvHJvYkLGW2owAQ4ABB54JJq9oOp6VrNj4an8e3VjdeHZfDcSRTX8itbtehgJQxY7RKAABn5vvY5zXttFNOyt/X2v8A5L8Bf1/6T/8AI/ieIxaQdE0Hw54q13TPt8lvdXGnSG5g82eWxnZ47cNkFieYxzztdgepqfwtoFlZf2h4Z8UWFrb2nhp579bsKIY41uF3IyScFNuZhuBBHlqc9K9nopPW/wDX9a3fzDt/X9aaHz74L1PQbGH4X3VvqNmupXUtzb3kxuVaaRGSTEbkknHmbMKejEY5NfQVFFU5XFYKKKKkZ578QfFFn4R8W6VqV7c28DnRtRhthcSiNZJmmsti5PTnknsAT0FcreXV58PfEXhLXtfGi2Fi6Npt5c2+qtO10sv7zzirQxjiT5iQWwHPGOa9Ivv+Sp6F/wBgXUv/AEfY10lC0d/6/rVg9VY+dfEGo+Friz+Jt/bavZXksMttcaZO1/55SXywQ0JZjghywG3p93pxWn401bS77XNUDalp0t9e2Fq2j6pNqkFt/ZbFcl0Z3V9rcNuhDZ+6ele71ysGm6ifEOqTaL4ms3t55wbu2msxPNbvsA2I6yKE4AIDq2M570Lou3/DD8zzjWb3w7pvjfxJZTeIFCN4UQF5NYkZjMCSArtIWBKiM4ByQQTnPMPhfVtA0vWfBL6bfW4uLvwtMt6LWdWnndUj2KeSWcFZAoPTaQOhFe4WNnFp2nwWdsCIoIxGmeuAMVPT2TX9fa/+S/AXW/8AX2f/AJH8TxX4azaZD8QNKfSpbKKDUtBkLLBJvkuJklTmeTgSzgM275QVO7rWv4xXw7b/ABksJPFk1uum3Gh3AmTUZybYsJYguVc7B+QycdTivU65i58L6hP8SLPxOmq26W1tZvZ/YjZMXZXKsx83zAAdyrj5OmRz1p3TlG/S/wCN/wDMFon8v0/yPLFt7r+y9IsvE19YWHh6SG8Wzk8Q2TzwAG4/ch8yx7HEW0oXJIGcc1riw06y1LS9F+I+qpqeif2P5NhqOop5MMtwJGDNlmIEuzZsYknAJU8mvXDe2ovPshuYRc+WZfJ8wb9mcbtvXGSOfenWt1b3trHc2U8dxbyqGjlicOrg9CCOCKX9fn/mHf8Aq23+R45faRaaZ8Rbv+x7dbrVx4TUaTdXcIa4nuUZ08zeVBL7duW44IzxTIINAkk8P3Ph+7htpltJE8UyQ3JhkWH7OdxumBDLIJMYZiHBzg9a9rqKW7t4JoIZ54o5bhikKO4DSsAWIUHqcAnjsDS1tb+t3/nqD3v/AFsl+l12ufO/2fw3b/s9aXr321I9TlltoJLn+0HBlZbksY3G/D4RnO1gcDntXcaheWNh8RIdRt20nxAur3kEccatjULUAJhoSM+ZADtkIGAMscnNeq0VXN71/P8Ay/yFbSxXstRstSjeTTry3u0jkaJ2glVwrqcMpIPBB6jtXmPhqDQ9Q1qV/ElybbxnY6tPL8r7LuWDzGEaKPvPbmMrwPl6nggmvTbOxjs2ndGeSS4k8yWSQgljgAdMAAAAYHp65NWanzG9VY8G8P3uhHxjomoJc21jbX8WpQ38slyUu3ON226mGzDgZIXqgHB71H4cg0yL4RWeu6Y73BGpG11i6t7h5ZFsvtbO6tgk42lST12sxzya99ooWn9ed/uB6/1/Xl9x86+Jp/CtqnxDTQ5orbTbjRLR7KSxZ4rZpF8z5UdMJyWX5M4Yk8Hmr3xA1DR9UstRubSe1lvbPRLW5tLm4l8woAS2+zVcFT/fkDcYUEHFe9SSJFG0krKiKMszHAA9SajivbWexS9guYZbV08xZ0kBRkxncGHBGO9VzW17f8H+vkG/9en+R5WE0DXPFms2/jG9WDUGuIZtBuvNCS/ZxEjA2jdyXD7gmSc4OeK6r4mXVlb+DR/agc2k13bxyZmEMWDIP9exU4iOMPxyDjvXV291b3dpHdWk8c9vKgeOaJwyOp5BBHBHvRa3dvewCayuIriIsVEkTh1yCQRkdwQQfcUn0Xa39fO2olpqfO91caFZ2A0691SytFtvGkJgtba6a2hS2YROxWLfjyxnOSMDJIxmumtdA8E2Xxl1DRjNAljZ6NFci0l1J2S3lWYyEqGf5NqqjYGABzgA17PRRfReX/yKX6XG9brv/wDJX/4B88+GtT8N22meA7yK/wBPF9Nr15bzyG4UuYHM2UbJzsJaM7emWU9+epsvC+l6Z4s1L4f/ANi2x0rVLuPWYl+zKY/IX/WRnjHyyIgAP8MuBwK9XhvLa4mmit7iKWWBgsqI4YxkjIDAdDj1qhp2lXUWoyajq93Bd3hj8mM29uYUjj3FsBS7nJ4yd2DtHAppq/8AXlb8Vf7wet/66v8AR2PCtbg8M6B4U8c2Yh07Srt/EcMUaoiwOIPMgcKCMELgOwA9GI6E0eOtV8L2bfEHTLDVbG1hntLK4ggtb0R+dcEsJCArDexXaWHOeCa+iqKSbSS7W/BL/K4+rf8AW9/+AeIXsvgufxx4gsxdaRNps3hqO7kja4R4pJwXIlYE4aTYUO45bG05qp4U8U6PceI/B91/bq3l8fCc0V3HFfebL5yrEQgQsQspAfjAJxznFe9UUX0t/X2v/kvwF/X/AKT/AJfieBeGv7JbWEj07UrXSrXV/DE6vcWshkmaZXQeZO42iWdQxLYUEHdzXb+Atc0zTV1Szu49BsINPaGA6npUwjsbhmLAIAeElDE7kyTlxya9Gqvf2SahZSWszyJFKNsgjOCynquewI44wfQinzf182/1sK3f+tEv0OL+NESP8K9SleSZPJeFwYZnTrKqkHaRuGGPByPbOK5jUptGttQ8S3/hVpDoR0Nhqj6M4QNdGTClXAKiULv3tgkDBavQPHPhi58W+E5dEsdQh01ZnQvLJamfCowYBVDpg5Uc5PGeO42LK6R/9Dlvba4v7eNDcrB8pUkcNs3MUBIOASenU4qV1/rdW/rzHfb+utzwS+vdI0rwx8RbS2u9HtLO60a2ltLfT32W7s6SKTHkgSMSFBZQMnHGa6C6n8Iz/EeCfxHeWdxo994XjkH2y5Mls7+aFG0MSgOFGAOpGRzXs1cwPC+o/wDCzD4o/tW2+ymx+w/YfsTb9m7fnzfMxu3f7GMcYzzTveS/ro1+ore6/wCusf8AI808IyW8Hj3wpY67e7ru50O8hNpfXBLmIzKYEaJzwxizxjJwc5xWd4dh8MQ+GNC0e5sLCOa41C+W4S7iCWjSLI6ok67f3soBGyPII65HGfoOih6q39bt/qP+vwseCaRDo99pvwtvNbhtL5YZbq1nmuIhKQyxvsjO7JyGA2qecgY5p+l6jZyWOt2+l36XmkReMA+qFbszFbEoo3O24sYyygEkkYDdga9rbWtKTV10p9Ss11Fk3rZmdRMV/vBM7se+KsXN3b2UPm3k8VvHuVN8rhV3MQqjJ7kkADuTTvrf+t0/0C2lv62a/X8DwDxmmj2Wi+IJNE1CG18Ky3OnnTxZ3nlWzXJlIuBDsYKy+XywGVBycZBI2JDoN54w8ZaBoutaXp9tcwWFyqArLBLMHbzPMRSNysPLWQ55DDJ5r2aK7tp55YIbiKSWHAljRwWjz03DtnHepqV/6+7/ACD+v6/rucP4A8SabLohSaHStJ3XxtLc2VyDaXzhFw1sTjcu0Y2qOCrdcZruKrXtjHfrGk7P5aSLIY1IAcqcrnvgEA4GM45yOKs0N3ElYKKKKQzm/iP/AMks8V/9gW8/9EPXSVzfxH/5JZ4r/wCwLef+iHrpKACiiigDm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5ux/5Knrv/YF03/0ffV0lc3Y/8lT13/sC6b/6PvqAOkooooAKKKKACiiigAooooAKKKKACiiigDyX41XmpWN/pkuj3cdrK2m3UUjPEX3Rvd6ejKMMMfeHPpkcZyNPxV438QeF7krK+kTLai1EsQgkMl55rhHdQsjG3Vc8GQMGPGaveM/D1p4p8aaVpOoPNFDNo1+3mQMFdGW5sGVgSCMgqDyCPap9R+Gmn6kdT8zV9XjTVBCbpEmjIaSLbslBaMkN8o4zt/2aF+v+X/B/rYeqGr4j8SatqV9L4ctLCaw03UhYT21wGE04G3zJFk3BU27uFKtu29RmuOttVvvBl1471LRbfTorC08QQG4t2hbMiyRwh9m0qEbL7skNk5yB1r0ODwbBZ61c6jYarqVoL1hJe20Tx+VdSBdu85QsjEAZMbJnFY178K7S/s9atZ/EetiLW7tLu7Cm2B3rjAU+TwPlT/vgc8nLjp936xv8tGD1+/8Az/HUjk8VeI7HXPEml6jLpX2i2tY7nRvLs5B9oEjFF35l+Yh9qELt6g55wJYvEfizULjUI9Fg0u7fRLiK0vIZI3ja9kKI8hiYyYiAD8bt+cY46me70a21/wAZaJcbL95NAMonu7i3eATnaoVeVVZAXAfKAqDH24rTbwhbp4iudX0/UtQ0973ab23tnTyroqu0MwZGKtjjchU8DnihWVv666fhuJ/1+pzmoeOtZsPGlrYMmmta3GqDTvsiq7zorIWWZplYomSP9WyBsc5qnZfEPxMNC1PW9UsNIS2sL6fTTawSyl5JxIkcREhGNpZiCSoOMEelb0nw2sWmZ4dY1aBBqf8AasMSSRFYZ+dxXdGSQ2TkMWx2xT9P+HWm2nhvVdDvb7UNUtNVuHuZzdtGrrI53MymJEwd2GHoQMYpR0Wv9bf8Ep2vp/W//A/rV8tEms6X8YdVu54tJuNTPhnzleCJ7aOYibgSHLtkAAbucgDgdKtz/EDXpvBWhaxbDSrOTUNLe+laeJ598gUMIY4UcSHOSdw3BQvIOa21+HFt/aJ1KfxBrtxqP2A2C3clxGGWIknlFjCMeerKegPXmo7D4Yafp1rp8EGs6uVsbF9PVmkhzLbsc+W2Ix0wMFcN6k0fZsv61k/1X/B2a+1f0/KK/R/8Dp0fhzVW13wvpmrPEIWvrSK4MYbIQuobGe/WsjX/ABHqml+NvDuk2trZyWerGdXlkkYSB44mcAADABwPm578d6n0TQbzQJNN06y1C8n0qxshblbrySG28IQUQNuA4JJC4A4JJINe8Hpr3iDS9XOs6lYz6WXa3jtfI2bmBViQ8TE5U4649MHmqlbmvHbUUb8tnvY5LSviF4jns9H1HU7XS4ra812XR57e3EjuCHdFkWQkDgpyCvI5+XpWvpXiTxVr0NtrGj2OmT6RdTTRLbSs8c0SoXVJWlyQQWUAoEyA2cnGKjj+FNpFp1lZL4l1zyrLUm1SMk2uTOWLEk+RyNzMcf7R7Yxsaf4Lh0iS6XSdY1Szs7h3lFjG8Rihlc7i6Foy4+bJ27inJ+XHFT0/rsv1v/Wz6/13f6W/rfk9N+IniR/CNv4g1Wz01Yb24ayhgs4biaRJvtDR7tqgl12KThQGJXtu+Wxa+OvEc2m3S3NlBZSQ38dsmq3+nz2dvJE6kiRbeZlkZgw2eWGJJIIOK3NP+Hmm2Hg7/hHHv9Qu7ZLg3MFxM8az28m/eGRkRRkPkjIPUjpxUt34JS/i09rzXdWmvtPuBcQX5aESghWXBURCMja7D7meeueaemv9dv8Agh/X5/8AAObg+I+pSeDNP1a7W2shJqE9ne6g1jPLBbrE7L5jRBg6BtuPmbCZ5JxT9a+IuoRSG10BYL+5hsY70yWmmXd9Ddhy+yNGgyI8hPvsSOehwcdFp3gpNI02ez0zXNWt1muJ7gOGhdkaVtzAboyCM5xuBIyeahtfh5p2ltZSaDf6hpE1rD5Dy2rxsbmPcW2yCRGU/MzHIAI3HBAo3/ry/wA/+GDZ/wBd/wDIw9V8Ral4u0fVNNstOtLVLfSI7nULXV7dnZmmjZhBs3LsIC8swbBwNtXPDFtBefADTILyCOeF9Aj3RyoGVv3IPIPBrV1DwJY3upvf2+oalp809qLO7+yzLi7iAOA+9W5G44ZcNz1rQ0Pw1YaB4Xg8P2huJbGCEwKLmdpHKEYxuPbHAAwAOABUy1hOK62/9u/zQ4u0ovt/wP8AI4HwXrOp6Z4V8CadqcVhd6Nrenx2aRrCwlhcW5cbyWKurKpBG1ce9QfD/W7jTvBvhrw5oa2sF5qU+oGKS4iZ4reOKZyT5aspbkqANy/XjFdlpfgCx0pLZItS1GZNPiaLTFneNhp4K7cxjYNxC8AybyBx0JzW034Z2GlaPaWVrrGq+fYTyz2V+zQefbmTJkUfutjKxJJDq3X2GNZyUpN9/wDgkpWSRl2nxC1a5v4/Db29lD4hOpy6c8+x2tgEh87zgm4MQVK/JuGCfvcZpYviDqw1Cbw1cW1kPEK6munpOqt9lYNCZhNs3bhhAfk3dcDdzmugfwJphtIglxdxahFcteLqiMn2nz2XY0hJXYcr8u3btwAMcCo7n4faXdWHly3V99v+1rff2qkiLdfaFXYJMhdn3Rt27duOMVGnXy/T/g/1s/Tz/W36fd9+L8MrWaz8UeOYbpLRZxqkTSGzhMUTsbdCWCEkruJyRk8k8nrTLrxp4rx4ultrXSIk8Mz5MLebK11EIhKQHyuxtpHO1gDxg9a6fw/4PtPD2q6nqUV9qF5eaoyPcyXU+VZlULkIoVAcDqF9hgYFcVo2gf8ACSeNfG0OoNr1jp17eRloWtHt4L+JYUjYb5I843KR8jKSPUUb2Xl+KsGi1e1/8y/YeOvEepa9qyxWmlW+laXBbXrl2leaS2lR3PYBZNqg4wRkEZOcitYfEfxHdS+ZD4fub+3udNlu4Vi0i7tvs8qpuWF5ZV2y7ugZAvI6HINdZpvgq103xFqurfb725/tWJIZ7OcQ+QqICEVQsYYAKSOWOQecnml0vwemk2bWVvrWrNZomy1t3ljxaDGAEYIHOAcDezYo0/r+vQWvX+tv+Cc+vjy8k8HXGqWN/p+qSwSRRTva6dOGsizHe0trvMnyjaduQTg9BUlt401G78TeG7aw1LRdS0vWo7ofabSFyQ0SZBB8wgcnBUgkY6+m5a+DorW/vtRXVtRbUr1k8y9JiDhEDBIwqxhCq7z1Uk8ZJxVNPh1p0K2cttqOowX1reS3pv42i82aSRdsm8GPZhhgYVRjAxijS/8AX9f116GttP6/r+rdeag+IXip9P0j/RNHmnvPEE+jTTYljVdjsFdY8seQjE5frgd8hb74jeJbKW5gi0xdQvdJmjt7610/R72dbtyqM5imUFIsB+FfcTjtwTsL8KNLhNp9j1nWrZbXU31VVFwkoadieT5iNgfMwwuM5JOTzW3L4Sg/t6fVLHUr/TzeYN7bWzRiK6IXaGYMhZWwANyFTwOeKI26/wBbf8Eb30/rV/pY3lbcitgjIzgjkV5FqF7feFvGnxG1fw7Bp0X2Oys72dJoWInISRmGEK4Zhn5yTz2NemWEGoR6vfvcXEr2LbPs8Uoj/dkA7tuxQdnT75LZz0GK53UvhrbandeIJpvEGsoPEEKwXccZttqxrkBUzCSMKWXJJOCec4IXW67DVtn5GZ4j+I2p29zcQ+HNPkuZrO0huWgGlXd2bppFLCEPCNsJwB8z55P3cDNM1v4h6zpuo28i21lb2z3FlEdPnjd7t0uCoLsUbEG1mIxInzFTgjIro4vBEVrdW11Y61qlrdRW8dtPPEYc3kafdEqmMrkAkblCnB61Uvvhppt7Jf7dU1W2ivriC7khhljKrNDs2SAsjNnEaggkrx0zzVK3N5X/AF/y/rqTry69v6/H+uhiTeKfHGpr4qjsRoempodxLC8hWWd2QW/mKy8oN2WXqMcn0+bpfh0dQk+GmhyahdQ3FxLYQukiQsgAMYKhgXYsw7nIz6CnaR4HttKbXDLquo6iNdYvdrdGEAMU2Er5caY+UAdxx65zpaBoUXh7w/b6Ra3d1PFbRCKOW4ZWkCqoVeiheAB29zkk0lpFryX3q9xvVr5/8A8z0KXWrLTNa1G+m0G7lj8STRpc3VkYxaSbhG04LTEsAuFWNSG5xuNaa/EbXP8AhDotUWz0+aaPX10m5kKywqyGZY/MSJssCdw+Vm465PStWD4YW8Nu6HxJrkkn9o/2nHM5tg0Nwc7nXEIU7gxBVgR6AU68+GFld6XPYLruswQT6mNUby3gLCYMGGC0R+XcobHr7cUR0spdLfhy/wDB/q1iW7a7v8eb/Nf1vytxqd14Quvilq3h2Gxinsri2ufLmgLRyEwKXyEZTkkk5z1OTmtnxL458RaHrWrwWlvpd3Ba6B/a8CSrJEylW2urOGYNwGIwq9gSOta8fw4sS3iH7fq+qahH4ij8u9juDAq8LsDLsiUqQowOceoJ5qrqHwq0/UzLLe69rr3c2nf2bJdC5jDNAScqUEflkkHGdvYEYb5qnXlSXb9LfnZlJq+vf9U/yuUp/HHiGys9Mj1BLFLvWYftNq9lpt3eiCJY0Lh4ovmY73wCCowcnkYPVeDdbv8AxB4ZhvtX02bTbze8ckM0LxbtrEB1VwGCsACARnmoJ/BVtPpWk2y6nqEN5pC7bTU4miW4UY2kH5PLYEAAgpg4BxkZq2NP1G21LTxbahdSwJvN4Z/KKz5HBOEDB84wF2oBnjoKt2u7Gavyq+/U2aKKKko5v4j/APJLPFf/AGBbz/0Q9dJXN/Ef/klniv8A7At5/wCiHrpKACiiigDm/iP/AMks8V/9gW8/9EPXSVzfxH/5JZ4r/wCwLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm7H/kqeu/8AYF03/wBH31dJXN2P/JU9d/7Aum/+j76gDpKKKKACiiigAooooAKKKKACiiigAooooA5XWLy2sfiZoc99cRW0I0bUQZJnCKCZ7HHJrUk8WeHYoJp5df0tIoJvs80jXkYWOX+4xzw3sea8z+OlkuoahotuNLn1SY2dy0UNvZPcupF3YFm2qpK/IHGeOuP4sF+sET+JvG89tomqmG88NxW1q40W5AlkxICi/u+vzxjHt/snCbsm/X8r/wDAKSu0vT87f8E9Nj8SaHLqsumRazp76hCpeW0W6QyooAJJTOQMEHJHeoT4v8NLZW143iHSha3bmO3nN7HsmYHBVG3YY5BGBXnk0eoaTo/hHxJo1hcpfTWMeh30M9u8MgLqFjd1cA/JMo5P8LEitNtKXw74o1dNT0u7v9Kv9KtrGx+zWT3IAQOHicIp2biwbc2FOeTxVyXLfy/T/gW+/qRF8yTfWz/r8fu6HdalrelaNbxz6xqdnYQyMESS6uFiV2PQAsRk0298QaNplzbW+pavY2k92cW8U9ykbTdvkBOW6jpXmfh/RNR8KXOjJ4u0+81Oyfw+umu9vbSXn2WXeWeNljDMFZSq7gMfuwCelUvG2jTf2druk6H4e1C0hGjW8Nr5FlJctdpESVi3ncibM/d/1jbs5yKLK+/X/P8A4f5/Nv8A4H6f8N8vu9bn1zSbW8FpdanZw3LMiiGS4RXJckKNpOcnBx64rm/EHjpdP8X6HoulXGl3bXl99lv4/tW64tsxs6/u16Z2nlj6cHPGBpWlWd/8WfENzHoM0K3Wl2vk3V1pEkcbXCMzFt7oFLgmI5znKjH3eMW2gv49K8CWMnhbVpNT0LU/+JkVsjtOYpA8olbCOrsdxIY+/JAIltfy/P8Aq/qhX0fp+lz1ca3YWthdX2o6zpotIJmVrgSLHHCOPkdi5G4dzx16CsbxB4wlsrnwxJof2C/03WtQW0e6WcvgMpYGPb8rZCtzu444Pbz/AEBJbHQ1gtfDOo28MXiqe5heTR7lfsUL7/LlSAKpcY+XGCE3AsOMVFaQ3unaR4bs7jSdbeWy8XXF3ORpMzFYd8uJT5ce3B8xT8vHJx0OFFXcf+3f0v8AmOVkpf8Ab3/t1vy/E9n1S6WzsHla9tbE5AE92Mxg56Eblznp1FQ33iHRdLaRdT1ews2j27xcXKRldxwuckYyQQPWuS+MdqLzwGI49LudRulvbaS3S2sXuZIysqszAIpK/IGGeOuO+K5jWYbeTxX47vbXw9qRXUfD0cMMqaHcZuJiJAwB8vlvnjB+nP3Tib6N9r/lcpK7S72/Ox1viTx4lv4ttvC+havodtqk1u0xbUZd678oI4NiurBn35B5OBkK1dHp3iLS75pbZdW02a/tEBvYLW7WTyG75GcgZzyQK868N6pM/izw7JJpGu5g8Nmxme40i6iUXG6I7GdowBnY3zZ2+9YtlZym50ifVfDupLYLod9Zy6cuiTyR2rlo2WHlWeTOD85JViMrjmqkuVff+HNb8l96+cR97V6bfja/6/j8vYU8S6FJaz3Ka1pzQW0ayzyi7QrEjDKsxzhQR0J61lav8RPDGj/2QZ9ZsGj1aXZbzC6TyyoBJk35xtGMZ9SBXB6Nok2n/D/wFqUWgXWdKki/te0WwZLlgscihjGVDybJH3gAHPJXNbOtadbxal4X1Tw7oeoJZLrsl7dKlnIr7pIHUyGJhuQFiAchQDycDmqcUpW87fl+f9eRf3b+V/z/AC/rz72C/ie7vQdQs5Y7fbujjwHt+OfMO49cZHC8evWo7TxJod/ps2oWOs6fc2UBImuYbpHjjx13MDgfjXk9xo97e6n46ttF0W9t4rjVLG8Eb6fJBHeRRFPtARmUKzMQ3f5s55BzR4/0n/hI4PEmt6boeoyWtzoQslt5NJmEtzd+ZmNhCyb8oP4yuBu4PBqFsn/W1/z09Sutv63/AMtfQ9estY0zUrm4t9O1G0u5rYgTxQTq7RE8jcAcrn3q5XmWiXKw/FK3uINK1W3sF8NR25kOk3EcYkV9+zmMDcFJwPX5evFekWtwl3axXESyKkqB1EsTRuAfVGAZT7EAiqa/r5tfja5Kb6+X5J/rYloooqRhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Ef/klniv8A7At5/wCiHrpK5v4j/wDJLPFf/YFvP/RD10lABRRRQBzfxH/5JZ4r/wCwLef+iHo+w+N/+hh8P/8Aghn/APkyj4j/APJLPFf/AGBbz/0Q9cvpljoHw1+I2qxx6fZ6dY6zZG+t5oolTY0I/fQjHRcbXCjj71Aa9DqPsPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkyuestPXwP4TgvND03StIvdZvBJfT3CKqW3mFmVSishlK5CKikEk8d6hg+I+pSeDNP1a7W2shJqE9ne6g1jPLBbrE7L5jRBg6BtuPmbCZ5JxTsHmv63/AMjp/sPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TKyW8Wa5rF9Np/hKTR7m5s9PivpJ5A8kN35pfy44irjbkIcuSwGR8pqpc+MvE8U/i23aPTLa40fSrfUbdHgeTYXV2eKQiUB8eWQGXb1zg9KT0Tb6f1/X/DDSu7L+tv8ANf1c22Txel2lq/inw0txIpdITokwdlHUhftmSBnrU32Hxv8A9DD4f/8ABDP/APJlcgl4118R/C+vLZW51G88K3E8ojAj81swsE3HoAWIGTxk1Lp3xC8QTvq0Bj0e/uLbR11SFoBLDCp3ENEZMyCXAH30wCeMDqHL3Vr5/g3/AJExfNqvL8bf5nVfYfG//Qw+H/8AwQz/APyZUN0vi6xh8298VeGrePcF3y6JKi5JwBk3nUmpvBGqa7rnh+11XXU09I760guLdLMOGTegLhtxOeTwR2OD0yfP/Hmq33ivwmNVSHThpFpr8FvbpLAzXIeO7WJphJu2rkhl27c7TndzinytT5X3/WwJpx5v62ud1Eni+4mmig8U+GpZLdgkyJokxaNiAwDAXnBwQcHsRU32Hxv/ANDD4f8A/BDP/wDJlYQ8c67/AGd4rd9NtjcaLqSWkQtUluAsTLGxlZRhnKq5YqoHTAPepYfHFzqUmj6doep6PqF3qzTGK/ihcwRJCily0W/du3tjZvGAeTxU7rT+tLjehsfYfG//AEMPh/8A8EM//wAmUya38Z28Lyz+JfDsUaDczvocwVR6km84rlJfiN4mS8tNLGm6X9uTXRo17O0kgjLNGJEkjTrgpyQWyDxznITxTqmva/4S8U6Rcw6K50fTiNT3wvIlxM0JkxECw8sKNjBmD88Y4zSk7Qcl/Wl/1X3lRjeai/61t+jOrht/GVzbxz2/ibw5LDIodJI9DmZXUjIIIvOQfWpPsPjf/oYfD/8A4IZ//kyuMj8dajpXh3S9K0G1ea7s9DtLp1/sq6vBOXQhYgYBiInYfnbI5+6cHGlpXjPxfrniifT7bSdOsIoLKzv2hvTL5+yUtvjYYGyQBWwMEAgZzn5dJRtJpdP6/QzjK8FJ9V/l/mdD9h8b/wDQw+H/APwQz/8AyZR9h8b/APQw+H//AAQz/wDyZVLwR4tuPEkkkd9d2C3kSFrnTFtpILmyYkbUdXY7wPm+cBQeMCuxqWrFHN/YfG//AEMPh/8A8EM//wAmUfYfG/8A0MPh/wD8EM//AMmV0lFIDm/sPjf/AKGHw/8A+CGf/wCTKPsPjf8A6GHw/wD+CGf/AOTK6SigDm/sPjf/AKGHw/8A+CGf/wCTKPsPjf8A6GHw/wD+CGf/AOTK6SigDm/sPjf/AKGHw/8A+CGf/wCTKPsPjf8A6GHw/wD+CGf/AOTK6SigDm/sPjf/AKGHw/8A+CGf/wCTKPsPjf8A6GHw/wD+CGf/AOTK6SigDm/sPjf/AKGHw/8A+CGf/wCTK5+zs/GP/CydZVdd0MXA0mwLyHRZijL515tAX7VkEENk5OcjgYJPoleVePPDOl+JvGWqwanbI0osdGjhulQedbb726DGN8ZQnA6dcCjrYDsfsPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkyuBupYNTn0/wl8RLGxv9e0zULf7Pc3NurC/tWkA81Nw6kAB1HcelbV74/1eDQLzxVY29i+gaffPaS2Zjf7Q8ccvlNKsm7aOeQhQ8D7wzw0r7f1t/n8hbO39df8AI6T7D43/AOhh8P8A/ghn/wDkyoAvi5r1rNfFXho3Sp5jQDRJd4Xpu2/bM496zfB93rd38TPGC32o209layW8UcK2rK6qYt6gN5hAA3tn5TknOR0rE1rUoPDvxvv/AOzktLfVNW0W3htjLF8k1wZnCtIQVyAq885IUAZOBSW6Xf8AyuP7Lfb/ADSO0+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrnrnxR4zt/EmpaC39g+fY6ONRW8EExWVtxG0xbwVHysPvnHDc52ifT/G+q+KG0yz8OLY2V7daLFq00l9E8yRiQ4WMKroTk7vm3cADg5oWquv63/wAmG2/9bf5o2vsPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MrmNM8fa9qlzokzjTdOsdRe7sZ1ltnlaC9gD8BxIoMbFGI+UHC4zzkP8NeNfEniPRrdrVtJOqRXN0l5DJayxxtHFjZt/eFk3B4juIfh/u8cj0A6T7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkyuZ8NeP9e1MeD7zVLfTktPEnnRGC2STzIHRXdW3s2CCEwV25B5yelelU2mtwOb+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTK6SikB53eWfjH/hZOjK2u6Gbg6TflJBoswRV86z3Ar9qySSVwcjGDwcgjoPsPjf/AKGHw/8A+CGf/wCTK4r43WFpfQv9ttYbn7P4Z1aeHzYw3lyCWyw656MMnkc8ms/xxa2V74Y8NWFx8PptNtINWsoopbmKxMUaPMu9AsczMA/cBcHvTSu0u7S+8Hor+v4HZy+GfG9xrCX114v0maOJg8Fm2guIYnCld4xchycMfvMR3AFaX2Hxv/0MPh//AMEM/wD8mVgaj4y1e30/xBqPh2200aV4Xma3ms5Yn8y5Ecas/lurBYtoYgAq2cdqTwjqesav8Utfmk1CB9MWxsZIbY2rK6pIsjqA3mYBBJ3Had3GNuKEr7ev37feD03/AK6P7rmrqM3ijR7JrzV/F/hawtlIDT3WjyxICemWa8ApbCXxRqsLTaX4v8L3sSttZ7fRpZFBwDgkXh5wQfxFZvi+HWJ/il4Ths76wjtXju2WK4sXmwQihySJVByrEDgbcnO7OBzWjalceDLXWR4cttPt7RvGi2MlsbYhVil8lP3YRlCEZz0I9qIe87f1ul+oPRX/AK2b/Q9B+w+N/wDoYfD/AP4IZ/8A5MqCZfF1tNDFceKvDUUlw2yFJNElUyNjOFBvOTgE4FYl9441+w1DxVayRWky6Tc2qwz29jNIYYZhuLyRK5aTYMZ2lc4J47Z/iC9TXNa8Aaxp11pGpXL6tLFBqFqh2FPs8mR1LDkZKbuoAyOtC1/D8f6/qwPS/wAzsvsPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MrmI/iRqS6aLS6jh/tf+1brTmntNOuLmICEZ80W8ZaQ5BUbd3GT83FNi+JGsJp2mz67Zr4ehe4nhu9Q1DTbgQHy2UIQjFGhEgYkNISF2kcmktdg/r7v+GOp+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MrespXmsLeWV4ZHeJWZ4DmNiRyVPdfT2qam9HYFqc39h8b/8AQw+H/wDwQz//ACZR9h8b/wDQw+H/APwQz/8AyZXSUUgOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAPO/H1n4xX4beJWvNd0OW3Gk3Rlji0WZHZfJbIVjdMFJHQkHHoeleiVzfxH/5JZ4r/AOwLef8Aoh66SgAooooA5v4j/wDJLPFf/YFvP/RD1heKNX+GXi+Gwj1nxdobCwu0u4vL1eBcsuflPzcqQSCO4rd+I/8AySzxX/2Bbz/0Q9c9J8RfEVtaa/e3HhbTza+HpzFfeTrLNIQI1kZo1a3UNhXHBZckEUdb9tR2b076FjX/ABF4A8QPp8snj3SbK4065+0209rq1sGVtpUgh9ykFWI5HfjFUtO1LwJpGmz2emfE61t1muJ7gONWs3ZGlbcwG5SCM5xuBIyea7b/AISXSI/Dttrl7f29hp9zEkqT3kqwqA4BUEsQAeelS3OvaPZfZ/tmq2Nv9qBNv5tyi+cAMkrk/NxzxTaaumJO6TX9f1c88tT8NdLmsp9B+IGn6TcWsH2dpbbV7Vjcx7i+2RZAyn5mY5ABGTggcVJqtx8ONVvry5b4h2Vt9vsBp95HBrdti4jG7aWLZYMN7cgjOecjiu8vPEmh6fMIr/WdPtZC6xhJ7pEYs2dq4J6nBwO+KkfUIYtTkik1GzRI7fzHt2IEqc/6wndwmOPu9e/ak9dwWmq8jzGWy+Gcs1mf+FkW4trTTpNMS1Ot2rqYJBh1LMDJk4HO7jaAMDipNngDa5/4WnD50mmf2W8x1axLNBuyBjZtBAyMgDg85PNehN4r8OpZS3j69pi2sGzzZzeRhI94BXc2cDIIIz1BrP1v4geG9CbSBeatZBNXk220puUEZTaSZN2cbeAM9CSB3pu70f8AV7/5v7wWi06fpb/JfcjP8P8Ai7wJ4e8P2WkQePNHuorKIQxy3OqW28ovCg7No4GB07c5PNc5qFr8MtQivbU/ES1ttOvbpb2SwttctkiWcOHLqfvrlhkgMBySADzXpX9vaOdYGk/2rY/2kV3iz+0p5xX12Z3Y98VWv/F3hvSmZdU8Q6VZMr+WwuL2OMhsA7TuYc4IOPehtt8z/r+mCWlkcTo154E0S51Oe1+KMEj6ncJcSmXWLMlXUBQQQoJ+VVUht2QOecmo42+G0K+fD8QdOj1b7U92dXXVbMXBkdQjHGPLwVVQV2Y4BxnmvQIvEmhz/YfI1nT5P7R3Cy2XSH7Vt6+Xg/PjvjNXbq6gsrSW6vJkgghQvJLIwVUUDJJJ6CleyBa7HmF3/wAK6um0+RfiRZQTWd9/aLzR6rZFrq5xt8yXcpz8uRhdoAPTgYn1m5+HOr6lqF4nxCsNPOqW32XUIrPWbUJdLtKgsG3EMAcBlKnscjirCfFSDU7jw1c6FJps2k6pezW13M9zmS32Ru65UYC5VAx3HIBHB612q+INGfRv7XTVrFtMwW+2i5Qw4HU787f1oa01/r+kCeum/wDwf8zgLaf4c6c1i+i/EWz02ezt1tTNFrdtK9xCpJVJPN3hgCTggArnAIHFT6fqngHTvFV7rsfxIsZJry2S1eCTVrQxqiZ2YIAfILMcljncc54x3K69o76fDfpqti1ncMFhuBcoY5CTgBWzgknjioH8V+HYxZmTXtLQX/8Ax6bryMfaOcfu+fm544zTd29f6uJJJaf1Y5Sw1zwBaeIf7aufiDpmoXiW32WBrrVbX9zESCyjZtLZKgktuPoRW7/wsfwR/wBDl4f/APBpB/8AFVrX2t6Vpl1b22panZ2lxdNtt4ri4SN5j6KCcsfpSxXqNqd5EdQs3WCNGa3TiWDO7LOdx4OOPlGNp5PYvdD2Mj/hY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqtfTNZ0zW7d59G1K01CFHKNJaTrKqsOxKk4PtTbjXtIs9Uh0y71Wxgv7j/AFNpLcossn+6hOT+ApAZX/Cx/BH/AEOXh/8A8GkH/wAVR/wsfwR/0OXh/wD8GkH/AMVWnN4i0S3ultrjWLCKdphbrE90isZSMhACc7sEHHXmsH4i+Nl8HeF7y5sLjS31aKAzQWV7c7GlUfeKoPmfHoMfUUDSu7Fv/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4quhgcy28cjYyyBjj3FPo2JTurnN/8LH8Ef8AQ5eH/wDwaQf/ABVH/Cx/BH/Q5eH/APwaQf8AxVdJRQM5v/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrpKKAOb/4WP4I/wChy8P/APg0g/8Aiq4fVdf8I694/wBSf/hYdlpdsun6ayT2eo2eJZIp7t9u6VXB2koSBj7wzwa9crzfxP4j1Twv481rUtM0VNYiXSdLSaFboxTfNc3ir5a+Wwc/MeCV6DrngGi3q2u/DXW7vSbvUfF2gy3ekTrcWtyNUtw4YDBzg4w3cY/LAqg918NmuJlHj3TE0y4uPtU2krq1r9mkl3byx/jGWGSocKT1HJreu/Gs91oGkax4SsrLVrPUpkh3XF81sY2dgoBAifochgcEY6Gt5te0mLVo9Jn1Sxj1ORdy2RuU85h6hCdxHvinZr7/AMdP+ATo/u/z/wCCcjY+IPh7p3ifUtbtvHWkiXUvLM8B1e38osi7A4Gc524HUjjpnmsXX4fhv4k1rUNR1H4j2Wb+zFm8CapY+XEincpTKFgyuS4bcTn24ruNK8baJrPirUtAsL+2lvNOCiSNZlLMedwC9SF+UE9icdqpf8Jdc2vxD1TRtYFhZaVZaYl+l405B2lypMhbCoAVb14wc9qXb+un+Q9bP5fmv1sclEvgdNQub6X4vC4urnT/AOznll1TTifJySOkQ+YEnk5JzzmprFvh5pen6bDpnxLtLW6061+xRX8eq2Jme3zkROChRgOMHbuHryc943i/w0tkLxvEOlC1KCQTm9j2FS20Nu3YxnjPrxVnUdd0nR7NLvVtUsrG2kICTXVwkaNnphmIBp6/18/8397D+vy/yX4HDX158Lr7wxb6E3i/RYbS3uEuEaHWIVkMgfeSW3EksS249SGPrUserfDe21nWNVsPG2j2d9q8KRTSxarbHy9q7Q6K2QGIxnIIO1eOK6+bxPoFterZ3GuabFdNCbhYJLuNXMQBYuFJztwCc9MA02LxX4dnt7WeDXtMkhvJDFbSJeRlZ3HVUOcMR6Dml/X6foH9fr/wTzmwtfh5p0Xh6KD4pQmLw9K0lmj6rYYO4EEP+7yRtZh2OD1zzXcf8LH8Ef8AQ5eH/wDwaQf/ABVadt4h0a9vksrPV7C4unjMqQRXKM7IDgsFByRnjPStGndgc3/wsfwR/wBDl4f/APBpB/8AFUf8LH8Ef9Dl4f8A/BpB/wDFV0lFIDyLxvrfgrxf4n06wm8d6fZ6fLo+oQXVxZala8h5bTERZwwXcFYjGGOw4PBq/rd74H1/RtO069+Klui6fMk6zRanp4kmkRgyM+YyvykcBQAe4NW/iJ4hvPCvibT9bsdOh1H7FoepSzQS3Rg/diayyVYI+T04IHfnsb2oeN9W8OW0F/4t8P29rpUroj3unagboW284DSq8UZC5IGV3YzTV+nf8egP/P8A4Jj3N18OrmW7/wCLhafFbajzqVnHq1oIr5toUs/G5SQBnyygPcVetNd+Hdj4qutdtfHGkRy3UEUMtsur24hIjDBDjOcgMRjOOnGRmuoh8W+HLlbxrfxBpcosFLXZS9jb7MAcEyYPyDg9cdKki8S6FPcw28GtafJPPEs0USXSFpI2OFdQDkqSRgjg0agcZq2s+B9W8U6drv8Aws2ytJtOVlgt7fU7HysNjfnerMdwAB+bjHGDzWXHB8ORp+q2k/xNtrgalfJqLSyatZB4LlWDCSMqgAOVXhgw46dc+kReI9Env47GDWNPlu5d3l26XSGR9pIbCg5OCCD6YpW8RaIl4lo+sWC3MkxgSE3SB2kABKBc5LYIOOvIpLTb+tf8wfmcHZ3fw9sNYv8AVrb4k241G/8AL+0XB123IYom0Hy/9X7/AHcA9MDiqnlfDlbrTrmL4l2kU1jevqBddVsf9IuHG1nkBQjlSVwu0AHgZ5r0mfXtItdVh0y61Wyh1Cf/AFNpJcIssn+6hOT+Ap0+taXa6pBptzqVnDf3AzDayTqsso/2UJyfwFC7oH5nmVpB8OrOGfb8Tbd7qS/fUYr1tXshLbzuMOybUC4YHBVgy+1bF34g8GXenG1b4oWiNJGY5511WyLTA4yWUqUBIGPlVcAnGK7M69o66yNIbVbEamV3CyNynnEeuzO7H4Vfo6f16B1/r1OI0rxZ4C0aK2ttP8daNHp9papaw2J1S2MaBejbj85bHHLY9s81p/8ACx/BH/Q5eH//AAaQf/FV0lFNtt3YbHN/8LH8Ef8AQ5eH/wDwaQf/ABVH/Cx/BH/Q5eH/APwaQf8AxVdJRSA5v/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrpKKAOb/4WP4I/wChy8P/APg0g/8AiqP+Fj+CP+hy8P8A/g0g/wDiq6SigDm/+Fj+CP8AocvD/wD4NIP/AIqj/hY/gj/ocvD/AP4NIP8A4qukooA5v/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrpKKAOb/4WP4I/wChy8P/APg0g/8AiqP+Fj+CP+hy8P8A/g0g/wDiq6SigDm/+Fj+CP8AocvD/wD4NIP/AIqj/hY/gj/ocvD/AP4NIP8A4qukooA5v/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrpKKAOb/4WP4I/wChy8P/APg0g/8AiqP+Fj+CP+hy8P8A/g0g/wDiq6SigDm/+Fj+CP8AocvD/wD4NIP/AIqj/hY/gj/ocvD/AP4NIP8A4qukooA5v/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrpKKAOb/4WP4I/wChy8P/APg0g/8AiqP+Fj+CP+hy8P8A/g0g/wDiq6SigDm/+Fj+CP8AocvD/wD4NIP/AIqj/hY/gj/ocvD/AP4NIP8A4qukooA5v/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrpKKAOb/4WP4I/wChy8P/APg0g/8AiqP+Fj+CP+hy8P8A/g0g/wDiq6SigDm/+Fj+CP8AocvD/wD4NIP/AIqj/hY/gj/ocvD/AP4NIP8A4qukooA5v/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrpKKAPO/H3j7wfefDbxLa2fizQ57ibSbqOKKLUoWeRjCwCqA2SSTgAV6JXN/Ef/klniv/ALAt5/6IeukoAKKKKAOb+I//ACSzxX/2Bbz/ANEPXmv/AAj8/iXVPFV/Y2OrrdLqq31tY6na3UFlqUCwxoY3jkURkkhsEjcCFPQV6V8R/wDklniv/sC3n/oh66ShaO6/rVP9A6WPK9Yv7rX9S0PXLe38TaPptvbT2tzDBo+65tpX8sjMMsEm9MKylo1OPXGarXXh2fwjotu3hGTW5rqC0NvFa3+mG6i1CN5JHWGQIi+Tgk8nYFDLu9B67RTv2/r+rsDxkCzt/FXxEsD4dmnudTtrVBbWVkZFeWS3JKs6rtTLHJdyB3zmqk2jDTdb1az1TQr/AFAyeEoLK4uI9Fnnju7xMn7yxkO33MNk9Bzxx3Xh2LQrfxR4o17S/EWoatMZRFqVskSTJDIg+VUWOIOWVflwCx9cnmu3ByKlq8fVfo1+v5DvZ+n+af6fmeTWNgth4P8AAslt4duILqNI47m7GlzNPZyJAyZaEAMclmUM4Kru3dwao6Npmp2Hh/wT5mk6ox0rX7s3SGyYSKr+eEcqFA2nevzKNoz1Ar2eq817BBC0hLyKsgjYQRtKwYkDBCAnuMnsOTgc1o5Nyb7u5CjaKXlb8zyb+wtRuvB0PhefT7xPEUWtfbhffZH8lR9qMhnFxjZnyyRt3bu2K1fAvh/SrjxH40S58ONBBPqfm25utKeBHQwiNmjLoAct5mcc/MT0bJ9MqG7gkubOWGG6ltJHUhZ4QheM+oDqy5+oI9qjo/P/AIH+RW7v/XX/ADPP/Asd3YSXlhq8MzW/hESWVtKsbStOjYdGVVyzMsPlrwMkswArvLe7h1LTFubNi8UyEoWQofoVYAg9iCAR3rK0O60SafU9E07UjfXtowbUWD/vRI+eWZAAGO08LjAA4AxWhe3umeGtEe6vpodP06zjG53O1I16D+golrH3u3/DsF8Wn3fkePaRBdW+h/DbTtQ0HVxJpOoO14G0qZ0hwkqhiQhGNzLg9O4OASJtEh1H+1E1N9J1VdL0/wAT3t9LbyaZOjtFLGwilSMoGcBiSQoLDOcV69a6raXsdnJatLLHewefBIIH2FMAglsYUkMMBsE84HBxcqrtSbe+v5r/ACFpJeX/AAH/AJnhmv8Ah8G/Orf2BfTWl94ntL60hTSZpJIIVVPtErIELRb2GSpAZsdK0PiHo88n/CTafovh+5tlm0yHynsNOeUX212cpuwY49rMTtADsWyDwK9jpGYKpZiAAMkntST5Ukun+SX6D3d/63v+p5t9jgk8T+IbXxTomoX+m+IIrb7JMllLIvlrGAYXKLuhIfLfNtHzZznNc/quk3l5r3jy20HQr6L7ZHYyqhsJIIr3yXJuIxIyhGZgdvU7s8EjJr1nRNf0vxJp5vtDvY7208xohNFnaWU4OD357jitGi7X9fd/XUFtY5/w6dJvr661jTNJvLK5u4o47l7uzltmby87VKSAZwGPzAY9zgV5740tdQutX1kQaLqEQj1fTro/ZdPln+3JG8e6UyYYYUAjy4wGG3JyCa9iooTtJS7f53/r/PUOjR4LqdqE8PeP00rw3q0cuoazbzWSw6Fco0qr5TF1/djgMkhz68/xDOj4ltb+68L+OtLn0DU72/1mQXWnTJYSOs0RRPLUtjEbIVPyNtI6gc17TRSWi+Vvy/yQ+t13v/X3lXTJJJtJtZJreW1kaFS0E23fGcfdbaSMj2Jq1RRTbu7kpWVgooopDCiiigArzbxRqCWPxA1Hda39yWtNFfbZWM1yVVLy7ZiRGrYAAJ569smvSa5ux/5Knrv/AGBdN/8AR99R1TA5bVfCmp6R4x0++8LwmTQdW1KC51Ky2EG1mUhvPReoDYw4xwcH1rNvdC1C58I6t4VuNPvH1+61iS9tr5bWQwjdcb0n+0AbFKpxtLBvlwB0r1+inF20/rp/kD1d/wCuv+ZxPhe2u7H4leMBdWV0sV7LazQXJiPlSKsAQ4foTuBGOvtjmuQ8cnWf+Fp3t/pOmajd21rpUK3FuNOuDFqISR5HgWVUIztYEYJDEbTnJFey0Uuqfb/KwdGu/wDnc8ceaxvfiDrmtW3hnVoYbvw15G+Tw/cozz7myn+q5bbsHcEAAE4qXwgt7pS+HdW1/S9UlsV8Nx6YYv7MnlmtrhWHmK8QQuAwAG7btO3rjGfXqKa0Vv6+1/8AJMHrv/Xw/wDyKPJbTw3rfhbwr4e1Oy0+a4v9O1CdVsYxudLO5kYLEfQJmJj2XYfSrPhvw9faLca1oviCxlvtD04TXVvKbYyrdfaFy6LGoO4qfOG0A8SKK9RopPVPzDqn/X9dDw7wpBPp2l/DG3GhavbS2NzcfbgNHuEEG+N0y58vABZl5PHfoM17jRRVOVxWCiiipGeV/GRpDKtrbWd5eXN54c1S3ghs7WSd2dpbLGQgJA46nA9+RVrxdf3XjXwbJ4W8N6Rqhn1CNLe4u7/TprSG1jyN7kzKpY4BwFB5xXTX3/JU9C/7Aupf+j7Guko6WY77NHmms6LcaJ41trLS7dn0/wAU2yWN6y/8s5IRkyH/AHofMXPqq1Jq1nfad4wI0K2ub221S+iGoaXeaYXtiiqiNOlxjbHtUA7WJ3FcAA12sGjiPVn1C5vrq8k+YQJN5YS2VsZVAirn7o5Ysffk1flRpIXRJGiZlIEiAblPqMgjI9wRTvs3/XW39f5Ct0X9ef8AX+Z4f4Ws01TwLpmg6NpVzHd2/iOS6W5js2SC3ijvHLMJcbM7AU2A7ucYxUE9qLXwv4li03w3q0Ek/iuC7to4NCuULQLJE29QI+gCSH/67DPrvhHwrD4P0d9NtdRvb6Fp5Jw16Yyys7FmAKIvBYk856+nFbtNOzuv6+H/AORX4g9b/wBd/wDM8g1HSL268MeKvDt1pl7PrGs6jLd6fdrZSeVhiphkabbtiMYAGGKsNvAORlbjwncXutappXiO98SL9p1CO9tTp9nE9vPsVDGTP5DNEylMHdIvTjrXr1FKLta3T9LW/JA9b/N/fv8AmeO6hb383ia2mGi6jax2nitbiaGHTpZFdCrJ9pMxDb88cR4CDhh3r1q1vYrt51iWdTBIYn823eME4BypYDeOfvLke/FWKKS0jb+tkv0B6yv/AFu3+oUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9dJQAUUUUAc38R/wDklniv/sC3n/oh64NPFXi6Pw7Nq1zrsbzWnif+yjDHYxrDLEZ1h+YHL5Gdww49Dmu8+I//ACSzxX/2Bbz/ANEPXIf2T8Pf7Pex/snxf9nkuxeun2PW+Zwc+ZnbndnnPqAeopx0ld7f8FfpcH8Nl/Wj/W33BeeMde0TUvEGkfaZ9Vlt9Rsba0mMUCzKtwu5gP8AVxkjBC7sckZJpYPEfjOzuLbQ9ZS5sG1TVFtrDU70WjXKweS0jFkhLRbwUKqcYOQSpwRVkx+BWvNSupdH8Tzy6oqreefpOryLLtIKna0ZClcDaQAV7EVPNP4LudF/su70rxNdW4dZFe40fVpZlZTlWWZozIpGTghuM8Uo6LXy/T/L8Qfl/W/9W8jlbi+13wxpfxKvtN1cPqFlqFuxu7i1R2kXyIh90bUDYI5244+7zW5438Va7pd/eXGk6q5TT2swbO2tUkjAkdQ/2l3XIJDfKsbhsckYIpJ9L+HVzbX0M3h/xGw1Fka8lGkauJbjYAFDyCPew4BwTgnk5PNS3Nr4BvFuBc6N4okF1FHFPu0vWP3ojxsZvk5cYH7w/P7077eVvwS/yB63+f4s0ZNe1Kz8cy6fr15qOmQXdysOmOlpE9nOpXO3zNpZJSc8OQDgbQea43RdR8Q6D8PhqVl4guJ2m8UtazreQRSExtemNtrBVwzZySdw4woWuw/tHwib+3vJNM8TSyW8hliWXRtVeNZD/H5ZjKF+T8xGR61n3dl8P720ktptE8TrBJd/bWjh0rWIh527duGxBj5iWwOAxzjPNEXa1/L81/wRS1v/AF0f+aKGu+KPFdkvj26XXERPDcsEtpDBZRqsiMgcxyF9xIIbBIIORkEdKteJvFuuWWtPcabqjPBb6hY2z2dtbI8CJMUDieR1DeZ8+QI24BUsMGlm034f3EOpxXGleL5U1Uqb4PZa2ftG3pu+XsOPoMdKkks/AEyTLJovihhOYmkzpesfO8W3ZIfk++Nq/P8AeOOSaI2Vr9Lfpcb628zW8O/8lg8Z/wDXtp//AKBJWX4v1LU9etvHFjZ6k2n22h2BQwJCjG6Z7cuxcsCQmCANu05BOT0q7p1/4R0rxDea3Zaf4qXUL5QtxJJpOryLIB0+RoyvHbA4BIGMmotXm8Ea7fyXupaL4ieea3NtM0WiapCJ4jn5JAkQDgZON2cdsVElzRt5Fxkoz5vQq6BrGuW2r+E9JtbqBrC68Lm4jtjAAfOjWIAs+SSPn6ADHv2q/wDCfanpehywX9zqEfiLfbQy2WqWUaCEzTLGZY2jAWSJdxx8zHoGOatxWvgC3vbS6ttC8SW72du1tbpBo+rRxxxN95fLWMJg9TxycE8irq3ngzdeNNo/iK5a8jEUxu9D1Sc7AchF3xHYuecLgZ561rKScr/1u3+Tt+RjGLjBR9PyRi+L/Efi3wl/b+nWmti9NvorarbX95ZxtLEUfa0ZEYRDnOVJXjByGrXF94iPiDS/Ds/iJ1k1W2l1A3sVnEskKIsQ8mMMrIcs5bcykheOvzVDMnga50e60y50rxVPb3iqlw0umaw8sqLnCNKU3lBk/Lu28nirF9eeDtRsbC1vNL8TONOx9knGj6ss8PGOJhGJORwfm575qVZb/wBb/lp6282W9/68v+D6X8jk/DOuaxp+lR6Fpq3093f6zqry3GnJbCb91NztFwwjGS+TnPAOB3Gt/bHxAkv/AArpmqX0Wi3GpS3dvcgWsMsx8uN2jlJDsgJGwlAMAg8kHFW0tfh7DYva23hzXbZWujeGW30LVIphMc5cSrEHB5I4bocdOKsTTeDLjU9N1CbTfFbXWlkm1k/svWBtJ6lgEw5PQlslhwcihW0v/WgPrbz/ABZJa65q+l+ME03xVqF/As80cFjMtlF9hvPkGfnUF45WbdwzAdAoNd/XCSap4Sl1OG/m0zxLJNDKZo0fRdUaJZCSd/lGLZu5OG25Hatf/hPNI/58/EH/AITmof8Axii+mu4ra6bHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxSGdJRXN/8J5pH/Pn4g/8ACc1D/wCMUf8ACeaR/wA+fiD/AMJzUP8A4xQB0lFc3/wnmkf8+fiD/wAJzUP/AIxR/wAJ5pH/AD5+IP8AwnNQ/wDjFAHSUVzf/CeaR/z5+IP/AAnNQ/8AjFH/AAnmkf8APn4g/wDCc1D/AOMUAdJXN2P/ACVPXf8AsC6b/wCj76j/AITzSP8Anz8Qf+E5qH/xiufs/Gmlr8SdZuDa65sk0mwQAaBfFwVmvCcp5O4D5hgkYPIBO04APRKK5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYoA6Siub/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGKAOkorm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABigDpKK5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYoA6Siub/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGKAOkorm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABigAvv+Sp6F/wBgXUv/AEfY10led3njTS2+JOjXAtdc2R6TfoQdAvg5LTWZGE8ncR8pyQMDgEjcM9B/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAdJRXN/8ACeaR/wA+fiD/AMJzUP8A4xR/wnmkf8+fiD/wnNQ/+MUAHxH/AOSWeK/+wLef+iHrpK878feNNLuvht4lt4rXXFebSbpFMugX0aAmFgNztCFUepJAHUmvRKACiiigDm/iP/ySzxX/ANgW8/8ARD1n6V4k1zxjPez+Fn06x0qzuXtUur63kuGu3Q4cqiyRhFB4DEtnB4FaHxH/AOSWeK/+wLef+iHrnfDmia34BttR0NdCfxFoNxcyzWhs5oVliSQktFJHM6KQCTghjkHkCjr/AF5D6f1tr/wDpk8SPpmjtdeLIlsZ/tTW8cVssk5nOTs8tVXe5ZRnAUkc+lOh8aaDc6fZ3lrdyXEV7I0cCQWsskhZThwY1Uuu08NuA298VwOj+BtX8OaHF/Znh62ge616S9uYbIW4ube2YN5ao74QMu7acHhSwU5NP0/whqtr4XNtc6LrMWoWWoX1xZXenanD9oUSy7l+aSQB1ZWywk/ucgkin0/rsri6/f8Ar/kvvOmvPiXpNn4utdKlFwlpLpr38l89pL5SLldpLbcKuCxZjgDgEgnFXbL4i+FNQtnuLLV0lhSNJA4ikw4ZyihMr85LKV2rk57ciufi0vxbZ+JtI1vUtOGq3KeH5LK9a0mij/f+Yj8Byo5AOMcZ67RzVLRfCfiCL4YeFLWbTpLbUvD18l1Lp8k8X+khS+QrqxXJD5GSORzjrRZW/ru1+VmHp/Wif56HU3vj3wy3hy9vpNebTIrd/s80skDRXFvIRkDyZU3BiOQChz6Gpb74heF9Nu760udWV7jTo1lvIoIZJmgQ/wATBFOAOpP8I5OBXF+LfC+va1pfirVLHQblb3XLW2sodOae3EiCJmYyyN5mznOAFZjgD1OH6jp/iW91nxZeR+EtRVNV0CKwtle5tMmUCQEHE/A/ejn/AGW9sp6K6/rQaSbS/rdf18rnVr49sZPHw8ORxXJUWAuzdfZJTEdx+U+YF2hNob5iQucAHORV218b+HryS6SPUBGbWA3MhnhkhBhHWVC6gOn+0uR71wtl4P8AEVzMkc+nSWCX3hJNHlma4iJtJkLAkhGO4ENkbc++2rui+DIpLNpNX8J6idQhsXspDfa7JdRTo4AZYd0z7VbAPzKhHHHpTVtO1/zdv0+RKd7N+X5K/wCvzRseIviTpmi6DHqEFvqE7S3EEKxtptwjL5sm0MylAwHDY4yxAAzkVabx14ZgutSuLjxCIY9PtonvLadPLW03k7SwKBw7ZA2E5GB8oJ54+/8AC/i240C+soYb+60+11GyuNOtNTuoXu9sUwaUCQMVKkKNu9t3XOKXxHpXii+1vxjNb+Fb2VNX0KPT7Z0urXaZQJMk7pQQv70ckZ+U8dMy9Itrz/JfqVHV2fl+f+R3Nl438O6hJMltqI/c2gvmeWGSJGgI/wBYrsoV1HcqTg8HFZGu+O7e88F+ILvwlqAj1LS7I3W28sZVIXaWVtkgQsrBSA4yvfnGK5m80fxZNqemzWXhVybfwvNppN9NavCLhghCuolJZf3ZB4I+YdskQ3PhrxP5HiaSPQNTuZNY8OxWMQnvbUuJx5ilWAkCIoDg4T5cA45OKKiVnbz/ADdvyX3hSesXLy/S/wCb+49S0O7kuvDenXd3IGlltIpZXIAySgJPHArjLnx99r+JHh6x0fVEbR7uG5e4V7J0Evlx7hIkzgB4+RynGR945xW5FpN9qvwt/sa4il0q+n0s2bLKyM0L+XszlGYEZ54PSuXg07xZca94Nu5vC62w0GGeC8LX0O1w0aoGh2kkg4JAYJ6Hb1q5W9o7bf8AD/8AAM4X9mr72/y/M6rTvGegz6XBd2msTatDe3MsdvJDbNKzlXwwVYo8lE6b8Yxglj1qzqHjLQ9Mt4Jrm6lZZ4ftCLBayzOIv+ejIillT/aYAD1rz7SPDGtDwqU1Dw5rdjqdrf3t3Z3Gn6hapPH50u5QP3uxlIb5lc4+ToeK2tM0zxVomuJrmq2La7d3+k29leR2UkSGGaNnJb94yKUbfzt5BHCkVPT+u3+Zf9fj/kbl78SPCFhJHHPrtuzy2v2xFgDTEw8fPhAeMHP0BPQGsT4g+Pv7LsoofDmpql6moW0M5+wvLGVeRVaMS48tJMNuwSWx27jN8LeD9Z8NeLvDEbaVLNZafpt3DcXsUsPlRyzyrLtVS4cquCudvpx1xW1Twx4sj8J6h4Zs9DF8/wDbQ1G21A3cUcU0ZuhMQ+TvVxkg/KRgcEnAppLmXr/7d/lqLWz/AK6f5nodz4v0O01iPTLi9KXMkohDGGTyhIRkRmXbsDn+6W3e1Z0fxO8HTyOlvrkM2yR4i0UcjoXQAlQwXBbDDAByeQMkGuZtPAsp1i8tvEGiajqEc2otqNvdxa5KLONmfzAHg85fmRuAVjIbAJxk4s6DoGoXOl+LrXX/AA1dxw6rq5uoomu4Vd4m2DcrxyHa6bN3JHbB9JW2vb/L/N/cU7X02v8A56/kd5puq2urQtLZ+cAhCuk9vJC6kqGAKOoYcMDyO9XK5fwLa6/aWN7Hr8l40H2j/iXpqMkUl0kO0cSvESrfNnByTjGTmuopu3QnXqFFFFIYUUUUAFeaeLNR8R6R461m+8KiwnnXS9KjazvIXb7QXurtFCyCRRGeTyQ2eOmOfS6868RvqH/CwtSTS9Gu9Vk+xaNK620kKbFju7tyT5siDkAgYzz1x1o6r1Qy0/jS/wBe8O6XqvhK6sbQzXqWV7balZPNJbyswVkIWVNrKc5BznjBHfdn8a6Baaomn3V/tnMwtzL9nk8gTHpGZtvlq5/uFs8jiud13wRfP400zxD4db7NFc3cEmtWLkAShDlZRzgSLjBweR645zrnwdrUvhTVfBcmnyTQ6hqEl0us+bF5SRyXHmnKlvM8xRkABSpIHzDtSs9+/wDl/wAGxL3+79f+AdVonja21vxnrWgw213G2lmNDJJZyqrsRlvnK7QOVwCQW5IyOazpfFF9pXxM1m01i+Q6JaaMmoJHDaEvFmQq2du5nPyk8AdcY4zVnw7pGp6X8QfFFzPZ/wCgam9vNBdeauDshCFdud27I7gDB69q5Pxn4d8Vah8SrjW9D0i6KWenwraM81ube8mikaTy5EMobad2AxAwwDdADUreP4/d/mP7Mvlb71+h2J+JnhRWmjOpSm4t7f7TNaiynM8UfHzNFs3r1B5HQ56c1oX/AIv0TTrS2uJ7t5UuofPhW0t5Lh3iwCZAkas20ZGWxgZFcS8Xie+8ZarrUvg3UreO68PCwSNruzYmcO7EcT/d+bgnHQ5ApnhLQvEfhlND1S40K7upIdBi0m506K4t/NgkjfPmAmQRsjezbhgcdQGtv6/vf5L7w/r/ANJ/zf3HZJ478PTX1paW15NcyXtq13bG2s5pUmiUZYq6IVJHTbnOSBjJAMcfxB8Ny6Rbaot7OLG6lkiSd7GdVVo879+UHlgbWyzYHB54rl18Da3ovhTR5NESGTW7DVJrsReYFjSO5d/Mj3HqFWQH3MfA6Va8NeEtV8K6vrSrC99pEKvcaYiyIZpZZlUyr8zAA7kJBJAPmnnik+v9f1/mHb+v67+h0WlePPDet3Vnb6XqP2hr9He1cQSCOYIfmCyFQpYY5XOcc4xXQ149oHh/xRY6f8O7W58MXiNodxM1+/2m1Kxq6OgIxLlh84PAzgHjPFew1TSWwgoooqRnN33/ACVPQv8AsC6l/wCj7Gs/w145uNZ8cano13aR29r5X2jSZhnddRK5jkY59HGRj+FlNUfiDPrEXi3So/Dun3F9fXGjajAPs8kSNArTWQaX946qSo6DPJx2yRma14N17Qb3wtq/hp9Z1+fSZPJ+wzNYQLFasm103KsWTwuBlhle3WiO+u39flp8rg9tP6/4c09L8enTPEPii28X6kDb2GoxwW0sNg4jgjeJXHmMobaMtgu7AZHbpVv4j+N4/D3hbVRpGorDq9vaG4jYWb3KR8ZXeVG2PdghS5AJ6BulZV54f8QPL4wtIdFaSPxWqmK4eeIJZZt1iYTDduJBBP7sOD6jrVLUfCXiPTNE8X6Bp2lPq8GuWg+yXq3EUfluLZYdkodgR9wEFQw55x1oa935L77a/wDD9So25k+l/wCv+G6HZyeN9H0nTbQ61fMs5tYprhoraSUQhh9+UxqREpIPzNtHB9KmvPHXhuy1JtPl1RJb1bX7Z9nto3nkMPHzBYwxPBBwOSOegNcppmh+JNEfVjcaJ/aJ12zt4ytvdxlLORIfKKuZChKdGyiseWG3pmvpHhzXfC/inSUh0O91Kx0vw0dMN5DNbqJpsq/yq8qsAdu3JA5I7c1UrXf9dG/zSXnfQiN+VX/rVf8AB+47GDx94ZuZrZIdUUrdwNcQTtFIsMqKu5tspXYWABJXO4AHIqva+PvC0Gl6dcS+JY7mLVJ5I7KaUANcMHIKqqqMhT8oOORjk5yeG0nQ/FWmaH4Ajm8KahNNoE073scd1aZAaN0XaTMAc7wevQHpwKbpmg+Krfwz4RsZ/Cl8s2l6/JfXWLq0IWItIwIPncn96OP9lvbJZXsu/wCF/wDIHtfy/R/18z0VPHHh+TSW1FbyXyVuTaGM2kwn88dY/J2eYX77ducc9KxNc8ZS3EnhK98L6jC+manq4srpWtj5jDDEr82DGQUIIK557Y55+DR/Fqatqs6+GrmG3uvEQvt/nWbXHkGER7oiZCEfcvJODsY7TnpXg8N+J9P03QbNPDV9cf2d4nn1KVxe275gLyFTueUMzESDrzwc44yRSvF/4f0v+b+4ctFK3n+UrfkvvPT9c8S6N4bjt31zUIbIXUywQCQ8yOTgAAcnr+Heq0PjXQJrG/u/txij05xHdJcQSQyRMfugxuof5sjbgfNnjNYPxbd08MaW8UfmyLrtgVj3Abj568ZPArN1XQ/EmpT674gtNEFvdXsdnbQ6fcvbyTeXDKzvLyzQiT5jsyxAKgn0pJXV/O35f5jf9fezo7rx74al0SW7bXX01Fuls2aS3aKeOY4Ij8qVNwYjsV6HI9akvPiJ4VsLrULafVkaXTSv21YYZJfs24kAuUU7QMHJPC8ZxkV5/q3hbxOdB8U2dn4d1C6k1XVrS8t2lvrd2KIIi+9nlGCDGRgcZIA+XkW9b0nxPqU3j6SDwnqCjXdMhtbIPc2g3OqMh3Ym4Hz5+invgE6f12X/AAQW/wDXf/I9aVg6hkIKsMgjuK57UfHvhrStSvNPu9TDXtlD59zbW8Mk8kUfHzFY1Y4wQT6Dk8c1J4f1OYR2ek3+l3dhdR2Ech85omU4AVlBjduQSOuAexODjmNXsNePxF1zUrbw7e3NnNoIsIJo57YCWUMzcBpQQPnxkgcg9sEqfuvTXf8AC/66Chqrvy/Fr9Hc6bVPHHh7R7a3uL2/PlXEH2mNoLeSfEPH71vLVtqcj5mwBnrQ3jfQVuL+AXUzyafbJd3Cx2cz/uX+66YQ+YDzym7ofQ151H4X8WTeDtP0afQZ7cJ4abTmMNzbpItwAV2yyByxiOAVCE5JO4DtqW+heI7LUhdxaDLKb/wzFprqbqFfss8e/iQ7zlTv4KbunIpz05rdL2/8m/yX3hHpf+vh/wA39x2MfjfQJobWWC7lmjurVbyN4rSZwsLAlXchD5YODjfjOCB0qW+8X6HpuqR6fe3vlzvKsO7yZDEkjY2o8oXYjHIwrEE5GOtee23hLxTp3hXRRpun3Wn+JrGwgshdWWoRPayKmcC4R8bkHX5VZhuIU96vT+BHuNf1S31zRtR1a01G9+2RXMGsyw2sZwpCywecv3WXgqjZGM4xVNR57LbX8/8AIm75b/1/VzsY/GmgS68ujJfE3jyvCn7iQRPIgy0ay7fLLgA5UNkYPFbteUjw94nk8TaVfXWizAWGvzXDi2uII7f7O6SKsiRhgWb5lLlxvyWxkGvSNK1QapDO32We0kgmaGSKfYWBGDnKMykEEHg98HBBFT9nz/4b/Mp6P+vP/IyYPH3h+607Ub6Ca9eDTJhBd/8AEsuQ8chx8uzy9zHkZwDgEE4qWXxx4eg1GOymvmjkklWASNbSiFZT0iaXbsWT/YLBuelZT+HNTh+I081rEp0DVFiu71vMAKXMPCgL1O8CMk9P3XPWsK58Ha1L4U1XwXJp8k0OoahJdLrPmxeUkclx5pypbzPMUZAAUqSB8w7Cs7X/AK2v+tvIHpt/X9aHV3HxF8KWs19HJq8btp0qw3hhiklW2ZjgeYVUhRkYLHAB6kUt3488NQw6itzrP2D7HAJZZpomj2o52rJGXXbIM8AruBPHtXDazoXie6tviPb23hi+f+3kjjsH+02oEm2IREnM2VGRu55x78UnifSPFOoanfzWfhLUZUvPCp0lT9qtBsnYlvmzP90ZwSM8jjI5qX8P9dr/AJ6fMpWv/XdL8nf5HXXHj+wsfFGi6Hi8uEv7Fro3pspWUoNoViVTaM7sscBV77cipbT4g+FI7CzuG8TRXUWpXUkNnJIBmZg+CiBVG5VJChsHtknOTj2eka9D4h8I6udEm22WjTWF3A1xCHgc+VgnDkMD5ZxtJ6jOOSOc0/QvFcWm6DbzeEdQRrLxPNqkx+1WZCwu8rDH77lv3o4/2T7Z0aV7ef8A7db8tTNN8l/L/wBtv+eh6VF400GbRZtVW8cW0M5tpFe2lWZZgceX5JUSb8kYXbk5GBVnRvE2jeIDKmkajDcTQY8+3zsmgz2kibDoeDwwBry680vXom1iR/D95bXt54mi1DSSZbaVm2xAFgnnANgRtlWZPlbhsjjpPDN7N4ctdZutY0vVf7Ru7pb2+Rkt0UK6iMPGizuAgEfK72cnoDkVMbNfd+S/zf3FS0en9av/AIH3nc3+oWml2Ml5qE6W9vEMvI54HOB9STwB3Nefab8Qkk8UeLTrGtiz0PTrS1kheaya1ktGk8wHcsq7i+QuNwweMLzz0XjzSNR1fQrVtGjSe7sL+C+W1kcILgRvuMe48AnsTxkDOK43WNG8V6jeeNL+HwxIkeuaJFZW8D3sHniUB15AbZj95knf0XgMTgT0b66/l/X9MqNm0n5fn/kdtfeOPD2iWlqdR1ORhJbJceaLaSQiI8CWXy0xGpP8TBVznpUV/wDErwfpt9cWd7r1tHNa+X9oADMsO84UuwBCjOOSQBkZxkVxGueG/FeseHZ9PGg3ECzeHEs4xDc20b/aFDApPIH3MnQoFYp8zbsZ43PDlprtv4/1TVr3w1fW9tLo9tbRM09qxeSHeWUBZTjO8AE4HByRxVySu/n+v+X4mcb8q76fp/m/uKvjH4o2MnhJ7/wTr1uZYZYpJJHtWZXgM4hfa7YUEMevzcdsEGuyt/GOhXMeout95Q0xgt39oieExZGVOHUEhuzDIPYmvOT4c8T/APCj00AeGbv+1P7S8xrcXNtwn2rz9+7zduNvy4znd2xzVjWvDHiTxB4t1+5i0e5sbe4TTpraS4uINkz2spkaNgkjMu7dgHGODntkstvP/L+rdyvP+t/6+R3th4y0LUYr14b0wmwUPdR3kEltJCp6MySqrBTjg4we1Mg8b+H57G9u/tzQx2BUXKXFvLDLHu+7mN1D/N/DgfN2zXH+I/B2seNL2+1kWE2i3H9nR2kFrcXKLJOyXCzHc8DtsU7AoYNkbicDHJP4XvF0K/1DQvC99baxc/Z4501fU1vp5ESQMfKMs0sYKjcULEfNjIFL1/r+vwA7zRPEOmeIoJpdKneT7PKYZ45oJIZInAB2tHIqspwQeR0NadcH4Q0/V/D194oubnRNRmS+vorm2DXcMssqmKNGyWkABUqSQSBjhc8Cu8ofT5fkIKKKKQwooooAKKKKAOb+I/8AySzxX/2Bbz/0Q9dJXN/Ef/klniv/ALAt5/6IeukoAKKKKAOb+I//ACSzxX/2Bbz/ANEPWdJbrFqb6bL8UtRS+SMytas2mCVUHVin2bIHvitH4j/8ks8V/wDYFvP/AEQ9cDqkV/4V0zVpb6yt/Evgm9vJbu4uoiEvdPYyEuxVhiUIw4Iwwx7ULewdNDq9Oi/tbVdQ03TPiVrd1d6ayrdxxwWB8lmzhSfsuM/KeM5Her3/AAj+qfbPs3/Cc+JPM8vzM/Y7HZjOPv8A2Tbn2znviuIvNda2+LWv2FnqEulyawumww6oI0ZIDskYD51Zdz/dUEck9c4rY1HWvE2m+Kte0iHWopo7Lw8t/aS3FkpYSBirNJtKhidhPG1Ru+7xym7K7/qyuxpXenl+LS/U6T/hF9X/AOh78Qf9+NP/APkWj/hF9X/6HvxB/wB+NP8A/kWua8KeItek1zwlHqmqm+i17Qnu54mt441ilQRHcm1QeQ5yCSM9MdK0fH2rataXUdto2qy2brYz3PkWNvHNcyOmNhPmqY1i65JKknaAetVNcm/n+F/8hR97by/H/hzU/wCEX1f/AKHvxB/340//AORabJ4b1SGJpJfHuvIiAszNDp4CgdSf9FrlrLxF4m1zXvC9qNYjsLXWfDrX0wtrNDIkwEeWVn3DrJwCuBg5zkEN8LeL9b8XW/h/TH1JtOurnTZr26vYIYzJMY5vKAVXVkGeWbj0Ax1olFp266/hf/JiUk1f0/G3+Zu6JaSeJNKTUtD+I2u3lnI7okyW9gFYqxU4zacjIPPQ9q0P+EX1f/oe/EH/AH40/wD+RayPg6si/DmNZnEkov70O4XAZvtMmTjtWO/ibXI9J1q01PVdU0rxFDYXN3Fby2UBhby8ENbyBCroMYKuWfD84wKU2o3+8qMW3bzt+J02oaPd6Tp89/qXxE1y1tLdC8s0sWnqqKO5P2Wk0zSLzWNLttR074geIJrS7iWaGT7NYLvRhkHBtARx61zdxr+tTXnh+OfU5JbXV/DFxc3Vs0MQUzJFGd4IQMCfMORnHTAFZ2ga7q/hHwX4GvI72TULC/0wRSaa8MY8spatKrxsq7v+WeCGLDnIxVNcqlfp/wDbL9CYvmSa6/5J/qd//wAIvq//AEPfiD/vxp//AMi0f8Ivq/8A0PfiD/vxp/8A8i1zL3Hi+XwNJ4ltvEwaK60V70xpaw5tZ9gkQQ/Icp1VhIWPcEUW+t67d694Vt31u4SDWvD0txcIkMI2TKkZEqEx5BzIeDleBxSaabXVf8H/ACYJp2a6/wDA/wAzo4/Depyrui8fa865K5WHTyMg4I/49exBFP8A+EX1f/oe/EH/AH40/wD+Ra848J3+t23w48Nw2viW+M9/a3N0Y4beGa7LKeAm6LYI9xJZpDnLABhmtfTPFHijXL3wNEdXisoNe0ia4u/Is0MglRFO5Wcso5cEDaQMHOc4A09f67/5MfT+v66nYf8ACL6v/wBD34g/78af/wDItH/CL6v/AND34g/78af/APItcLp3jnxJq2l6PpcH9oT6hcLfGa802O0E7/Z5xErBbgrEM5y2AT6AdRq6Zrvi3WNR0nw3rUj+H9Uk02e8vZ7ZYJZCUmWNAufMjGQdzDBxkAEUWf8AXz/yB6bnS/8ACL6v/wBD34g/78af/wDItH/CL6v/AND34g/78af/APItcboHi3xLqPinw/aX2oMsct1qWnXixQRiO4a2+5MuVLKTnkBtvy9OtJpvibxS3h2O6urrVL+0tNXvba+vNPtLd7oRRSFY8x7NpXAO7Ym7pil5h/w35/5HZ/8ACL6v/wBD34g/78af/wDItVzomobrYJ488RyrcnETxWljIn3S2Sy2hCjA6kgE4HUipdQvf7V+F1zfaZrEsnm6Y0sWo26KjP8AITuCkEKTjpjj2Ncf4W1DXNItfhrYR6w1zp+q2Z8+Ke3j8z5bXeqh1A+QHGBjdxyxppatPpb9f8hN6J+v4W/zOz/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWuYs/EfiTZqGnXEt9H4oFtPNb6bd2sKwTYKgNbSqAGUDs7FssN2BVS+8X6gNFspdM13VY7221qys7+01OwginVJXCssgEYUgg5Dx4HHBNCV2kutvxdvz3G9L/P8Nf8Ahjsv+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFrkNQ8Ya9o/iHxPp6XVxqIj1GwtrFPKt1eAXClmCk7FYjou89cZJ5z1Hge58USf2nb+KrW6jiimU2E961t9omiK8+YtuxQEMCMjGRjjOaS1V/66f5g9HYn/wCEX1f/AKHvxB/340//AORaP+EX1f8A6HvxB/340/8A+Ra6SigDm/8AhF9X/wCh78Qf9+NP/wDkWuPnjj0b4m6jbax8Sb7TZp9KsPJkun06KS4/fXY2ANb4IU/3RnLnJPygeqV5v4u0201jxZrmnajCJ7W6stDimjboym+ugRR1SA0tWij0Dyf7d+Kmoab5+fK+2PpkPmYxnbuthnGR09a0R4Y1ZlBXx5r5BGQRBp/P/krXErqF94c1PSvA/iWWS6ZdStpdG1CQZN3brIMo5/56xjg+owfWp77xb4ibwnqPjOx1Bli07UpbcaM0EZimhjn8o5bb5gkPUENjoNp7tJNXXf8Ay/zE7p2/rr/kdaPDepmVox4+14yKAzIIdPyAc4JH2Xvg/kaz7eH7X4gutDtfiVrc2p2kYluLZILAtEpxjd/ouATkcdaqeCoLxvih42luNXvp4oZ7ZFtpRFsAaEOOiBhtyQACBg8gnmsbxdrx0P4w3QS4exe+0S2tE1Dapjs2e4kAkfcCMDoMjBJAOAchLeK7/wCV0P7Lfb/NI7f/AIRfV/8Aoe/EH/fjT/8A5Fo/4RfV/wDoe/EH/fjT/wD5Frlby88V2/i7VtAHiuU29poIv4bkWEAnMm9h8x2lD9w9EHBxwRuMmi+KNZ8ZzaRp1vqMmjSz+HodVnubWGN3eSQ7Qq+YrLtGCSNueRgihaq6/rf/AORYPTf+tv8A5JHTf8Ivq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i1xWneK/EFyug6rrGszWVhcz3mlXqW0EIiE8XmLHOpeNmAYxt8u4jdt7ZBl8J694k1+yGmTa9c22t6dc3TXhntIDvjAUwCSNUGARJGflKk4cZ9Dv/X9d/QP6/r8jsP8AhF9X/wCh78Qf9+NP/wDkWj/hF9X/AOh78Qf9+NP/APkWuM8K+LPElzF4E1DVNW+1r4hM8N1ai2jjjUqjurqQNwYbMH5sEdgea9XptNCOb/4RfV/+h78Qf9+NP/8AkWj/AIRfV/8Aoe/EH/fjT/8A5FrpKKQzy7xDa/2D4+0SXXPiNqGnxSaXfhLy9Onw7SJbT92C1uFO7qcgn5Bggbs6dxdadZ2NteXfxfuYLW7BNtPLPpSpMAcHYxt8Njvisv4yDMF1xn/ilNX6/wDXWyqLxzceJJdA8Ppq+j6TbWn9tad+9ttUkncHzlx8jW6D/wAe496cVdpd2l94PRX8n+B2EXhzU54Ulh8fa9JHIoZHSHTyGB5BB+y8in/8Ivq//Q9+IP8Avxp//wAi1zd5quvaN4o1/Rr3xBdTPfWiTaCzW9uvlM7+WyjEXzFHaP72flYZHBNVVvvFz3/jCwfxXtfw/DBLazCwhXzSYmkImyCCDgA7dnTI29KTaS5un9X+4aTvy9Trv+EX1f8A6HvxB/340/8A+Rahu9Cv7Czmu734g65BbwIZJZZItPVUUDJJJteABXGt428Z+JYZpfC2l6gt1Z21rItvELPyJJJYUlZZjNIJAuGwDGBjBOT0Gt4e1DxXrXi/xBb3+tww2mk3MJFpBZJiSOSAuY2YknILL8wPJXpg4oknG/kKNnZ9zV0nTbnXdKg1LSfiHr1zZ3C7oplt7ABxnGRm1z2qe20DU7qNni8c+JVCuyHzbOyjOVODgNaAkccEcEcgkVwXw+1LWNJ8O/D2GHUy1nq6XFq9o1unlxlUkkSQHG/cCuD82CD0FamheMNf1PStG0y81NI9Q1TVr+zk1GG3RfLjt2k/1aMGUMQoA3bsc53VTjq0v61Fstf63/yN3R4D4g+2f2N8SdcvBZXBtrhooLAqkgAJXP2XBxkdM+laX/CL6v8A9D34g/78af8A/IteZWt/4j0G71ldN1mIST+NIbK6mms1Z5kkjhGeCFU464XnPG2uuhufE1/rmreHo/E0sFxodnDL9tWyhBu5JfMYeYrKRsAVQdm0k5OR0pP4VLyX5Jv8yvtW/rdr9CfxF8Lj4qt7eDW/G3ieWO3lE0Swy2sG1xyrfu7dckHkZ6HpWjF4e1M3D2ieOfE2+FFJZ7Sy2kHOMObTDHjkAkjjPUVydv471q60fR/EGtvfaPo93pyO11Y2sc8EVwSysZwys6x/cZSuBydzdK05Nd8VSa/400/Tp4757CG0l06GGBEZFk3lwCxIZ9o4LHaSBwOaGmrr1/y/ryFv+H4nQf8ACL6v/wBD34g/78af/wDItH/CL6v/AND34g/78af/APItHgvW49Z0+5Av766ntZhFPDqVqsFzbtsU7XVVVST97KjB3cZAp/jPULqw0i3FjqC2E1zdxweYsXmzMpPKwptYNJgcbgVHJPApPR/11BamPqdimgXNt/afxE1i0uNSnS3gBt9P33EhICqMWmT1/D2rV/4RfV/+h78Qf9+NP/8AkWuAutY1LWPCWlf21LJNcWfjSG0Ek8aJKyJPhS4j+TdjrtwPatLVPFfiCXw54j8VabqRt49Av54E0treMxXMcJAbzGKmQM3zEFWUDjg93HVX/q1ov/24Hvb+r3l/kdb/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i1yjaz4q1HU/GUcfiBdPXRYYLmzSKyj2gNE0myUvuLDoCQVPGRt6VSbxt4z8SwzS+FtL1BbqztrWRbeIWfkSSSwpKyzGaQSBcNgGMDGCcnoD/gfiHp/X9XO4/wCEX1f/AKHvxB/340//AORahi0DU5ppok8c+JQ0DBXL2dkikkA/KTaAMMHquRnI6gisrTNS8T+KbzULzS9Ui01tL1NbQ6bJEjxSxqqGQyPtL7juYqUZRwM5qpH4p16Ox8ZLe6xaRTabq0dpaXBtSBHG6xHaqKHZ5PnIUHdlscY4ot+V/wAv8w/4b8/8jpv+EX1f/oe/EH/fjT//AJFpkPhHUreIRweN9dijXoiW2ngD8Ba1U+H2s6pqM3iCy1i4ubk6ZqAgglvIYo52jaJHG8RAJn5jjABxjIzmuyoasBzf/CL6v/0PfiD/AL8af/8AItH/AAi+r/8AQ9+IP+/Gn/8AyLXSUUgOb/4RfV/+h78Qf9+NP/8AkWj/AIRfV/8Aoe/EH/fjT/8A5FrpKKAOb/4RfV/+h78Qf9+NP/8AkWj/AIRfV/8Aoe/EH/fjT/8A5FrpKKAOJ1n4by+IIIo9U8Z+IpPIk8yGWNbKKWF8Y3JIlsGU4JGQRwadY/DufT4Fjh8aeIpNrBvMuVsp5Cw6EySWzMSOxJ4rtKKAOb/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFrpKKAOb/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFrpKKAOb/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWukooA5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRa6SigDzvx94c1SD4beJZZfGmuXKR6TdM0MsNiEkAhYlW22wbB6HBB9CK9Erm/iP/AMks8V/9gW8/9EPXSUAFFFFAHN/Ef/klniv/ALAt5/6IepZfA/h+aUM1lII/MaV7dLqVYJXLbi0kIYRyEnnLKeai+I//ACSzxX/2Bbz/ANEPWD468eGwuNMtPD2prHcNrNtZ3f8AoTyI6vKFeNZiPLDgZyuSwHYdaa1kkt2HRmxffDXwvqdxqc99Z3Uz6sFF4G1K52y7WDJ8okwu0jjaBgZAwCRSTfDXw1cXc11NFqTzz2os5ZDrN5ueEfwE+byP5kk9SasxeL9B83WJ01z7VHp8qQXMMabxbyn5RGuxdzux425Y5wAB0q1L4q0iDTvts080aGQRLE1rKJmkKhwiw7fMLbTnaFz7cUug9f68ilY/D7w7p2oaZe2lveLPpUJgsi+pXLiGM9U2tIQR04IPAA7DF7VPC2j6zqMN9qNq0lzDE0AdJ5I90bdUYKwDr3w2Rnms5viR4RSG1eTW4Ua7na3hhdHWYyrgFDERvVhkZBAPI9az/FXxD0638GXV7oGqKt49g15bObGWYRrglWlUAeWCVKgybRn1xilJ6OTCKu7Ivw/Djw3b3FpPbwX8UllaGytmTVboeVCRgoMScDp78A9QMFv8NvC1pp9lZ2thPFHYSPJaul/cCWEv94LJv3hT3XO0+lNs/Gun6d4S0e98RXri4ubCG4neO2eTaGQFpHEakRpnPzHCj1qaT4ieE49UbTv7bgkukaJXSFWkCGU4TcVBABJHJPGRnGRVyTUmv63/AMyItOKl0NHQvDWj+GbKS00HT4bKCWRpZFjBy7nqxJ5J+tQ23hDRbS7a5S1kkkNv9mX7RcyzLHEQAURXYhAQBnaBnAzmptJ8SaZrbY02WaQMrOjPbSxrKoIBZGdQHX5hhlJBzwTWpUvzK2Oasvh34VsZ7GaLSUll0+NorR7maScwI3VVMjNgY4A6AZxjJqzpPg3QtEnEunWJRlQxxLJPJKsCHqkSuxEan+6gA4HFblFFwMPTPB2h6Qssen2jxwSAj7M1zK8EYOciOJmKR53HOwDrVew+HvhfTbqwubfSlefTUaOzkuJpJ2t1P8KmRjgDHA7c4xk10lFAHMW/w58LWhtTa6Y0JtN4hMd1MpVXOWjJD8xk/wAByvtTbf4b+GbSfT5rW2vYn0yFoLPZql0BAjfeVR5mOf6D0GOpooA5a3+G/hi00uPT7azuo4YbhrmF11G582GRvvMkvmb0z3AYA5OeprRvvCmkahb28VxBMrW27yZ4LqWGdN33v3qMH+bHPzc981sUUAYl14P0O7tLC3ksjGmnSmW1NvPJC8TEEEh0YMc5OcnnJzmq0Hw+8M2dtNBp+nNYLO7vK1jcy27uXYM2XjYNyVHGegx04rpKKAKkGlWNtpC6Xb2sUdisPkLbquECYxtx6YrCj+HPhmGbSpYbS6jfSBiy26jcgRcY6eZhuML82cqAvQYrqKKOtw6WMKLwXoUVz9oFrM8oiWGMy3c0nkoCp2xhnIjHyrnbjOBnNNk8D+H5tMvLGezkmivZFluJJrqV5ndTlD5pYuCpA24b5e2K36KAOcX4feFla+dtHhkm1BFS6nld3llC425kYlsgqpznORnrzWrpWkWmjWvkWXnsvd7m5kuJD6AvIzMQM8AnjtV6igAooooAK4e+8O6f4j+Jmrw6p9rMcOk6ZKgtr6a2+YT3pBJidScEAjOcHkV3Fc3Y/wDJU9d/7Aum/wDo++oA1rzRtP1AWf222WdrGVZ7Z5CS0brwGDZzn+eec1SfwfocmrNqLWj+c0gmeMXEggeQHIkaEN5ZcEA7iueBzxW3RR1uBm2/h7S7XXrrWbe12X94qrPKJGw+0YB2525xxuAzjjNZupfD/wAOavql9qGo2tzNcX9sbS5P9oXCpJCRjZsDhQOSeAMEk9ea6SigDk4Phl4YtpZZYodS8ya1+xu7azeMTB/zzyZeFHYDpk4qzH4B8PQ6XY2EFtdQw6ehjtXh1C4SaJCclBKHD7OnylscDjgV0dFAGVeeGNF1DRIdHu9OhfT4XjeO3AKqrIwZTx6EA+/fOaV/DmlNeajeLbGK61OFYLueGV45JEUEKAykFSAx5XB9+BWpRQBylr8NPC9kNKFta3iLo8hksF/tS6KwMeuAZMEHkYORgkdDiurooouwCiiigDiPF3h7TvFHj3RtM1qOaWzk0bUTJFFdSweYPOshhjGyll5+6Tg8ccCtXUvAmhavpdjp+opfzW1g4e3U6rdBgwOQxYSBmII4LEkdsU2+/wCSp6F/2BdS/wDR9jXSUAcvNoo1nxTpV1d6TNbxaA8ptrm6lR3nZkCAqQ7MVwSSXw2QvFc9Y+D31j4keKLvxJ4fvY9NvjB9mla+VYrhYk2MskcUuWVjyFdSMdQDxXpNFPrcOljGvPCWjX2qx6lLbSR3ccYi8y2uZYPMQdEcRsBIoyflYEcn1qGz8FaJYXWq3FnFeRS6uMXjjUbj5+MAr8/yEDgFcEDAGBW/RSA5KL4Y+FoIdNigtb6NNKZmsVTVrseQW67f3vuR9CR0qSD4b+F7fRzpcdjObX7T9rXff3DyRTZyZEkLl0YknJUjOTnrXU0UAchL8K/B80xmOlypO1wt080V9cRySSr912dXBYjqCScEkjkmtjVPC2kaxdpdXsEwnVBGZLe6lgaRM52OY2XenJ+Vsjk8Vr0UeQGLf+ENE1KNIrq0cwKqIbeO4kjhdEBCo8asFdRn7rAj2qCPwNoMWs3uqpb3QvL4obhzqFwVfYwZMKX2rtI4wBgZAwCRXQ0UeYHOjwha2UcCaK1xav8AbFup7lr6d5ZSMA7yWJlyo24kJAGCBwBWjrWgad4htYoNVheRYJlniaKZ4XikXoyuhDKeSOD3NaNFAHKXPw08LXUZjks7tY/thvtkOpXMai44/eALIMNwD7HnqTV+fwdodxqjX8tpIZXZXlQXMqwzOuMNJEG2SMMD5mUngc8CtyijYNzzax8HvrHxI8UXfiTw/ex6bfGD7NK18qxXCxJsZZI4pcsrHkK6kY6gHiuwvPCWjX2qx6lLbSR3ccYi8y2uZYPMQdEcRsBIoyflYEcn1rZoo2SXYN22Yr+ENEfWX1RbR4rqUATeRcSRRz4GB5kasEkwOPmBql/wrnwyU1JXs7lxqkyz3XmahcMXlUgq4Jk+RhgYZcEYA6AV09FAGHa+DtGsZLuSzju4JL2SOW4ePULhWldAArEh85woB/vfxZrcoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh66SgAooooA5v4j/8AJLPFf/YFvP8A0Q9cLdeGfF0XhO28N22gpdS6drkd/FfteRRw3MQuDNk8l1fnB+Q9yCeld18R/wDklniv/sC3n/oh6oaVaf27FJLonxP1PUo4m2SPZnTJQjehK2xwfamrpprpr9zDpYxbfw/qd/4g8ZDW/DF99g1W6tpbeSO+hRj5SKu9GWTcrBl3rnbwOcHiktNA8Xg6Pq+ord6gdG1GeW3sLqaD7ZJbPCYwHdWERlVixHzYKnls1t3Fp9k1aDS7r4oanDqFwMw2ch0xZpRzyqG2yeh6DtV//hF9X/6HvxB/340//wCRaE7LQHq9f6ucNqPhXX28UWuuW/h+6kF54gg1Oe2Se3BtIooPK+fMgBdixbCFhgdc9dbXdE8Q2+peMYrDSG1W28SWWIJ0uIk+zSLAY/LkDsDtPBBXdyTkDrXR/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItS0nHl6f8AAS/RFKTUub+t2/1OJg8EarHLYS69o1/fwz6Rb6ddWuka28H2dot4y/72FZUZX5HJU5ABBzWv4X0C/wBH8faky+HprXSP7HtbG1kNzFIhMO/KcyGTGHABZedpzjjOrqOkXekadPf6n8RNctbS3XfLNLFp6qg9SfstO0/Rb7VNNtr+w8f+IJbW6iWaGT7NYDcjDIODa5HB71bk5Nv+tb/8GxCiopL+tLf5IpeD9F1nRfEUlvbQ39l4bW1wtlqFzHOIpsggW7KzOIwNwIcjnG0Yrua5v/hF9X/6HvxB/wB+NP8A/kWsyzh/tDXL3R7H4k63Pf6eqtdQxwWBMO7OAx+y4zweM5pXvoHmdvRXN/8ACL6v/wBD34g/78af/wDItZ1pbNfa3e6RZ/EnW57+wVWuoEhsCYQ33d3+i4BOOnWkM7WiuabwzqqKWfx5r6qBkkwaeAB/4C0L4Z1V0DJ4819lYZBEOnkEf+AtAHS0VxMFu1z4guNEt/iTrcupWsQlntkhsC0SnGC3+i4Gcjg81pf8Ivq//Q9+IP8Avxp//wAi0eYeR0lFc3/wi+r/APQ9+IP+/Gn/APyLUF5od9p9lNeX3xC1y3toEMksskWnqqKBkkn7LwKAOrorkNK0u61vSrfUtL+IWv3FncpvhlFvYAOvrg2oNW/+EX1f/oe/EH/fjT//AJFo2A6Siub/AOEX1f8A6HvxB/340/8A+RaP+EX1f/oe/EH/AH40/wD+RaAOkorm/wDhF9X/AOh78Qf9+NP/APkWj/hF9X/6HvxB/wB+NP8A/kWgDpKK5v8A4RfV/wDoe/EH/fjT/wD5Fqu2iagotyvjzxHKty22N4bSxkU8E5LLaEKuB944HQZyRQB1lFc3/wAIvq//AEPfiD/vxp//AMi0f8Ivq/8A0PfiD/vxp/8A8i0AdJXN2P8AyVPXf+wLpv8A6PvqP+EX1f8A6HvxB/340/8A+Ra4+eOPRvibqNtrHxJvtNmn0qw8mS6fTopLj99djYA1vghT/dGcuck/KAAeqUVxOrRR6B5P9u/FTUNN8/PlfbH0yHzMYzt3WwzjI6etaI8Masygr4818gjIIg0/n/yVoA6WiuYHhvUzK0Y8fa8ZFAZkEOn5AOcEj7L3wfyNZ9vD9r8QXWh2vxK1ubU7SMS3FskFgWiU4xu/0XAJyOOtHWweZ29Fc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQAX3/ACVPQv8AsC6l/wCj7Gukry7xDa/2D4+0STXPiLqGnxSaZfhLy8Onw7SJbT92C1uFO7qcgn5Bggbs9UnhvU5IllTx9rzRsu4OIdPII9c/ZelAHT0Vxml2Z1yOSTRPifqeopE2yRrQ6bKEb0JW2OD7Vf8A+EX1f/oe/EH/AH40/wD+RaAOkorm/wDhF9X/AOh78Qf9+NP/APkWs5rZl8RJoJ+JOtnVXgNwLQQ2BcRg43H/AEXgZ9etAHa0Vzf/AAi+r/8AQ9+IP+/Gn/8AyLR/wi+r/wDQ9+IP+/Gn/wDyLQB0lFc3/wAIvq//AEPfiD/vxp//AMi0f8Ivq/8A0PfiD/vxp/8A8i0AdJRXF65av4a0mXU9d+JGt2VnFjfLLDp+MnoABa5JPoOauxeG9UmhSWPx54gKOoZT9n0/kH/t1oA6eiub/wCEX1f/AKHvxB/340//AORaP+EX1f8A6HvxB/340/8A+RaAOkorm/8AhF9X/wCh78Qf9+NP/wDkWj/hF9X/AOh78Qf9+NP/APkWgDpKK5v/AIRfV/8Aoe/EH/fjT/8A5Fo/4RfV/wDoe/EH/fjT/wD5FoA6SiuJvYDp2tWGk3nxJ1yLUNRLC1tvIsC8u1SzHAteAADycDtWl/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQB0lFc3/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLQAfEf/klniv8A7At5/wCiHrpK878feHNUg+G3iWWXxprlykek3TNDLDYhJAIWJVttsGwehwQfQivRKACiiigDm/iP/wAks8V/9gW8/wDRD1w8txD4C8dz+LJn8nR9XvZrDVnJ+SKRWJgmPp3Qn3Wu4+I//JLPFf8A2Bbz/wBEPUlr4H0G0sbuzFtcXFveSrNPFe309yrurbg3712wcgE4xnAznFC0lf8Arp+n4g9Y2/rr+pwOmWd3N8WJNVneay1LVvDdxcblCs9svnIIlAYFcqgXIII3FuOataJ4o8Q3dr8Nry51aRzrYkj1CEwQhJyIXcNwmVOVH3SB7V3D+DtGk8VL4jeO7OqKnliX+0LgIE/ueXv2beM7duCecZ5qpb/DjwnbyWrrpCSfYp2uLVZ5pJVtnJyfLV2IQZ52qAAeQKpNJJf1u/8AP8Aerb7/AOSX5o5C48e6t4f0vVG12a9h123t5Zk0+9tYxbP86KJIJYwN0aZyQzF8Nzir/i9vGHhrwT4g1SDxQ1wkFmtzaTm1g86OUH50wI9hiIxjILDn5u9dVH4L0BJpJJLE3PmWxtdl3PJOiQkAFESRiqAgDIUDOBnNLa+DtEtdJuNMW1lmsriJoXhurqWcCMjBRfMZii4A+VcDil0HpzeRyWtarqg8Va3pc2oyTadN4Ve9W2eKMCKXJQlWVQ2CBnBJ5J9gK3hTUtT1Sx8O+F9N1ObSEh8MW1891BDG8js2EVR5isu0bSTxk5GCK6h/hp4Tky0umSSTG1+yfaXvJ2nEPPyCUvvAwSOvTjpxU6+AvD8emWNjFb3UUWnoY7aSLULhJooz1QSiQSbOB8pbHA44FCsrr+vtf5r7idf6/wC3b/fZ/ecXb+N/EU+hadqurC+tdPt2uoNQvdItI5x5sMpjDvGwZhEQpY+WMg9SBVLU/EYsvipfx2mpNbHWNL063h1hI0MUBZpiJDuDL83RQRglgMjrXpV14R0W7sks3tZIrZIxCIra5lgVowSdjBGG5eTkHIOec1n3Xw18K3s99Lc2E7f2hbra3MYv7hY3iX7qBA+1QOwUDGTjqaE9f6/r/LzB+X9bf15+Rzev614wGq6honhf+1L+80m1hdJ0SwC3Mrhj/pHmMhCHAH7pVPXntVO88Q3uieLvFmtvaKt/F4c0+Q2+5WVJWeUYzkAgE9cgcde9d23gnQ2ks5fKu1ms4xDHOmoXCytGDkI7h90i5PRywoTwP4fTWbzVPscj3N9b/ZrgSXczxSRYwE8osU2gE4AXjJx1NF/1/r+th/8AA/T/ACPOvFN341Pgjxemqf2rZ6aNKa4tbu7axW48wZ3w4t2YGMgjBwGHI3dDU3ibX/EXhzRpm0zxDdXbaTptvcCJLSB2csxLfamMaqqbcBRGVcgMea9Bg8GaHBo91pf2aaeyuomhkhuruacCMjBRTI5KL7LgVTm+G3hW4jnjl06RkubYW06/bJwJkHTfh/mYdnOWHrTTS/r1F/X5f5GfZtu+PF4x6nw5Af8AyYes/wCJPiXWtIfUn0TVXhbTdM+2raWlskrMwZsm4MilViIXgKyucNjOK6y18G6NZ+JP7fgju/7S8gW5mfULhwYwMBSjOVI79OuT15pNX8FaBrt5cXWqWTSy3VsbScpcSxrNFz8rqrANjJwSMjPBFT0S7X/Nv9Sl8Tb62/BJP8jktQ1rxPd+MNU02DXVsLSPw8mpQfZrKMyRyFiMFpN4YZQ9hw2BgjdUej+KdZ8bQ29rDqJ0h49AttTnaCGNzcSTBvl+dSBGNhztwx3DDDHPUH4deHGvJrow6h589oLKRxq11loAMBP9bwPp3JPUmiL4c+GILawhhsJo10+IwW7LfTh1iJyYmffueP8A2GJX2odnFr+vtf5r7hLR3/r7P+T+8yvhzenTPgTo98IzKbXSfO8sfx7VJx+OKis9W8SWPhUeMbrVotT0+TRnv57AwIvlS7A6CEooJXqDvZj0IPauv0Tw9pPhvRo9K0Owhs7GMELDGODnqSTySe5OSar6T4R0XRC40y1eKJs4t2uZZIIs5z5cTMUjzk/dA605vmcmuu34/wBfII6KKfT8dv6+ZxN7rvivSY/D91HraXv/AAkVu4aOezjMdlL9naZXjCbWKfKQVdmPT5vWLwz4n8TXT+CZb3WRct4k0ud5o3tIxHDKkausihQGPXBG7B7ba7OHwJ4ft4ZoobW4RJYmhVRfT4gRuqw/P+5B6Yj29KqxfDLwvB/Z3k29/H/ZcbRWWzV7sfZ0bOQv73jIOPoAOgFDa1t/W/8AmhK9l/XY5Dw/4t8TNp/hHVNU1j7X/auq3NhdWyWsccbIpm2sMAsGHlgfewR1BPNO0zxn4zu4bPxLDpV/No08U011DObJYIowjFDCUkMxbIAIcHOTwvSusg+GPha1h0+GC1vlj024a6tE/tW6IilbqwBl+vX+8394507Hwloum6hPd2VrJE07tI8P2mUwb2+8whLeWrHnJCg8n1olrsPS/wDXd/8AAORA8U6j4Jk1w+Ji1nqGiPcyxxQxI1rKYw6eQwQ/LjIO8sehBFUNBv8AXNF0H4Z2tvrLzWWqqkVyk1vGZMG1LqquAAFXbjlSx7se/d6d4M0LSo5obGzdLeZWX7K1zK8EYYEERxMxSPIYg7AOtVP+FdeGgmlItpdIukNvsgmo3C+UcYB4k+Y7fl+bPy8dOKd1d9nb8L/5i1t56/p/kc9pt74ga41jw1e+Jr5tYi1SJba6FtahxaOu8MF8raflWUElfvLxjpVaw8T+M9Y1eDUNI0+/m05NUks7mKQ2S2ot0laNpA3mef5o25xjaeQF6E+gnQdMPiNdeNmn9qLbG1Fzk7vKLbtuOnXvjNV4/Cmjw61NqkNvLHczuJJVS5lWGR/77QhvLLcD5iueOtKLta/9bfnb72xvrb+v66ehsV5v4u0201jxZrmnajCJ7W6stDimjboym+ugRXpFcPfeHdP8R/EzV4dU+1mOHSdMlQW19NbfMJ70gkxOpOCARnODyKXVX8hp2OcXUL7w5qeleB/Essl0y6lbS6NqEgybu3WQZRz/AM9YxwfUYPrU994t8RN4T1HxnY6gyxadqUtuNGaCMxTQxz+Uctt8wSHqCGx0G09/RrzRtP1AWf222WdrGVZ7Z5CS0brwGDZzn+eec1SfwfocmrNqLWj+c0gmeMXEggeQHIkaEN5ZcEA7iueBzxTT79/8v8iWtbry/X/M5jwVBeN8UPG0txq99PFDPbIttKItgDQhx0QMNuSAAQMHkE81jeLteOh/GG6CXD2L32iW1omobVMdmz3EgEj7gRgdBkYJIBwDkek2/h7S7XXrrWbe12X94qrPKJGw+0YB2525xxuAzjjNZupfD/w5q+qX2oaja3M1xf2xtLk/2hcKkkJGNmwOFA5J4AwST15pdY+X+Vv6ZXSS7/5p/ocreXniu38XatoA8Vym3tNBF/DciwgE5k3sPmO0ofuHog4OOCNxk0XxRrPjObSNOt9Rk0aWfw9Dqs9zawxu7ySHaFXzFZdowSRtzyMEVvQfDLwxbSyyxQ6l5k1r9jd21m8YmD/nnky8KOwHTJxVmPwD4eh0uxsILa6hh09DHavDqFwk0SE5KCUOH2dPlLY4HHApq1tf6+L/ADX3C9P6+H/J/ecTp3ivxBcroOq6xrM1lYXM95pV6ltBCIhPF5ixzqXjZgGMbfLuI3be2QZfCeveJNfshpk2vXNtrenXN014Z7SA74wFMAkjVBgESRn5SpOHGfTv7zwxouoaJDo93p0L6fC8bx24BVVZGDKePQgH375zSv4c0przUbxbYxXWpwrBdzwyvHJIighQGUgqQGPK4PvwKT1v/X9a3+Qdv6/rT8Tzzwr4s8SXMXgTUNU1b7WviEzw3VqLaOONSqO6upA3BhswfmwR2B5r1euUtfhp4XshpQtrW8RdHkMlgv8Aal0VgY9cAyYIPIwcjBI6HFdXVNp7CCiiipGeefEW0g1DxFYWd3GJILjRb6ORD0ZTdaeCPyNZOhahd21hcfDCaaU6na3H2WOYsQx00jcJs+oT93ns+2uj8V6DYeI/iFodhqq3DW50jUHKwXUtuWInssZaNlJHfBOMgHsK6I+HNMLPJ5Mone0Fk10LiQTmEZIHm7t+ckndndnnNLv5/wBf8D0bD0/r+t/VI8s8F3t/onhHwHBpF49tZ3Wt3dlcWqxRskke+dhyVLAgoMYI6nOa1Itd8WNFr8MN5qOoxab4gNtLNZ21u13Fa+Qr/u0KBHIdhnKltucZOK6u3+HHhi10NdIgs7pbKO5F1Ep1G5LQygk743Mm5Dkk/KRnJz1qaHwF4atZLqWy037JPeOZJ7i1nkhmkYgjJkRg2cE9+5PWr5tW/wCun+T+8NOn9b/5r7jnbfxNd+KdUsNH8P8AiGW3iuNPnvv7RW1jEzMs3liLy5EKrsOQ+Vzx/DVbULrUdL+Inh+61wwXGoWvhu/kuDagiOR1aEnaDyAcV1s3gXw7NZ2VuLBoBYljbTW1zLBNGWOXxKjB/mPLZb5jyc09vBmht4gtdbNvcfb7SMxQyC9nCqh5YFN+w7jycg5PJyaXp5/iml+f4B6+X6f5fict4O1rxnqWt6ZeX1letouo2ZluJLs2SxwSlQyeR5MjSMh5GHyehyORV7xXqGpaL4wsJJteu7TRdRtbiAxxQwHyLlY96OpaMk5VZDgkjIHGOK6DSPCukaFM0ml28sIYkrCbqV4os5z5cbMUj6n7gFWtW0TTtdghh1a1S6jgnS5jVyflkQ5VuPQ0Ozat/X/DdPkJXV7nnfhLxRrl/o8batql4dR0Jb19YtjFbqZmRv3SMBH8oKnI2Feh5PWo9N8T+N2t01i4ieDSbrSpLiW61ZrNLa0m8vdG0fkSNIYjzkOGboc9RXpFrounWOpX+oWlpHFdaiUN3KM5lKrtXP0HFZkPgTw7BZ3Vmli7Wd0jJJaSXMrwqrAghI2YrHkE/cC0r7+n46/15WH1+f8AX9dTzTXNe1i78I+OtK1S9vL22j8PR3kEt7axwSZkEgbaqKpCZTgOocc5rYXxLq994I8QeItD12SyfSLR400m5tYnEDxJktINocM4GVG8qAQcN0HUXPwx8K3kMsVzZ3jrPbLaTH+1LoGaJSSqORJlwMn72eOOlNufhf4WvHmee2vy1xbLazldXu18+JQQqSYlG8YJHzZ605appf1uOOjTfT/gX/I5a58ba94bkW4v746qk/hZ9W8l4I41inj2D5doB2tv5DMcY4IHFXbLUviGG1Ly9OvpoJdOM1nLqRsVdbnI/dxiCQgoVORv5BHLHNdLB8PvDlvqVrfLbXTz2lqbOIzajcSqISMGMo0hVlPoQeg9BVqw8H6Lplm9raQXAgbG2OS8mkEQBB2x7nPlrkD5VwOBxTbT28/zdvuTX3Exukk/L8l/k/vOOPibV7vQSNHu9euJ7O6jj1WGSwt01K0jKMcrGUEcmW28qrAru25Ndr4d1e21fw3FqNpqH22F/MInli8ojDEFXXA2lcbTwOQahj8GaLFHMscV0sk7l5LkX8/nsSpX/Xb/ADOASAN3HbFaOn6RYaVpS6bYWyxWihh5eSc7iSxJPLEkkknJJJJpPVMFujzHSvFXiefWoIE1r7Umo6PdXaTy2KfZUmiZAptwBHI8eH6vndwQxFJovjXxBa2nhDVNW1JtRi1rR7m5urUW8caq8UQkDIVXdk8ggkg9QBXYL8NPC0ccCRWd1ELaKSGExalco0cb43RqRICE4GFHA7AU60+G/hiym0qW3tLwNo6FLENqdyywqeqhTIQQQcEEHIwOgAoe1l/Xxf5r7h9b/wBdP8mcY0uqaj4k+Gut6lqxu11K4luPsqwosVuWtHYLGQoYgA4O8sSeeOldl4m1W+/4SjRPDmn3raadTS4lkvY0R5FEQU7EDhl3EtnJU8KeOch0Hw28J29xayppCv8AY5zcWsUs8kkVs57xxsxVBnnCgDODitXW/D2meIYYY9Vt2kNvJ5sEsUzwywv03JIhDKcccEcU5NPYFfr2OI1W58cWOt+FdFuPENnC+pNdQXFxbWKs7bI3aOT5/lBxsJULjcDyRxVV/EviOy8UaZG2uNqMD6yul3CwWUa2m3yzkliofztwJIRmReh5FdrN4J0O41PTdRmhu2u9MObWT+0LgbSepYB8OSOCWyWHByKik+H/AIblu3uGsZVke8F/8l5MipOOfMVQ4CE552gbu+aS3T/rf/K4nqn6fo/+AcJd+KvFlrofiLVZdcjaTR/ESWUUMdjGsUsLNEpVgct/y0JBDA57kcB3irxV4r8Pv4stLHW1mbTI7G5gnu7ONnRZ3ZGjAQIuAQCCwY9Qc9R1z/C3wpLZ3dpJa37QXtyt3cIdXu/3sw6Of3vXOD+C+gxhfEb4fRXHh3VZvDWkahqWtaosFvLnU3KtGjq3zCaYJgBSBgE5b3JoTskn5fkv1TK3b/rr/kT6pqnizSfEWo6Npt5JrMk+mfb7bfFCktuwlVHRcBVIKsSm/PK4JIrofBetx6zp9yBf311PazCKeHUrVYLm3bYp2uqqqkn72VGDu4yBUml+FNIhs3lGn3MM94InnNzdvLOhQ7lQyb2ICt0VW2jnFWLPwrpWn2zQ2aXUe+4W5ll+3TmWaRcYMkpfe4wANrEjAxjHFPRaP+tf8vvJ31/rb/M2KKKKkYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9dJQAUUUUAc38R/wDklniv/sC3n/oh65i2+JQn8K+I9T8T6Nq9nYWWoS2YNoVLgKdm0NDJuVgQSXJVRuGGNdP8R/8Aklniv/sC3n/oh65XUvAXiV/BHifw/YPpUn9r6lNdQSzXEkexJHDndiNuQRjAyDnOR0oXxa9v1X6XHpZev4Wf/AOz/wCEnibWptNtNPvrs2pjW5nhCFIWfBVWBcOflYMSFIAzk1Wj8Zxz6fd39ro2p3FpbiUpNGIdtx5eQ2zMgI5BA3hc44rG1jwfq+r6xp+pxWumaXqcUkJl1OzvZRMkSbS0RURgTqTvX5yoAIOM8UW/gW8TxVNqEMVlpFtc28yXyWFzIy38ki43NCVCIVPO8FmPQ4pSvy6b6/8AA/r89xLpfy/4Jo2nxD027utAjFjfww69ZNe2tzKsYjVVTeyvhywYKR2I569asaZ44sNS1u20w2l9ZvfW5ubCW6jVUvY1xuZMMSMBgcOFODnFcjafDrxJLb+FbPULrSoLbQbOexlMJkle4ieNY9wyECMVB4+YA45bOBs+C/Aq+HJrf7R4e8M281nH5ceqafbhbi5G3bll8tfLJ4Jw7Z56Vo+Xmdtun4/8D8SdbL+v66m34g8QxWM39lW0N/dahcW7yiPT1jMkEY+UykyEKME8A5JI4VsEVxvw98YQ3Hh3wbaa5Pq13qup/aZIbljIEYqZc+a2QrfKOEOcfKQBgEdLqugazD44j8ReH2spvPshY3lteyvGAiuWWRGVW+YFmypABz1FcroXgHxfoz+D45ZNEu4dBmuJJXWaaFmWYMpVRsYMV3E5JXPAwPvGI/1+P/A/rapLt/Wn+eh2lj4zsrzTZdTe0vLXS44ZJ1v5wnlSRpjLja5YZycBgpODxVIfEbTorjydS03VdPeW2e7tBNbBzexqMsY1jZjuAIOxgrYOcdaw5fhndahdapE4tNE0/U9Plt7uHTLmR0up5AP3xhZVSMqQ3ILFgeSKvXPhfxFqkljdalDpS3OjW08VikN3JtuZJI/L3yExZjG3PygPyevHI9tO3+f/AAPv+56Xt/XT/g/1vasPiZpmo6TBqEGmausV4sRsFktlVr1pN2Ei+bBYbCTkgAc5xzWN4Q8V3MOqeLn1d9VnaPVYrezsLnyzOjPCreSoU+WOSeQcYGSx5NTWfgfX7XwP4Tto5dPj1vwy6tGvnSPbXAEbRkFtgZdysTnadp9aoXvwz1zV73WNQ1X+wpmutSg1K306aJ54GdIRE0crMoypXcAQmQcN/s1bUVJ22/4K/S/+XdK7Sv8A07P8Nv623n+KuiwvbwTWOrJfTX39ntZ/Zdzwz4BCOykoMggghjkZI4Bxo6d40j1O58m20TVg0axfahJFGrWjSY2pIhfdnDbiVDKBnmubvvA2q50BtB0Dwzo6WWqJqF3bWc7RISisgCstuN5IcnJVcbQOc5Gl4l8HX+r+JrXU9NhsbC6iuIz/AGtDcyx3AgXaTE0artmDHeMMwABBwTUq3Xv+i/W/9br07fq/0sdvRRRSGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc3Y/8AJU9d/wCwLpv/AKPvq6Subsf+Sp67/wBgXTf/AEffUAdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN33/ACVPQv8AsC6l/wCj7Gukrm77/kqehf8AYF1L/wBH2NdJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/8AsC3n/oh66Sub+I//ACSzxX/2Bbz/ANEPXSUAFFFFAHN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzdj/wAlT13/ALAum/8Ao++rpK5ux/5Knrv/AGBdN/8AR99QB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcf4j1Wy0Tx/pWpapcLb2lvoepPJIwJwPPsew5J7ADk1YPjq2tZIG1nSNU0iyuZFigvr2OMQuzcKDtdmjz28xV5IHXiuM+M+k3+q6/4ebTLaS7ksLW5vpLWIZaeOK6sWZQO5xyB3xV34heIdK8a+A73w54Wu4dV1fUvLgS0gYNJbHeCXmUcxBcEndjkY60L9dv6/rQf9XPTqK8lvPDdh4d8aXeippdvLF4ysUhaUWwI86P/AFxY4x8yMZOerIe5rM1vQ1u/FWpaPc6zpHhya2mh/sHzdNZ7mOBI0wLRxMgxuDBkVST3yCKaV2v68mT6nttYF34oa18e6f4abTpSL60luUvTIoT92QCgXlifmHJwOeM848r0uys7w/EW98NT/wBo6/pl3JLprpeNNLE7WoUlQWPVi4wcjKgfwjDra68PJ468O3PgNI5LqfRr5HNtEzsbrbHjzyAdsmfvM+D0yelLs/K/4Nj/AK/FHuNFeLaLDYyP4Pn8PTJH4ljZR4kMTf6QI/IbzTdDrneBt385+7VRbm70nR9U0Tw/FpuoXUFms761pCOZTEZY/NF1EpDee0fzff3NtbG2qa1a/r/hvP1De39f0/I90orz34a6ZaW1/qN/oviDSdR068jj/wBE0SyNva28i5y2PNkw7AjcODxkiuU8SS+FpfiF49i1e/tJQuhQv5V1e7ljmHmfdVmwrKfLwAAQWBGC3MS937rjiub71+J7bRXz4/iLQdP/AOEa1BNQX7VqXhS5/tB9PuV+13UuyMKC2SWkDCQLuyQVYDoRWv4S0Tw/4g1/XvD8sekvpeq6JaTpbWB3RF90itKG4EkgIXMgVTnGRkVcotNrtf8ABv8AyJTTSb8vxt/me2VgT+KDB4+tPDLafKPtVlJdpeGRdh2MqlQoy2fmHJwPTPbkvhzZwapLZrqOlwRXvhCF9KD/AGdVxPnDMnAwDGqNxx+9NS+INWtIvjpodrHe2y339i3iRwvKobzGaIouM9TtYgd8Gk7KS67/AJNr79GPWzv5fmrno9FeFeG7Y+VHrlx4gtl1ixsJxrOmaXpzR6lOxiOROzTNllYZRygGcbeCBVfRbo2dxrB8FSWKXV94U8+zi06TeZrhXYF2bgTTjPzMFBzwaGrO39dX+g/6/FL9T1678UNa+PdP8NNp0pF9aS3KXpkUJ+7IBQLyxPzDk4HPGecaV1q9naarY6bNJ/pV8X8mMdSEXczfQcD6kV5NoVz4UX4o+EbjwoqMtxpt3HdNaxM7ed+6/wBfgEiTruZ8Hpk9K3PG+n6Ufi74NvNTsLSXdDeRrLPbq+6VVRolyQcsDuKjqOSKGrW+f4X/AMiU73+X6HpVFeI2EMVzpuhSWrRx/EWLVEOohWH2sRmY+cJf4jD5ecZ+XG3b2rq/i2lokfha6vppIoY9et0lIndEMZyW3qDgj5QckHHPTmjt5u35a+mo+/km/wA/8j0OivnvxUNBtrXUZtLvobPw1JremnTxb3Rgtnk3j7S0QVgrIFwSRlQQxGCCa3fFXh+wh8SNoct/o+h6FPZK2lSanavPGtw8kjSNA/noI5QWUjqcY24AIotpf+tk/wBQ0v8A13sez0V4HMvh2PxD4us/EWtW+pTQ+GbbfJfXBXdcKHBcRs58t8+WcDlSwxgty6y8QaHY6h4U1CK/jN3qHha5bUGsrhTdXcoSPaCcktIGWQLuyQVIHQijv/X83/yP4hre39dP8z3S8vLfT7Ga8vJVht4IzJLI5wFUDJJpLG7j1DT7e8gDCK4iWVAwwcMMjP518/w2+k3Nn4htdOj02W31HwebiK2sz5onnRm+dmwBLODjc4UEGug06HwvpXiDwHqcNvptlpl5o1xZSzpCkcU8rLGwjJAAYsTJgc5Jbqc0Jb/1/N+qF2/r+V/r+B7PRXzf4cj8N3d94K0m/fyFbUtUgksLiSS3RoXMvlARMVUht4UEDk/LnIwOitdFNz4qks7rXtN0fWNN1TdZQPYSSag9ojDy44pWnG+JowAQEIB3Z5BNNK7Q5aX8v+D/AJfke3UVxXxRlvIvDtk0MsMNh9ujGpS3Fu08SW+GyZI1dCybtm75gMZzxmvO7rSdM0V/Dd3N4itNR0afxBuX7AHt9Pt4mgctGqCV0KbkBOThckcAkVK1/L8v8wei+Tf3X/y/E90uWuEhzZxRSyblG2WUxrtyNxyFbkDJAxyeMjqJa8A1+TR9N0W9uLG9isvDv/CTWEmjqlwYrdhmM3BiUEK8Wdx6FQQxHrVjUk8OPefEK1u5hcam10kuiq87TXHntbK6G2LEtu3tn5OgPZafS/8AX2f8x9bf11/yPV9O8UNf+ONW8Ovp0tsdOt4ZxcPKpE6yFgCqrnAGw9SD7Dv0FeDeIbnRLnXvGcXia+0+W9tvCtqrrLOvy3SiQkhc/fDsmD1BYYxnnRzY6Q3hnx7p1lbX8ut6YumXs0UYcyXLxjynJAPJdTGx/wBoZ6U7dF/w+9vvt+JN/wAfwslf8/wPaKK8d8SaPpXgaWzksrfRtQis7KO0Gi3CeVcMzFiz2bD/AJavltygZbA5GKrrYz6z40uf7T1/TdI1+11YzW0MmnM2oSWwfKJFJ54DRMnBCoQDuzyCaLJuy/r+r3B6K/8AX9dD2onAPGfasDwh4oPivTbu6bT5dPa1vZrNoJpFdg0ZwSSuR1z0J+teVpqGlL8Q9J1WCS3tJh4jubW8muZc3pUxy4SVsKEiJUbIzuyNpB6iux+EGqWGpaZ4i/s+9t7rGv3kh8mUPhXkJRuOxHIPelFX18v8v0Y5aaef/wAl+qPQqwPCvic+Jv7W36dLYPpuoPYtHLIrsxVVO75cgZ3dMn+lcTpNvoWpeKNQTxXdG08WWmsvNaPv2XT2ytmJYepaEpwyqMH5s881g2ms219Hr4sL6C60seMhLqxgmDBbIoo3ttP+rLqAT0wGzwDRHX5r83H/ADY5aX8n+j/O2h7nRXj8ek2N2PE9v4Z1KysfCVyLNrR0US2BuQ5MqBVIUxMAiuFIX5j3zWdDqOlyap4S1250zStKttP1qezl1CykDWUiNalVaKQgARE7Vx0DDHJppXZL0/r5nuNFfN6SeHIb+xsXl/s6EeOJvLtmaS1he2IOcIdqMoZVB4O3IHG7B6LX/DtufEl94cn1jSvDkEMcCeH2vbKSaaOMIMm0lM6gOH3AqAW+7nIIFStUn3/yT/X8xvSTXb/Nr9LntVw062srWkccs4UmNJZCis2OAWAJA98H6GnruKDeAGxyAcgH61wfxaeCL4L6ydSvGicWXySGYwGSbHyjgjJJ/g5B6YNcNeXvg/VfG+ste6rp99Zv4TjcpPfiWESgnopYqGACHAAwcHqclN2v5f5N/oNK6X9dUv1PUviP/wAks8V/9gW8/wDRD10leZRakNX/AGXbm8+1rdyP4WmWWUOGzILZgwJHcEEH3r02rnHlk49iYu6TCiiipGc38R/+SWeK/wDsC3n/AKIeukrm/iP/AMks8V/9gW8/9EPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN2P/JU9d/7Aum/+j76ukrm7H/kqeu/9gXTf/R99QB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc3ff8lT0L/sC6l/6Psa6SuF8Ya9H4f8AiF4enaFria406+tbaBWC+bK9xYhRk8AdST2APXpWH441DUtQstGk1fRbjT7/AE/xLZRLHDeM9vcqzghkYhBIOg+ZRtIP1oWrS80vvaX6g9E35X/P/I9WorzzWfiCYfCfiWTWPDCXkmi3ItLyxS5SWGRHRWVyzquVIcZG0kHsaig1Gz8PfFLxhql7LMlnb6JaXcwaRpAmDLnaCTjhRwMDP1p26/1tcP6/Gx6RRXkt/q+rJ8VdF1e+0KWJzot7NDaQaj5pmVfLKgq+xI5BuOcZHI+Zsca0HxVb/hGrDWdU0m20m31ZIjp0l9qkccUjsrswkfb+7ChM5w2dwwM8UW0v/W7X6B1/rsn+p6JRXm2nfF9NWk0yDTdF+1zXuoy6bLLb38b28UyRl8rJ1kUqMhgo4z3+U9Z4S8SP4l067luLNbK7sr2WyuYEm81VkjOCVfau4EEEHA69KLP+v680D0/r1/yZu0VzfjHxZN4Uj0xodIm1EahfRWe6OZI1iZ2Cgtk5PU9AenJFc3rvxbTw5HJHq1jp1pqNnAtxe2FxrMaSbSWwsHy/vn2rux8n3gM54pdL/IdtbHpFQXyXcllIumzwW90R+7luITKin3QMpP8A30K5jS/HX9u69PY6Pa2ssUKQufOvvKuHWRVcSLDsOYwrfe3ZJUjHesxPiVfHw/Z6pJoMC+Zrn9j3MS6gT5Ted5XmIfKG8Z5wQvFPlbdv67fqK6tf+tr/AJHZ6Tpo0y2kVpPOnnlaeebbt3ux547ADAAycADk9avV4rfatqvhjS/iDPoGJJV8QQQ77q6k3RrLHCDtYhjnL8DgKDx0ArsLjxpLY+ItVt73wtnU9M0Zb15be5jczxluUjdgp2hg3LbT8v3eRSbVk/L9L/kFnd/11t+Z3VFcVoPxAm1TUdHg1DRxYRazpZ1G1dbrzWAUIXR1CgDhwQQTkdQDxUel/Eaa/vNFEmgSiz8Qbm02eC6R3KqMs0yPs2fL82FMhIB78VXK07f11X6MV1a53NFcz4l16HTPE3hvT7jRftv9oXbpDdsybbWRYnbIB+bcVDDIAGCeexw7T4oXVxBFeT+HHs7H+2v7Hnaa9UyxSFwisERWVhuOD8wx1G6kld2X9bL9RvRX/rr/AJM9CrmPGfhfUfEzaQdP1W208abfJfYmsmn810+6OJEwOTnqTxyMcyeNfFcnhDS7W9j0mbUhPdxWpEUqRiMyOFBO45PJxgA++BzXPa78Vf8AhHQ9vq1jptlqdvCbm4srvWo4i0W9wvksV/euwTcFwuMgEg0vPs/xWo7Pbv8AroeiDpz1orzHxV4yHirwLraeGrCS7tItJFzc3P2xrZ4vMiMiKm0Es4G1mBKjBxk5Iq14W8WX8FtYeH4NKt5Hh8M2+o20z3pUTfKqbHHlnZznkbuMcdqNm0+n/Bf6E9rdf+Av1PRKK4LTfiPea9pOny6DoKXWo3OmjUp7SS98tYYySqqJPLJZ2KnA2gcHJHGa/iD4v2GhQ7pLa2hnhs4ry6sdS1BLS5VXBPlxxkEySgDlflHIG7JxTatv/X9WGtf6/ruei0V5V8QfFjeJfh74lj8P2LXNhaWG+5vftrW7xu0QlUIqjL4DIWBZRg4+bkVv+L4Vn+B+ohnlQpopkVopWjYMsW4cqQcZA46HocipleMW30HFc0opdf8Agf5nbUVwHh/xsdMtrLTddsFsbeLw+mpQ3K3IkLxRqokDptARhkEYZgQeo6VTtvjBY3815aR2VnqMg0+S+gh03VIroyRrjckv3VjcA525YEA4JPFVNcrfz/C/+TJg+ZJ97fjb/NHpdcx4r8L6h4g1TQrux1W2sU0i8+1+XNZNMZm2lcZEibRtZux5x6YOda+NHOm+H7Tw7oEDT3+kjUUs2ufIhtoFCfIrCM5b5wANoHHJWuafxE/iPx94K8RaJpl2rahYX3lW17dqiMFVdrEI0ioMswyFL+o44bTjL0/S/wCqBax9f1/4DPXa5jw14X1HRPEmv6nearbXkesXCz+RFZNCYSqhANxkbcNqjPA5546Vy7+Ptd1nUvBb6Np9rBDqV1dR3dvNesCJIVkV03LGcqCCwOPmIUYXrXp9KzWvyDyCsq60q7v9WilvLuBtOt5EmhtUtyHMig4LyFyGAJ3ABVIIHJrVopD8gooooAKKKKACiiigAooooAKKKKACiiigDm/iP/ySzxX/ANgW8/8ARD10lc38R/8Aklniv/sC3n/oh66SgAooooA5v4j/APJLPFf/AGBbz/0Q9dJXN/Ef/klniv8A7At5/wCiHrhWuvAUUWqT3PwjENto83k6hOdJ091tiFVySqSlmAVgSVVuKAPXqK5W08B+Ab+ygu7Pwj4elt7iNZIpF0uHDKwyD930NTf8K48Ef9Cb4f8A/BXB/wDE0PTRiTuro6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaBnSUVwfizwv4J8L+FNQ1tfh/ol+LGEzNBFp1shKjqcsuMAc9zxwCeK0bHwD4IvdPt7r/hCvD6efEsm3+zIDtyAcZ2e9AHV0Vzf/AArjwR/0Jvh//wAFcH/xNUIvCHw9udYvdKtfCHh6S8soY5ZU/syABfM3bQTtOD8hPToRQB2dFctb/Drwc1tE134J8NxTlAZEi06F1VscgMYwSM98DPoKl/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImqOq+EPh3o1vDLf+EvD6Ce4itoh/ZcGXkkcKoA2+p/IGgDsqK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImszxF4P8E6B4bv9WXwDol79jgaYwRabbKzhRk8sAOBk/hxk8Um0ldjSbdkdvRXmup6R4J074bHxavw50S5C2KXrWkVhbAqpUMfmZQMAHrjPHAJ4rfsfAPgi90+3uv+EK8Pp58Sybf7MgO3IBxnZ71TTTafQlNNJrqdXRXN/wDCuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNIZ0lFc3/wrjwR/wBCb4f/APBXB/8AE1Rj8H/DyXXJtIj8JeH2vIIFnlQaXB8isSFz8vU7T+VAHZVzdj/yVPXf+wLpv/o++o/4Vx4I/wChN8P/APgrg/8Aia8/8R6f4I8H+NdXuNQ8AWd7pUOlae7mz0y1dLVnnukLmNipJbCglFY4QZ6CgNz2SivOdU0nwDY6bpuoad8O9M1u01JkWCbTtOsiuXxsz5jJwc9RnGOcV0I+HPggqCfBmgAkdDpcHH/jtOzFdHS0Vxtr4P8Ah5e6re6fbeEvD8k9iI/tAGlwYQuCQv3euBn8RWZa6D4KuPH974Yf4d6JAbWyS8W6ewtisys235VCkgZBHzYPHTHNLrYfS/8AXY9Form/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDF8b+HU8TePfD9r9qksri302+ura5jUMYZY7ixKtg8EdiO4Jq34g8I+IfENhpkd14i0+Oexvor1mTSW8uRo23IAvn5X/ayxzxjbznlfG+i+CvCHifTtQn8CafeadDo+oT3VvZaba8BJbTEpVyobaGYDGWG84HJrrNI8E+C9V0qC9k+H2kWBmXcLe60u18xR2J2bl5HPXvzg8U1daro7/P+kD8/wCv6uZOp/DPWtTs/FVs3iWyjXxHcRyyEaSxMARQoUfv+SQi8nvnjni2fh3fahrGs3PiHWbS8tdZ0xNOuLe109oCqoGw6uZnwcux5B7enOx/wrjwR/0Jvh//AMFcH/xNH/CuPBH/AEJvh/8A8FcH/wATS6W/rawf1+phTfD3X7q+069uPF8bXWm2c9nA66WoEqSBRmUGQ7j8vJUpnjG3nNyy8AXVn4M0HSk1lF1LQCDZahHaELwpTDxGQ7gUYg/MM9RitH/hXHgj/oTfD/8A4K4P/iayvE/hTwR4b8MX+sjwBol8LGFpmgh022VmVeScsAOBk+vHAJ4ocrK7/rd/qwUbtJf10LGreEdc1fVNAv59fsll0m6N06DTG2SsUMZCjzsoNrN1LHJznAxUGh+HvEHhL7SI9Ts9TbVNXa8mRdMeLash/eAN5zBQMAgnPQjBJGLWl+BfBGpaRZ33/CE+H4/tMCTbP7MgO3coOM7OetWv+FceCP8AoTfD/wD4K4P/AImq1i7f10/yEmpJP+uv+bE8aeGL/wATw6ZHYapb6eLG+ivT51m0/mNGcqvEiYGc5659qfc+HNQi8TS6xoWrRWbXiRx30FxaGdJdmQrJiRSj4JGfmHTjim/8K48Ef9Cb4f8A/BXB/wDE0f8ACuPBH/Qm+H//AAVwf/E1K0/r+uw9ytrPgmXXNX0y6vdQgMenXSXMUosgLsbcEIs4b5VJB3DYdwOOKyrv4YXdzZ3OnxeI2tdPfWBq8Cw2SmaKTzPMKl2ZlYb+R8gx0O4Vvf8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TTTa2/rb/JB/X5/5swJ/hnqF7Y+Jra98QQP/AG5eRXqPFpxQ28kZTbnMp3riNcj5e/IzgT6j4E1698RajqsfiSxRr/Sv7MKSaSzbEySWyJ1ycs2OMYwOcZOx/wAK58Djr4N8P/8Agrg/+JqjpHg/4ea5p/23TfCPh+W382SJXGlwYYo5RiPl5GVODStdW/ra35Du1r/W9/zM+08D6tod1oGpza5b3UPhvS5LMW8GlOJLlCoyQfOOGxGmBg859QBgeArS3h1DT73Tdc0TWrxWCz2MUM5uLISH96cNcMluRyWxCgYrtwMiu9/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiarmfNd/1u399ybK1l/XYj8VeF9S17WtCv9P1a1sV0e5a5Ec1i0/msUZMZEqYG1j2POD7Vzh+GGuHQ30//hJ7Dc+t/wBsmX+yH/1nmCTZj7R93cPXOOPetiHwh8PLnWrzSrfwj4fe7s4o5ZlGlwYQSbtoJ29fkJ+mPWrVr8OvB72sbXvgjw3FcFR5kcWnwyKp7gMY1JHvgfSkrrVf1s/0Q3ro/wCtH+jZJ428MX3ivR7Wxs9Tt9PMN3DdPJLZtPvMTh1AAkTA3KM8nj060698N6gPEg1zRNVhsrqaBLe9juLQzxXCIWKkKJFKMNzYOSMHkGk/4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJpbAZmp+AL24u9Yk0rX/skOu2n2fUY57MTF3EZjEqEOuxsYBBDA46DrRa/D680+60u4sPEDebaaWdKnkuLNHaaHIKldpUIy4wCQwI6gnmrtx8OvCCohtPBHhqVi6hhLp8KAJn5iCI2yQMkDjJ4yOtTf8ACuPBH/Qm+H//AAVwf/E0W0/rz/zYX/r7v8kYehfDS+8Lx6XLoXiQ/bbOz+wzSXtiJYriEMWVdiOhUqScNuPBOc1tyeGdTt/EL6to2tR28l3HHHfxXVn5yTbM4ZArpsbBIz8wwBkHFc3rGgeFrfXJdJ0D4a+HdWvLa3jurmN7a3tyI3ZlAQmMhn+RjglRx96ukHw58EFQT4M8Pg46f2XBx/47Tu3qFrOxk6v8Obu8XX7fTNf+x2XiGApfRTWYmbzfLEfmowddpIA3AhgccbetbGq+GLu++Hc3hmDVsTTWf2Nr65thISpXax2IUGcZx0A4696F/wCD/h5ptxYwXfhLw+s1/P5Fun9lwZdtpY/w9AFJNZPi7QPCXhHw1qOszfDjw/ew2jL5aQWluGZDgFn3RjbhjjC7zjB9gt1y/L+vvGrqSa3/AK/yLQ+HF9c6rYT6trVpc2dvo0mjzW0WnPEZonA3MH847T8q9j39cjSXwz4hPhe60a48SW04a3a2t7h9NIdUI25lAlxI23uuwZ5IPSmyeAvBcBaa48GeGYrFIPMedrCEMpHJBXy8bcc7t34d6TS/BPgDV9JtNSs/B2gm3u4VmiLaVACVYZHG30NOV5Jp/wBXb/4Iou1rdNvw/wCAcVrujx6XJ4e8P654q03Tf7J00xR6heW89pFc5IQKjx3MZ3bE+ZfMIOQdvp0OmeE9Xu9U0LV7bUNLsbfRIZ7S1t4dJkWOZHwu8Az5RflXA56E5IYY3/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+Jou3q/6/q4rdjA0f4ZahpcOjeZ4ihluNJ1C6u0lj07YHW4Db02mVsEFyQ3IHAKnrXd2qXiPP9snglVpCYBFCYyiYGFYlm3NnPI2j2rD/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaLsZ0lFc3/wrjwR/wBCb4f/APBXB/8AE0f8K48Ef9Cb4f8A/BXB/wDE0gOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAD4j/8AJLPFf/YFvP8A0Q9dJXnfj7wD4Ps/ht4lurPwnocFxDpN1JFLFpsKvGwhYhlIXIIIyCK9EoAKKKKAOb+I/wDySzxX/wBgW8/9EPXlTyL4kv8AxtJ4f10arZrqwmvdBs7iLGoWggiWRkdR5mc5HDbTt245zXqvxH/5JZ4r/wCwLef+iHreur21sY0e9uYbdHdY0aWQIGdjhVGepJOAO9C0d/l+Kf6D6f15nkfiPXtC8RLoH9latoUfhD7LLBK2o2huLSCf935UcqCWPy2C7tu88Htkg1nW+maHoHjLQ7XxlrkOraa2hXSPdakzJbSgTp5Y2SOygBTgHPzYU8nFe3R3VvLcTQRTxvNBjzY1cFo8jI3DqMjpmudufC+oT/Eiz8TpqtultbWb2f2I2TF2VyrMfN8wAHcq4+Tpkc9apNcy7a/in/mLp935o8pgs9Nl1fwHp3iS6bZc3OoRQ2V7duhayYSrbho2buGCgkbjkLk9K0dZsNOjs/FdhqwSHxJbzMvhhXkJuhEsKCD7MSdxG4Hdt753V7ZTJpo7eF5Z5FijQbmd2AVR6knpSv8A1+N/Xz82Prf+vT08vJHhXi2S0n0fxpbePPJPiKLTwdJE4+Yx/Zl3G39/M8zft5x97gCkujocP/CXpf20MK6x4WtZ7e3uLUo91LHHKGYRsoZnUhSTjI4PvXu0M8Vzbxz28iSwyKHSSNgyupGQQR1B9afRLVNd9PzCLs010/zT/T8TxHRxoWsGDT/HcjWdvNo1jHost6DbGKQIVkMBkA2zhwOQNxG3GRTtSsvDen+LPHsuopBZzNo1tLb3cgME5zHIGfzBtZSzBQxyMnCnk4r2yiib57+d/wASaa5El2t+Fv8AI8Xjj0e08C+AviDFb216dFtreC8nhjEriFo/KbkZO6NznHUYYd6XxFoVrpl7YW2p/wBhaJpGpW89zcvqen+baG8kkDENtljVZAuArMT9045r2einKXNJvzb+/p+vqEVZJf1p/VvQ5bSdPfTvhgNPv9dnuvIsZIm1byikhUBgJAMscgYIOTnAPeuF0vw3pni7Rdf8G3mm6HO9pbIItW0dcwGbL43JyI51YksMsSH5POK9jqrqEd/LaFdKube2uNwxJc27TIBnkbVdDnHfdx6GperbfUcfdSS6Hl2n2tp4w8J3OsXUNtod7BaQ6Ms72o2wSI4EqYGCYi5EZGQNoboCaw9WfR9Z8H2TXuh6Ilpp3iazhlu7BVl0+eI7FZ4yRhUxhGUcAjBJr2vStNj0nTktYWL4ZneRgMyOzFmY47liT+NXKq/vX80/ud/8/vFbSy8/utb/AC+48TvtN/tfxZe29zr2l6FqNvfxzaQsumOb37MqoUW2bzlGxgCGRU/vZFYWuXvhqPRfiRcrqdrLfWmsRS2Ekt8ZJIpNkfzREsSDuEg+XspXoMD6JopJ2t/XbX8B9b/1109NTzHwpqGhQfGjVrHQr2wWK80e1uTDazKRPNuctJgH5nKFCW5JBBNc78TrrTZNe1ybMMOp6W1jIk14+Zok8xSzWqgAxpg4eTcQTkEcCvcKKL6p9v8AMVt79f8AgHzv4jvvDElv8T7yLVLO6uLea3m06WS+85ophGDui3McESFh8vTlegxW54n1HRdVbxX/AMJRNbzyzaOs3h2SRtyyxm3JZ7c9C+8tuK/NjHavbKKlq8OX+trFxlaXN/W555dLJqn7Oc0Vjb3Ek0nh4xJCYHWRnEO3AQgN1HHHPauQ1JPD8kP2/wAP3UFvZJoE6a9dWdyYU85Uj8hJZFI/fb8jBO7GQeDg+5UVU3zuT7/8H/Mmn7iiu3/A/wAjwyDT9Otfh54P1Cwm06DS9QgiXWry9ie8tXdLcognQSoMBsqSTgEKD0GLUmn6Xpuj6BomqarZa7Y3d5cyWU1xH5emBSgKxBC0nm7S37pQ46HB+UV7TRTm+Zt9xRVkl2PBrC7hX4d+G9YlvtG1KbS7KWGTTNYcjzW8wqPJkJJScbCoGGODjjOa6fw5aaOPjZd3kukQ2V5daJZz2qzW485GPmCQg4zuC7VY59AT0r1KihS1v/Wt/wDMGlay/rb/ACCvM/F2s6Vo/jzUDrGo2lksttom37TMsYcLe3RbG484HJ9BXplc3Y/8lT13/sC6b/6PvqnqmM4q80i+8H+JNK0/RovtXhPV9VguIPLbI02beGKj/pk/JGOjcdxWTqMMd1pOpido4viMmrO1hhgLwR/aP3Wz+IweX1x8mN2e9e30U4u39en+Qnq7/wBdf8zzbwXp+k2Xxf8AGv8AoNpDqLS28kTrbqsnltCpdgQMhWcHJ6Fh61y3xD160tfitqkby2d3Yx6HDHrFp5yec1uJXeRUU8FgpVivXYTjBINe5UUuq8v8rFX0a7/5p/oeCSzfDy88aa3HYXukS6J/wi4eK3F2pt45N7EhYy21GACHAAIPPBJNXtB1PStZsfDU/j26sbrw7L4biSKa/kVrdr0MBKGLHaJQAAM/N97HOa9topp2Vv6+1/8AJfgL+v8A0n/5H8TxGLSDomg+HPFWu6Z9vkt7q406Q3MHmzy2M7PHbhsgsTzGOedrsD1NT+FtAsrL+0PDPiiwtbe08NPPfrdhRDHGtwu5GSTgptzMNwII8tTnpXs9FJ63/r+tbv5h2/r+tND598F6noNjD8L7q31GzXUrqW5t7yY3KtNIjJJiNySTjzNmFPRiMcmvoKiiqcrisFFFFSM8l+N9/aWFvJ9tuobf7R4Z1aGHzZAvmSGSywi56scHgc8Gs6JvBnjL4r2Ns2q2up21z4dIkii1NiolWSMgKFf5HCpuwuCNu7qM16Pff8lT0L/sC6l/6Psa6SmtHf8ArZr9Qeqt/W6f6Hgnh+ysZ/APifVvCs/23VLLV7mGK6juZLqWOzaZN3STc4MSEjnLYyDk5q5JY2un+Ddf1TRfFWkXGmXQti9ro9qbSzRllXepYzSCNpFO1slQOrY5Ne31leItIuNZ01IbLUDYTwzpPHIYhKhZDkB0JG5c4OAQeBgiltZei/L/AIcfV+rf9fkeJajYaRrXgvxdqOjCzSwt/s09lpFrqMdytgEcGWXyYJHhjLYYgrzjdyMkVd8UazoC6946vrCa3W21HwmmLyGMiG4lJlUfvQNpY5RRzkkYGSMV7Bpul3sd0t9rd7b3l8kTQq1ram3jVCwJwpd2ydq5yxHHAHOdWiWqt/WqsEXyu/p+DTPn/wAX6ho+r+GcQS2s91beFYri0nuZfMVWUNlrRFGfNBUh5Aw2YXg81vabB4Z8S/GiSC4votS8zQbW4EJ1BnAnWQPuVd/ysFVGwuOue5z7FRV83vc3q/vv/n+BHL7nL6fhb/L8TzT4tXOlQax4K/tTUFtSdaTcj3jRK0W1txZQwBAbYMkcZx3OeC1m88MWnhzx0bG702JtK12BtKEUyD7IW8osYRn5MsJc7cZw3pX0RRUR93+vT/L8Snr/AF6/5niVvB/wkXiyWe58T6RYaxDqn2my22LSX1xabt0Yhl88B4XjxkKhUZbPIJrAudR8M2eh+ItQt9Vs3vbXxhC1lcy33myxpviyUZmJwVWTJHUKc5A4+jKKcXytW6f5p/oD1v5/5P8AzPKbaWwtviMtvs0fxFHrV3K/mxDF/aJtdT5q8+Zbj5kBOANwwDwa4XT4PC1l4f8ABlvLJaafeHxLLHewrN9n3xiWUYlUEBsYjHzAlQQOA3P0hRQrK3lb8GEtb+d/xT/zPDdY0Lwx4T1Px3oaWFnZWd74ehlsrMx7vtDxiYsyqcl2VtpJ5I4PasXxFeabfeE3YIIdU03w9ZyQPqSOssJTlmtYiqshyPnkzjheCK+jKKE2nf0/C/8AmD1f9eX+X4njy2/hiL4geN7u+WytjcaTbTw3iERPsaKTzJFlXBUEgAsCMnAJzisrwleaJqGjeGR40n0+bw1/wjqRQveyqbb7aHxIrFjtEoULjPzfex3r3aij+vz/AM/vQun9eX+X3M8Gt1tYNa+H9p4t1A72ub9Ugv7xgXsyJBb+ZGzYO4ELlhls7TnpXYfCPxDoh8My6fb6vYbV1i8t7G3W5TmMSsyJGM8jYcgDt04r0mq13Yx3zQeezlIZBKIwQFZlOVJ78EA9etPm7/1qDV/69fw1/A4L4v3umWEPhefUtQjtHTXbVlEl0Y1aMOC7FcgMFABJIO32rzrWtQ8Mw6T4+voNVs5ry11+2l0+eS+86SNsREtEWYkdJRx2UjouB9F0Uovl/r/D/wDI/iN2f9ev+Z4xcTeHLv4peJp/DJ0O5199Cjk014fJaV7vExYoRyX27Mkc4xnisK7sdL/4QvWtbj8WaYn/ABJpYryx022ksZTc4Bja5Y3DN5ocbfmAL5IORxX0JRUtXVl2/wA/8ylLVN/1t/l+Z4ff+GvCEVr8PdY/s6wube9u4he3cqi4WY/ZGUBicg5ZVGO7Ad6zdZ1vQrfwZ8U7WDWLZg+pp5KSXnmO2Ui4G5iT8yuMdtpHGK+gqKtyvJv+t0/0IiuVJdrfhf8AzPGNQvNA1j4j+JLS1v7TUxf+FFZLf7SLhZJPmYBEJIB2BGwo9GxzmoLbQvD1j8M/CHjfSNJsWuPD8dvcXjwWqgyxlAJycL8zLuL55IZT3zXt1ZWtaXd6uotPtkEWmTIUu4TblpZlPZZN4CgjIOVbIPBFJO23l+Db/WwWT32/4CX6XM3wvFpWj6bHcyraadeeILl7oo22J55JMuFxxuYJjI68E+tdPQAFAAGAOgoofkGvUKKKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh66SgAooooA5v4j/8AJLPFf/YFvP8A0Q9cB4w1S+8VaLoOu+Tpw0oeJLWO0RoS1zGFudnmeZuwN237gUEA/ePSu/8AiP8A8ks8V/8AYFvP/RD1xN1Z/DG6gktD8RLaHTXvRfpYQa7bpHDMH3lkYfvFBbJxvwCcjFOLtOL7NP7mgfwtf1szZn8c67E3i6L+zbYyaJdW8MP2dJbj91IAxldBhn2q24ouOhAJ61Mvjie7t9GtdG1HSdSu9auZILe+hifyIlji3uzxb924MCNm8dRk1m6ffeBNN1rVtTt/ijbmbVZUlmVtXstqMgATbhQcBQFwxOR1yeaZHJ8NYrcsvj7Tf7TN419/ao1a0FwJ2TYXwB5fKALt2bT3GeaFa2vl+n/B/rYfl5/1+X9bsuPiN4ottbh0I6fpT3sesx6XdXW+RY2EkfmRyJHyR8obILnBAAJzkHinVNe1/wAJeKdIuYdFc6PpxGp74XkS4maEyYiBYeWFGxgzB+eMcZpl2vw7u57K4PxKs47q1vhqElwmq2O+6uAoQPJlCOF+UKoVQD06Ys6zc/DnV9S1C8T4hWGnnVLb7LqEVnrNqEul2lQWDbiGAOAylT2ORxUSV4OPX/gL9b/gXFpTT6f8F/pb+tSrH461HSvDul6VoNq813Z6HaXTr/ZV1eCcuhCxAwDEROw/O2Rz904ONLSvGfi/XPFE+n22k6dYRQWVnftDemXz9kpbfGwwNkgCtgYIBAznPy1baf4c6c1i+i/EWz02ezt1tTNFrdtK9xCpJVJPN3hgCTggArnAIHFT6fqngHTvFV7rsfxIsZJry2S1eCTVrQxqiZ2YIAfILMcljncc54xrKScm/X9f+B/W+MIuMFHyX6X/AF/rbX8EeLbjxJJJHfXdgt5Eha50xbaSC5smJG1HV2O8D5vnAUHjArsa8+sNc8AWniH+2rn4g6ZqF4lt9lga61W1/cxEgso2bS2SoJLbj6EVu/8ACx/BH/Q5eH//AAaQf/FVLt/X9f1+JXU6Siub/wCFj+CP+hy8P/8Ag0g/+Ko/4WP4I/6HLw//AODSD/4qkM6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpK5ux/5Knrv/YF03/0ffUf8LH8Ef9Dl4f8A/BpB/wDFVz9n4+8Hr8SdZum8WaGLeTSbCNJTqUOxmWa8LKDuwSA6kjtuHqKAPRKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgAvv+Sp6F/wBgXUv/AEfY10led3nj7we3xJ0a6XxZoZt49Jv43lGpQ7FZprMqpO7AJCMQO+0+hroP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoAPiP/ySzxX/ANgW8/8ARD10led+PvH3g+8+G3iW1s/Fmhz3E2k3UcUUWpQs8jGFgFUBskknAAr0SgAooooA5v4j/wDJLPFf/YFvP/RD1Bb+L77W9QvIfCekwX9rYXDW1zeXd6bdGkXG5YgI3Llc4JO0Z4zU/wAR/wDklniv/sC3n/oh65vwVLc+ALe88O67pmpPH9vnnsr6ysZbuO4jkfeN3lKxjYFiCGAHGQcULf8AryB7X/rqdZa+KbMaHJqevGPQYoriSCQahcIgQq5UEtnbzgEc9CKvtrWlJbW9w+pWawXQzBKZ1CyjG75TnDcAnjsK5LXGvo/GWheI77TrttKtbe5heCCBrmaGSQpskMUYZuVVh8oOM89TjiV8N/2d4k8O3U2g3jQP4kur6BU0uWX7FaSRsFDFUPlgyYfYcYzkgYOGtX/Xe3/B9AeibX9aX/4B6+PEGjNov9sLq9gdMwT9tFynk4zjPmZ29fepW1fTU0n+1X1C1XTvL837YZ1EOz+9vzjHvmvGo7i5ttPmuk0vVEmh8YzX1nbXWm3UaTxujkEqImfBG45RGKtgkAZNPt9DkWy/tXTFu7W6OutqWrRaZpTR3UEbxusYSO5gDTKrEnJj5y20AjFC1V/T8bf5/h5g9Hb1/C/+S+/yPYE1zSZLK3vE1Sya1uSBBOLhCkp/2Wzhvwqu2vadeaRHfaVrmmG3kmWNLsyrLC53gFAVcAseVHPBI4PQ+Van4Y07Tp/DM1np+u6uJfEf9oy3F7o7NJEjJ+8OyOBfKUvsO0qpJBOMDNUdYje4h13Ph7WpZf8AhL7bULM/2HcsRCDF5kiHy+OEkzjk/iMuKTdn/Wsf839wPTb+vi/yX3nq2n+O/D+peJNV0a21O0NxpaqZwbhQe5fA9F4BPQE44xVXxN42htPh7qviTwjc6ZrX2CJpMpdh4vl5Ybo85IHbjPqOtclqsF9Df/EAnw5falFqTWc9uhtpfLljEaKx+XDMVIJManccYwM5rM1S31D/AIR34kIdP1i7m1e2gNmw0eVDcFoNmFRU4wRghvmH8VR017fiNfEu1/wPZ7SZrixgmcANJGrkDpkjNcn4w8c2+ia5pugWmr6PYanf728zUpAUgUD5d0YdCS7fKvzDv1xitnRdatLiGysQl3DctZpMI7mzmhyuACMuoG4HqvUZGRyK57xNemH4qeFmFjqc0VtFdLNPb6dPLFGZVVUzIqFRkqc88dTgVUl71iIt8tzodJ8QWlzKul32qaS2vQxBryys7sOYzjkhThwvPcDrUyeJNDlnSCPWtPeWRXdI1ukLMqEhyBnkKQQT2xzXlMFvcDX9BvLzQNStrGz1PUftdjHpM0yRLLHL8xYqzzbyc5X5PmxjgVn6La/ZfCHgmzHhvVoZLPxHLcXMX9h3A8qItLh2/d9Nskf+VOGtbedvxKel/K/4X/y/E9jbX9OvdIjv9J1zSzbyTLGl2ZVmhc7wCgKuAWPKjngkcHocmw8U31x4s8UaVqAsLG30iGCS3uS7MCJA53SZ2gY2j5R7/N6eYa0hmOvIfDutTXB8W2+oWbjQbp8QqYRJIjeVgcI/Q5I6ZzWp4lA1K/8AiSkmg6tdRahpdvHZb9FuXWeZEdRszHgkO6EH8RwCRL+DmXb9E/1a+RSV5cvn+tvy1PU7jxFpGmQWX9r63ptu92qiF5LhIluGIHMYZuQc8AE9e9Ztr4jv5fibfeHJ7a2Szh02O9hmR2aSTc5TDAgBcFW4Gexz2rzfxFb6hqvhq6tbPQtTgln8Kx26zDS5nluXQNm3IcbYdpGeV3PuG08DPTeH7iSX4v8AnnTtUit38PQWwuJ9Nnji81XZyhdkCghWHU9eOvFXy+/9/wCT/wAjO/7u/p+cf82dzqeu6RogiOs6pZaeJ22RG7uEi8xvRdxGT7Ci+17SNL3f2nqtjZ7Y/OP2i4SPCZA3ckfLkgZ6ciuC+JFte32q39paaVdlrnQJ4I762s3uTMxJP2fPMcXQHLDLZAUgjnIsI7eDx1p2pS+HtTUJ4T+zz3H9h3BJnwhCEiPJbYpGP+A9eKzTuvv/ACl/l+P321Z/1/d/z/D7vUdU12w03SReSahp8KzLi1ku7pYopnI+Qb+evHQH2BrP8BeIbrxX4IsNav4oYZ7oOWjgJKLiRlGCeTwBz/KvOfAqX+kx+G7nXdD1aWzGgjTFU6dMz2dwJCXV49u5Vddg342/LgkCuy+EVreWHwx06x1LS7rTJrcyJ5NyqqxUuzAgAkgYbHODx0q2rX/rq/8AgMnt/XT+kdTba1pd7qNxp9nqVncXtrjz7aKdWkhz03KDlfxpINc0m61C5sbbVLKa8tBm4t47hGkhH+2oOV/GvGdHsotTm0Gy1G18iy0e+uJbO8utKuna4eQuIxI7weShDMDvEj7mVcYNaPhzwvEbPTm8TnxLc3+hWksNxYz6ZGbVleMrIFdLcG4RuoUO7EkZGc1PS5XWx6lbeIdGvb5LKz1ewuLp4zKkEVyjOyA4LBQckZ4z0pp8SaGJ72H+2LAzWCF7uIXKFrdcZy4zlR9a8c8O2t3ZaD8N7S30XVrO6s5rkXZ/si4QW5kjkQFz5eACzJyeO/QZrd8FeF5DcaI2r3PiT+2dChkha3uLOKK1UuhVysywL5yMcEfvGbOCec05K17f1/Wn3i7XOy0DxvpPivTbG+0XV9PWOe5eIwvIHkkxuwgAYFHICvgg4GeO42TrelDWBpJ1OzGpFN4sjcJ5xX+9szux74rxrRbSexsPhrHeeHdVS+0i8lju5hpMzmGMpKpBdUOFLMh64PUZAyOs8L6dDFJLo/ijRL6bVLXWptRt7v7LI0Uu6VmjmE4GwEIwUqzA4XGCMVVlf+vL+v6uJ6L+vP8Ay/H5Ho9eb+J/EeqeF/HmtalpmiprES6TpaTQrdGKb5rm8VfLXy2Dn5jwSvQdc8ekV5t4o1BLH4gajutb+5LWmivtsrGa5Kql5dsxIjVsAAE89e2TUdV6oo27vxrPdaBpGseErKy1az1KZId1xfNbGNnYKAQIn6HIYHBGOhrebXtJi1aPSZ9UsY9TkXctkblPOYeoQncR74rgtV8KanpHjHT77wvCZNB1bUoLnUrLYQbWZSG89F6gNjDjHBwfWs290LULnwjq3hW40+8fX7rWJL22vltZDCN1xvSf7QBsUqnG0sG+XAHSqVn9/wDl/m36fhL0f3frr+CX9a9/pXjbRNZ8ValoFhf20t5pwUSRrMpZjzuAXqQvygnsTjtVL/hLrm1+IeqaNrAsLLSrLTEv0vGnIO0uVJkLYVACrevGDntVbwvbXdj8SvGAurK6WK9ltZoLkxHypFWAIcP0J3AjHX2xzXIeOTrP/C072/0nTNRu7a10qFbi3GnXBi1EJI8jwLKqEZ2sCMEhiNpzkipW8f66fox/Zl8vzX6HpreL/DS2QvG8Q6ULUoJBOb2PYVLbQ27djGeM+vFWdR13SdHs0u9W1SysbaQgJNdXCRo2emGYgGvK3msb34g65rVt4Z1aGG78NeRvk8P3KM8+5sp/quW27B3BAABOKl8ILe6Uvh3Vtf0vVJbFfDcemGL+zJ5Zra4Vh5ivEELgMABu27Tt64xlpXX9f3v8l94f1/6T+V39x6VN4n0C2vVs7jXNNiumhNwsEl3GrmIAsXCk524BOemAabF4r8Oz29rPBr2mSQ3khitpEvIys7jqqHOGI9BzXndp4b1vwt4V8PanZafNcX+nahOq2MY3OlncyMFiPoEzEx7LsPpVnw34evtFuNa0XxBYy32h6cJrq3lNsZVuvtC5dFjUHcVPnDaAeJFFJ9fL+vy/EO39f1/kegW3iHRr2+Sys9XsLi6eMypBFcozsgOCwUHJGeM9K0a8O8KQT6dpfwxtxoWr20tjc3H24DR7hBBvjdMufLwAWZeTx36DNe41TVhBRRRUjOH8YeILHwv430nVNTL+TFo2oKqRjLyu1xYhUUd2JIAFWNQ8Zan4ftk1HxToUVhpDyIjXNvfefJbbjhWmj8tQoyQCUZ8Z9Oa5z4teHb/AMR+J/D8ejokt9Y2V3fwQO+0TNFc2LbM9BkZAzxnFXfGl7deO/B9z4Y0bSNUgvNR2Q3El9YSwRWabgXYyOAsmACAIy2TjtzQvxv+H9X9B6ddv6/rzOvj8W+HJhemLX9LcaeCbzbexn7MAcEyc/JyMc4qX/hJNDE1lF/bOn+ZqC77NPtSZuV65jGfnHuM1x2oaFfaV41W10qymm0zxFZJa306JlbdoeN7ntviLKD/AHgtZGt+FpdR8S6/pmu3XiKGz1S4insxpVlFLDIqRoFUymB2hdXQ9XVeQR1NNJNr+v67on1PTBrmktqAsV1OzN4XMYtxcJ5hYLuK7c5yAQcenNc2vjpbv4l2Ph/SrjS72wmtrh55re582WKaIrmNlXhPvjqSTzwMc8bpnhlryx+I1vomiS2GoXFy8mlzXGnPbZJtxHujd0UZLeYMr/eJ6NkzOl5qvizw3PoHhvVNPMGi3mnyyzWJt1spCsYQMX2hlBBwU3A9s84XZ76X/Bv89B/1+K/Q9Ptde0i+1KfT7LVbK4vbf/XW0NwjyRf7yg5H40Weu6TqDzJYapZXTW5ZZlhuEcxlcbg2DxjIznpmvNdP0e4vrHwRp8OlX1lqPhxl/tGWS0eJVjEDLIiSkBZd7Y+4W9TiqdzpXiRtFvvDmhJfX2l21jGbee704W11bhZY2NqryLsn3RhhnaQCoDE5qrK7V/67+n9drnb+vkes6ZrGma1btPo+o2moQqxRpLWdZVDDqCVJGfao77xBo2mNIupavY2bRBTILi5SPZuOFzk8ZIwPWuZ8D6RbJq9/rsF54gubi+hjiuDrFklpgpnaBGIYskBiN2CMYGTXM6tb28PxA8c3K+H791vNCjt0nh0ad1uJgJA4DLGQ5IaMZBOcf7JxEvd+4cdfvR6dDrelXN/PY2+p2ct3boHmt0uFaSJT0ZlByB7mqi+MPDLafcXy+ItJNnbOI57gX0flxOeArNuwp9jXkdz9qjsPCYTwvq988Hha6tLm1/sy5hVpnSNRE7hBs3Mj85HrnkE9F4U0l9Q8X6tHq9jeS2GqaDawbrjSntoflMitEAwyuAw4cluepGKuUbXS8/wb/wAvxJTTSb8v0/z/AA+70KPxDos0tjHDq9hJJqCl7NFuUJuVAyTGM/OAO4zWVc+I9Qt/ibYeHTbW32C70+a6E+9jLvjZFK7cAAfOOcnPt3x/hxDqMjS22tRN5nhwNpEEz8+eAQ3mj6x+T+O6m681w/xl0c29pf7E0i7tzdpYzNBHLI0ZQGUKVH3D3479RSdlJW8/ybX6BrZ38vzV/wBTsrfW9Ku9RuLC01OznvLXm4torhGkh/3lByv40mm69pGsvOmkarZX7W7bJltbhJTE3o20nB9jXk+h+GZ10mzk1JPE19rmg2M8P9mzW0VvbSloirqtwkC+ajnGMSM2SCec1Db6Trd9LqK6VaahbT33hEWdo76bJaRwSozfuQXG5SAcAuxJ6gkUPR2/rq/0/H73/X4pfrf+rru18dLd/Eux8P6VcaXe2E1tcPPNb3PmyxTRFcxsq8J98dSSeeBjnS1jxtomh+JtM0LUL+2hvdRLFElmVNoA4Jz3ZsKB3OcdK4vTnkvPiH4QvdO8L6raW9pplxZXRlsDAtqf3e1SX2hlGDgruBzxnnG74ptrxfiZ4T1GCyup7aGG9gklghLiJ5FTZux90HaeTge9DVrfP9fz0Ene/wAv0/4J1Ca9pEmsNpMeq2T6ki7msluEMyj1KZ3Y/Cp76/s9Ms5LvUruCztoxl5riQRog92PAryiz0LULnwroHhqXT7yHxDperR3dxfNaSLCoExeWVZ8bG3oSNoYsd2CBzjrvG8V3DrnhrV1srm/07TruR7yC2iMrpuiKpKIwCz7Seign5sgUdPn/T/T5D6/15/18zoW8QaMllBePq1itrcqWgnNygSUAEkq2cMMAnjsKYfE2hC8tLQ61pwub1A9rD9rTfOp5BRc5YH1FedeINH0UeJPBc+k+GL0W66tLdTSf2RO3lpJG5JfKExgysp2ttwRnAAzVDxXplyt9qtrpnh+8s7e21XTp0isdMklW7ijaIGQOAVAUAgRxgMNmTkE00rtX7/5f5/h9w+vp/n/AJHq03iLRLe6W2uNYsIp2mFusT3SKxlIyEAJzuwQcdeakivUbU7yI6hZyLBGjNbp/rYM7ss53Hg44+UfdPJ7eJanahPD3j9NK8N6tHLqGs281ksOhXKNKq+Uxdf3Y4DJIc+vP8Qzf1HTbvWNY8eQ+HtGv7f+1ILGVDNpk1sl55bEzpudFUuwOOT82fqQlqv67L8rv7ge/wDXc9bsfEGjapb3Fxpmr2N5DbErPJb3KSLERyQxBIX8aqS+NPC0FlFeT+JdHjtZjiKd7+IJIfRWLYP4Vxep6PD4s8Tzapa2Oq2WmNo76feN9hkt5pZGkQx7Y5FBfywGO7BXnAzyKkg0jWfFvhPX9K1fMrwujaVq82ntZTSyoNyO8TAHKOANwChgTgAUtErv+tbf8FB1t/Wx3U3iLRbe7ltZ9YsIriFFkkhe6QOiNwrFScgHIwe9SWmtaXqEdy9hqVndJaOY7hoZ1cQsOqvg/KR6GvJPFKTeK/hOda1Lw/c3Gp6leWrRWsdg11JAsTqG4RW2jAmbPcPjvil16x1HWPFviePRtL1JbWaLS5QsmnzQx3SQSlpo1Z1ClthUYzz07HDtrZ/1tqLpc9XsNf0fVbKW80vVrG9tYSRJPbXKSImOTllJArG1v4j+F9F0u0v5Na0+aC8uY7eF47tCh3sAW3A42qCWJ6YFc3d6NF4n8Tatq8FnqtnpN5o62FwfsUlvPNN5uVcRSKGPlr/EVIwcDIzWZqA8SX+kwm+s7rU4NO8QWEsd+mlSW1zcwo3zs8GNxKf3goBHIAAoWrXy/O35a+g3pf5/lf8A4B6dc+I9Es5rSG81jT7eW9ANqkt0itOD02An5uo6Z61LPrWl2uox6fc6lZw3si7ktpJ1WRxnGQpOSMkD6mvOtTsbhZPGllrGjX18/iJQdO8qzeZSvkKixu6grEVcE/OQOcg9aZ/Z2ueG7vThpzXupX832O31KyudOea2ujGkYadLjGIio5yzYJQ4XNC1/D8f8uoPT+u3+fQ9BGt2Nrb393qGtaaLS2m2PL5ixrbfKvySMXI3ZOc/Lww47m/b3VveW4ntJ454WziSJwynHB5HFeQaFpsUlh4hggstc0LyvEb6hp89vokoEa+V8riJo8Op2upUAnLDgZBr0DwfdajeeDxN4ksEgnZ5t6x2jRfaI9xxIYTllZxyUPOTz6Uvs38l+SG1Z283+b/r+lfRt9Ys0s/PvNX06WN7loY5onCJu34WPl2y44U88nsOlWdO1TT9XtjcaTfW19AHKGW2mWRQw6jKkjI9K8Lg0+H/AIQXRLSTwtqnmWfitrlIToFxmC1NwXLAeV8qlCvA+mOMD0PwJJIfGnjUtY39tBcahHNbvc2MsEcoEKIzIXUA/Mp6deD0wapK6f8AX8v+b+4luz/ru/8AL8Tqjq1pby38l5q1gtva7fMBcIbbjnzGLEc9Rwv41Bd+LdBtNN1C9fWLBodN4uiLpP3LdkY5+VieAD61454p06Kez+JNnb+F9Tl+33dvLYLHoU7JLIqKskiER4zu3nd3yTk5ro5b5bfxv4hubfR9ZWxn8OQW8LRaLdbXlBk+QAR9QJF+nI7HGbvyXXb9L/8AALSXNZ9/1S/W5u+F/Hy6ho8ev67r3hqDRrqJDGY7ry3tZyATBIzOVZgCOfkOf4a6u617R7CISX2q2NtG0JnDTXKIDGMZfJP3eRz05FeY2Zu5vD/g22TRdTt5IdIks5rx9LnaW2l8qNTEI3UKu4j/AFrqyfLgdc1l+ELWOw1/wbdX3hzVIpdP8Ny217O2hXBKSjZtQsI+ThZMYz1wPvYOs0k2l5/r/kvvXq843aT/AK6f5/h93pur+P8Aw7o2paLZ3WqWYbWGPkOblAmzYWEm7OCCQFHqWGK2LfWtLvL6aytNSs57uBts1vFOrSRnGcMoOQceteReFLbUrfSPh1PNo2rL/Zd1exXMT2MqPDvjcR5VgCFOVG77o7kV03hxNT0jxbFYWKXt5obLPcyLf6Y0Umms53hY5sBZQxJG0bmHc9qTSTt6/wBfcPX+vmeiUVDZ3Ud9ZxXMKzLHKu5RNC8Tge6OAyn2IBqapGFFFFAHN/Ef/klniv8A7At5/wCiHrpK5v4j/wDJLPFf/YFvP/RD10lABRRRQBzfxH/5JZ4r/wCwLef+iHreur21sY0e9uYbdHdY0aWQIGdjhVGepJOAO9YPxH/5JZ4r/wCwLef+iHrgPGGqX3irRdB13ydOGlDxJax2iNCWuYwtzs8zzN2Bu2/cCggH7x6U4q8ku7S+92Do3/Wx69HdW8txNBFPG80GPNjVwWjyMjcOoyOmalrz6fxzrsTeLov7NtjJol1bww/Z0luP3UgDGV0GGfarbii46EAnrUy+OJ7u30a10bUdJ1K71q5kgt76GJ/IiWOLe7PFv3bgwI2bx1GTSWq0B6b/ANWOk1zw+mtSWs6ahfadd2bM0FzZOoZdwwwKurIwI4+ZT7YqezsodHt5Z7u9luJSoM97eMgZgo4ztCqoHJwoA5Jxya88uPiN4ottbh0I6fpT3sesx6XdXW+RY2EkfmRyJHyR8obILnBAAJzkHinVNe1/wl4p0i5h0Vzo+nEanvheRLiZoTJiIFh5YUbGDMH54xxmpk7Qcl/Wif6oqMbzUX/Wtv8AM9QhniubeOe3kSWGRQ6SRsGV1IyCCOoPrT68oj8dajpXh3S9K0G1ea7s9DtLp1/sq6vBOXQhYgYBiInYfnbI5+6cHGlpXjPxfrniifT7bSdOsIoLKzv2hvTL5+yUtvjYYGyQBWwMEAgZzn5dZRtJpdP6/QzjK8FJ9V/l/mei0Vx3gjxbceJJJI767sFvIkLXOmLbSQXNkxI2o6ux3gfN84Cg8YFdjUtWKIRaQC9N3szPs8sOSTtXOSAOgzgZx1wM9BU1FFIAooooAKKKKACiiigAooooAKbLGs0LxSZKupVsEjg+4p1FG+gHO6T4PTSoorZtZ1S90+32/Z7G6eJo4dpyo3LGJGAwPvu3QV0VFFO7YBRRRSAKKKKACubsf+Sp67/2BdN/9H31dJXN2P8AyVPXf+wLpv8A6PvqAOkooooAKKKKACiiigAooooAKKKKACiiigDm77/kqehf9gXUv/R9jXSVzd9/yVPQv+wLqX/o+xrpKACiiigAooooAKKKKACiiigAqC+t5buykggvJ7GRxhbi3VC8fuA6sv5qanooAq6dp8WmWnkQs75dpHkkOWkdjlmOOMknsAB0AAq1RRQAUUUUAFFFFABRRRQAUUUUAFFFFABVPU7CbUIEjh1K70/a4Z2tRHmRe6HejYB9Vw3oRVyigCK0tYbGzhtbWMRwQII40H8KgYAqWiijcAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/iP8A8ks8V/8AYFvP/RD10lc38R/+SWeK/wDsC3n/AKIeukoAKKKKAOb+I/8AySzxX/2Bbz/0Q9cTdWfwxuoJLQ/ES2h0170X6WEGu26RwzB95ZGH7xQWycb8AnIxXbfEf/klniv/ALAt5/6Ieq8Hi++1vUL2DwjpMGoW9hObe4vby9NtE0g+8ke2OQuV6EkKM8ZNC30/r+nYOn9f13Oe0++8CabrWranb/FG3M2qypLMravZbUZAAm3Cg4CgLhicjrk80yOT4axW5ZfH2m/2mbxr7+1Rq1oLgTsmwvgDy+UAXbs2nuM813Nj4hhl0e51DV4v7GjtZZI5xeyooj2HG4tnbtPUHPQipxr+jtZ292urWJtrrPkTC5TZNgEna2cNwCeOwo2QdTzm7X4d3c9lcH4lWcd1a3w1CS4TVbHfdXAUIHkyhHC/KFUKoB6dMWdZufhzq+paheJ8QrDTzqlt9l1CKz1m1CXS7SoLBtxDAHAZSp7HI4rvB4g0ZtF/thdXsDpmCftouU8nGcZ8zO3r70r6/o8dnBdyatYpbXKloJmuUCSgAklWzgjAJ47Ch7Wf9f0hpu91/XX8zgLaf4c6c1i+i/EWz02ezt1tTNFrdtK9xCpJVJPN3hgCTggArnAIHFT6fqngHTvFV7rsfxIsZJry2S1eCTVrQxqiZ2YIAfILMcljncc54x2p8TaELy0tDrWnC5vUD2sP2tN86nkFFzlgfUVmeGvEeoav4o8S6XqFtbQLpFzFFCYHZzIrpvDMSBzgjgDg55PWnq3r5/8AB/MnRLTy/wCB+RiWGueALTxD/bVz8QdM1C8S2+ywNdara/uYiQWUbNpbJUEltx9CK3f+Fj+CP+hy8P8A/g0g/wDiqf408Uw+FvD11dJc6cuoLA8lra3t0IftBUbiF6ljgHgD8utSaFrjapZ6VPc3tjHNd6al3NZqMSZYIS65fIQbiMFT1HzDuJ3+X/Bf6MNvn+lv80Qf8LH8Ef8AQ5eH/wDwaQf/ABVH/Cx/BH/Q5eH/APwaQf8AxVatpr2j6hbS3FhqtjdQQgmSWG5R1QAkHJBwOQR+Bplv4k0O70p9TtNZ0+fT4yQ93HdI0S465cHA/OkMzf8AhY/gj/ocvD//AINIP/iqP+Fj+CP+hy8P/wDg0g/+Kq/c+JdFt9MlvjrGmrAkhg86W8RIhKDjyy+cA54x19qxfB/jZdU8CL4g8UT6dpai5nhkkE+yBAkzRr87kZztHPGfQdKOlwLf/Cx/BH/Q5eH/APwaQf8AxVH/AAsfwR/0OXh//wAGkH/xVadx4h0W0to7i71ewggljMscstyiq6AZLAk4Ix36U+LXNJm1E6fDqllJeqATbJcIZACCQduc8gE/QUAZP/Cx/BH/AEOXh/8A8GkH/wAVR/wsfwR/0OXh/wD8GkH/AMVWvqms6XodqLnWtSs9OgLbRLdzrEpPpliBmkudb0qyhSW81Ozt45IzKjy3CKGQDJYEnkAc56UAZP8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVWjdeIdJtdFTVH1XT0s5lHkXU12iQyk/dxJnGCfTNZnw/8SXnivwjHqmpRW0Nw1zcRMlqxaMCOVkGCeTwo54z6DpTs9fIOlx3/Cx/BH/Q5eH/APwaQf8AxVH/AAsfwR/0OXh//wAGkH/xVdJRSA5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qukooA5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qukooA5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qukooA5v/hY/gj/ocvD/AP4NIP8A4qufs/H3g9fiTrN03izQxbyaTYRpKdSh2MyzXhZQd2CQHUkdtw9RXoleb+J/EeqeF/HmtalpmiprES6TpaTQrdGKb5rm8VfLXy2Dn5jwSvQdc8AbnSf8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FVVu/Gs91oGkax4SsrLVrPUpkh3XF81sY2dgoBAifochgcEY6Gt5te0mLVo9Jn1Sxj1ORdy2RuU85h6hCdxHvinZ/oK6Mv/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qpNK8baJrPirUtAsL+2lvNOCiSNZlLMedwC9SF+UE9icdqpf8Jdc2vxD1TRtYFhZaVZaYl+l405B2lypMhbCoAVb14wc9qXbz/4cfRvt/nYs/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVXG8X+GlsheN4h0oWpQSCc3sewqW2ht27GM8Z9eKs6jruk6PZpd6tqllY20hASa6uEjRs9MMxANAGV/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVaE3ifQLa9WzuNc02K6aE3CwSXcauYgCxcKTnbgE56YBpsXivw7Pb2s8GvaZJDeSGK2kS8jKzuOqoc4Yj0HNAFH/hY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqtO28Q6Ne3yWVnq9hcXTxmVIIrlGdkBwWCg5IzxnpWjQBzf/Cx/BH/AEOXh/8A8GkH/wAVR/wsfwR/0OXh/wD8GkH/AMVXSUUAed3nj7we3xJ0a6XxZoZt49Jv43lGpQ7FZprMqpO7AJCMQO+0+hroP+Fj+CP+hy8P/wDg0g/+KrA+IniC78K+JtP1uy0+HUPsOhanNNDLdGDMYlsiSrBHy3TggDrz69HpWq+Jbie3fV9D021sZoy7XFrqrzNF8uRuR4I+D0yCcelAPQj/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqXUfH3hnT/Dmoa2ut2F1aaeCJmtrpJMP2j+Un5ieAOtW9N1+y1lrCfTdX06aC6t3lEMUiyvLggZRg2MKchvlPJHIxybgU/+Fj+CP+hy8P8A/g0g/wDiqP8AhY/gj/ocvD//AINIP/iq018Q6K9zeW6avYNPYJvu4hcoWt1xnLjOVGO5xTIvE+gzvYrBremyNqAJswl3GTc46+Xg/PjvjNAbGf8A8LH8Ef8AQ5eH/wDwaQf/ABVH/Cx/BH/Q5eH/APwaQf8AxVa661pb6u2lJqVm2oom9rMTqZlX1KZ3Y98Vcd1jjZ5GCIoyzMcAD1o6XA5z/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qk0D4geHPEWl3+o2WrWQtLCZ455WuUAjVWIDtz8qttJBPUc1rprmkyWdveR6pZtbXRAgnW4QpKT0CtnDfhQBk/8ACx/BH/Q5eH//AAaQf/FUf8LH8Ef9Dl4f/wDBpB/8VV5PFXh6WO2kj17THS7lMNsy3kZE0gOCiHPzNnsOakl8R6JBeJaT6zp8dy8vkJC90gdpMA7ApOS2CDjryKAM3/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrXuta0qx1C3sL3UrO3vLrPkW806pJNj+6pOW/Cm/27pH277F/atl9q3MnkfaE37gu4jbnOQvJHpzQBlf8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUuo+PvDOn+HNQ1tdbsLq008ETNbXSSYftH8pPzE8AdansPGnhvUbYS2+v6U7C1+1yIl9G3lxD7znB4UHILdOKAK//AAsfwR/0OXh//wAGkH/xVH/Cx/BH/Q5eH/8AwaQf/FVfPinw+tjFetrumi0mRpI5zeR+W6r1YNnBAxye1THXdJXVItNbVLIX8yeZFam4TzXX+8Ezkj3AoAyv+Fj+CP8AocvD/wD4NIP/AIqj/hY/gj/ocvD/AP4NIP8A4qtjU7sWlqrm+tbEtKiCS7GUOWA2gbl+Yjgc9SOD0MV14i0Sxn8m91iwt5fNWHy5bpEbzG+6mCfvHsOpoAzP+Fj+CP8AocvD/wD4NIP/AIqj/hY/gj/ocvD/AP4NIP8A4qn2XjjQ7/xlf+Gre/tmvrGJHkTz13MTu3KF6kqFBbHTcM1O/iSyvtJ1Gbwzf6bql1ZI+Yo7tWVZAD8rlNxXp6ZpN2Vx21sVf+Fj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqZoHjKzuvAGj+I/Ed5Y6UNQto5WaaYRRqzjO0Fz/Wte61/R7FkW91axtmdQ6ia5RCykhQRk8gllGfUj1qnFp2JTurmX/wALH8Ef9Dl4f/8ABpB/8VR/wsfwR/0OXh//AMGkH/xVakOv6NcatLpUGrWMuowruls0uUM0Y9SgOQOR1FJb+IdFur2KztdXsJrmZWaOCO5RncKSGIUHJAIIPoQaQzM/4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKrWXW9KfWG0lNTs21JU3tZC4QzBf72zO7Hviltta0q81K40+z1KznvbbHn20U6tJF/vKDlfxoAyP+Fj+CP+hy8P8A/g0g/wDiqP8AhY/gj/ocvD//AINIP/iq6N3WNGd2CqoyWJwAPWuD0Lx83ifXLyXRtX8PPo+n3EkVzC05NwIlH/HwHViu0twAVAxzv7UbuwbK5s/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FVafxn4Xjs7a7k8SaQttdMUt5mvogkzDqFbdhiMjgVabxBoyXF5A2r2KzWCB7uM3KBrZSMgyDOUGO5xQBl/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVaaeIdFksIb6PV7B7S4OIbhblDHIfRWzg/hVy1u7e/tIrqxuIrm3mUPHNC4dHU9CGHBHvQBgf8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FV0lFAHN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FV0lFAHN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FV0lFAHN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FV0lFAHN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FV0lFAHN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FV0lFAHnfj7x94PvPht4ltbPxZoc9xNpN1HFFFqULPIxhYBVAbJJJwAK9Erm/iP/ySzxX/ANgW8/8ARD10lABRRRQBzfxH/wCSWeK/+wLef+iHrlPBy3fw+03UfDPiLTNUlsvtk8tlqOm2s10JopWLYbyA0iOCSMkD2NdX8R/+SWeK/wDsC3n/AKIeukoH0PF4PD/iKHQLbUZ5/Eoih8QTXJVpWvLuOz2usLJFOJOV3Aldu/vjcBTZvDOnaX4k8K3VnYa7qiya3Lfz3l7o7F4lkhIOVjgXylMm07SqnOWxgZr1jVPEOlaLdWNtql9Hbz6hMILSJslpnJAwAOe4yeg71pU07ar+rW/yRL1un1/W/wDm7Hh9jbarLJNew23iHT7K18S3l232fSmE6xTIRHLHFNC28Z3ZCqWG7OKsT+FdM0rWPBv2LTNa1OL+2ZryW7vNJZnijljbO4JCoiQysDsYLg5OABmvY7q5S0tZLiVZWSNSzCKJpHI9lUFmPsATUoORRHS3lb8Lf5BLW/nf8b/5njHivTLlb7VbXTPD95Z29tqunTpFY6bJKt3FG0QMgcAqAoBAjjAYbMnIJrqvBU0knxG8ayPY6jbw3VxbyW81zYTQxyqkKoxVnUA4YevI5GRzXcG5RbxbYrL5jIZARExTAIHL42g89CcnnA4NPkkSKNpJXVEQFmZjgKB1JNCdl/Xl/kN6v+v66nl3ie2vINU8c2+oaLfaj/bemhNMntrN7hCqwkGAlQRGQ5LDdgHdwSeKyNHsv+KosF1HwzrNqJPCDaffPHpr7nlG3CeagKFiinGW44U4PFe1A5GRyKKS0/rya/Ubd9f66P8AQ8eubDxPd2sunLFcavpelXljJ9ruNNa0ubmGKUmSDawUTBQAwZVCnJAyaofEHRP7etfFGtWOhahPa6hYW1vb27aTN5012kjEy+SU3rtjO3eyjrgH19pe9gRY2BaVZJfKBhjaQBskHO0HaAQQScAdzU9O/wCf+X9fiLRf1/X9aHnl5BHpHjjRtai0O5k0WfT5IsWmnOz29w5Q75IVXeCyLtLFcjGDjNchoej65p+g6FJPYa9o1jp9/qCyrZWUU06CaQtFKsLJKSgUspwm4buPl5r3Kii/9fO4LT+vKx4xY+ENJ0r4g+FILfR9Vv7NYL7z72/0lm4mwUWRliVUXJlwhA2hjkDNdFZW+oaN45t7TQobu40q7vZp7qzvdMZEsOGBmhucBcEjhCWba/GBXoFxcpaojSrKwd1jHlRNIcscDIUEgc8k8AckgU9ZEaRkV1LpjcoPK56ZoT2f9dw8v6/r+tTiPHCXMniXSEt9OuCr2t1F/aVvaPctAXCjygoyib8f6yQFRtx3zXEeGrJLTWfhxcXvh3U0n03R5oL2dtEnJhfaojVmEfXIkx6Z/wBoZ9wopLRf15/5jev9en+R4j4F+36VfaVf6toWstpsI1C1WNtLnL2kktyZEfyiu7Y0ZC7gpA5BI5rtvhHZ3eneBzZX2k3WltDfXRjiuEVNyNMzqVUEkDDAcgdOOME9xRVX0t/W9xPV3+YUVR1nWtO8PaTNqetXkVlZQAGSaU4C5OB9SScYHWpYL+C5kjWHzGEkInR/JcIVPT5iMZ/2c59qkCzRVc3sG62CF5VuTiJ4o2kT7pbJZQQowOpIBOB1IqxQAUUUUAFFFFABXm3ijUEsfiBqO61v7ktaaK+2ysZrkqqXl2zEiNWwAATz17ZNek1zdj/yVPXf+wLpv/o++o6pgctqvhTU9I8Y6ffeF4TJoOralBc6lZbCDazKQ3novUBsYcY4OD61m3uhahc+EdW8K3Gn3j6/daxJe218trIYRuuN6T/aANilU42lg3y4A6V6/RTi7af10/yB6u/9df8AM4nwvbXdj8SvGAurK6WK9ltZoLkxHypFWAIcP0J3AjHX2xzXIeOTrP8AwtO9v9J0zUbu2tdKhW4txp1wYtRCSPI8CyqhGdrAjBIYjac5Ir2Wil1T7f5WDo13/wA7njjzWN78Qdc1q28M6tDDd+GvI3yeH7lGefc2U/1XLbdg7ggAAnFS+EFvdKXw7q2v6XqktivhuPTDF/Zk8s1tcKw8xXiCFwGAA3bdp29cYz69RTWit/X2v/kmD13/AK+H/wCRR5LaeG9b8LeFfD2p2WnzXF/p2oTqtjGNzpZ3MjBYj6BMxMey7D6VZ8N+Hr7RbjWtF8QWMt9oenCa6t5TbGVbr7QuXRY1B3FT5w2gHiRRXqNFJ6p+YdU/6/roeHeFIJ9O0v4Y240LV7aWxubj7cBo9wgg3xumXPl4ALMvJ479BmvcaKKpyuKwUUUVIzyv4yGR5BaW1peXdze+G9Vt4IbO1kndnaWyxwikgcfeOAPXkVqQ6DZWvgHVNS0nT9Z1Oe90ryG03Urm68yXaGGwCc+ZHksRgYBGCPWty+/5KnoX/YF1L/0fY10lHRruO9mn2/4H+R4deaTquoWni9YNP1Kd9S8LQRWu7SpLZC6eYDEqsMgjIwrksc9SMV0VuyyfFvw3qMWialAG0SW2uLttKmQBiYzGskmzA4V+GI255wTXp9NljWaF4pMlXUq2CRwfcU3J7/11/wAybaW/rp/keIaBZ22o33h2z1iz8vTtG1Cea2ubnSrp2uWkZwiyO8HkodzA7xK25lXGDU2lWWq2mh+CNLTw/q0tzoeuym8xaFFRMTAOHfarKQ4O5SR264B9J0nwemlRRWzazql7p9vt+z2N08TRw7TlRuWMSMBgffdugroqL2B63/rv/meSeHvC8smrWMGv3XiQalpOpy3sUSWUS2blnbMguFgyysr8oZNx6Y4Feoabqdtq1n9psjLs3FCs0DwurDqGRwGU/UCrZGRiobW0hsoBDbJsTJY8kkknJJJ5JJ7ml0sN73PHbbStcg8N20f2XWbJdL8SXl1dm0tFeZopHmKSRJIjiUDejcK3B4+YcM1Xw1p2mSeGp7TT9e1hZPEf9pTXF5o7PJEjJ+8OyOBfKUvsO0qCSCcHGa9ropp2afp+Fv8AIHrfzv8Ajf8AzZ4ZrkU82gfENLXQtYaa+1i3ltAmjXG6ZV8rLL+75GY5Dn8f4hllpDaahovxA0HRdDumutV1QiyWLTnjjicwxMGdtoEJRjvw+05zgE17tXP+G/CUfhq/1a6i1XUL1tVuPtM6XflbVkwFyuyNSOAowSRwO+ckdNH2t/6T/kD7rvf8/wDM4HVPClzfa7releI77xGtvqU0M1q+mWUUsMwjjQANMYHaFw6E/M6rzkdTTNG0W1jtviI0PhCa5d7l5rK3n06S2+0g24jPluUXlm8wEoc/MT/Fk+w0UX0t5W/L/IFo15Hh15pOq6haeL1g0/Up31LwtBFa7tKktkLp5gMSqwyCMjCuSxz1IxXVSPcQ+O/DWuNpWptaSaLPYnZZSM8cpeJlEigZjBCty+AO+K9Hopt3/rvdfqK2n9eX+R4J4N0Nl17wPFrfhC/gltrS+gvJbnSmdNsjZiDyKrKB8zjDEbcnIAIJ34fCktxrl5peuXPiKF01g6hZR2NjF9kkUOGiIuBASm1QEKtIDhcDgivXKKV7O/8AW9/zG9U1/Xb8jgfi7brceHdMKaXdahcwatazxfZbCS5eJUlVpGGxWK/IG54z05ziuG1mzVrD4oHS/DeqJJqpg+w+VoVwjXDbBuK/ux/y0ySfX5u+a93opLT+vT/Id9U/66/5nj+q6XrWr3XjWLS7C+STW9Gsvsks1u8SvtR96MzgbX527ThssMjGTWnex/2j4mtdf0vS9Ss7bTdHubS9V9NmikmLBPLhSPbul2kMcqGX0PNem0US97+vJr8mJaW/rt/keI6LpupR+HfCM9+viLTbK30RtOuVs9JEs8E2V3B4ZYJH2MBjcq/w9cGrvh3whpOk/EzTdPj0PULmwh0F7RrzUNMZ1lfzVZFklEYQkRjAz0AC9eK9hoqub3ub1/G/+bFbS3p+Fv8AI8VgtZ/7e0K7vdA1G3sbPUtR+12EekTTJEsscvzFirNNvJzlfk+bbjgVT8O28mn+HvAtvD4f1e1ls9fuJ7lV0W4TyYm80Bm/d8AiSMfT/dOPdqKSdvw/AHrf5/jf/M818K6ai6bFo2u6LejX9Ovbm5gvGtZPKd3d8XAnA8s5V+VLbuMbTgVR8D+G3ju9Dm1q58S/2voETxPbz2Ucdsu5CHKzJAvnIxAIAdmzgnnNesUjDcpBzgjHBxQm1sN6lWw1S11LThe2hlMJ3cSQPHIpBwQY2AYEEdCM15NDFqOq+FNZisLHW7V08StqTo2mPDLLbGUMGiE8Wx243bCCfl5HIr1+1tYbK3WC2jEca5IGc5JOSSTySSSSTySalpfauv61T/QN1Z/1o1+p5afBcd74U16+0W41m81K7ni1KCTV7RbZjdwcriIRRFc7FUnb8wPU1NrtprOseE9P15LXUrGebUYb69tLeBHu4YFQqqiORGDMp2uVKk53Y5xXplFO/by/D/hl9wevn+P9M8R1Twxptrqfh6/tbHX9Ye58QpqFxdX2jNviXyysh2RwJ5SlhGSCo3EZ5xmvYbV7OzuF0qztntxFD5iJFaukKrnGA4XZnP8ACDnvjFXaKL6W/rZL9Bdb/wBbt/qFFFFIYUUUUAFFFFABRRRQAUUUUAFFFFAHN/Ef/klniv8A7At5/wCiHrpK5v4j/wDJLPFf/YFvP/RD10lABRRRQBzfxH/5JZ4r/wCwLef+iHrk7DxXro8caSsmqPf6fqV5e28qRWqC0jWJXaMQuVWVnATDHLJncARgV1nxH/5JZ4r/AOwLef8Aoh65u2XwLaXdtc22jeJY5LW5e6t8aPq22GRwQ21fLwqnccqBtOelC3B7WMLUtQ1TxHpPgnxJc6oTBqHiG3ZNOEKCO3XMgUBgN5cAYbLEE5wBUqeKvF0fh2bVrnXY3mtPE/8AZRhjsY1hliM6w/MDl8jO4YcehzWlPp/w6upHNz4c16WN7n7X9nfQ9VMCzc5dYvL2KTk5woyeTUI0n4ejT3sRpPi/7NJdi9ZPset8zg58zO3O7POfUA9RTjZPXa9//Sf0T+8Ja7f18X+a+4g8Q+KfFGjaZ45gs9aEs2hPbS291dWkbSbJUBZMIFXgnglT75q3ruueKF8Q+L7W215bS30vRYtRs1gsoyyuRIdrF924Hy+eBwRjaRks1DSvh9qlxfzX2leL5W1EqbwfY9bVZ9v3QyhQCB2GMDtUjWPgOSS8kk03xi731strcs9nrZMsS9EJK9Ov5t6nM68vn/wP8xq19dv+Cv8Agliy8UeJb/xTaQW09s8d94WOpW1mYQoW5JQDc+ckZY9NoAPfrXPeKtcvNS+FniSzutZ1q01aztInurK9tYYZVDOQcMibHibO0Fc/d5bJNbVtY+AbS7iuYdK8W+bDaGyj32GtOFgIwY9rKRt9sdQD1Aq3JN4JnttSgutH8SXK6onl3bXOi6rK7pkkIHaMsigkkKpABORirbXT+tW1+GnyJjdJX8vyV/y/Eihm8WP8RZfDkfirbZW+lwXyTPp8RlcmbayuQApyFYZVVwGGBkZNLTPEniC98U6faPrk9xZ6xb32ZoLWJLeFosbDbOyB2wDyXDqTyDitKwm8F6ZrzazZ6Z4pW+aD7O0j6Vq8itH/AHSjRlTzk9OpJ6kmorFPAmm3NnPZaN4liexeR7X/AIlGrFYd4wyqpjwEP9zG32qXqrev43/4ALT8PwS/U5/whqmv6R4F+H80OtyXEGsakILuO5gjZ9r72wjgDAyhJ3BmJb7wxitfVPFfiCXw54j8VabqRt49Av54E0treMxXMcJAbzGKmQM3zEFWUDjg93NYfD429jAui+KYotPnNxapDpmsRiKQnORtQdMnA6KCQMAmtC4vPBl1qrahNpHiMzSOskqLomqLDM64w0kIiEbsMDllJ4HoKq+t/X9P8n94/T+t/wDNfcc/q3izxZDaeOL8a0sK+Hmt57W3hso1DI0YkMUhfcSMNgkbTkZBHSvQvE9zrC+E5bjw7FJJfERsEh2GQIWG/wAsP8hcLu27uM4zXG3Vj4Bvf7VF1pPi2Qaw4e/X7BrQE5HTIC4AHTAwMADoMVunxJ4cbS4dPay8TNbwBBGTomqGQbfunzPK3k8dSc1P2ben/BDZ/eYd74x1BtI0e50PW5pFbX7fTr+LUNPWO6QMUDRuMKEbqSQnIcYxgGsqDVtV8N6j441GHUb/AFGX+3bexht5BAVBlWABhlU+ZQ5CguE6Z5ya17q18BXljDa3GkeKjHDc/a1ZdN1lZHn4xK8gQM7jAwzEkY4xVx7rwTLPqUsuha7I2qKBeB/D+pMsuABnaYsBsKvzAAnAyeBVJr+v+3f8n94f1+f+a+40vBNz4pe81O28TWl4lpGUewudQa1FxICDvV1tmKfKQMHAyD6iqVrf+JPEmq6rcaNq8diuk6t9iGnywo0U8ShC7SNtLhiGJXaVA4yDU+k+IfDeiW/k2Nn4oK4A33OjarcPgdBvkiZsDJwM4FVZb/wdLrcmrf2V4kju5seeYdE1SNLjAwPNjWIJJgcfODSv71/66f18xdDJvvFviJvCeo+M7DUGWLTtSltxozQRmKaGOfyjltvmCQ9QQ2Og2nvV1LxX4ss7DxbqMmtp/wASHWIIoLeGyjRJYnERMbltzdJOoIORnOPlG+954Mk1ZtRbSPEfnNIJnjGiaoIHkByJGhEXllwQDuK54HPFZtzpvw/u4NQhudJ8XSRalOtzeIbHWsTSL0Yjb2446fKv90YI6W/rt/k/vG9X/XmQeOtT1PxF4Z8fpb6k9haaHbyWv2RIo2+1ZtxIzSFlLAfPhdhXpk56VJNq2uPeavov9qm3sovCcd9a/ZYVSWFyCpy7btx+Q84GA3TIzVvUIvAeqSyyX2i+JJGntha3BGj6sv2mMDAEuIx5hA6M+SOuc0lnB4B0/Uzf2Wh+I4ZWtfsZRNG1byfIxjy/K8vZt5Jxt6knqc1MleLXl+jX5u/kNPZ9v80/yTXmUfDGpa3otn8NrJdXe507U7JjcQzW8fmfLa71UOoHyjjAxu45Y1JD4t8RP4X0PxnHqJlg1O/jtpdHe3jESRSzeWpRgvmeYvBOWIPPA7WIrXwFDPpU0OkeKo30j/jy26brAEXGOmzDcYX5s5UBegxVyC78GW2pG+g0jxIknmNKsf8AYuq+SkjZzIkPleWjnJ+ZVB5PPJrSUk5c3n+F/wBfwIStG3kYNr4r8VxaWmq3+tpO1v4q/siS2hs44opoTMIuc7nBGdwIYeh3V0mka/qMXjR9L8S3d/ZXNxdS/Y7eS1jNncwqGKCGVV3b9u1mDtnKnAArGOk/D02BsjpPi825u/tpT7HrfM+c+ZnbndnnPrz1rXg1Lwjb6pDqKaZ4le4tw3k+douqyJCWzuZEaMqrHcQWABwcZxUxaSSf9aL9U/vKlq3b+tX+j/A7yiub/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GKQHSVzdj/yVPXf+wLpv/o++o/4TzSP+fPxB/4Tmof/ABiufs/Gmlr8SdZuDa65sk0mwQAaBfFwVmvCcp5O4D5hgkYPIBO04APRKK5v/hPNI/58/EH/AITmof8Axij/AITzSP8Anz8Qf+E5qH/xigDpKK5v/hPNI/58/EH/AITmof8Axij/AITzSP8Anz8Qf+E5qH/xigDpKK5v/hPNI/58/EH/AITmof8Axij/AITzSP8Anz8Qf+E5qH/xigDpKK5v/hPNI/58/EH/AITmof8Axij/AITzSP8Anz8Qf+E5qH/xigDpKK5v/hPNI/58/EH/AITmof8Axij/AITzSP8Anz8Qf+E5qH/xigDpKK5v/hPNI/58/EH/AITmof8Axij/AITzSP8Anz8Qf+E5qH/xigAvv+Sp6F/2BdS/9H2NdJXnd5400tviTo1wLXXNkek36EHQL4OS01mRhPJ3EfKckDA4BI3DPQf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAHSUVzf/CeaR/z5+IP/Cc1D/4xR/wnmkf8+fiD/wAJzUP/AIxQB0lFc3/wnmkf8+fiD/wnNQ/+MUf8J5pH/Pn4g/8ACc1D/wCMUAdJRXN/8J5pH/Pn4g/8JzUP/jFH/CeaR/z5+IP/AAnNQ/8AjFAB8R/+SWeK/wDsC3n/AKIeukrzvx9400u6+G3iW3itdcV5tJukUy6BfRoCYWA3O0IVR6kkAdSa9EoAKKKKAOb+I/8AySzxX/2Bbz/0Q9c7pfjy+02+8ST+OtY0W10nRLsWYlgspYnmdo0kB5lfs2NoBJ65HSui+I//ACSzxX/2Bbz/ANEPXnWr6R4uvtF8c2UPgvUg/iC8Se0ZruywqhI1O/8Af8H92TxnqKcd9e36r9Lj6fP9GejS+PfDsNtqU73k2zTESS6C2U7MkbZ2yBQmXQ4PzqCvB54qyni7R5P7PImuFTUbdrm3keymVPKUZLOxTEYwR98r1HrXOaZp2q3fxP1HUNR8PXdrpV7osFn5s81uw3qzsylUkZukmM4xkHtgmpp3gvXbrwLrXh/VXW3eO1m0rSp/N377fkpI2OQSNikdf3ee9HT+vNf5fK4lq/68v+D+B1EHjnw9cLeFL9ozZoJJUmtpYnKMcK6KygurHgMoIJ4GazvEfxG0/RNLs7qC2v5zdX8FnsOnXAaPeVJ3Js3A7GyFxknAAPNYtj4Ktr21mn1TwnqyXzW4s5mvNfkuGZDIjEwO077QCu8E7Gyo4GarT+HvF914cgS5gvb1bHX7W8s7a/uIDeC2jYFg7q3lsc7iMsSR1OeKdldeq/PX8P1F0v6/l/n+h22n+J9FvtS1X7LrXmnT4o2vLd1CJZ8McsSoIYgHcrE42jhe8MPxC8KS+YH1qC1eOMzeVeq1tI8YBYyIkgVnTAJ3KCDjrXI39hqZ1bx9d634duItN1TS44YpGu4dszRxupQFXLjcXG0le3IBwDQTT/Ezw3EmqaTczazPpJ0zT0vLW1jtZQP3hV0W5m3SEKxBYKnGMDPK/wAv8ytv69P839x2Gp/EzQ7TwrrOsWRu7p9JiDzWrWU0UqllyhZHQMEP98jbjJzxVvS/F2k6vq2n2seqTQ6hLZNctpklu0TFMgGR1kQOmDnbkqCCThuCOJuPB/iG+svGsS6beI+uaNBFbSX95C7GZFkDI21iEPzD7o2e/WtC90jxDqvjHR5n0K8s7VdDudPnuxcW7fZ5Jdm0kCTcduznaDyRgnrQ9Nv60f6iTvb+u3/BOts/HHh2+1FbK31HEsiM8LSwyRx3CqMsYpGUJIAOSUJxUOn/ABD8LarNZpp2qrci9ne3t5Y4ZDE8q5ynmbdgbAJAJ5HIyK5qx8Nazc2HhLTL/SJLQeFZI5pLsTRMl2Y4WjCwgPu+YkE7wmPesO20HxXF4b0a1bwlf+da+KJNUmT7VafLAZXcc+dycSAY9VPsS7K9v63Wv/A8hO/Lfy/R6fgtfM9S03xJpmr3Bh0+aWQ/MVdraREkCkBijsoVxlhypIrUrg/Cmi61o/ikJZW1/p3h42zNNZX11FPGk7EEC2Kszqoy4IbavTaK7yl0Q+oUUUUgCiiigAooooAKKKKACiiigAooooAKKKKACvNPFmo+I9I8dazfeFRYTzrpelRtZ3kLt9oL3V2ihZBIojPJ5IbPHTHPpdedeI31D/hYWpJpejXeqyfYtGldbaSFNix3d25J82RByAQMZ56460dV6oZafxpf694d0vVfCV1Y2hmvUsr221KyeaS3lZgrIQsqbWU5yDnPGCO+7P410C01RNPur/bOZhbmX7PJ5AmPSMzbfLVz/cLZ5HFc7rvgi+fxppniHw632aK5u4JNasXIAlCHKyjnAkXGDg8j1xznXPg7WpfCmq+C5NPkmh1DUJLpdZ82LykjkuPNOVLeZ5ijIAClSQPmHalZ79/8v+DYl7/d+v8AwDqtE8bW2t+M9a0GG2u420sxoZJLOVVdiMt85XaByuASC3JGRzWdL4ovtK+Jms2msXyHRLTRk1BI4bQl4syFWzt3M5+UngDrjHGas+HdI1PS/iD4ouZ7P/QNTe3mguvNXB2QhCu3O7dkdwBg9e1cn4z8O+KtQ+JVxreh6RdFLPT4VtGea3NveTRSNJ5ciGUNtO7AYgYYBugBqVvH8fu/zH9mXyt96/Q7E/EzworTRnUpTcW9v9pmtRZTmeKPj5mi2b16g8joc9Oa0L/xfomnWltcT3bypdQ+fCtpbyXDvFgEyBI1ZtoyMtjAyK4l4vE994y1XWpfBupW8d14eFgkbXdmxM4d2I4n+783BOOhyBTPCWheI/DKaHqlxoV3dSQ6DFpNzp0Vxb+bBJG+fMBMgjZG9m3DA46gNbf1/e/yX3h/X/pP+b+47JPHfh6a+tLS2vJrmS9tWu7Y21nNKk0SjLFXRCpI6bc5yQMZIBjj+IPhuXSLbVFvZxY3UskSTvYzqqtHnfvyg8sDa2WbA4PPFcuvgbW9F8KaPJoiQya3YapNdiLzAsaR3Lv5ke49QqyA+5j4HSrXhrwlqvhXV9aVYXvtIhV7jTEWRDNLLMqmVfmYAHchIJIB8088Un1/r+v8w7f1/Xf0Oi0rx54b1u6s7fS9R+0Nfo72riCQRzBD8wWQqFLDHK5zjnGK6GvHtA8P+KLHT/h3a3Phi8RtDuJmv3+02pWNXR0BGJcsPnB4GcA8Z4r2GqaS2EFFFFSM83+J2sap4e1y01nQ3s1uLDQNTuGS8gaVJFWWyyuFdCCeOcn6c8XrHxVr1l4+0zw5rUmm6mupWklwJtOtpIHtNgB/eI0kmVbIAbI57Vl/Fmz1HU9Qh0zRdMm1K8v/AA9qlskUUkSbN0tl8zGR1G0e2TyOOuJdL0LUvBuoQ6r4U8KyLp+qIq6locUltFJayqMCaP8AeeWcgYZQ/PB65pxt1/rQJbaf1t/wTr08X6G+uR6Qt7/pcrtHFmGQRSOudyLKV2M4wcqGJGDxXL+LvHv2fW9Bs/D2pLtm1mOyvQLF3WVSTuRJiNm5SpDKu5hn+HFUfD3gRoLy3tdb0TU55rG8e7tdSfWpGtQS7MGEHnnbIAxGBHtznnBqiPDXi+Hw34c0CPQEml8P6xFcfbnvY0guoVLneMZkDHcNwKdemaI7x9V+a/qwPaVuz/J/8A7mP4heG5NPtL5byf7NeXv2CJ2sZxi43bPLcFMod3HzYGasv4y0GPXE0h7/ABdyS+Qp8mTyjLjPlebt8vzMfwbt3tXnt34V8Vrodxo1joayvD4nGrRXM17HHDPCZ/OwMbnBH3SCo9Ru6V0nhTSdU0RZtD1XQRewJqM17a6l5sTQgSSmQFgx8xZF3EDCEcDkZ4FZq/8AWy/zf3BLS9v63/4H3nQJ4v0N9cj0lb3/AEuV2jizDIIpHXO5FlK7GcYOVDEjB4rmNe8eFvGPhrT/AA9qStb3WpNa3imxcrMAjk+XOw2NtZMMEyQSMkYwc7R/h+0c6WGs6Rqc81ndSXNpqp1mVrQEuxVxAZvlkAc8eXtznnmq1r4e8XRaX4L0n/hHo9/hm/QzXb3sSw3ESxOgkTG58ncCQUBz6jJBGztfy/r/AIAS2duzOq8b6/qWg654WNrdxxWF7qP2a8iFt5kkg8t2G05OOUxgKScjBHQ6cHjXQLnSJNSivm8iKf7O6NbyLMJf+efklRJvPZduT2FUvHGkajfzaBqGl2v2xtI1IXktskipJKnluhCFiF3ZcfeIHvXOT+D9bl10+Llsytz/AGvHqH9jiVPMaJLYwbS+7Z5vzFvvbeg3d6S2s+/+X/BB738v8/8AgHUP8RfCcOmrfXOsw20RuhZlbhHilWY/8s2jYB1bnOCBgc9Oau2ni3RL21v54rwomnSeVdCeGSFomIBAKuoJyCMEDDZGM1554k8La/fPqWs2Xh+6a41XU9OnNgtxbh4IrVgzM5MgTc3IAVm6Lk9cO1Pwr4i13W/F0n9j3VjDe3FhdWbyXkcf2j7MRuj3Qyl4y2PlbjHXg8U+n9eX+b+4P6/M9H0XxFpniCOc6XO7tbP5c8M0EkEsTYyA0ciqy5HIyORXKfFDxz/wjvhTVhompLb6xawiQN9ie4SInGFZgNkbMD8u88+hrU8G6BbadPealHomo6Xd3yRrcf2nqbXk8hTOMsZZRtAPGGzzyBiuT8ReGfEzaL420Gx0b+0E1+Z7q0vluYkVC6opjkDMGBXZwQGBGORRpf8Ary/r8Bxet/P8P6/zO4u/GOi6VNb22qXpimkEau4gdo42fG0SSKpSMtngMRntVY/Ebwp500aaukxt7tbOd4YpJEhlYgBXdVKqCTjcSBnjOeK5BvAl1d6pqUXiXQb7UrbWDHOwsddlitrdxEiGOWPzY94BTIdUYkdQMCqGseHvFNzoPjaztvCt60msapBPZ5urUBo0WIFiTNx/qjwefmX3w9L6/wBarT8/uJV7I9Pk8TaVHq0mnNPKZ4WRZWW2kaKNmxtVpQuwMdynaWzgg4xXM6l8TNH03Q7fUtLvLnXIL3VksklgtXlSIl1DqDGnICk7fvFjwCaivtI11fFVtqvhvT9S0ye6uYn1FZLuF7SaJVUN5ke8kS7cqDGMZUZbFYFr4a8Ty+HJkl8O3NvcReLV1hIJLm3LSwGbedpWQqGA6gkexNKO6v5fmv0b89Ab0uv60f6pfed5ZeP/AA/qEWqyW016BpCeZfLLplzE0IxuwVeMEnHOACcc4retLqK+sobq38zypkEieZG0bYIyMqwDKfYgGuE8RaNfnx/pc1lHGsGvW4tNXiD52rCfNVxxzwXjJ4/1i13MdxK99NA1nPHHGqlLlinlyk5yFAYtkd9ygc8Zo6XH1LFFFFIAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh66SgAooooAzfEekf8JB4V1XRvP8As/8AaNlNaeds3+X5iFN23IzjOcZFZv8Awi+r/wDQ9+IP+/Gn/wDyLRRQAf8ACL6v/wBD34g/78af/wDItH/CL6v/AND34g/78af/APItFFAB/wAIvq//AEPfiD/vxp//AMi0f8Ivq/8A0PfiD/vxp/8A8i0UUAVtQ8DXerafNY6l4y1y5tZl2yRSW+nlWH/gLVPSfhnLopzZ+OvFUjAFVe8mtbpkBxkK0sDFRwOBgcUUUAav/CL6v/0PfiD/AL8af/8AItH/AAi+r/8AQ9+IP+/Gn/8AyLRRQAf8Ivq//Q9+IP8Avxp//wAi0f8ACL6v/wBD34g/78af/wDItFFAB/wi+r/9D34g/wC/Gn//ACLR/wAIvq//AEPfiD/vxp//AMi0UUAH/CL6v/0PfiD/AL8af/8AItH/AAi+r/8AQ9+IP+/Gn/8AyLRRQAf8Ivq//Q9+IP8Avxp//wAi0f8ACL6v/wBD34g/78af/wDItFFAB/wi+r/9D34g/wC/Gn//ACLR/wAIvq//AEPfiD/vxp//AMi0UUAH/CL6v/0PfiD/AL8af/8AItH/AAi+r/8AQ9+IP+/Gn/8AyLRRQAf8Ivq//Q9+IP8Avxp//wAi0f8ACL6v/wBD34g/78af/wDItFFAB/wi+r/9D34g/wC/Gn//ACLR/wAIvq//AEPfiD/vxp//AMi0UUAH/CL6v/0PfiD/AL8af/8AItH/AAi+r/8AQ9+IP+/Gn/8AyLRRQAf8Ivq//Q9+IP8Avxp//wAi1Ri8C6pFr93qg8da5vubWC3JFtY78RtKwyfs+0j96cAKCOclsgKUUAXv+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFoooAP+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFoooAP+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFoooAP+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFoooAP+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFoooAP+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFoooAoy+BdUl1+01Q+Otc321rPbgm2sd+JGiY4P2faB+6GQVJPGCuCGvf8Ivq//Q9+IP8Avxp//wAi0UUAH/CL6v8A9D34g/78af8A/ItH/CL6v/0PfiD/AL8af/8AItFFAB/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLRRQAf8Ivq/wD0PfiD/vxp/wD8i0f8Ivq//Q9+IP8Avxp//wAi0UUAH/CL6v8A9D34g/78af8A/ItH/CL6v/0PfiD/AL8af/8AItFFAB/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLRRQAf8Ivq/wD0PfiD/vxp/wD8i0f8Ivq//Q9+IP8Avxp//wAi0UUAH/CL6v8A9D34g/78af8A/ItH/CL6v/0PfiD/AL8af/8AItFFAB/wi+r/APQ9+IP+/Gn/APyLR/wi+r/9D34g/wC/Gn//ACLRRQBQtfh9d2moTX0fjnxM9zMTl5zZy7AcZVA9uRGpwPlXA4HFX/8AhF9X/wCh78Qf9+NP/wDkWiigA/4RfV/+h78Qf9+NP/8AkWj/AIRfV/8Aoe/EH/fjT/8A5FoooAP+EX1f/oe/EH/fjT//AJFo/wCEX1f/AKHvxB/340//AORaKKAD/hF9X/6HvxB/340//wCRaP8AhF9X/wCh78Qf9+NP/wDkWiigA/4RfV/+h78Qf9+NP/8AkWj/AIRfV/8Aoe/EH/fjT/8A5FoooAP+EX1f/oe/EH/fjT//AJFo/wCEX1f/AKHvxB/340//AORaKKAD/hF9X/6HvxB/340//wCRaP8AhF9X/wCh78Qf9+NP/wDkWiigA/4RfV/+h78Qf9+NP/8AkWj/AIRfV/8Aoe/EH/fjT/8A5FoooAP+EX1f/oe/EH/fjT//AJFo/wCEX1f/AKHvxB/340//AORaKKAD/hF9X/6HvxB/340//wCRaP8AhF9X/wCh78Qf9+NP/wDkWiigA/4RfV/+h78Qf9+NP/8AkWj/AIRfV/8Aoe/EH/fjT/8A5FoooAP+EX1f/oe/EH/fjT//AJFo/wCEX1f/AKHvxB/340//AORaKKAD/hF9X/6HvxB/340//wCRaP8AhF9X/wCh78Qf9+NP/wDkWiigA/4RfV/+h78Qf9+NP/8AkWj/AIRfV/8Aoe/EH/fjT/8A5FoooAo634F1TWdA1DS5fHWuFL21kt2EttYsmHUqdwW3ViOeQGU+hHWuyoooAKKKKAP/2Q==" /></p><p><strong>To reports any side effect(s):<br />Saudi Arabia:</strong></p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td><p>-The National Pharmacovigilance Centre (NPC):</p>- Fax: +966-11-205-7662<br />- Call NPC at +966-11-2038222, Ext 2317-2356-2340<br />- SFDA Call Center: 19999<br />- E-mail: npc.drug@sfda.gov.sa<br />- Website: https://ade.sfda.gov.sa/</td></tr></tbody></table><p><strong>Other GCC States:</strong></p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td>- Please contact the relevant competent authority.</td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Signs and symptoms</u><br />Symptoms of a moderate-to-severe increase in metabolism may occur in the event of overdose and intoxication (see section 4.8), including agitation, confusion, irritability, hyperactivity, headache, sweating, mydriasis, tachycardia, arrhythmias, tachypnoea, fever, increased intestinal activity and intestinal spasms. The clinical manifestation of such hyperthyroidism may be delayed for up to five days. Thyrotoxic crisis, leading to irregular heartbeat, heart failure and coma, has occasionally been reported to occur after massive or chronic intoxication.</p><p><u>Treatment</u><br />The therapeutic objective is to restore clinical and biochemical euthyroid status, by interrupting the administration of levothyroxine or reducing the levothyroxine dose and, if necessary, by further measures depending on clinical status.<br />Discontinuation of tablet-taking and a follow-up examination are recommended.<br />In the event of severe beta-sympathomimetic effects (e.g. tachycardia), symptoms can be alleviated by beta-blockers. For neurological/psychological symptoms, benzodiazepines and/or neuroleptics can be used.<br />Antithyroid agents are not appropriate, as the thyroid is already fully quiescent. At extreme doses (suicide attempt), plasmapheresis may be helpful.</p><p>Other appropriate measures must be performed depending on severity or in accordance with national recommendations.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: thyroid hormones (chemically defined), ATC code: H03AA01.</p><p><br />The synthetic levothyroxine contained in Eltroxin is identical in its action to the naturally occurring thyroid hormone mainly produced by the thyroid gland. Following partial conversion to liothyronine (T3) - especially in the liver and kidney - and transfer to body cells, the characteristic thyroid hormone effects on development, growth and metabolism are observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Largely dependent on the type of pharmaceutical formulation, orally administered levothyroxine is absorbed up to a maximum of 80% in the fasting state, mainly from the small intestine. Peak plasma levels are reached approximately six hours post ingestion. The onset of action occurs after 3 to 5 days upon initiation of oral therapy.<br />Distribution<br />The volume of distribution is calculated to be 1/2 L/kg. Levothyroxine is more than 99% bound to plasma proteins.<br />Biotransformation<br />The primary metabolic pathway of thyroxine (T4) is its conversion by deiodination to the active metabolite triiodothyronine (T3). Further deiodination of T4 and T3 leads to the formation of inactive products.<br />Elimination<br />Metabolic clearance is approximately 1.2 L plasma per day, with degradation occurring mainly in the liver, kidney, brain and muscle.<br />Due to the high protein binding, thyroid hormones appear only in small amounts in the haemodialysate.<br />In a typical person, levothyroxine is eliminated with a half-life of seven days. This may turn out to be lower in cases of hyperthyroid status and higher in patients with hypothyroidism.<br />In humans, 20-40% of levothyroxine is excreted in the faeces and 30-55% of a levothyroxine dose in the urine.<br />Bioavailability<br />A bioavailability study, conducted in 2003 on 36 subjects, revealed the following for T4 compared to the reference product:</p><table border="1" align="left" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td>&nbsp;</td><td>Reference product</td><td>Eltroxin</td></tr><tr><td><p>Peak plasma concentration&nbsp;(C<sub>max</sub>)</p></td><td>177.4 (115.6 to 284.3) pmol/L</td><td>166.6 (115.9 to 262.1) pmol/L</td></tr><tr><td><p>Time to peak plasma concentration(t<sub>max</sub>)&nbsp;</p></td><td>2.0 (1.0 to 8.0) h</td><td>2.5 (1.5 to 8.0) h</td></tr><tr><td>Area under the concentration-time curve (AUC)</td><td>6,495 (4,647 to 11,442) pmol x h/L</td><td>6,371 (4,594 to 9,949) pmol x h/L</td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Values expressed as mean and range</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acute toxicity:<br />The acute toxicity of levothyroxine is very low. Doses of up to 10 mg levothyroxine have been tolerated without complications in the event of intoxication (suicide attempts) in humans. Serious complications, such as a threat to vital functions (respiration and circulation), are not to be expected unless coronary heart disease is present (see also section 4.9).</p><p><br />Chronic toxicity:<br />Chronic toxicity studies have been performed on various animal species (rat, dog). At high doses, signs of hepatopathy, increased occurrence of spontaneous nephrosis and abnormal organ weights were seen in rats. No significant adverse reactions were observed in dogs. Several cases of sudden cardiac death have been described in patients with long-term levothyroxine abuse.</p><p><br />Mutagenicity:<br />There are no available data on the mutagenic potential of levothyroxine. To date, there has been no suspicion or evidence of any damage to offspring due to changes in the genome caused by thyroid hormones.</p><p><br />Carcinogenicity:<br />No long-term animal studies have been performed to investigate any tumorigenic potential of levothyroxine.</p><p><br />Toxicity to reproduction:<br />Only a very small proportion of thyroid hormones cross the placenta. Following injection of small doses (up to 24 micrograms) of levothyroxine into chick embryos, the incidence of strophosomy was increased. In humans, there is considerable experience with levothyroxine therapy in all phases of pregnancy. There is no evidence of any toxic effect on the foetus or induction of malformations.</p><p><br />There are no available data with regard to harmful effects on male or female fertility. Nor is there any suspicion or evidence of such effects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline cellulose, pregelatinised starch (maize starch 1500), magnesium stearate (Ph.Eur.), talc, colloidal anhydrous silica.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The shelf life is 2 years.

This medicinal product must not be used after the expiry date.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 25&deg;C.</p><p>Keep tablets in the tightly sealed multidose container in order to protect from light and moisture.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Eltroxin 50<br />Packs with 100 tablets [N3]</p><p><br />Eltroxin 100<br />Packs with 100 tablets [N3]</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aspen Pharma Trading Limited
3016 Lake Drive
Citywest Business Campus
Dublin 24, Ireland
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                September 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>